
<html lang="en"     class="pb-page"  data-request-id="b7b61963-984a-4433-8d57-6ac4e6c6011c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2018.61.issue-20;requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.8b00159;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Inhibitors of Mutant Isocitrate Dehydrogenases 1 and 2 (mIDH1/2): An Update and Perspective" /></meta><meta name="dc.Creator" content="Tianfang  Ma" /></meta><meta name="dc.Creator" content="Fangxia  Zou" /></meta><meta name="dc.Creator" content="Stefan  Pusch" /></meta><meta name="dc.Creator" content="Yungen  Xu" /></meta><meta name="dc.Creator" content="Andreas  von Deimling" /></meta><meta name="dc.Creator" content="Xiaoming  Zha" /></meta><meta name="dc.Description" content="Isocitrate dehydrogenases 1 and 2 (IDH1/2) are homodimeric enzymes that catalyze the conversion of isocitrate to α-ketoglutarate (α-KG) in the tricarboxylic acid cycle. However, mutant IDH1/2 (mIDH..." /></meta><meta name="Description" content="Isocitrate dehydrogenases 1 and 2 (IDH1/2) are homodimeric enzymes that catalyze the conversion of isocitrate to α-ketoglutarate (α-KG) in the tricarboxylic acid cycle. However, mutant IDH1/2 (mIDH..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 31, 2018" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00159" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00159" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00159" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00159" /></link>
        
    
    

<title>Inhibitors of Mutant Isocitrate Dehydrogenases 1 and 2 (mIDH1/2): An Update and Perspective | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00159" /></meta><meta property="og:title" content="Inhibitors of Mutant Isocitrate Dehydrogenases 1 and 2 (mIDH1/2): An Update and Perspective" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0035.jpeg" /></meta><meta property="og:description" content="Isocitrate dehydrogenases 1 and 2 (IDH1/2) are homodimeric enzymes that catalyze the conversion of isocitrate to α-ketoglutarate (α-KG) in the tricarboxylic acid cycle. However, mutant IDH1/2 (mIDH1/2) reduces α-KG to the oncometabolite 2-hydroxyglutarate (2-HG). High levels of 2-HG competitively inhibit the α-KG-dependent dioxygenases involved in histone and DNA demethylation, thereby impairing normal cellular differentiation and promoting tumor development. Thus, small molecules that inhibit these mutant enzymes may be therapeutically beneficial. Recently, an increasing number of mIDH1/2 inhibitors have been reported. In this review, we summarize the molecular basis of mIDH1/2 and the activity, binding modes, and progress in clinical application of mIDH1/2 inhibitors. We note important future research directions for mIDH1/2 inhibitors and discuss potential therapeutic strategies for the development of mIDH1/2 inhibitors to treat IDH1/2 mutated tumors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00159"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00159">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00159&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00159&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00159&amp;href=/doi/10.1021/acs.jmedchem.8b00159" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 8981-9003</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01202" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.8b00378" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Inhibitors of Mutant Isocitrate Dehydrogenases 1 and 2 (mIDH1/2): An Update and Perspective</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Tianfang Ma</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tianfang Ma</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Engineering and Department of Biochemical Engineering, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, P. R. China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tianfang++Ma">Tianfang Ma</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Fangxia Zou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fangxia Zou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Engineering and Department of Biochemical Engineering, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, P. R. China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fangxia++Zou">Fangxia Zou</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stefan Pusch</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stefan Pusch</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">German Consortium of Translational Cancer Research (DKTK), Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), INF 280, Heidelberg D-69120, Germany</div><div class="loa-info-affiliations-info">Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-Universität Heidelberg, INF 224, Heidelberg D-69120, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stefan++Pusch">Stefan Pusch</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yungen Xu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yungen Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yungen++Xu">Yungen Xu</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andreas von Deimling</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andreas von Deimling</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">German Consortium of Translational Cancer Research (DKTK), Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), INF 280, Heidelberg D-69120, Germany</div><div class="loa-info-affiliations-info">Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-Universität Heidelberg, INF 224, Heidelberg D-69120, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andreas++von+Deimling">Andreas von Deimling</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Xiaoming Zha</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiaoming Zha</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Engineering and Department of Biochemical Engineering, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, P. R. China</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +86-25-83271057. Fax: +86-25-83271142. E-mail: <a href="/cdn-cgi/l/email-protection#9ce4f1e6f4fddcffece9b2f9f8e9b2fff2"><span class="__cf_email__" data-cfemail="fb839681939abb988b8ed59e9f8ed59895">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoming++Zha">Xiaoming Zha</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath6">View Biography</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00159&amp;href=/doi/10.1021%2Facs.jmedchem.8b00159" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 8981–9003</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 31, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 January 2018</li><li><span class="item_label"><b>Published</b> online</span>31 May 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 October 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00159" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00159</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8981%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DTianfang%2BMa%252C%2BFangxia%2BZou%252C%2BStefan%2BPusch%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D20%26contentID%3Dacs.jmedchem.8b00159%26title%3DInhibitors%2Bof%2BMutant%2BIsocitrate%2BDehydrogenases%2B1%2Band%2B2%2B%2528mIDH1%252F2%2529%253A%2BAn%2BUpdate%2Band%2BPerspective%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9003%26publicationDate%3DOctober%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00159"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2549</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00159" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Inhibitors of Mutant Isocitrate Dehydrogenases 1 and 2 (mIDH1/2): An Update and Perspective&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Tianfang&quot;,&quot;last_name&quot;:&quot;Ma&quot;},{&quot;first_name&quot;:&quot;Fangxia&quot;,&quot;last_name&quot;:&quot;Zou&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;Pusch&quot;},{&quot;first_name&quot;:&quot;Yungen&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Andreas&quot;,&quot;last_name&quot;:&quot;von Deimling&quot;},{&quot;first_name&quot;:&quot;Xiaoming&quot;,&quot;last_name&quot;:&quot;Zha&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;31&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;8981-9003&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00159&quot;},&quot;abstract&quot;:&quot;Isocitrate dehydrogenases 1 and 2 (IDH1/2) are homodimeric enzymes that catalyze the conversion of isocitrate to α-ketoglutarate (α-KG) in the tricarboxylic acid cycle. However, mutant IDH1/2 (mIDH1/2) reduces α-KG to the oncometabolite 2-hydroxyglutarate (2-HG). High levels of 2-HG competitively inhibit the α-KG-dependent dioxygenases involved in histone and DNA demethylation, thereby impairing normal cellular differentiation and promoting tumor development. Thus, small molecules that inhibit these mutant enzymes may be therapeutically beneficial. Recently, an increasing number of mIDH1/2 inhibitors have been reported. In this review, we summarize the molecular basis of mIDH1/2 and the activity, binding modes, and progress in clinical application of mIDH1/2 inhibitors. We note important future research directions for mIDH1/2 inhibitors and discuss potential therapeutic strategies for the development of mIDH1/2 inhibitors to treat IDH1/2 mutated tumors.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00159&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00159" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00159&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00159" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00159&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00159" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00159&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00159&amp;href=/doi/10.1021/acs.jmedchem.8b00159" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00159" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00159" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00159%26sid%3Dliteratum%253Aachs%26pmid%3D29847930%26genre%3Darticle%26aulast%3DMa%26date%3D2018%26atitle%3DInhibitors%2Bof%2BMutant%2BIsocitrate%2BDehydrogenases%2B1%2Band%2B2%2B%2528mIDH1%252F2%2529%253A%2BAn%2BUpdate%2Band%2BPerspective%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D20%26spage%3D8981%26epage%3D9003%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291445" title="Chemical structure">Chemical structure</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/jmcmar.2018.61.issue-20/20181025/jmcmar.2018.61.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0035.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Isocitrate dehydrogenases 1 and 2 (IDH1/2) are homodimeric enzymes that catalyze the conversion of isocitrate to α-ketoglutarate (α-KG) in the tricarboxylic acid cycle. However, mutant IDH1/2 (mIDH1/2) reduces α-KG to the oncometabolite 2-hydroxyglutarate (2-HG). High levels of 2-HG competitively inhibit the α-KG-dependent dioxygenases involved in histone and DNA demethylation, thereby impairing normal cellular differentiation and promoting tumor development. Thus, small molecules that inhibit these mutant enzymes may be therapeutically beneficial. Recently, an increasing number of mIDH1/2 inhibitors have been reported. In this review, we summarize the molecular basis of mIDH1/2 and the activity, binding modes, and progress in clinical application of mIDH1/2 inhibitors. We note important future research directions for mIDH1/2 inhibitors and discuss potential therapeutic strategies for the development of mIDH1/2 inhibitors to treat IDH1/2 mutated tumors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47203" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47203" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Isocitrate dehydrogenases (IDHs), which include three subtypes (IDH1, IDH2, and IDH3), catalyze the oxidative decarboxylation of isocitrate to α-ketoglutarate (α-KG) and are involved in multiple metabolic processes.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> IDH2 and IDH3 are both located in the mitochondria, whereas IDH1 is located in the cytosol and peroxisomes.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Somatic mutations in IDH1/2 have been found in several human cancers including glioma, acute myeloid leukemia (AML), intrahepatic cholangiocarcinoma, and chondrosarcoma.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The mutant IDHs lose their normal enzymatic activities and instead gain a neomorphic activity and produce the “oncometabolite” 2-hydroxyglutarate (2-HG).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> High levels of 2-HG competitively inhibit the α-KG-dependent dioxygenases involved in histone and DNA demethylation, thereby impairing normal cellular differentiation and promoting tumor development (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> To date, several inhibitors of mutant IDH1/2 (mIDH1/2) have entered clinical trials, and the mIDH2 inhibitor AG-221 (also known as enasidenib; see <a class="ref internalNav" href="#sec3_2_1" aria-label="section 3.2.1">section 3.2.1</a> for its details) has been launched for the treatment of AML. These molecules have shown encouraging results in patients with IDH-mutant hematologic and solid tumors.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Functions of normal and mutated IDH.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Unlike other reviews, this article focuses on the molecular basis of mIDH1/2 and the clinical progress of reported mIDH1/2 inhibitors.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Furthermore, future research directions involving mIDH1/2 inhibitors are also discussed to provide a reference for potential therapeutic strategies for the treatment of IDH-mutant tumors.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Mutant IDH1/2 in Tumorigenesis</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76707" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76707" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Mutations in IDH1/2 predominantly consist of a change in a single residue in the active site. The most common mutations are to arginine at position 132 in IDH1 and at position 140 or 172 in IDH2.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Other missense mutations lead to a wide range of substitutions, including polar (C, T, Q, H, K, S) and some nonpolar (M, V, W) amino acids, in which R132H accounts for more than 93% of IDH1 variants while the R140Q mutant is predominant in AML.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> Studies have demonstrated that more than 70% of low-grade gliomas and up to 20% of secondary glioblastoma multiforms are related to IDH1 mutations.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> Moreover, IDH1 mutations also occur in about 10% of AML cases, 10% of cholangiocarcinomas and other indications.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11−13)</a> However, mutant IDH2 is only found in about 4% of gliomas and 10% of AMLs.<a onclick="showRef(event, 'ref6 ref12'); return false;" href="javascript:void(0);" class="ref ref6 ref12">(6,12)</a> Therefore, the location of the mutation can be concluded to be more significant than the new type of residue.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> An early report found that the loss of normal IDH function is caused by point mutations in the IDH1/2 genes and induces the HIF-1α pathway to promote tumorigenesis.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> This report demonstrated that IDH2 mutations mainly affect codons R140 and R172 and result in high levels of D-2-HG, a tractable metabolic biomarker of tumorigenicity.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> Under homeostasis, 2-HG is normally produced in low amounts by errors in catalysis (<10 μM) and is cleared rapidly from the blood by specific chiral L-2-HG/D-2-HG dehydrogenases.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> However, the production of 2-HG by IDH1/2 mutants overwhelms the normal clearance mechanism and results in massive accumulation in the blood.<a onclick="showRef(event, 'ref2 ref16'); return false;" href="javascript:void(0);" class="ref ref2 ref16">(2,16)</a> Therefore, mutant IDH1/2 proteins functionally converge on a common neomorphic product, suggesting that 2-HG functions as an “oncometabolite” to promote tumorigenesis.<a onclick="showRef(event, 'ref2 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref2 ref16 ref17">(2,16,17)</a> Consistent with 2-HG promoting the dysregulation of chromatin structure, gliomas harboring IDH mutations exhibit a glioma-CpG island methylator phenotype (G-CIMP).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Recent studies have indicated that the overexpression of mutant IDH1/2 can block cell differentiation and induce DNA/histone hypermethylation, which can be reversed by specific mIDH1/2 inhibitors.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Taken together, these findings support the contention that oncogenic mIDH1/2 is responsible for the initiation of cancers and is an attractive drug target in cancer treatment.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.1.  Glioma</h3><div class="NLM_p last">IDH mutations have been clearly shown to define certain brain tumor entities such as diffuse astrocytoma and oligodendroglioma,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and the WHO 2016 classification of brain tumors has been updated accordingly.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The close relationship of glioblastoma with IDH mutations (formerly secondary glioblastoma; this term has been abandoned by WHO) to astrocytoma is now also much clearer.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> IDH-mutant diffuse astrocytoma WHO grade II, IDH-mutant anaplastic astrocytoma WHO grade III, and IDH-mutant glioblastoma should be considered different stages of the same disease.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The other major brain tumor entity with IDH mutations is oligodendroglioma.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In addition to IDH mutations, these tumors always carry a 1p/19q co-deletion.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Whether IDH is a prognostic factor in astrocytomas and oligodendrogliomas has lost its relevance due to the altered brain tumor definitions in WHO 2016.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> IDH mutations are observed frequently in several subtypes of glioblastomas, including the diffuse astrocytomas, oligodendrogliomas, oligoastrocytomas, and secondary glioblastomas.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2.2.  AML</h3><div class="NLM_p last">In contrast to glioma, the IDH mutations do not define isoforms of AML, but the clonal origin of these mutations in therapy-related AML was explored.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The mutations of several genes including IDH1, DNMT3A, TET2, and NPM1 in M1 genomes samples are demonstrated as having essential roles in chromatin modification. It provides proof that they more likely initiate tumorigenesis as is proposed for glioma.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> To further explore the biological consequences of IDH mutations in AML, transgenic mouse models expressing either mutant IDH2 (R172K, R140Q) or mutant IDH1 (R132H) in specific hematopoietic tissue have been generated.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> The expression of these mutations sufficiently initiated hematologic malignancy with increased numbers of early hematopoietic progenitors, leading to splenomegaly, anemia, and histone and DNA hypermethylation.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> In addition, the relatively long latency period of tumors in these models is related to a secondary mutation that leads to tumor onset and tumor progression.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> The level of 2-HG was elevated in the studied patients with IDH mutations, and 2-HG levels in serum or urine and the mutant IDH1/2 allelic burden in marrow decreased rapidly in response to treatment but rose again after the therapy was terminated.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Serum and urine 2-HG may serve as easily measured, noninvasive biomarkers of disease and can be followed during treatment in patients with elevated baseline levels.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> These observations suggested that 2-HG was a discriminatory marker. Early myelodysplastic syndrome (MDS)/myeloproliferative disease (MPD) is also accompanied by IDH1/2 mutations, which are linked with leukemia transformation.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> These findings suggest that IDH1/2 mutations play an essential role in the early malignant transformation process, although additional mutations might be required to promote tumorigenesis in AML.<a onclick="showRef(event, 'ref2 ref31'); return false;" href="javascript:void(0);" class="ref ref2 ref31">(2,31)</a></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">2.3.  Other Solid Tumors</h3><div class="NLM_p last">The prognostic role of the epigenetic expression of mIDH1/2 has also been investigated in several solid tumors.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> It has been shown that mutant IDH blocks liver progenitor cells from undergoing hepatocyte differentiation through the production of 2-HG and suppression of HNF-4α in intrahepatic cholangiocarcinoma.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Other studies have suggested that enchondromas belong to benign cartilage tumors and precursors of malignant chondrosarcomas.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The mutant IDH1/2 in growth-plate cells gives rise to benign precursor lesions, and additional mutations lead to malignant progression.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> In addition, a broad range of IDH1 mutations in enchondromas and chondrosarcomas were identified, including the IDH1-R132Q mutation which also exhibits the ability to convert α-KG to 2-HG.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> Frequent mutations in IDH1/2 have been identified in 50–70% of malignant chondrosarcomas tumors, including Ollier disease and Maffucci syndrome.<a onclick="showRef(event, 'ref7 ref35'); return false;" href="javascript:void(0);" class="ref ref7 ref35">(7,35)</a> It has been reported that 81% of patients with Ollier disease and 77% with Maffucci syndrome harbor somatic mosaic IDH1/2 mutations (predominantly mIDH1), which were linked with a hypermethylation phenotype.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">3.  mIDH1/2 Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54214" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54214" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Recently, mIDH1/2 have emerged as promising therapeutic targets, and a variety of mIDH1/2 inhibitors have been developed. As summarized in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00159/suppl_file/jm8b00159_si_001.pdf" class="ext-link">Table 1S (in the Supporting Information)</a>, some mIDH1/2 inhibitors have entered clinical trials.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">3.1.  mIDH1 Inhibitors</h3><div id="sec3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9">3.1.1.  Agios Pharmaceuticals Compounds</h4><div class="NLM_p">Agios Pharmaceuticals reported AGI-5198 (<b>1</b>, also known as IDH-C35), identified by high-throughput screen (HTS) for IDH1 R132H mutant homodimers, as a compound that can delay the growth and promote the differentiation of glioma cells and that exhibits selective and potent inhibition of IDH1 R132H and IDH1 R132C with IC<sub>50</sub> values of 70 nM and 160 nM, respectively.<a onclick="showRef(event, 'ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref40">(38−40)</a> The treatment of IDH1 mutant chondrosarcoma cell lines with <b>1</b> decreased the production of D-2-HG, inhibited the colony formation and the migration distance of chondrosarcoma cell lines, and enhanced both cell cycle arrest and apoptosis.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a> In 2017, a metabolic study indicated that <b>1</b> reduced phospholipid levels in and decreased the proliferative potential of cells carrying IDH1 mutations.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The study also found that DNA methyltransferases would promote DNA methylation by producing a hypermethylated phenotype after treatment with <b>1</b>, which suggested that combining <b>1</b> with a DNA methyltransferases inhibitor might lead to better curative effects in patients with IDH1-mutated gliomas.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> An Agios patent also disclosed analogs of <b>1</b> and claimed them to be therapeutically effective against cancers with IDH1 mutations (IC<sub>50</sub> ≤ 100 nM).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> These analogs suppressed 2-HG levels in the HT-1080 cell line (a cell line with an endogenous IDH1 R132C mutation) and the U87-MG cell line (a cell line with ectopic expression of mIDH1/2) with IC<sub>50</sub> values of less than 0.25 μM.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The structures of <b>1</b> and the two analogs <b>2</b> and <b>3</b> are shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures of compounds <b>1</b>–<b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">AG-120 (<b>4</b>, also known as ivosidenib), an analog of <b>1</b>, is a first-in-class oral, reversible, and selective inhibitor of various IDH1 mutants.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44,45)</a> Owing to its promise as a drug for IDH1-mutated diseases, it has entered into multiple clinical trials (NCT03343197, NCT03282513, NCT03071770, NCT02632708, NCT02677922). The phase I studies in patients with IDH1-mutated hematologic malignancies or IDH1-mutated cholangiocarcinoma showed that <b>4</b> was well tolerated at doses ranging from 100 mg to 1200 mg and exhibited a favorable safety profile (NCT02073994, NCT02989857, NCT02074839).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Overall, the major adverse events of <b>4</b> in the treatment of acute myelogenous leukemia, solid tumors, and other hematologic cancers were reported to be fatigue (22%), diarrhea (23%), nausea (18%), vomiting (17%), febrile neutropenia (16.7%), and pneumonia (12.8%) (NCT02073994, NCT02074839).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> A phase III clinical trial is currently in progress to study the therapeutic effects in untreated IDH1-mutated AML patients by combining <b>4</b> with azacitidine (NCT03173248). Agios has submitted an NDA to the FDA for the use of <b>4</b> to treat relapsed or refractory AML with IDH1 mutations. In addition, an Agios patent (WO 2013107291) identified <b>4</b> as a lead compound for designing mIDH1 inhibitors, and two other patents were disclosed to examine their pharmaceutical compositions.<a onclick="showRef(event, 'ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref48 ref49 ref50">(48−50)</a><a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> shows five representative compounds (<b>5</b>–<b>9</b>) that inhibit D-2-HG production with IC<sub>50</sub> values less than 100 nM.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Chemical structures of compounds <b>4</b>–<b>9</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">AGI-14100 (<b>10</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) is a novel orally available mIDH1 inhibitor. In human cell lines transfected with IDH1 R132H, <b>10</b> inhibited cell proliferation with IC<sub>50</sub> values of 0.76 nM (HT-1080), 0.74 nM (U87-MG), and 1.75 nM (TF1).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> In addition, <b>10</b> can specifically induce cellular differentiation in AML patient samples with mutant IDH1 ex vivo.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> One month of continuous treatment in a xenograft model with a primary human IDH1 R132H/FLT3-ITD tumor achieved a significant reduction in the leukemic blast burden in the peripheral blood.<a onclick="showRef(event, 'ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref53 ref54">(53,54)</a> Preclinical trials of <b>10</b> for the treatment of primary human myeloid leukemia therapy have been underway since 2013.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Chemical structure of compound <b>10</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As an analog of AGI-5198, (±) ML-309 (<b>11</b>) is capable of potent and selective inhibition of IDH1 R132H and effectively decreases 2-HG levels in a U87-MG glioblastoma cell line ectopically expressing IDH1 R132H (IC<sub>50</sub> = 250 nM).<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> The stereochemistry of the phenylglycine group significantly affects the inhibitory potency. For example, the (+) isomer <b>11</b> (IC<sub>50</sub> = 68 nM) demonstrates potent inhibition of IDH1 R132H, while the (−) isomer exhibits weak inhibition (IC<sub>50</sub> = 29 μM).<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Mouse xenograft models showed that <b>11</b> has a half-life greater than 3 h and is stable in vivo.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56,57)</a> The synthesis procedures for <b>11</b> and its analogs have been disclosed in two patent applications by the Janeta group.<a onclick="showRef(event, 'ref43 ref58'); return false;" href="javascript:void(0);" class="ref ref43 ref58">(43,58)</a> One patent application (WO 2013107405) emphasizes that two analogs of <b>11</b> (<b>12</b> and <b>13</b>) are also therapeutically effective against two mutant forms (R132H and R132C) of IDH1 with IC<sub>50</sub> values equal to or less than 100 nM, respectively (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Chemical structures of compounds <b>11</b>–<b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10">3.1.2.  GlaxoSmithKline (GSK) Compounds</h4><div class="NLM_p">GSK321 (<b>14</b>, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) belongs to the class of tetrahydropyrazolopyridines, which were identified by a high-throughput biochemical screen using an IDH1 heterodimer mutant, and exhibits highly potent and selective inhibition of IDH1 mutants.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> It specifically binds to the Seg-2 allosteric pocket (see the <a class="ref internalNav" href="#sec4_1_3" aria-label="section 4.1.3">section 4.1.3</a> for its details) and prevents mIDH1 turnover by locking the protein into the catalytically inactive “open” state.<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59,60)</a> Treatment with <b>14</b> reduces H3K9me2 levels and inhibits cell growth and differentiation in HT-1080 cell lines overexpressing IDH1 R132C (EC<sub>50</sub> = 85 nM).<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> In addition, an efficient dosage of <b>14</b> abrogates the myeloid differentiation block in IDH1 mutant primary AML cells and induces granulocytic differentiation at the level of leukemic blasts and stem-like cells both ex vivo and in vivo.<a onclick="showRef(event, 'ref19 ref61'); return false;" href="javascript:void(0);" class="ref ref19 ref61">(19,61)</a> GSK864 (<b>15</b>, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) is an analog of <b>14</b> with IC<sub>50</sub> values for IDH1 R132C, R132H, and R132G in vitro of 9 nM, 15 nM and 17 nM, respectively.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Preclinical studies indicate that treatment with <b>15</b> decreased D-2-HG levels in HT-1080 cells harboring hypersuccinylated IDH1 R132C.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Chemical structures of compounds <b>14</b> and <b>15</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11">3.1.3.  Baylor College of Medicine (BCM) Compounds</h4><div class="NLM_p">SYC-435 (<b>16</b>, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>), discovered by Baylor College of Medicine (BCM), belongs to the class of 1-hydroxypyridine-2-ones.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> It binds at the isocitrate pocket of mutated IDH1 with <i>K</i><sub><i>i</i></sub> values of 190 nM against IDH1 R132H and 120 nM against IDH1 R132C.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> It is cell active and capable of significantly reducing D-2-HG production in an HT1080 fibrosarcoma cell line expressing IDH1 R132C (IC<sub>50</sub> = 2.4 μM).<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Its 4-methyl-1-hydroxypyridin-2-one ring is located in a pocket surrounded by Arg100, Ser94, Thr77, Asn96, Arg109, and NADPH. The two O atoms of the 1-hydroxypyridin-2-one core form two H-bonds with the two N atoms of the guanidinium group of Arg100. The planar −CONH<sub>2</sub> of Asn96 is located right underneath the pyridine ring of <b>16</b>, with the distance of ∼4.1 Å.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> The X-ray crystal of <b>16</b> and IDH1 R132H in complex with NAPDH (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I3L">4I3L</a>) was depicted in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>. Its derivatives <b>17</b> and <b>18</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>), which express similar bioactivity, have also attracted scientific interest.<a onclick="showRef(event, 'ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref63 ref64">(63,64)</a> In particular, <b>18</b> possesses favorable cell permeability and inhibitory activity, facilitating research on the role of mIDH1 in a variety of biological systems.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Chemical structures of compounds <b>16</b>–<b>18</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. X-ray crystal structure of IDH1 R132H and <b>16</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I3L">4I3L</a>). The yellow dotted lines represent hydrogen bonds interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12">3.1.4.  Bayer Compounds</h4><div class="NLM_p">BAY-1436032 (<b>19</b>), a benzimidazol-2-amine compound, was screened and optimized using a homodimeric mutant enzyme in a biochemical assay and is the first potent and highly specific pan-inhibitor of IDH1 toward different codon 132 mutations.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> It strongly reduces D-2-HG levels in different tumor cells harboring IDH1 R132H, IDH1 R132C, IDH1 R132G, IDH1 R132S, and IDH1 R132L mutations.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Furthermore, it exhibits a favorable selectivity profile against wild-type (WT) IDHs and a large panel of off-target proteins in vitro.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> In two independent experiments, <b>19</b> significantly prolonged the survival of mice transplanted with IDH1 mutant astrocytomas.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> An open-label, phase I trial of <b>19</b> (NCT02746081) is underway to determine its safety, tolerability, maximum tolerated dose (MTD), or recommended phase II dose (RP2D) in patients with IDH1-R132X mutant solid tumors, and the selected starting dose of <b>19</b> has been determined to be 300 mg/day (150 mg b.i.d.).<a onclick="showRef(event, 'ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref66 ref67">(66,67)</a> Another phase I trial, started in April 2017 and expected to be completed by September 2019, is characterizing the safety, tolerability, pharmacodynamics, and preliminary clinical efficacy of <b>19</b> in patients with metastatic cancer and AML (NCT03127735). In 2015, Bayer released analogs with therapeutic potential in controlling the proliferation, growth, and survival of cancer cells associated with mIDH1.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> The evaluated compounds with IC<sub>50</sub> values of less than 10 nM against IDH1 R132H are presented in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a> (<b>19</b>–<b>22</b>).<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Bayer has reported an adduct (<b>23</b>) consisting of fumaric acid and <b>19</b> (1:4) that displayed higher improved bioavailability than <b>19</b> in Wistar rats.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Chemical structures of compounds <b>19</b>–<b>23</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13">3.1.5.  Sanofi Compounds</h4><div class="NLM_p">VVS (<b>24</b>, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>), discovered by screening with a homodimeric IDH1 R132H, shows nanomolar inhibition of both IDH1 R132H and IDH1 R132C by a mechanism that is noncompetitive inhibition with NADPH.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Compound <b>24</b> efficiently suppresses the cell-based production of D-2-HG in an HEK293 mutant embryonic kidney cell line (IC<sub>50</sub> = 81.5 nM).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> In addition, <b>24</b> can bind in the divalent magnesium pocket of mIDH1 if the conserved catalytic residues are displaced from their catalytically competent conformation.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Chemical structures of compounds <b>24</b>–<b>26</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14">3.1.6.  Broad Institute Compounds</h4><div class="NLM_p last">BRD-2879 (<b>25</b>, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>), an eight-membered ring sulfonamide, shows potent inhibition of IDH1 R132H (IC<sub>50</sub> = 50 nM) in a fashion that is particularly dependent upon chilarity.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Its inhibitory activities are particularly dependent upon its chirality.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> In a steady-state kinetic study, this compound displayed competitive patterns with both the α-KG substrate and the Mg<sup>2+</sup> cofactor.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Consequently, <b>25</b> represents a new class of mIDH1 inhibitors that deserve further structural optimization.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></div></div><div id="sec3_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15">3.1.7.  Cancer Research UK Manchester Institute (CRUK-MI) Compounds</h4><div class="NLM_p last">As part of AstraZeneca (AZ)’s Open Innovation initiative, the Cancer Research UK Manchester Institute (CRUK-MI) and AZ entered into a collaboration to conduct a high-throughput screen (HTS) of AZ’s approximately 1.35 million compounds against IDH1 R132H.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Importantly, the bound ligand cocrystal structure elucidated a novel binding mode in an allosteric site of IDH1 R132H and led to the identification of a series of nicotinic amide-derived carboxylic acid-based inhibitors.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> The most encouraging compound, <b>26</b> (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>), with IC<sub>50</sub> values of 0.27 μM, 0.47 μM, >50 μM, and >50 μM against IDH1 R132H, IDH1 R132C, WT-IDH1, and WT-IDH2, respectively, was found to induce myeloid differentiation in primary human IDH1 R132H AML cells in vitro.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a></div></div><div id="sec3_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16">3.1.8.  Novartis Compounds</h4><div id="sec3_1_8_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i17" class="anchor-spacer"></div><h5 class="article-section__title" id="_i17"> 3-Pyrimidin-4-yl-oxazolidin-2-one Scaffold</h5><div class="NLM_p">In 2014, Novartis reported a series of novel mIDH1 inhibitors with a 3-pyrimidin-4-yl-oxazolidin-2-one scaffold as potential antitumor agents by high throughput screening targeting IDH1 R132H homodimer protein in a NADPH fluorescence-based biochemical assay (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>).<a onclick="showRef(event, 'ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref73 ref74">(73,74)</a> IDH 125 (<b>27</b>), with IC<sub>50</sub> values of 220 nM against IDH1 R132H and 150 nM against IDH1 R132C, was identified as a lead compound for the development of novel mIDH1 inhibitors such as IDH 662 (<b>28</b>) (IC<sub>50</sub> = 38 nM) and IDH 889 (<b>29</b>) (IC<sub>50</sub> = 20 nM).<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> While <b>28</b> showed relatively strong cytotoxicity toward WT-IDH1 (IC<sub>50</sub> = 1.03 μM), <b>29</b> exhibited excellent selectivity over WT-IDH1.<a onclick="showRef(event, 'ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref74 ref75">(74,75)</a> Moreover, <b>29</b> also exhibited better brain permeability and deserves further optimization for the treatment of patients with IDH1-mutated brain tumors.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Currently, <b>29</b> is in the preclinical stage of development as a potential drug for the treatment of cancers with IDH1 mutations. Two other analogs, <b>30</b> and <b>31</b>, showed potent inhibitory effects of the IDH1 R132H homodimer in fluorescence-based biochemical assays (IC<sub>50</sub> < 100 nM).<a onclick="showRef(event, 'ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref73 ref74">(73,74)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Chemical structures of compounds <b>27</b>–<b>31</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">IDH 305 (<b>32</b>, <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>), obtained by the optimization of <b>29</b> for potency and pharmacokinetic (PK) properties, is a highly potent allosteric inhibitor that selectively inhibits mutant IDH1 and induces cell differentiation in vivo and ex vivo.<a onclick="showRef(event, 'ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref76 ref77">(76,77)</a> It showed strong inhibitory potency toward IDH1 R132H (IC<sub>50</sub> = 0.018 μM) and exhibited better brain penetration than <b>29</b>.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> A nonrandomized, open-label phase II clinical trial of <b>32</b> was recently begun in patients with IDH1-mutated low-grade gliomas or grade II or III gliomas for the treatment of solid tumors, myeloid leukemia, and neurological cancer (NCT02987010 and NCT02977689).<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> The preliminary results demonstrated an objective response rate ranging from 31% to 40% with durable responses (>1 year) observed.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Chemical structure of compound <b>32</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As shown in the crystal complex of IDH1 R132H (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5SUN">5SUN</a>), IDH 146 (<b>33</b>, <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>) binds in an allosteric pocket of mIDH1, which accounts for its inhibitory activities against IDH1 R132H (IC<sub>50</sub> = 590 nM) and IDH1 R132C (IC<sub>50</sub> = 50 nM).<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Chemical structure of compound <b>33</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_8_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i18" class="anchor-spacer"></div><h5 class="article-section__title" id="_i18"> 1-(2-(Ethylamino)pyrimidin-4-yl)pyrrolidin-2-one Scaffold</h5><div class="NLM_p">A series of 1-(2-(ethylamino)pyrimidin-4-yl)pyrrolidin-2-one-based mIDH1 inhibitors was patented by Novartis scientists in 2014 for the treatment of diseases associated with IDH1 mutations.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> More than 100 compounds were reported, and most of them exhibited potential IDH1 R132H and IDH1 R132C inhibition, as determined by enzyme-linked fluorescence assay.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> The structures of compounds <b>34</b>–<b>38</b>, which have highly potent inhibitory activities (IC<sub>50</sub> < 100 nM), are listed in <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>.</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Chemical structures of compounds <b>34</b>–<b>38</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19">3.1.9.  Forma Therapeutics Compounds</h4><div class="NLM_p">Forma Therapeutics scientists reported three patent applications claiming quinolone-based mIDH1 inhibitors in 2016.<a onclick="showRef(event, 'ref80 ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref80 ref81 ref82">(80−82)</a> Compounds <b>39</b>–<b>47</b> (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>) are selected candidates reported in the three patent applications that are claimed to show strong inhibitory activities (IC<sub>50</sub> < 10 nM) against IDH1 R132H and IDH1 R132C in enzyme-linked fluorescence assays.<a onclick="showRef(event, 'ref80 ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref80 ref81 ref82">(80−82)</a> The cellular activities of these compounds were also tested via the detection of D-2-HG levels in human HCT-116 cells overexpressing mIDH1.<a onclick="showRef(event, 'ref80 ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref80 ref81 ref82">(80−82)</a> Currently, Forma is developing FT-2102 (structure not yet disclosed) as an oral formulation for the treatment of AML and myelodysplastic syndrome in an open-label, multicenter phase I trial (NCT02719574) aiming to evaluate its safety, PK, and pharmacodynamic (PD) profiles alone or in combination with azacitidine. Approximately 48 patients will be enrolled in the dose-escalation portion of this study in one or more schedules, followed by approximately 14 patients in the expansion cohorts.</div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Chemical structures of compounds <b>39</b>–<b>47</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20">3.1.10.  Daiichi Sankyo Compounds</h4><div class="NLM_p last">DS-1001 (also known as DS-1001b, structure not determined) is a potent oral mIDH1 inhibitor discovered by Daiichi Sankyo. DS-1001 has recently entered an open-label, multicenter phase I trial to assess its safety, tolerability, pharmacodynamics, and antitumor activity in patients with gliomas harboring IDH1 R132 mutations in Japan.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> The study also aims to determine the maximum tolerated dose (MTD) and/or recommended phase II dose of DS-1001 (NCT03030066).<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a></div></div><div id="sec3_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21">3.1.11.  Eli Lilly Compounds</h4><div id="sec3_1_11_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> 7-Phenylethylamino-4<i>H</i>-pyrimido[4,5-<i>d</i>][1,3]oxazin-2-one Scaffold</h5><div class="NLM_p">In 2017, Lilly reported a series of 7-phenylethylamino-4<i>H</i>-pyrimido[4,5-<i>d</i>][1,3]oxazin-2-one compounds as mutant IDH1 covalent inhibitors, in which <i>N</i>-acryloyl azetidines could present Michael acceptors to nucleophilic residues in mutant IDH1 and enable these compounds to efficiently and quickly react with the protein.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Among them, compound <b>48</b> (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>) effectively inhibited IDH1 R132H and IDH1 R132C mutants (IC<sub>50</sub> = 29.1 nM and 26.6 nM, respectively) and exhibited good selectivity against WT-IDH1, WT-IDH2, IDH2 R140Q, and IDH2 R172K with IC<sub>50</sub> values of 3800, 10700, 41800, and 1670 nM, respectively.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> Meanwhile, in vivo studies suggested that <b>48</b> dose-dependently inhibited 2-HG production in athymic nude mice bearing IDH1 R132C-positive HT-1080 and IDH1 R132H-positive human glioblastoma TB08 xenografts.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> Other representative compounds (<b>49</b>–<b>53</b>) (IC<sub>50</sub> < 100 nM) from the patent (WO 2017019429) are presented in <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>.</div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Chemical structures of compounds <b>48</b>–<b>53</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_11_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> Novel 3-Pyrimidin-4-yl-oxazolidin-2-one Scaffold</h5><div class="NLM_p">Subsequently, another series of potent mIDH1 inhibitors with a novel 3-pyrimidin-4-yl-oxazolidin-2-one scaffold were patented by Lilly scientists in 2017 and also includes the <i>N</i>-acryloyl azetidine element designed for covalent inhibiton.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Most compounds in the patent application were claimed to exhibit potent inhibition of IDH1 R132H and IDH1 R132C (IC<sub>50</sub> < 100 nM), and compound <b>54</b> (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>) showed strong inhibitory activity against IDH1 R132H and R132C with IC<sub>50</sub> values of 0.011 μM and 0.00889 μM, respectively, and good selectivity against WT-IDH1.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> The structures of the representative compounds <b>55</b>–<b>57</b> are presented in <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>.</div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Chemical structures of compounds <b>55</b>–<b>57</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24">3.1.12.  Merck Compounds</h4><div class="NLM_p">Recently, a series of novel tricyclic compounds that act as mIDH1 inhibitors were discovered by Merck & Co. for the treatment of cancers with IDH1 mutations. Compound <b>58</b> (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>) strongly inhibited IDH1 R132H (IC<sub>50</sub> = 3.5 nM) in Kinase-Glo luminescent assays.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> The patent application also claimed the potent mIDH1 inhibitors <b>59</b>–<b>61</b> with significant inhibitory activities against mIDH1 (IC<sub>50</sub> < 10 nM) (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>).<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a></div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Chemical structures of compounds <b>58</b>–<b>61</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25">3.1.13.  Zhejiang University of Technology (ZJUT) and Shanghai Institute of Materia Medica (SIMM) Compounds</h4><div class="NLM_p">Researchers from Zhejiang University of Technology (ZJUT) and Shanghai Institute Materia Medica (SIMM) collaborated to discover a series of double aryl maleimide compounds that act as novel mIDH1 inhibitors for treating glial tumors, acute myelogenous leukemia, and other malignant tumors mediated by mutant IDH1. The representative compound <b>62</b> (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>) exhibited strong inhibition of IDH1 R132H and IDH1 R132C with IC<sub>50</sub> values of 0.09 and 0.38 μM, respectively, as well as high selectivity against WT-IDH1 in fluorescence-based assays.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> In addition, at 5 and 20 μM, it significantly suppressed 2-HG production in a concentration-dependent manner in human glioblastoma U-87 MG cells overexpressing IDH1 R132H.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Chemical structure of compound <b>62</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26">3.1.14.  Shanghai HaiHe Pharmaceutical Compounds</h4><div class="NLM_p">Recently Shanghai HaiHe Pharmaceutical Co. collaborated with SIMM and reported a series of novel mIDH1 inhibitors, most of which exhibited significant inhibitory potency against IDH1 132H (IC<sub>50</sub> < 100 nM).<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Among the compounds <b>63</b>–<b>66</b> disclosed by this group and shown in <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>, compound <b>63</b> reduced 2-HG levels in human fibrosarcoma HT-1080 cells with an IC<sub>50</sub> value of 10 nM.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a></div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Chemical structures of compounds <b>63</b>–<b>66</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of AG-120 discovered by Agios, the Wan group from Shanghai HaiHe Pharmaceutical developed another class of conformationally restricted indane analogs as IDH1 inhibitors.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> The installation of a quaternary center at the α-position of the amide would prevent epimerization and potentially slow down amide hydrolysis. Compounds <b>67</b> and <b>68</b> (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>) strongly inhibited IDH1 R132H with IC<sub>50</sub> values of 45 nM and 49 nM, respectively, and showed significant selectivity against WT-IDH1 and IDH2 140Q.<a onclick="showRef(event, 'ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref90 ref91">(90,91)</a> Notably, both <b>67</b> and <b>68</b> exhibit favorable PK properties in mice.<a onclick="showRef(event, 'ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref90 ref91">(90,91)</a></div><figure id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0021.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Chemical structures of compounds <b>67</b> and <b>68</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27">3.1.15.  Chia Tai Tianqing Compounds</h4><div class="NLM_p">Jiangsu Chia Tai Tianqing Pharmaceutical and collaborators simultaneously disclosed two patents for novel mIDH1 inhibitors with sultam (form I) or aziridinesulfonamide scaffolds (form II). Compound <b>69</b> (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>) from one patent application, which has a sultam scaffold, displayed potential inhibition against IDH1 132H in human fibrosarcoma HT1080 cells and against IDH1 132C in human glioblastoma U-87 cells (IC<sub>50</sub> < 20 nM for both) in cellular 2-HG assays.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Compound <b>70</b> (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>), which has an aziridinesulfonamide scaffold, was reported in the other patent application to inhibit IDH1 R132H with an IC<sub>50</sub> of less than 20 nM in NADPH depletion assays.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Both <b>69</b> and <b>70</b> exhibited good PK properties for the treatment of cancers with IDH1 mutations.<a onclick="showRef(event, 'ref92 ref93'); return false;" href="javascript:void(0);" class="ref ref92 ref93">(92,93)</a></div><figure id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0022.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Chemical structures of compounds <b>69</b> and <b>70</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28">3.1.16.  UNC Compounds</h4><div class="NLM_p">The University of North Carolina at Chapel Hill (UNC), in collaboration with the U.S. Department of Health and Human Services, developed a series of thiazole derivatives as mIDH1 inhibitors, among which the representative compounds <b>71</b>–<b>73</b> (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>) exhibited significant inhibitory potency against IDH1 R132H and IDH1 R132C (IC<sub>50</sub> < 0.3 μM) in enzymatic assays.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a></div><figure id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0023.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Chemical structures of compounds <b>71</b>–<b>73</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29">3.1.17.  Other mIDH1 Inhibitors</h4><div id="sec3_1_17_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> HMS-101</h5><div class="NLM_p">Using virtual screening, Chaturvedi et al. identified an mIDH1 inhibitor (HMS-101, 74, <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>) that efficiently blocked the colony formation of leukemia cells from patients with IDH1-mutated AML and significantly decreased 2-HG levels in vitro but did not affect normal CD34<sup>+</sup> marrow cells.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></div><figure id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0024.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Chemical structures of compounds <b>74</b>–<b>77</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_17_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> FX-03</h5><div class="NLM_p last">Docking-based screening of mIDH1’s allosteric site led to the identificaiton of FX-03 (<b>75</b>, <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>) as a mIDH1 inhibitor with IC<sub>50</sub> values of 55.50 μM and 65.38 μM against IDH1 R132H and IDH1 R132C, respectively, in HEK293T cells.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Interestingly, <b>75</b> displayed very weak cytotoxicity against HEK293T cells expressing WT-IDH1 at 50 μM.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div></div><div id="sec3_1_17_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> Clomifene</h5><div class="NLM_p last">Drug repurposing may be an effective route for the rapid development of new drugs. Clomifene (<b>76</b>, <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>), a selective estrogen receptor modulator for the treatment of female infertility, was discovered to be an mIDH1 inhibitor by structure-based virtual screening.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> The sensitivity to <b>76</b> was descreased by knockdown of mutant IDH1 in HT1080 cells.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> The tumor growth of HT1080-bearing CB-17/ICR-SCID mice was suppressed by <b>76</b> significantly following oral administration of 100 mg/kg and 50 mg/kg per day.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a><b>76</b> was identified as a safe and effective mIDH1 inhibitor, occupying the allosteric site of mIDH1 and dose-dependently inhibits mIDH1 (IC<sub>50</sub> = 37.86 ± 0.32 μM).<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a></div></div><div id="sec3_1_17_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> 3-Pyrazine-2-yl-oxazolidin-2-one Scaffold</h5><div class="NLM_p last">Recently, our group has reported a series of allosteric mIDH1 inhibitors with a 3-pyrazine-2-yl-oxazolidin-2-one scaffold.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> All synthesized compounds could suppress D-2-HG production in cells transfected with IDH1-R132H and IDH1-R132C mutations at 50 μM.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Among them, compound <b>3g</b> (<b>77</b>, <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>) displayed inhibitory activity against IDH1-R132H and IDH1-R132C at 10 μM and 50 μM and weak inhibition against WT-IDH1, respectively.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a><b>77</b> can effectively cross the blood–brain barrier (BBB) in a PAMPA-BBB model.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34">3.2.  IDH2 Mutant Inhibitors</h3><div id="sec3_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35">3.2.1.  Agios Compounds</h4><div class="NLM_p">AGI-6780 (<b>78</b>, <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a></a>), developed by Agios Pharmaceuticals, potently and selectively inhibits IDH2 R140Q (IC<sub>50</sub> = 170 nM).<a onclick="showRef(event, 'ref19 ref98'); return false;" href="javascript:void(0);" class="ref ref19 ref98">(19,98)</a> The cocrystal complex of IDH2 R140Q and <b>78</b> reveals that the inhibitor binds allosterically at the dimer interface of mIDH2.<a onclick="showRef(event, 'ref19 ref99'); return false;" href="javascript:void(0);" class="ref ref19 ref99">(19,99)</a> The slow, tight allosteric binding of <b>78</b> efficiently induced the differentiation of TF-1 erythroleukemia and primary human AML cells in vitro.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><figure id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0025.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Chemical structure of compound <b>78</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec3_2_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> AG-221</h5><div class="NLM_p">By use of a high-throughput screen based on a IDH2 R140Q homodimer, AG-221 (<b>79</b>, <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">26</a></a>), also known as CC-90007 or enasidenib, was identified as an orally available, selective, and reversible mIDH2 inhibitor with IC<sub>50</sub> values of 4.0 nM against IDH2 R140Q and 340 nM against WT-IDH2.<a onclick="showRef(event, 'ref100 ref101'); return false;" href="javascript:void(0);" class="ref ref100 ref101">(100,101)</a> It binds at an allosteric site within the IDH2 R140Q homodimer interface and blocks the mutant enzyme in an open conformation.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> It was developed by Agios in 2009 and then licensed to Celgene for further development.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Cianchetta et al. applied for a patent to highlight the importance of the 1,3,5-triazine-2,4-diamine core for mIDH2 inhibitors (<b>79</b>–<b>84</b>, <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">26</a></a>).<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> These inhibitors are claimed to be therapeutically effective against IDH2-mutated tumor types, as evidenced by their activities against IDH2 R172K and R140Q (IC<sub>50</sub> ≤ 100 nM) and their significant reduction of 2-HG production in U87-MG cells harboring IDH2 mutations (IC<sub>50</sub> ≤ 100 nM).<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> In a dose-escalation phase I clinical trial, administration of <b>79</b> specifically reduced D-2-HG concentrations (∼90%), thereby inhibiting proliferation and inducing differentiation in cancer cells (NCT02577406). Furthermore, treatment with <b>79</b> rapidly reversed histone hypermethylation in both gliomas and leukemia.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Phase I/II clinical studies with <b>79</b> alone or in combination with <b>4</b> in hematologic cancers or refractory advanced solid tumors are currently performing enrollment (NCT01915498, NCT02273739 and NCT02677922).<a onclick="showRef(event, 'ref104 ref105 ref106'); return false;" href="javascript:void(0);" class="ref ref104 ref105 ref106">(104−106)</a> On August 1 2017, <b>79</b> was approved by the FDA as a first-in-class drug targeting cancer metabolism for the treatment of IDH2-mutated relapsed/refractory AML.</div><figure id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0026.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Chemical structures of compounds <b>79</b>–<b>84</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37">3.2.2.  Teligene Compounds</h4><div class="NLM_p">Novel mIDH2 inhibitors with heterocyclic scaffolds were reported by scientists from Teligene. Enzymatic assays indicated that compound <b>85</b> (<a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a></a>) exhibited better inhibition than <b>79</b> against mIDH2 with an IC<sub>50</sub> of 262 nM.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> It also suppressed the mutant kinases ALK (L1152R), AXL (R499C), BRAF (G464V), and c-MER (A708S) at 10 μM.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Compound <b>85</b> displayed higher solubility than <b>79</b> at both pH 4 and 7.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a></div><figure id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0027.jpeg" id="gr27" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Chemical structures of compounds <b>85</b> and <b>86</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38">3.2.3.  Neuform Compounds</h4><div class="NLM_p last">Neuform Pharmaceuticals recently reported a series of novel deuterated compounds as mIDH2 inhibitors for the treatment of various hematologic malignancies. D8-Enasidenib (<b>86</b>, <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a></a>), with the IC<sub>50</sub> value of 0.360 μM, exhibits similar inhibition against IDH2 R140Q to <b>79</b> (IC<sub>50</sub> = 0.362 μM).<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> It also showed greater metabolic stability than <b>79</b> in rat and human liver microsomes.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> PK studies suggested that <b>86</b> increased drug exposure (based on half-life time and AUC) in cynomolgus monkeys at 1 mg/kg iv compared with the effects of <b>79</b>.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a></div></div><div id="sec3_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39">3.2.4.  Chia Tai Tianqing Compounds</h4><div class="NLM_p">Recently, a series of 1,3,5-triazine derivatives was discovered by Jiangsu Chia Tai Tianqing Pharmaceutical Co. and collaborators for the treatment of mIDH2-induced cancers. Compound <b>87</b> (<a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">28</a></a>) not only showed significant inhibition against IDH2 R172K (IC<sub>50</sub> = 31.69 nM) but also exhibited better PK properties than <b>79</b> in rats.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Other potent derivatives of <b>87</b> (<b>88</b>–<b>90</b>) with IC<sub>50</sub> values of less than 50 nM are shown in <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">28</a></a>.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a></div><figure id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0028.jpeg" id="gr28" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Chemical structures of compounds <b>87</b>–<b>90</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40">3.2.5.  Jiangsu Provincial Academy of Traditional Chinese Medicine (JSATCM) Compounds</h4><div class="NLM_p">Scientists from Jiangsu Provincial Academy of Traditional Chinese Medicine (JSATCM) reported a patent for novel IDH2 inhibitors (<b>91</b>–<b>96</b>), in which compound <b>91</b> (<a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">29</a></a>) inhibited IDH2 R140Q and IDH2 R172K with IC<sub>50</sub> values of 0.041 μM and 0.1 μM or less, respectively, and exhibited better selectivity than <b>78</b> against WT-IDH2 in NADPH depletion assays.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a></div><figure id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0029.jpeg" id="gr29" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Chemical structures of compounds <b>91</b>–<b>96</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41">3.2.6.  Sichuan University (SCU) Compounds</h4><div class="NLM_p">A series of 2,4,6-trisubstituted pyridine derivatives of <b>79</b> were identified by Sichuan University (SCU) as potent mIDH2 inhibitors. Among them, compound <b>97</b> (<a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">30</a></a>) exhibited approximately 1-fold better inhibitory activity than <b>79</b> against IDH2 R140Q with an IC<sub>50</sub> of 54.6 nM.<a onclick="showRef(event, 'ref111 ref112'); return false;" href="javascript:void(0);" class="ref ref111 ref112">(111,112)</a> Excitingly, enzymatic assays demonstrated that compound <b>97</b> had high selectivity, >550-fold, for WT-IDH2 and WT-IDH1.<a onclick="showRef(event, 'ref111 ref112'); return false;" href="javascript:void(0);" class="ref ref111 ref112">(111,112)</a></div><figure id="fig30" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0030.jpeg" id="gr30" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Chemical structure of compound <b>97</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42">3.3.  Dual mIDH1/2 Inhibitors</h3><div id="sec3_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43">3.3.1.  Agios Pharmaceuticals Compounds</h4><div class="NLM_p">AG-881 (<b>98</b>, vorasidenib, <a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">31</a></a>) is an orally available, brain penetrant second-generation dual mIDH1/2 inhibitor.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> It exhibits nanomolar inhibition of D-2-HG with IC<sub>50</sub> ranges of 0.04–22 nM against IDH1 R132C, IDH1 R132G, IDH1 R132H, and IDH1 R132S and 7–14 nM against IDH2 R140Q and 130 nM against IDH2 R172K.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> In addition, <b>98</b> has strong antiproliferative activity against human glioblastoma U-87 MG pLVX-IDH2 R140Q-neo, fibrosarcoma HT-1080, and neurosphere TS603 cells, all with IC<sub>50</sub> values of less than 50 nM.<a onclick="showRef(event, 'ref113 ref114'); return false;" href="javascript:void(0);" class="ref ref113 ref114">(113,114)</a> In pharmacological studies, <b>98</b> exhibited excellent brain penetration and dose-dependently reduced D-2-HG levels.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> In pharmacokinetics studies, <b>98</b> showed rapid oral absorption and relatively low total body plasma clearance in mice (0.406 L h<sup>–1</sup> kg<sup>–1</sup>) and rats (0.289 L h<sup>–1</sup> kg<sup>–1</sup>).<a onclick="showRef(event, 'ref113 ref114'); return false;" href="javascript:void(0);" class="ref ref113 ref114">(113,114)</a> Recently, <b>98</b> entered a phase I clinical trial in patients with advanced solid tumors to investigate its PK/PD, safety, and clinical activity (NCT02481154). Another phase I clinical trial is focusing on patients with mIDH1/2 advanced hematologic cancers (NCT02492737). Excitingly, a phase I study of <b>98</b> and <b>4</b> in glioma will soon begin to evaluate the suppression of 2-HG in IDH1 mutant gliomas in resected tumor tissue after presurgical treatment with <b>98</b> or <b>4</b> (NCT03343197). Other representative compounds (<b>99</b>–<b>102</b>) from the patent (WO 2015003640) with IC<sub>50</sub> values of less than 50 nM against mIDH1 and mIDH2 are shown in <a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">31</a></a>.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a></div><figure id="fig31" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0031.jpeg" id="gr31" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. Chemical structures of compounds <b>98</b>–<b>102</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44">3.3.2.  Evotec Compounds</h4><div class="NLM_p">Hay and colleagues at Evotec and Debiopharm reported <b>103</b> and <b>104</b> (<a data-tab="pane-pcw-Figures" href="#fig32" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig32" id="" class=" internalNav">32</a></a>) to be efficient dual mIDH1/2 inhibitors with IC<sub>50</sub> values of 2 nM against IDH1 R132H and 6 nM against IDH2 R172K.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> However, the two analogs <b>105</b> and <b>106</b> exhibited strong inhibition only of IDH1 R132H (IC<sub>50</sub> = 28 nM and 29 nM, respectively).<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></div><figure id="fig32" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Figure 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0032.jpeg" id="gr32" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 32. Chemical structures of compounds <b>103</b>–<b>106</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig32"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">4.  Binding Modes of mIDH1/2 Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12301" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12301" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">It was reported that not only IDH1 R132H but also R132C, R132L, R132S mutations lead to a gain-function for NADPH-dependent reduction of α-KG.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The mutations of R132 result in the effect on conformation equilibrium and the reorganization of the active site. The conformation caused by the change of equilibrium owns the high affinity for NADPH.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The loss of salt-bridge interactions between the guanidinium of R132 and the α/β carboxylates of isocitrate, changes in the network that coordinates, and the reorganization of the active site are discovered in the examination of the catalytic pocket.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The single R132H mutation results in formation of a distinct active site compared to WT- IDH1.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">Although the mutations affect the substrate site, allosteric sites play essential roles in the development of mIDH1 inhibitors. By contrast, the conformation of mIDH2 is closed and only one closed binding site has been reported.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> This difference leads to the selectivity of mIDH1 inhibitors over mIDH2. Some distinct binding modes of mIDH1 inhibitors at the active sites have been reported, but they still need to be more deeply understood. In addition, potential binding sites of other mIDH1 inhibitors, including <b>1</b>, may be revealed in the future. Compared to mIDH1, an allosteric site has been described on mIDH2 which lies along the dimer interface and displayed non-time-dependent and noncompetitive inhibition versus α-KG.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> This insight might guide the discovery of mIDH2 inhibitors.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46">4.1.  mIDH1 Binding Sites</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47">4.1.1.  Substrate Site (Isocitrate Active Site)</h4><div class="NLM_p">Two ligands (ICT and α-KG) bind to IDH1 R132H. The ICT substrate lies in the deep cleft binding site I, formed by residues Thr77, Ser94, Asn96, Gly97, Arg100, Arg109, and Asn101 (<a data-tab="pane-pcw-Figures" href="#fig33" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig33" id="" class=" internalNav">33</a></a>). The binding site of <b>16</b> lies adjacent to the ICT binding pocket, which has also been referred to as a “bed surface”.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Its two partially negatively charged oxygen atoms were found to form hydrogen bonds with the positively charged side chains of Arg100 and Asn101.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> On the basis of the X-ray crystallographic data (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I3L">4I3L</a>), the excellent selectivity of these mIDH1 inhibitors (<b>16</b>–<b>18</b>) is attributed to this unique binding site.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></div><figure id="fig33" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Figure 33</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0033.jpeg" id="gr33" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 33. The mIDH1 active sites are depicted in purple, red, blue, green, and yellow. Around the active sites, different inhibitors (SYC-435 (<b>16</b>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I3L">4I3L</a>), VVS (<b>24</b>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UMX">4UMX</a>), GSK321 (<b>14</b>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5DE1">5DE1</a>), IDH889 (<b>29</b>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TQH">5TQH</a>), IDH146 and <b>26</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L57">5L57</a>)) are shown and color-coded by their corresponding binding sites. The specific drug–target interactions between these inhibitors and mIDH1 are shown below, in which the green solid lines represent the π–π interactions and the yellow dotted lines represent the hydrogen bond interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig33"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48">4.1.2.  Allosteric Site (Divalent Magnesium Site)</h4><div class="NLM_p last">The first cocrystal structure of a mIDH1-<b>24</b> complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UMX">4UMX</a>) was published by Deng et al. in 2014 (<a data-tab="pane-pcw-Figures" href="#fig33" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig33" id="" class=" internalNav">33</a></a>).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Compound <b>24</b> strongly binds at the special allosteric site (also called the divalent magnesium site) of mIDH1, forming a direct hydrogen bond with Asp279. According to previous biological studies, three aspartate residues (Asp275 and Asp279 in one subunit and Asp252 in another subunit) are essential to form the chelation complex with the divalent magnesium ion.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> This finding suggested that <b>24</b> might compete against Mg<sup>2+</sup> in ion cofactor binding, further preventing mIDH1 from maintaining a catalytically competent state. These results point to a double role of the divalent metal ion pocket in the discovery and optimization of more small-molecule selective inhibitors of mIDH1.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49">4.1.3.  Second Allosteric Site (Seg-2 Active Site)</h4><div class="NLM_p last">The complex of compound <b>14</b> bound to mIDH1 was crystallographically determined (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5DE1">5DE1</a>) (<a data-tab="pane-pcw-Figures" href="#fig33" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig33" id="" class=" internalNav">33</a></a>).<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59,60)</a> It revealed that <b>14</b> binds in an allosteric site surrounded by the Seg-2 polypeptide chain and other residues. Biochemical studies showed that the Seg-2 chain is an intrinsically disordered loop but adopts a helical conformation in the presence of α-KG. Compound <b>14</b> forms strong electrostatic interactions and hydrogen bonds with the Val281 and Gly284 residues in the Seg-2 region of mIDH1, blocking the loop-to-helix transition while forming the ternary complex.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50">4.2.  Allosteric Site in mIDH2</h3><div class="NLM_p">Recently, an important crystallographic study revealed AG-221 (<b>79</b>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5I96">5I96</a>) bound to an allosteric site located within the homodimer interface of IDH2 R140Q, to which the selective mIDH2 inhibitor AGI-6780 (<b>78</b>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JA8">4JA8</a>) also binds (<a data-tab="pane-pcw-Figures" href="#fig34" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig34" id="" class=" internalNav">34</a></a>).<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> This deeply buried pocket is encapsulated by four helices (α9, α10, α9, α10′) lining the sides, two loops (L1, L1′), and the Y311–D312 interaction pairs capping the ends. Both <b>78</b> and <b>79</b> are anchored by multiple hydrogen bonds (Q316, Q316′, D312) and hydrophobic interactions within this pocket. They exhibit uncompetitive inhibition with respect to the NADPH cofactor and are among the slow-on/slow-off inhibitors of IDH2 R140Q.</div><figure id="fig34" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Figure 34</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0034.jpeg" id="gr34" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 34. An allosteric site in IDH2 R140Q is depicted in the purple circle. Around it, two mIDH2 inhibitors AGI-6780 (<b>78</b>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JA8">4JA8</a>) and AG-221 (<b>79</b>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5I96">5I96</a>) are shown. The specific drug–target interactions between these inhibitors and mIDH1 are shown below, in which the yellow dotted lines represent the hydrogen bond interactions and the green dotted lines represent the halogen bond interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig34"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i51">5.  Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84054" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84054" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Metabolic reprogramming is a fundamental aspect of cancer cells, and strong evidence has indicated that somatic IDH1/2 mutations contribute to glioma, advanced hematologic malignancies, and some solid tumors. Mutated forms of IDH1/2 represent promising targets for cancer therapy. This review highlights the research progress involving mIDH1/2 inhibitors, including their efficacy, selectivity, and clinical application (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00159/suppl_file/jm8b00159_si_001.pdf" class="ext-link">Table 1S</a>). Structurally, mIDH1 inhibitors include more reported ligands with more diverse scaffolds than those of mIDH2. The mIDH2 inhibitor AG-221 is the first marketed drug for the treatment of IDH2-mutated AML. Its approval has led to a better understanding of the role of these mutant metabolic enzymes and their corresponding metabolites in tumorigenesis. Importantly, new strategies are needed to further overcome the defects of the reported mIDH1/2 inhibitors and to more effectively treat patients with IDH1/2-mutated tumors.</div></div><div id="sec5_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i52">6.  Perspective</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75084" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75084" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Currently, mIDH1/2 and the “oncometabolite” 2-HG have attracted increasing attention for cancer therapy. With advancing progress in understanding their biological mechanism, a variety of mIDH1/2 inhibitors have been developed, and AG-221 has been approved for clinical use. However, some issues still need to be resolved.</div><div class="NLM_p">First, almost all reported mIDH2 inhibitors were optimized from the scaffolds of AG-221 or AGI-6780. Thus, identification of novel scaffolds for mIDH2 inhibitors is in demand. Second, the IDH2 R172K mutation is related to certain specific tumors; however, little research work has been reported on selective inhibitors of IDH2 R172K.<a onclick="showRef(event, 'ref75 ref115'); return false;" href="javascript:void(0);" class="ref ref75 ref115">(75,115)</a> The crystal structure of the IDH2 R172K enzyme and its specific inhibitors are worthy of deeper investigation.</div><div class="NLM_p last">Finally, clinical trials suggest that mIDH1 inhibitors alone are likely not sufficient for treating IDH-mutated tumors as monotherapy, especially glioma. Therefore, reasonable combinations with other anticancer drugs may be therapeutically beneficial.<a onclick="showRef(event, 'ref117 ref118 ref119 ref120'); return false;" href="javascript:void(0);" class="ref ref117 ref118 ref119 ref120">(117−120)</a> It was reported that mutant IDH1 lowered NAD<sup>+</sup> levels by downregulating Naprt1, the rate-limiting enzyme in NAD<sup>+</sup> biosythesis, sensitizing to NAD<sup>+</sup> depletion via concomitant inhibition of NAMPT, the rate-limiting enzyme in NAD<sup>+</sup> salvage synthesis pathway. NAD<sup>+</sup> depletion activated the intracellular energy sensor AMPK, triggered autophagy, and resulted in cytotoxicity. Thus, IDH1 mutant cancers are vulnerable to NAMPT inhibitors and combination of mIDH1 inhibitors and NAMPT inhibitors may be beneficial in cancer therapy.<a onclick="showRef(event, 'ref121 ref122'); return false;" href="javascript:void(0);" class="ref ref121 ref122">(121,122)</a> This discovery provides new insights for the development of mIDH1 and NAMPT dual inhbitors and the treatment of IDH-mutant cancers. In addition, combination with two DNA alkylating agents procarbazine and CCNU/lomustine, and a microtubule poison vincristine may benefit patients with IDH-mutant low-grade glioma and prolong their survival.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Recently, a new study indicated that gliomas with IDH1 mutations are particularly sensitive to Bcl-xL inhibition. Therefore, the addition of Bcl-xL inhibitors such as ABT263 may be efficacious for mIDH1-mutated tumors.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Overall, due to mutations in IDH1/2 being associated with some metabolic pathways, novel treatment strategies such as combining mIDH1/2 inhibitors and other anticancer drugs may benefit patients with IDH-mutated tumors.</div></div><div class="NLM_back"><div class="article_supporting-info" id="NOTES-d7e2604-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i53"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00159" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68634" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68634" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00159" class="ext-link">10.1021/acs.jmedchem.8b00159</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Mutant IDH1/2 in clinical trials and physical properties of some mIDH1/2 inhibitors (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00159/suppl_file/jm8b00159_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00159/suppl_file/jm8b00159_si_001.pdf">jm8b00159_si_001.pdf (154.21 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00159" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43416" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43416" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoming Zha</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Engineering and Department of Biochemical Engineering, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, P. R. China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#572f3a2d3f361734272279323322793439"><span class="__cf_email__" data-cfemail="5c243126343d1c3f2c2972393829723f32">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tianfang Ma</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Engineering and Department of Biochemical Engineering, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, P. R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fangxia Zou</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Engineering and Department of Biochemical Engineering, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, P. R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan Pusch</span> - <span class="hlFld-Affiliation affiliation">German Consortium
of Translational Cancer Research (DKTK), Clinical Cooperation Unit
Neuropathology, German Cancer Research Center (DKFZ), INF 280, Heidelberg D-69120, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuropathology, Institute
of Pathology, Ruprecht-Karls-Universität
Heidelberg, INF 224, Heidelberg D-69120, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yungen Xu</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andreas von Deimling</span> - <span class="hlFld-Affiliation affiliation">German Consortium
of Translational Cancer Research (DKTK), Clinical Cooperation Unit
Neuropathology, German Cancer Research Center (DKFZ), INF 280, Heidelberg D-69120, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuropathology, Institute
of Pathology, Ruprecht-Karls-Universität
Heidelberg, INF 224, Heidelberg D-69120, Germany</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>T.M., F.Z., and S.P. contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48148" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48148" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Tianfang Ma</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=BIO-d7e2571-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Tianfang Ma</b> received his Bachelor’s degree from China Pharmaceutical University in 2015. In the same year, he studied under Prof. Xiaoming Zha for his Master’s degree. His research mainly focuses on the discovery and optimization of small molecules that target cancer metabolism.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Fangxia Zou</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=BIO-d7e2576-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Fangxia Zou</b> obtained her Master’s degree from China Pharmaceutical University in June 2017. As a Master’s graduate, she mainly conducted the molecular simulation and drug design of the small molecules targeting mutant IDH1/2 under the supervision of Prof. Xiaoming Zha.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="37" class="article__inlineFigure"><h2 class="fig-label">Stefan Pusch</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=BIO-d7e2581-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Stefan Pusch</b> obtained his Diploma in Biology from the University of Cologne/Max-Planck Institute for Plant Breeding Research in 2004. In 2008, he graduated from the same institute. He joined the Clinical Cooperation Unit Neuropathology at the German Cancer Research Center (DKFZ) in Heidelberg as a postdoc in 2009. Beginning in 2011, he focused on drug discovery for mutant IDH1/2 tumors.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="38" class="article__inlineFigure"><h2 class="fig-label">Yungen Xu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=BIO-d7e2586-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Yungen Xu</b> graduated from China Pharmaceutical University with his Bachelor’s and Master’s degrees in 1987 and 1990, respectively. He received his Ph.D. in Medicinal Chemistry at the same institute in 2000. Currently, he is the Director and a Full Professor of the Department of Medical Chemistry, School of Pharmacy at CPU. He has published more than 80 papers in peer-reviewed journals and owns approximately 50 granted patents. His major research interests focus on the discovery and development of small-molecule antitumor, analgesic, and anti-inflammatory agents.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="39" class="article__inlineFigure"><h2 class="fig-label">Andreas von Deimling</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=BIO-d7e2591-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Andreas von Deimling</b> obtained his MD from the University of Freiburg in 1988. He conducted postdoctoral research at Harvard University from 1990 to 1992. Currently, he is the Chairman and a Full Professor in Neuropathology at the University of Heidelberg and Head of the Clinical Cooperation Unit Neuropathology at the German Cancer Research Center (DKFZ). He has published more than 400 peer-reviewed papers with over 33 000 citations. His main research focus is on the pathology and molecular genetics of tumors of the central and peripheral nervous systems.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="40" class="article__inlineFigure"><h2 class="fig-label">Xiaoming Zha</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=BIO-d7e2596-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Xiaoming Zha</b> obtained his Bachelor’s degree in Pharmaceutical Chemistry in 2002 and his Ph.D. in Medicinal Chemistry in 2007 at CPU. From 2013 to 2014, he was engaged in organic synthesis research in Professor E. J. Corey’s group at Harvard University as a CSC-sponsored visiting scholar. He has published more than 20 peer-reviewed papers and applied for 10 patents. His research interests mainly focus on the identification of small molecules that target cancer metabolism, including mutant IDH1/2 and epigenetic regulation such as histone demethylases.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i61">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07814" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07814" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful for the support from the Natural Science Foundation of Jiangsu Province of China (Grant BK20161458), the “Six Talent Peaks” Project of Jiangsu Province (Grant 2016-YY-042), the Postgraduate Research & Practice Innovation Program of Jiangsu Province (Grant KYCX17_0721), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">IDH</td><td class="NLM_def"><p class="first last">isocitrate dehydrogenase</p></td></tr><tr><td class="NLM_term">mIDH</td><td class="NLM_def"><p class="first last">mutant isocitrate dehydrogenase</p></td></tr><tr><td class="NLM_term">ICT</td><td class="NLM_def"><p class="first last">isocitric acid</p></td></tr><tr><td class="NLM_term">α-KG</td><td class="NLM_def"><p class="first last">α-ketoglutaric acid</p></td></tr><tr><td class="NLM_term">2-HG</td><td class="NLM_def"><p class="first last">2-hydroxyglutaric acid</p></td></tr><tr><td class="NLM_term">D-2-HG</td><td class="NLM_def"><p class="first last">(<span class="smallcaps smallerCapital">d</span>)-2-hydroxyglutarate which is equivalent to (−)-2-hydroxglutarate and (<i>R</i>)-2-hydroxyglutarate</p></td></tr><tr><td class="NLM_term">L-2-HG</td><td class="NLM_def"><p class="first last">(<span class="smallcaps smallerCapital">l</span>)-2-hydroxyglutarate which is equivalent to (+)-2-hydroxglutarate and (<i>S</i>)-2-hydroxyglutarate</p></td></tr><tr><td class="NLM_term">R132H</td><td class="NLM_def"><p class="first last">Arg132 mutation to His</p></td></tr><tr><td class="NLM_term">R132C</td><td class="NLM_def"><p class="first last">Arg132 mutation to Cys</p></td></tr><tr><td class="NLM_term">T</td><td class="NLM_def"><p class="first last">threonine</p></td></tr><tr><td class="NLM_term">R140Q</td><td class="NLM_def"><p class="first last">Arg140 mutation to Gln</p></td></tr><tr><td class="NLM_term">H</td><td class="NLM_def"><p class="first last">histidine</p></td></tr><tr><td class="NLM_term">K</td><td class="NLM_def"><p class="first last">lysine</p></td></tr><tr><td class="NLM_term">M</td><td class="NLM_def"><p class="first last">methionine</p></td></tr><tr><td class="NLM_term">V</td><td class="NLM_def"><p class="first last">valine</p></td></tr><tr><td class="NLM_term">W</td><td class="NLM_def"><p class="first last">tyrosine</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wild type</p></td></tr><tr><td class="NLM_term">HIF-1α</td><td class="NLM_def"><p class="first last">hypoxia-inducible factor 1α</p></td></tr><tr><td class="NLM_term">LOH 19q</td><td class="NLM_def"><p class="first last">loss of heterozygosity on chromosome 19q</p></td></tr><tr><td class="NLM_term">LOH 22q</td><td class="NLM_def"><p class="first last">loss of heterozygosity on chromosome 22q</p></td></tr><tr><td class="NLM_term">TP53</td><td class="NLM_def"><p class="first last">tumor protein 53</p></td></tr><tr><td class="NLM_term">DNMT3A</td><td class="NLM_def"><p class="first last">DNA methyltransferase 3A</p></td></tr><tr><td class="NLM_term">TET2</td><td class="NLM_def"><p class="first last">tet methylcytosine dioxygenase 2</p></td></tr><tr><td class="NLM_term">HNF-4α</td><td class="NLM_def"><p class="first last">hepatocyte nuclear factor 4α</p></td></tr><tr><td class="NLM_term">NPM1</td><td class="NLM_def"><p class="first last">nucleophosmin 1 gene</p></td></tr><tr><td class="NLM_term">MDS/MPN</td><td class="NLM_def"><p class="first last">myelodysplastic/myeloproliferative neoplasm</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">PK/PD</td><td class="NLM_def"><p class="first last">pharmacokinetic/pharmacodynamic</p></td></tr><tr><td class="NLM_term">FLT3-ITD</td><td class="NLM_def"><p class="first last">FMS-like tyrosine kinase 3-internal tandem duplication</p></td></tr><tr><td class="NLM_term">CD38</td><td class="NLM_def"><p class="first last">cluster of differentiation 38</p></td></tr><tr><td class="NLM_term">NAPRT1</td><td class="NLM_def"><p class="first last">nicotinic acid phosphoribosyltransferase</p></td></tr><tr><td class="NLM_term">NAMPT</td><td class="NLM_def"><p class="first last">nicotinamide phosphoribosyltransferase</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i63">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55420" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55420" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 123 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reitman, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span> <span> </span><span class="NLM_article-title">Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism</span>. <i>J. Natl. Cancer. Inst</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">932</span>– <span class="NLM_lpage">941</span>, <span class="refDoi"> DOI: 10.1093/jnci/djq187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1093%2Fjnci%2Fdjq187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=20513808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptlegs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2010&pages=932-941&author=Z.+J.+Reitmanauthor=H.+Yan&title=Isocitrate+dehydrogenase+1+and+2+mutations+in+cancer%3A+alterations+at+a+crossroads+of+cellular+metabolism&doi=10.1093%2Fjnci%2Fdjq187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Isocitrate Dehydrogenase 1 and 2 Mutations in Cancer: Alterations at a Crossroads of Cellular Metabolism</span></div><div class="casAuthors">Reitman, Zachary J.; Yan, Hai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">932-941</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Dysregulation of metab. is a common phenomenon in cancer cells.  The NADP+-dependent isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) function at a crossroads of cellular metab. in lipid synthesis, cellular defense against oxidative stress, oxidative respiration, and oxygen-sensing signal transduction.  We review the normal functions of the encoded enzymes, frequent mutations of IDH1 and IDH2 recently found in human cancers, and possible roles for the mutated enzymes in human disease.  IDH1 and IDH2 mutations occur frequently in some types of World Health Organization grades 2-4 gliomas and in acute myeloid leukemias with normal karyotype.  IDH1 and IDH2 mutations are remarkably specific to codons that encode conserved functionally important arginines in the active site of each enzyme.  To date, all IDH1 mutations have been identified at the Arg132 codon.  Mutations in IDH2 have been identified at the Arg140 codon, as well as at Arg172, which is aligned with IDH1 Arg132.  IDH1 and IDH2 mutations are usually heterozygous in cancer, and they appear to confer a neomorphic enzyme activity for the enzymes to catalyze the prodn. of D-2-hydroxyglutarate.  Study of alterations in these metabolic enzymes may provide insights into the metab. of cancer cells and uncover novel avenues for development of anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaDJbCVLIvebVg90H21EOLACvtfcHk0lhxy20fI_42wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptlegs7c%253D&md5=09b5d48e9c10d5e103f73b4a74e0327b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjq187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjq187%26sid%3Dliteratum%253Aachs%26aulast%3DReitman%26aufirst%3DZ.%2BJ.%26aulast%3DYan%26aufirst%3DH.%26atitle%3DIsocitrate%2520dehydrogenase%25201%2520and%25202%2520mutations%2520in%2520cancer%253A%2520alterations%2520at%2520a%2520crossroads%2520of%2520cellular%2520metabolism%26jtitle%3DJ.%2520Natl.%2520Cancer.%2520Inst%26date%3D2010%26volume%3D102%26spage%3D932%26epage%3D941%26doi%3D10.1093%2Fjnci%2Fdjq187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attar, E. C.</span></span> <span> </span><span class="NLM_article-title">IDH mutations in cancer and progress toward development of targeted therapeutics</span>. <i>Ann. Oncol</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1093/annonc/mdw013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1093%2Fannonc%2Fmdw013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=27005468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A280%3ADC%252BC28fjtFGntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=599-608&author=L.+Dangauthor=K.+Yenauthor=E.+C.+Attar&title=IDH+mutations+in+cancer+and+progress+toward+development+of+targeted+therapeutics&doi=10.1093%2Fannonc%2Fmdw013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">IDH mutations in cancer and progress toward development of targeted therapeutics</span></div><div class="casAuthors">Dang L; Yen K; Attar E C</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">599-608</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) are key metabolic enzymes, converting isocitrate to α-ketoglutarate (αKG).IDH1 and IDH2 mutations have been identified in multiple tumor types, including gliomas and myeloid malignancies such as acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).  Here we provide an overview of the function of normal and mutated IDH, discuss the role of IDH mutations in tumorigenesis and progression and review the key clinical considerations when treating IDH-mutated tumors based on emerging clinical data from mutant IDH1/2 inhibitor trials.  IDH1 and IDH2 mutations confer neomorphic activity in the mutant protein, resulting in the conversion of αKG to the oncometabolite, D-2-hydroxyglutarate (2-HG).  The subsequent accumulation of 2-HG results in epigenetic dysregulation via inhibition of αKG-dependent histone and DNA demethylases, and a block in cellular differentiation.  There is growing preclinical and clinical evidence suggesting that IDHmutations are involved in neoplasia.  Furthermore, preclinical studies assessing small molecule inhibitors of mutant IDH1/2 enzymes have provided proof of concept that this approach decreases intracellular 2-HG levels, reverses epigenetic dysregulation and induces cellular differentiation.  Phase I studies of mutant IDH inhibitors are currently ongoing in patients with IDH-mutant hematologic and solid tumors, with early data in hematologic tumors suggesting a manageable safety profile as well as clinical benefit, with a mechanism of action based on differentiation of malignant cells.  Inhibition of mutant IDH shows promise as a treatment approach in hematologic malignancies, with further development ongoing in solid tumors and glioma.  The mutant IDH inhibitors may have clinical utility both as single agents and in combination strategies that target additional oncogenic pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5w5RykA08B0HdcurJClFcfW6udTcc2eb2ddJSPejyS7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fjtFGntg%253D%253D&md5=676354660c8d5ff27487d50b1ba80218</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdw013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdw013%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DL.%26aulast%3DYen%26aufirst%3DK.%26aulast%3DAttar%26aufirst%3DE.%2BC.%26atitle%3DIDH%2520mutations%2520in%2520cancer%2520and%2520progress%2520toward%2520development%2520of%2520targeted%2520therapeutics%26jtitle%3DAnn.%2520Oncol%26date%3D2016%26volume%3D27%26spage%3D599%26epage%3D608%26doi%3D10.1093%2Fannonc%2Fmdw013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span> <span> </span><span class="NLM_article-title">IDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectives</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">5562</span>– <span class="NLM_lpage">5571</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-1773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1158%2F1078-0432.CCR-12-1773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=23071358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFahu73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=5562-5571&author=H.+Yangauthor=D.+Yeauthor=K.+L.+Guanauthor=Y.+Xiong&title=IDH1+and+IDH2+mutations+in+tumorigenesis%3A+mechanistic+insights+and+clinical+perspectives&doi=10.1158%2F1078-0432.CCR-12-1773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">IDH1 and IDH2 Mutations in Tumorigenesis: Mechanistic Insights and Clinical Perspectives</span></div><div class="casAuthors">Yang, Hui; Ye, Dan; Guan, Kun-Liang; Xiong, Yue</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5562-5571</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Genes encoding for isocitrate dehydrogenases 1 and 2, IDH1 and IDH2, are frequently mutated in multiple types of human cancer.  Mutations targeting IDH1 and IDH2 result in simultaneous loss of their normal catalytic activity, the prodn. of α-ketoglutarate (α-KG), and gain of a new function, the prodn. of 2-hydroxyglutarate (2-HG). 2-HG is structurally similar to α-KG, and acts as an α-KG antagonist to competitively inhibit multiple α-KG-dependent dioxygenases, including both lysine histone demethylases and the ten-eleven translocation family of DNA hydroxylases.  Abnormal histone and DNA methylation are emerging as a common feature of tumors with IDH1 and IDH2 mutations and may cause altered stem cell differentiation and eventual tumorigenesis.  Therapeutically, unique features of IDH1 and IDH2 mutations make them good biomarkers and potential drug targets.  Clin Cancer Res; 18(20); 5562-71. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLxU4GOoxoYLVg90H21EOLACvtfcHk0ljxnfo58Xg1xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFahu73E&md5=248a8579316f9942e684669e6cedb594</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-1773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-1773%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DYe%26aufirst%3DD.%26aulast%3DGuan%26aufirst%3DK.%2BL.%26aulast%3DXiong%26aufirst%3DY.%26atitle%3DIDH1%2520and%2520IDH2%2520mutations%2520in%2520tumorigenesis%253A%2520mechanistic%2520insights%2520and%2520clinical%2520perspectives%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D5562%26epage%3D5571%26doi%3D10.1158%2F1078-0432.CCR-12-1773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Voelxen, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walenta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proescholdt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dettmer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pusch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller-Klieser, W.</span></span> <span> </span><span class="NLM_article-title">Quantitative imaging of D-2-hydroxyglutarate in selected histological tissue areas by a novel bioluminescence technique</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.3389/fonc.2016.00046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.3389%2Ffonc.2016.00046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=27014623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A280%3ADC%252BC28fjvFKksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=46-46&author=N.+F.+Voelxenauthor=S.+Walentaauthor=M.+Proescholdtauthor=K.+Dettmerauthor=S.+Puschauthor=W.+Mueller-Klieser&title=Quantitative+imaging+of+D-2-hydroxyglutarate+in+selected+histological+tissue+areas+by+a+novel+bioluminescence+technique&doi=10.3389%2Ffonc.2016.00046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative Imaging of D-2-Hydroxyglutarate in Selected Histological Tissue Areas by a Novel Bioluminescence Technique</span></div><div class="casAuthors">Voelxen Nadine F; Walenta Stefan; Mueller-Klieser Wolfgang; Proescholdt Martin; Dettmer Katja; Pusch Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">46</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">Patients with malignant gliomas have a poor prognosis with average survival of less than 1 year.  Whereas in other tumor entities the characteristics of tumor metabolism are successfully used for therapeutic approaches, such developments are very rare in brain tumors, notably in gliomas.  One metabolic feature characteristic of gliomas, in particular diffuse astrocytomas and oligodendroglial tumors, is the variable content of D-2-hydroxyglutarate (D2HG), a metabolite that was discovered first in this tumor entity.  D2HG is generated in large amounts due to various "gain-of-function" mutations in the isocitrate dehydrogenases IDH1 and IDH2.  Meanwhile, D2HG has been detected in several other tumor entities, including intrahepatic bile-duct cancer, chondrosarcoma, acute myeloid leukemia, and angioimmunoblastic T-cell lymphoma.  D2HG is barely detectable in healthy tissue (<0.1 mM), but its concentration increases up to 35 mM in malignant tumor tissues.  Consequently, the "oncometabolite" D2HG has gained increasing interest in the field of tumor metabolism.  To facilitate its quantitative measurement without loss of spatial resolution at a microscopical level, we have developed a novel bioluminescence assay for determining D2HG in sections of snap-frozen tissue.  The assay was verified independently by photometric tests and liquid chromatography/mass spectrometry.  The novel technique allows the microscopically resolved determination of D2HG in a concentration range of 0-10 μmol/g tissue (wet weight).  In combination with the already established bioluminescence imaging techniques for ATP, glucose, pyruvate, and lactate, the novel D2HG assay enables a comparative characterization of the metabolic profile of individual tumors in a further dimension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT704covJK7BCXXDYhVZBdlfW6udTcc2eb2ddJSPejyS7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fjvFKksQ%253D%253D&md5=dcd74cbcdc3a502b1b5d9a0fa44e6686</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2016.00046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2016.00046%26sid%3Dliteratum%253Aachs%26aulast%3DVoelxen%26aufirst%3DN.%2BF.%26aulast%3DWalenta%26aufirst%3DS.%26aulast%3DProescholdt%26aufirst%3DM.%26aulast%3DDettmer%26aufirst%3DK.%26aulast%3DPusch%26aufirst%3DS.%26aulast%3DMueller-Klieser%26aufirst%3DW.%26atitle%3DQuantitative%2520imaging%2520of%2520D-2-hydroxyglutarate%2520in%2520selected%2520histological%2520tissue%2520areas%2520by%2520a%2520novel%2520bioluminescence%2520technique%26jtitle%3DFront.%2520Oncol.%26date%3D2016%26volume%3D6%26spage%3D46%26epage%3D46%26doi%3D10.3389%2Ffonc.2016.00046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knobbe, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itsumi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elia, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chio, I. I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairns, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCracken, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakeham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haight, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ten, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snow, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2038</span>– <span class="NLM_lpage">2049</span>, <span class="refDoi"> DOI: 10.1101/gad.198200.112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1101%2Fgad.198200.112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=2038-2049&author=M.+Sasakiauthor=C.+B.+Knobbeauthor=M.+Itsumiauthor=A.+J.+Eliaauthor=I.+S.+Harrisauthor=I.+I.+C.+Chioauthor=R.+A.+Cairnsauthor=S.+McCrackenauthor=A.+Wakehamauthor=J.+Haightauthor=A.+Y.+Tenauthor=B.+Snowauthor=T.+Uedaauthor=S.+Inoueauthor=K.+Yamamotoauthor=M.+Koauthor=A.+Raoauthor=K.+E.+Yenauthor=S.+M.+Suauthor=T.+W.+Mak&title=D-2-hydroxyglutarate+produced+by+mutant+IDH1+perturbs+collagen+maturation+and+basement+membrane+function&doi=10.1101%2Fgad.198200.112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1101%2Fgad.198200.112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.198200.112%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DKnobbe%26aufirst%3DC.%2BB.%26aulast%3DItsumi%26aufirst%3DM.%26aulast%3DElia%26aufirst%3DA.%2BJ.%26aulast%3DHarris%26aufirst%3DI.%2BS.%26aulast%3DChio%26aufirst%3DI.%2BI.%2BC.%26aulast%3DCairns%26aufirst%3DR.%2BA.%26aulast%3DMcCracken%26aufirst%3DS.%26aulast%3DWakeham%26aufirst%3DA.%26aulast%3DHaight%26aufirst%3DJ.%26aulast%3DTen%26aufirst%3DA.%2BY.%26aulast%3DSnow%26aufirst%3DB.%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DS.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DKo%26aufirst%3DM.%26aulast%3DRao%26aufirst%3DA.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DSu%26aufirst%3DS.%2BM.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DD-2-hydroxyglutarate%2520produced%2520by%2520mutant%2520IDH1%2520perturbs%2520collagen%2520maturation%2520and%2520basement%2520membrane%2520function%26jtitle%3DGenes%2520Dev.%26date%3D2012%26volume%3D26%26spage%3D2038%26epage%3D2049%26doi%3D10.1101%2Fgad.198200.112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellinghoff, I. K.</span></span> <span> </span><span class="NLM_article-title">Molecular pathways: isocitrate dehydrogenase mutations in cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1837</span>– <span class="NLM_lpage">1842</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-1333</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1158%2F1078-0432.CCR-13-1333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=26819452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsFeqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=1837-1842&author=O.+Clarkauthor=K.+Yenauthor=I.+K.+Mellinghoff&title=Molecular+pathways%3A+isocitrate+dehydrogenase+mutations+in+cancer&doi=10.1158%2F1078-0432.CCR-13-1333"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Pathways: Isocitrate Dehydrogenase Mutations in Cancer</span></div><div class="casAuthors">Clark, Owen; Yen, Katharine; Mellinghoff, Ingo K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1837-1842</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">IDH1 and IDH2 are homodimeric enzymes that catalyze the conversion of isocitrate to α-ketoglutarate (α-KG) and concomitantly produce reduced NADPH from NADP+.  Mutations in the genes encoding IDH1 and IDH2 have recently been found in a variety of human cancers, most commonly glioma, acute myeloid leukemia (AML), chondrosarcoma, and intrahepatic cholangiocarcinoma.  The mutant protein loses its normal enzymic activity and gains a new ability to produce the "oncometabolite" R(-)-2-hydroxyglutarate (R-2-HG).  R-2-HG competitively inhibits α-KG-dependent enzymes which play crucial roles in gene regulation and tissue homeostasis.  Expression of mutant IDH impairs cellular differentiation in various cell lineages and promotes tumor development in cooperation with other cancer genes.  First-generation inhibitors of mutant IDH have entered clin. trials, and have shown encouraging results in patients with IDH-mutant AML.  This article summarizes recent progress in our understanding of the role of mutant IDH in tumorigenesis.  Clin Cancer Res; 22(8); 1837-42. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRe25vsB2yx7Vg90H21EOLACvtfcHk0lhCjr2AYJEBlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsFeqsrg%253D&md5=ba94ff8b176c87efe75df99646c13564</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-1333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-1333%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DO.%26aulast%3DYen%26aufirst%3DK.%26aulast%3DMellinghoff%26aufirst%3DI.%2BK.%26atitle%3DMolecular%2520pathways%253A%2520isocitrate%2520dehydrogenase%2520mutations%2520in%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2016%26volume%3D22%26spage%3D1837%26epage%3D1842%26doi%3D10.1158%2F1078-0432.CCR-13-1333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, P.</span></span> <span> </span><span class="NLM_article-title">The evolving landscape in the development of isocitrate dehydrogenase mutant inhibitors,</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1344</span>– <span class="NLM_lpage">1358</span>, <span class="refDoi"> DOI: 10.2174/1389557516666160609085520</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.2174%2F1389557516666160609085520" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=1344-1358&author=J.+Chenauthor=J.+Yangauthor=P.+Cao&title=The+evolving+landscape+in+the+development+of+isocitrate+dehydrogenase+mutant+inhibitors%2C&doi=10.2174%2F1389557516666160609085520"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F1389557516666160609085520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557516666160609085520%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DP.%26atitle%3DThe%2520evolving%2520landscape%2520in%2520the%2520development%2520of%2520isocitrate%2520dehydrogenase%2520mutant%2520inhibitors%252C%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D1344%26epage%3D1358%26doi%3D10.2174%2F1389557516666160609085520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pusch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahm, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mittelbronn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Deimling, A.</span></span> <span> </span><span class="NLM_article-title">Scientific correspondence</span>. <i>Neuropathol. Appl. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">430</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2990.2010.01127.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1111%2Fj.1365-2990.2010.01127.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=20874727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3MXot1Cqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2011&pages=428-430&author=S.+Puschauthor=F.+Sahmauthor=J.+Meyerauthor=M.+Mittelbronnauthor=C.+Hartmannauthor=A.+von+Deimling&title=Scientific+correspondence&doi=10.1111%2Fj.1365-2990.2010.01127.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Glioma IDH1 mutation patterns off the beaten track</span></div><div class="casAuthors">Pusch, S.; Sahm, F.; Meyer, J.; Mittelbronn, M.; Hartmann, C.; von Deimling, A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropathology and Applied Neurobiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">428-430</span>CODEN:
                <span class="NLM_cas:coden">NANEDL</span>;
        ISSN:<span class="NLM_cas:issn">0305-1846</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Up to now, IDH1 mutations were described in gliomas only affecting codon 132, however, three cases of a predicted, but so far never described mutation in codon 100 of IDH1 in gliomas, IDH1R100-Q, have been identified, affecting two anaplastic oligodendrogliomas WHO grade III and an astrocytoma WHO grade II.  The IDH1R100-Q mutation demonstrates that substitution of either one of the two homolog arginines by certain other amino acids lead to the same gain of function in both proteins.  Interestingly, the third conserved arginine, which is also involved in substrate binding, has never been reported to be mutated.  To obtain insights into the potential mechanism that leads to a focal loss of an IDH1 mutation in the sGBM sample, five flanking microsatellite markers (D2S322, D2S2274, D2S2208, D2S2242, and D2S2321, were analyzed in both portions.  It was obsd. in the tumor area without IDH1 mutation in all informative markers a loss of heterozygosity compared with the tumor portions with IDH1 mutation.  The observation of this sGBM with focal loss of the mutated IDH1 allele implies that is malignant gliomas other mutations may substitute for the role of mutated IDH1 protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSh1o8xTv6srVg90H21EOLACvtfcHk0lhCjr2AYJEBlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXot1Cqsr8%253D&md5=adb89e895671e4a2309c07ce8286c6d5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2990.2010.01127.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2990.2010.01127.x%26sid%3Dliteratum%253Aachs%26aulast%3DPusch%26aufirst%3DS.%26aulast%3DSahm%26aufirst%3DF.%26aulast%3DMeyer%26aufirst%3DJ.%26aulast%3DMittelbronn%26aufirst%3DM.%26aulast%3DHartmann%26aufirst%3DC.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26atitle%3DScientific%2520correspondence%26jtitle%3DNeuropathol.%2520Appl.%2520Neurobiol.%26date%3D2011%26volume%3D37%26spage%3D428%26epage%3D430%26doi%3D10.1111%2Fj.1365-2990.2010.01127.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capper, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christians, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felsberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mawrin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wick, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold-Mende, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unterberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeuken, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesseling, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reifenberger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Deimling, A.</span></span> <span> </span><span class="NLM_article-title">Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1010 diffuse gliomas</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">469</span>– <span class="NLM_lpage">474</span>, <span class="refDoi"> DOI: 10.1007/s00401-009-0561-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1007%2Fs00401-009-0561-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2009&pages=469-474&author=C.+Hartmannauthor=J.+Meyerauthor=J.+Balssauthor=D.+Capperauthor=W.+Muellerauthor=A.+Christiansauthor=J.+Felsbergauthor=M.+Wolterauthor=C.+Mawrinauthor=W.+Wickauthor=M.+Wellerauthor=C.+Herold-Mendeauthor=A.+Unterbergauthor=J.+W.+Jeukenauthor=P.+Wesselingauthor=G.+Reifenbergerauthor=A.+von+Deimling&title=Type+and+frequency+of+IDH1+and+IDH2+mutations+are+related+to+astrocytic+and+oligodendroglial+differentiation+and+age%3A+a+study+of+1010+diffuse+gliomas&doi=10.1007%2Fs00401-009-0561-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs00401-009-0561-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-009-0561-9%26sid%3Dliteratum%253Aachs%26aulast%3DHartmann%26aufirst%3DC.%26aulast%3DMeyer%26aufirst%3DJ.%26aulast%3DBalss%26aufirst%3DJ.%26aulast%3DCapper%26aufirst%3DD.%26aulast%3DMueller%26aufirst%3DW.%26aulast%3DChristians%26aufirst%3DA.%26aulast%3DFelsberg%26aufirst%3DJ.%26aulast%3DWolter%26aufirst%3DM.%26aulast%3DMawrin%26aufirst%3DC.%26aulast%3DWick%26aufirst%3DW.%26aulast%3DWeller%26aufirst%3DM.%26aulast%3DHerold-Mende%26aufirst%3DC.%26aulast%3DUnterberg%26aufirst%3DA.%26aulast%3DJeuken%26aufirst%3DJ.%2BW.%26aulast%3DWesseling%26aufirst%3DP.%26aulast%3DReifenberger%26aufirst%3DG.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26atitle%3DType%2520and%2520frequency%2520of%2520IDH1%2520and%2520IDH2%2520mutations%2520are%2520related%2520to%2520astrocytic%2520and%2520oligodendroglial%2520differentiation%2520and%2520age%253A%2520a%2520study%2520of%25201010%2520diffuse%2520gliomas%26jtitle%3DActa%2520Neuropathol.%26date%3D2009%26volume%3D118%26spage%3D469%26epage%3D474%26doi%3D10.1007%2Fs00401-009-0561-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paschka, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlenk, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaidzik, V. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habdank, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krönke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bullinger, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Späth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zucknick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Götze, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horst, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germing, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Döhner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Döhner, K.</span></span> <span> </span><span class="NLM_article-title">IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3636</span>– <span class="NLM_lpage">3643</span>, <span class="refDoi"> DOI: 10.1200/JCO.2010.28.3762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1200%2FJCO.2010.28.3762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=20567020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSksb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=3636-3643&author=P.+Paschkaauthor=R.+F.+Schlenkauthor=V.+I.+Gaidzikauthor=M.+Habdankauthor=J.+Kr%C3%B6nkeauthor=L.+Bullingerauthor=D.+Sp%C3%A4thauthor=S.+Kayserauthor=M.+Zucknickauthor=K.+G%C3%B6tzeauthor=H.+A.+Horstauthor=U.+Germingauthor=H.+D%C3%B6hnerauthor=K.+D%C3%B6hner&title=IDH1+and+IDH2+mutations+are+frequent+genetic+alterations+in+acute+myeloid+leukemia+and+confer+adverse+prognosis+in+cytogenetically+normal+acute+myeloid+leukemia+with+NPM1+mutation+without+FLT3+internal+tandem+duplication&doi=10.1200%2FJCO.2010.28.3762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication</span></div><div class="casAuthors">Paschka, Peter; Schlenk, Richard F.; Gaidzik, Verena I.; Habdank, Marianne; Kroenke, Jan; Bullinger, Lars; Spaeth, Daniela; Kayser, Sabine; Zucknick, Manuela; Goetze, Katharina; Horst, Heinz-A.; Germing, Ulrich; Doehner, Hartmut; Doehner, Konstanze</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3636-3643</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose To analyze the frequency and prognostic impact of isocitrate dehydrogenase 1 (IDH1) and isocitrate dehydrogenase 2 (IDH2) mutations in acute myeloid leukemia (AML).  Patients and Methods We studied 805 adults (age range, 16 to 60 years) with AML enrolled on German-Austrian AML Study Group (AMLSG) treatment trials AML HD98A and APL HD95 for mutations in exon 4 of IDH1 and IDH2.  Patients were also studied for NPM1, FLT3, MLL, and CEBPA mutations.  The median follow-up for survival was 6.3 years.  Results IDH mutations were found in 129 patients (16.0%) -IDH1 in 61 patients (7.6%), and IDH2 in 70 patients (8.7%).  Two patients had both IDH1 and IDH2 mutations.  All but one IDH1 mutation caused substitutions of residue R132; IDH2 mutations caused changes of R140 (n = 48) or R172 (n = 22).  IDH mutations were assocd. with older age (P <.001; effect conferred by IDH2 only); lower WBC (P =.04); higher platelets (P <.001); cytogenetically normal (CN) -AML (P<.001); and NPM1 mutations, in particular with the genotype of mutated NPM1 without FLT3 internal tandem duplication (ITD; P <.001).  In patients with CN-AML with the latter genotype, IDH mutations adversely impacted relapse-free survival (RFS; P =.02) and overall survival (P =.03), whereas outcome was not affected in patients with CN-AML who lacked this genotype.  In CN-AML, multivariable analyses revealed a significant interaction between IDH mutation and the genotype of mutated NPM1 without FLT3-ITD (ie, the adverse impact of IDH mutation [RFS]; P =.046 was restricted to this patient subset).  Conclusion IDH1 and IDH2 mutations are recurring genetic changes in AML.  They constitute a poor prognostic factor in CN-AML with mutated NPM1 without FLT3-ITD, which allows refined risk stratification of this AML subset.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocyoeI6L8VjrVg90H21EOLACvtfcHk0lga2QK6xgB3GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSksb3K&md5=18a4e6fe5f64a67e52d340e7aa34cdc1</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1200%2FJCO.2010.28.3762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2010.28.3762%26sid%3Dliteratum%253Aachs%26aulast%3DPaschka%26aufirst%3DP.%26aulast%3DSchlenk%26aufirst%3DR.%2BF.%26aulast%3DGaidzik%26aufirst%3DV.%2BI.%26aulast%3DHabdank%26aufirst%3DM.%26aulast%3DKr%25C3%25B6nke%26aufirst%3DJ.%26aulast%3DBullinger%26aufirst%3DL.%26aulast%3DSp%25C3%25A4th%26aufirst%3DD.%26aulast%3DKayser%26aufirst%3DS.%26aulast%3DZucknick%26aufirst%3DM.%26aulast%3DG%25C3%25B6tze%26aufirst%3DK.%26aulast%3DHorst%26aufirst%3DH.%2BA.%26aulast%3DGerming%26aufirst%3DU.%26aulast%3DD%25C3%25B6hner%26aufirst%3DH.%26aulast%3DD%25C3%25B6hner%26aufirst%3DK.%26atitle%3DIDH1%2520and%2520IDH2%2520mutations%2520are%2520frequent%2520genetic%2520alterations%2520in%2520acute%2520myeloid%2520leukemia%2520and%2520confer%2520adverse%2520prognosis%2520in%2520cytogenetically%2520normal%2520acute%2520myeloid%2520leukemia%2520with%2520NPM1%2520mutation%2520without%2520FLT3%2520internal%2520tandem%2520duplication%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2010%26volume%3D28%26spage%3D3636%26epage%3D3643%26doi%3D10.1200%2FJCO.2010.28.3762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mardis, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dooling, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLellan, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koboldt, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulton, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delehaunty, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulton, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locke, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magrini, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vickery, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wylie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmichael, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eldred, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peck, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukes, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brummett, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMichael, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schindler, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohl, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallis, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haipek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiechert, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivy, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalicki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ries, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payton, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westervelt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasson, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baty, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagarajan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Link, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubert, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiPersio, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ley, T. J.</span></span> <span> </span><span class="NLM_article-title">Recurring mutations found by sequencing an acute myeloid leukemia genome</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>361</i></span>,  <span class="NLM_fpage">1058</span>– <span class="NLM_lpage">1066</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa0903840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1056%2FNEJMoa0903840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=19657110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFaltLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2009&pages=1058-1066&author=E.+R.+Mardisauthor=L.+Dingauthor=D.+J.+Doolingauthor=D.+E.+Larsonauthor=M.+D.+McLellanauthor=K.+Chenauthor=D.+C.+Koboldtauthor=R.+S.+Fultonauthor=K.+D.+Delehauntyauthor=S.+D.+McGrathauthor=L.+A.+Fultonauthor=D.+P.+Lockeauthor=V.+J.+Magriniauthor=R.+M.+Abbottauthor=T.+L.+Vickeryauthor=J.+S.+Reedauthor=J.+S.+Robinsonauthor=T.+Wylieauthor=S.+M.+Smithauthor=L.+Carmichaelauthor=J.+M.+Eldredauthor=C.+C.+Harrisauthor=J.+Walkerauthor=J.+B.+Peckauthor=F.+Duauthor=A.+F.+Dukesauthor=G.+E.+Sandersonauthor=A.+M.+Brummettauthor=E.+Clarkauthor=J.+F.+McMichaelauthor=R.+J.+Meyerauthor=J.+K.+Schindlerauthor=C.+S.+Pohlauthor=J.+W.+Wallisauthor=X.+Shiauthor=L.+Linauthor=H.+Schmidtauthor=Y.+Tangauthor=C.+Haipekauthor=M.+E.+Wiechertauthor=J.+V.+Ivyauthor=J.+Kalickiauthor=G.+Elliottauthor=R.+E.+Riesauthor=J.+E.+Paytonauthor=P.+Westerveltauthor=M.+H.+Tomassonauthor=M.+A.+Watsonauthor=J.+Batyauthor=S.+Heathauthor=W.+D.+Shannonauthor=R.+Nagarajanauthor=D.+C.+Linkauthor=M.+J.+Walterauthor=T.+A.+Graubertauthor=J.+F.+DiPersioauthor=R.+K.+Wilsonauthor=T.+J.+Ley&title=Recurring+mutations+found+by+sequencing+an+acute+myeloid+leukemia+genome&doi=10.1056%2FNEJMoa0903840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Recurring mutations found by sequencing an acute myeloid leukemia genome</span></div><div class="casAuthors">Mardis, Elaine R.; Ding, Li; Dooling, David J.; Larson, David E.; McLellan, Michael D.; Chen, Ken; Koboldt, Daniel C.; Fulton, Robert S.; Delehaunty, Kim D.; McGrath, Sean D.; Fulton, Lucinda A.; Locke, Devin P.; Magrini, Vincent J.; Abbott, Rachel M.; Vickery, Tammi L.; Reed, Jerry S.; Robinson, Jody S.; Wylie, Todd; Smith, Scott M.; Carmichael, Lynn; Eldred, James M.; Harris, Christopher C.; Walker, Jason; Peck, Joshua B.; Du, Feiyu; Dukes, Adam F.; Sanderson, Gabriel E.; Brummett, Anthony M.; Clark, Eric; McMichael, Joshua F.; Meyer, Rick J.; Schindler, Jonathan K.; Pohl, Craig S.; Wallis, John W.; Shi, Xiaoqi; Lin, Ling; Schmidt, Heather; Tang, Yuzhu; Haipek, Carrie; Wiechert, Madeline E.; Ivy, Jolynda V.; Kalicki, Joelle; Elliott, Glendoria; Ries, Rhonda E.; Payton, Jacqueline E.; Westervelt, Peter; Tomasson, Michael H.; Watson, Mark A.; Baty, Jack; Heath, Sharon; Shannon, William D.; Nagarajan, Rakesh; Link, Daniel C.; Walter, Matthew J.; Graubert, Timothy A.; Dipersio, John F.; Wilson, Richard K.; Ley, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1058-1066</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND The full complement of DNA mutations that are responsible for the pathogenesis of acute myeloid leukemia (AML) is not yet known.  METHODS We used massively parallel DNA sequencing to obtain a very high level of coverage (approx. 98%) of a primary, cytogenetically normal, de novo genome for AML with minimal maturation (AML-M1) and a matched normal skin genome.  RESULTS We identified 12 acquired (somatic) mutations within the coding sequences of genes and 52 somatic point mutations in conserved or regulatory portions of the genome.  All mutations appeared to be heterozygous and present in nearly all cells in the tumor sample.  Four of the 64 mutations occurred in at least 1 addnl. AML sample in 188 samples that were tested.  Mutations in NRAS and NPM1 had been identified previously in patients with AML, but two other mutations had not been identified.  One of these mutations, in the IDH1 gene, was present in 15 of 187 addnl. AML genomes tested and was strongly assocd. with normal cytogenetic status; it was present in 13 of 80 cytogenetically normal samples (16%).  The other was a nongenic mutation in a genomic region with regulatory potential and conservation in higher mammals; we detected it in one addnl. AML tumor.  The AML genome that we sequenced contains approx. 750 point mutations, of which only a small fraction are likely to be relevant to pathogenesis.  CONCLUSIONS By comparing the sequences of tumor and skin genomes of a patient with AML-M1, we have identified recurring mutations that may be relevant for pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1qF271txIDrVg90H21EOLACvtfcHk0lga2QK6xgB3GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFaltLvL&md5=8ed6e59ccc06b690d4855d65cb5757b8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0903840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0903840%26sid%3Dliteratum%253Aachs%26aulast%3DMardis%26aufirst%3DE.%2BR.%26aulast%3DDing%26aufirst%3DL.%26aulast%3DDooling%26aufirst%3DD.%2BJ.%26aulast%3DLarson%26aufirst%3DD.%2BE.%26aulast%3DMcLellan%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DKoboldt%26aufirst%3DD.%2BC.%26aulast%3DFulton%26aufirst%3DR.%2BS.%26aulast%3DDelehaunty%26aufirst%3DK.%2BD.%26aulast%3DMcGrath%26aufirst%3DS.%2BD.%26aulast%3DFulton%26aufirst%3DL.%2BA.%26aulast%3DLocke%26aufirst%3DD.%2BP.%26aulast%3DMagrini%26aufirst%3DV.%2BJ.%26aulast%3DAbbott%26aufirst%3DR.%2BM.%26aulast%3DVickery%26aufirst%3DT.%2BL.%26aulast%3DReed%26aufirst%3DJ.%2BS.%26aulast%3DRobinson%26aufirst%3DJ.%2BS.%26aulast%3DWylie%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DS.%2BM.%26aulast%3DCarmichael%26aufirst%3DL.%26aulast%3DEldred%26aufirst%3DJ.%2BM.%26aulast%3DHarris%26aufirst%3DC.%2BC.%26aulast%3DWalker%26aufirst%3DJ.%26aulast%3DPeck%26aufirst%3DJ.%2BB.%26aulast%3DDu%26aufirst%3DF.%26aulast%3DDukes%26aufirst%3DA.%2BF.%26aulast%3DSanderson%26aufirst%3DG.%2BE.%26aulast%3DBrummett%26aufirst%3DA.%2BM.%26aulast%3DClark%26aufirst%3DE.%26aulast%3DMcMichael%26aufirst%3DJ.%2BF.%26aulast%3DMeyer%26aufirst%3DR.%2BJ.%26aulast%3DSchindler%26aufirst%3DJ.%2BK.%26aulast%3DPohl%26aufirst%3DC.%2BS.%26aulast%3DWallis%26aufirst%3DJ.%2BW.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DSchmidt%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DHaipek%26aufirst%3DC.%26aulast%3DWiechert%26aufirst%3DM.%2BE.%26aulast%3DIvy%26aufirst%3DJ.%2BV.%26aulast%3DKalicki%26aufirst%3DJ.%26aulast%3DElliott%26aufirst%3DG.%26aulast%3DRies%26aufirst%3DR.%2BE.%26aulast%3DPayton%26aufirst%3DJ.%2BE.%26aulast%3DWestervelt%26aufirst%3DP.%26aulast%3DTomasson%26aufirst%3DM.%2BH.%26aulast%3DWatson%26aufirst%3DM.%2BA.%26aulast%3DBaty%26aufirst%3DJ.%26aulast%3DHeath%26aufirst%3DS.%26aulast%3DShannon%26aufirst%3DW.%2BD.%26aulast%3DNagarajan%26aufirst%3DR.%26aulast%3DLink%26aufirst%3DD.%2BC.%26aulast%3DWalter%26aufirst%3DM.%2BJ.%26aulast%3DGraubert%26aufirst%3DT.%2BA.%26aulast%3DDiPersio%26aufirst%3DJ.%2BF.%26aulast%3DWilson%26aufirst%3DR.%2BK.%26aulast%3DLey%26aufirst%3DT.%2BJ.%26atitle%3DRecurring%2520mutations%2520found%2520by%2520sequencing%2520an%2520acute%2520myeloid%2520leukemia%2520genome%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D1058%26epage%3D1066%26doi%3D10.1056%2FNEJMoa0903840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLendon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasheed, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kos, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batinic-Haberle, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riggins, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reardon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herndon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzler, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velculescu, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigner, D. D.</span></span> <span> </span><span class="NLM_article-title">IDH1 and IDH2 mutations in gliomas</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>360</i></span>,  <span class="NLM_fpage">765</span>– <span class="NLM_lpage">773</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa0808710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1056%2FNEJMoa0808710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=19228619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitFWru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2009&pages=765-773&author=H.+Yanauthor=D.+W.+Parsonsauthor=G.+Jinauthor=R.+McLendonauthor=B.+A.+Rasheedauthor=W.+Yuanauthor=I.+Kosauthor=I.+Batinic-Haberleauthor=S.+Jonesauthor=G.+J.+Rigginsauthor=H.+Friedmanauthor=A.+Friedmanauthor=D.+Reardonauthor=J.+Herndonauthor=K.+W.+Kinzlerauthor=V.+E.+Velculescuauthor=B.+Vogelsteinauthor=D.+D.+Bigner&title=IDH1+and+IDH2+mutations+in+gliomas&doi=10.1056%2FNEJMoa0808710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">IDH1 and IDH2 mutations in gliomas</span></div><div class="casAuthors">Yan, Hai; Parsons, D. Williams; Jin, Genglin; McLendon, Roger; Ahmed Rasheed, B.; Yuan, Weishi; Kos, Ivan; Batinic-Haberle, Ines; Jones, Sian; Riggins, Gregory J.; Friedman, Henry; Friedman, Allan; Reardon, David; Herndon, James; Kinzler, Kenneth W.; Velculescu, Victor E.; Vogelstein, Bert; Bigner, Darell D.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">765-773</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: A recent genomewide mutational anal. of glioblastomas (World Health Organization [WHO] grade IV glioma) revealed somatic mutations of the isocitrate dehydrogenase 1 gene (IDH1) in a fraction of such tumors, most frequently in tumors that were known to have evolved from lower-grade gliomas (secondary glioblastomas).  METHODS: We detd. the sequence of the IDH1 gene and the related IDH2 gene in 445 central nervous system (CNS) tumors and 494 non-CNS tumors.  The enzymic activity of the proteins that were produced from normal and mutant IDH1 and IDH2 genes was detd. in cultured glioma cells that were transfected with these genes.  RESULTS: We identified mutations that affected amino acid 132 of IDH1 in more than 70% of WHO grade II and III astrocytomas and oligodendrogliomas and in glioblastomas that developed from these lower-grade lesions.  Tumors without mutations in IDH1 often had mutations affecting the analogous amino acid (R172) of the IDH2 gene.  Tumors with IDH1 or IDH2 mutations had distinctive genetic and clin. characteristics, and patients with such tumors had a better outcome than those with wild-type IDH genes.  Each of four tested IDH1 and IDH2 mutations reduced the enzymic activity of the encoded protein.  CONCLUSIONS: Mutations of NADP+-dependent isocitrate dehydrogenases encoded by IDH1 and IDH2 occur in a majority of several types of malignant gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMldYfHJnRn7Vg90H21EOLACvtfcHk0liasLl4f52tVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitFWru7o%253D&md5=2b3b5db5e16f3714f3ed6cab86939031</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0808710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0808710%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DH.%26aulast%3DParsons%26aufirst%3DD.%2BW.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DMcLendon%26aufirst%3DR.%26aulast%3DRasheed%26aufirst%3DB.%2BA.%26aulast%3DYuan%26aufirst%3DW.%26aulast%3DKos%26aufirst%3DI.%26aulast%3DBatinic-Haberle%26aufirst%3DI.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DFriedman%26aufirst%3DH.%26aulast%3DFriedman%26aufirst%3DA.%26aulast%3DReardon%26aufirst%3DD.%26aulast%3DHerndon%26aufirst%3DJ.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26atitle%3DIDH1%2520and%2520IDH2%2520mutations%2520in%2520gliomas%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D360%26spage%3D765%26epage%3D773%26doi%3D10.1056%2FNEJMoa0808710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawlik, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anders, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selaru, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streppel, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niknafs, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guthrie, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argani, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offerhaus, G. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roa, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gores, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popescu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandrescu, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fassan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simbolo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mafficini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capelli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawlor, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzenente, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guglielmi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortora, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Braud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarnagin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klimstra, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karchin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velculescu, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruban, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzler, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulos, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, L. D.</span></span> <span> </span><span class="NLM_article-title">Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1470</span>– <span class="NLM_lpage">1473</span>, <span class="refDoi"> DOI: 10.1038/ng.2813</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1038%2Fng.2813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=24185509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWjtb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2013&pages=1470-1473&author=Y.+Jiaoauthor=T.+M.+Pawlikauthor=R.+A.+Andersauthor=F.+M.+Selaruauthor=M.+M.+Streppelauthor=D.+J.+Lucasauthor=N.+Niknafsauthor=V.+B.+Guthrieauthor=A.+Maitraauthor=P.+Arganiauthor=G.+J.+A.+Offerhausauthor=J.+C.+Roaauthor=L.+R.+Robertsauthor=G.+J.+Goresauthor=I.+Popescuauthor=S.+T.+Alexandrescuauthor=S.+Dimaauthor=M.+Fassanauthor=M.+Simboloauthor=A.+Mafficiniauthor=P.+Capelliauthor=R.+T.+Lawlorauthor=A.+Ruzzenenteauthor=A.+Guglielmiauthor=G.+Tortoraauthor=F.+de+Braudauthor=A.+Scarpaauthor=W.+Jarnaginauthor=D.+Klimstraauthor=R.+Karchinauthor=V.+E.+Velculescuauthor=R.+H.+Hrubanauthor=B.+Vogelsteinauthor=K.+W.+Kinzlerauthor=N.+Papadopoulosauthor=L.+D.+Wood&title=Exome+sequencing+identifies+frequent+inactivating+mutations+in+BAP1%2C+ARID1A+and+PBRM1+in+intrahepatic+cholangiocarcinomas&doi=10.1038%2Fng.2813"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas</span></div><div class="casAuthors">Jiao, Yuchen; Pawlik, Timothy M.; Anders, Robert A.; Selaru, Florin M.; Streppel, Mirte M.; Lucas, Donald J.; Niknafs, Noushin; Guthrie, Violeta Beleva; Maitra, Anirban; Argani, Pedram; Offerhaus, G. Johan A.; Roa, Juan Carlos; Roberts, Lewis R.; Gores, Gregory J.; Popescu, Irinel; Alexandrescu, Sorin T.; Dima, Simona; Fassan, Matteo; Simbolo, Michele; Mafficini, Andrea; Capelli, Paola; Lawlor, Rita T.; Ruzzenente, Andrea; Guglielmi, Alfredo; Tortora, Giampaolo; de Braud, Filippo; Scarpa, Aldo; Jarnagin, William; Klimstra, David; Karchin, Rachel; Velculescu, Victor E.; Hruban, Ralph H.; Vogelstein, Bert; Kinzler, Kenneth W.; Papadopoulos, Nickolas; Wood, Laura D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1470-1473</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Through exomic sequencing of 32 intrahepatic cholangiocarcinomas, we discovered frequent inactivating mutations in multiple chromatin-remodeling genes (including BAP1, ARID1A and PBRM1), and mutation in one of these genes occurred in almost half of the carcinomas sequenced.  We also identified frequent mutations at previously reported hotspots in the IDH1 and IDH2 genes encoding metabolic enzymes in intrahepatic cholangiocarcinomas.  In contrast, TP53 was the most frequently altered gene in a series of nine gallbladder carcinomas.  These discoveries highlight the key role of dysregulated chromatin remodeling in intrahepatic cholangiocarcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8u7jSQOsIHbVg90H21EOLACvtfcHk0liasLl4f52tVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWjtb7J&md5=02fd339f0a64e9611c11f3e2ff0c157f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fng.2813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.2813%26sid%3Dliteratum%253Aachs%26aulast%3DJiao%26aufirst%3DY.%26aulast%3DPawlik%26aufirst%3DT.%2BM.%26aulast%3DAnders%26aufirst%3DR.%2BA.%26aulast%3DSelaru%26aufirst%3DF.%2BM.%26aulast%3DStreppel%26aufirst%3DM.%2BM.%26aulast%3DLucas%26aufirst%3DD.%2BJ.%26aulast%3DNiknafs%26aufirst%3DN.%26aulast%3DGuthrie%26aufirst%3DV.%2BB.%26aulast%3DMaitra%26aufirst%3DA.%26aulast%3DArgani%26aufirst%3DP.%26aulast%3DOfferhaus%26aufirst%3DG.%2BJ.%2BA.%26aulast%3DRoa%26aufirst%3DJ.%2BC.%26aulast%3DRoberts%26aufirst%3DL.%2BR.%26aulast%3DGores%26aufirst%3DG.%2BJ.%26aulast%3DPopescu%26aufirst%3DI.%26aulast%3DAlexandrescu%26aufirst%3DS.%2BT.%26aulast%3DDima%26aufirst%3DS.%26aulast%3DFassan%26aufirst%3DM.%26aulast%3DSimbolo%26aufirst%3DM.%26aulast%3DMafficini%26aufirst%3DA.%26aulast%3DCapelli%26aufirst%3DP.%26aulast%3DLawlor%26aufirst%3DR.%2BT.%26aulast%3DRuzzenente%26aufirst%3DA.%26aulast%3DGuglielmi%26aufirst%3DA.%26aulast%3DTortora%26aufirst%3DG.%26aulast%3Dde%2BBraud%26aufirst%3DF.%26aulast%3DScarpa%26aufirst%3DA.%26aulast%3DJarnagin%26aufirst%3DW.%26aulast%3DKlimstra%26aufirst%3DD.%26aulast%3DKarchin%26aufirst%3DR.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DPapadopoulos%26aufirst%3DN.%26aulast%3DWood%26aufirst%3DL.%2BD.%26atitle%3DExome%2520sequencing%2520identifies%2520frequent%2520inactivating%2520mutations%2520in%2520BAP1%252C%2520ARID1A%2520and%2520PBRM1%2520in%2520intrahepatic%2520cholangiocarcinomas%26jtitle%3DNat.%2520Genet.%26date%3D2013%26volume%3D45%26spage%3D1470%26epage%3D1473%26doi%3D10.1038%2Fng.2813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittinger, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driggers, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantin, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keenan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prins, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liau, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vander Heiden, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S. M.</span></span> <span> </span><span class="NLM_article-title">Cancer-associated IDH1 mutations produce 2-hydroxyglutarate</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>462</i></span>,  <span class="NLM_fpage">739</span>– <span class="NLM_lpage">744</span>, <span class="refDoi"> DOI: 10.1038/nature08617</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1038%2Fnature08617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=19935646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGlurzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=2009&pages=739-744&author=L.+Dangauthor=D.+W.+Whiteauthor=S.+Grossauthor=B.+D.+Bennettauthor=M.+A.+Bittingerauthor=E.+M.+Driggersauthor=V.+R.+Fantinauthor=H.+G.+Jangauthor=S.+Jinauthor=M.+C.+Keenanauthor=K.+M.+Marksauthor=R.+M.+Prinsauthor=P.+S.+Wardauthor=K.+E.+Yenauthor=L.+M.+Liauauthor=J.+D.+Rabinowitzauthor=L.+C.+Cantleyauthor=C.+B.+Thompsonauthor=M.+G.+Vander+Heidenauthor=S.+M.+Su&title=Cancer-associated+IDH1+mutations+produce+2-hydroxyglutarate&doi=10.1038%2Fnature08617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer-associated IDH1 mutations produce 2-hydroxyglutarate</span></div><div class="casAuthors">Dang, Lenny; White, David W.; Gross, Stefan; Bennett, Bryson D.; Bittinger, Mark A.; Driggers, Edward M.; Fantin, Valeria R.; Jang, Hyun-Gyung; Jin, Shengfang; Keenan, Marie C.; Marks, Kevin M.; Prins, Robert M.; Ward, Patrick S.; Yen, Katharine E.; Liau, Linda M.; Rabinowitz, Joshua D.; Cantley, Lewis C.; Thompson, Craig B.; Vander Heiden, Matthew G.; Su, Shinsan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">462</span>
        (<span class="NLM_cas:issue">7274</span>),
    <span class="NLM_cas:pages">739-744</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in the enzyme cytosolic isocitrate dehydrogenase 1 (IDH1) are a common feature of a major subset of primary human brain cancers.  These mutations occur at a single amino acid residue of the IDH1 active site, resulting in loss of the enzyme's ability to catalyze conversion of isocitrate to α-ketoglutarate.  However, only a single copy of the gene is mutated in tumors, raising the possibility that the mutations do not result in a simple loss of function.  Here we show that cancer-assocd. IDH1 mutations result in a new ability of the enzyme to catalyze the NADPH-dependent redn. of α-ketoglutarate to R(-)-2-hydroxyglutarate (2HG).  Structural studies demonstrate that when arginine 132 is mutated to histidine, residues in the active site are shifted to produce structural changes consistent with reduced oxidative decarboxylation of isocitrate and acquisition of the ability to convert α-ketoglutarate to 2HG.  Excess accumulation of 2HG has been shown to lead to an elevated risk of malignant brain tumors in patients with inborn errors of 2HG metab.  Similarly, in human malignant gliomas harbouring IDH1 mutations, we find markedly elevated levels of 2HG.  These data demonstrate that the IDH1 mutations result in prodn. of the onco-metabolite 2HG, and indicate that the excess 2HG which accumulates in vivo contributes to the formation and malignant progression of gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkIgPaD-aavrVg90H21EOLACvtfcHk0li8Y_YO_Jnlwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGlurzE&md5=b8661605276da5cbd92641e45c5b8c87</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnature08617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08617%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DD.%2BW.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBittinger%26aufirst%3DM.%2BA.%26aulast%3DDriggers%26aufirst%3DE.%2BM.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DJang%26aufirst%3DH.%2BG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKeenan%26aufirst%3DM.%2BC.%26aulast%3DMarks%26aufirst%3DK.%2BM.%26aulast%3DPrins%26aufirst%3DR.%2BM.%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DLiau%26aufirst%3DL.%2BM.%26aulast%3DRabinowitz%26aufirst%3DJ.%2BD.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DSu%26aufirst%3DS.%2BM.%26atitle%3DCancer-associated%2520IDH1%2520mutations%2520produce%25202-hydroxyglutarate%26jtitle%3DNature%26date%3D2009%26volume%3D462%26spage%3D739%26epage%3D744%26doi%3D10.1038%2Fnature08617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairns, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minden, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driggers, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittinger, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkein, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantin, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>207</i></span>,  <span class="NLM_fpage">339</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.1084/jem.20092506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1084%2Fjem.20092506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=20142433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFGqur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2010&pages=339-344&author=S.+Grossauthor=R.+A.+Cairnsauthor=M.+D.+Mindenauthor=E.+M.+Driggersauthor=M.+A.+Bittingerauthor=H.+G.+Jangauthor=M.+Sasakiauthor=S.+Jinauthor=D.+P.+Schenkeinauthor=S.+M.+Suauthor=L.+Dangauthor=V.+R.+Fantinauthor=T.+W.+Mak&title=Cancer-associated+metabolite+2-hydroxyglutarate+accumulates+in+acute+myelogenous+leukemia+with+isocitrate+dehydrogenase+1+and+2+mutations&doi=10.1084%2Fjem.20092506"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations</span></div><div class="casAuthors">Gross, Stefan; Cairns, Rob A.; Minden, Mark D.; Driggers, Edward M.; Bittinger, Mark A.; Jang, Hyun Gyung; Sasaki, Masato; Jin, Shengfang; Schenkein, David P.; Su, Shinsan M.; Dang, Lenny; Fantin, Valeria R.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">339-344</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Mutations in isocitrate dehydrogenase 1 and 2 (IDH1/2), are present in most gliomas and secondary glioblastomas, but are rare in other neoplasms.  IDH1/2 mutations are heterozygous, and affect a single Arg residue.  Recently, IDH1 mutations were identified in 8% of acute myelogenous leukemia (AML) patients.  A glioma study revealed that IDH1 mutations cause a gain-of-function, resulting in the prodn. and accumulation of 2-hydroxyglutarate (2-HG).  Genotyping of 145 AML biopsies identified 11 IDH1 R132 mutant samples.  Liq. chromatog.-mass spectrometry metabolite screening revealed increased 2-HG levels in IDH1 R132 mutant cells and sera, and uncovered 2 IDH2 R172K mutations.  IDH1/2 mutations were assocd. with normal karyotypes.  Recombinant IDH1 R132C and IDH2 R172K proteins catalyze the novel NADP (NADPH)-dependent redn. of α-ketoglutarate (α-KG) to 2-HG.  The IDH1 R132C mutation commonly found in AML reduces the affinity for isocitrate, and increases the affinity for NADPH and α-KG.  This prevents the oxidative decarboxylation of isocitrate to α-KG, and facilitates the conversion of α-KG to 2-HG.  IDH1/2 mutations confer an enzymic gain of function that dramatically increases 2-HG in AML.  This provides an explanation for the heterozygous acquisition of these mutations during tumorigenesis.  2-HG is a tractable metabolic biomarker of mutant IDH1/2 enzyme activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8uyv8xo4qzLVg90H21EOLACvtfcHk0li8Y_YO_Jnlwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFGqur0%253D&md5=7e900e78bc4b5a715c504272d6248551</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1084%2Fjem.20092506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20092506%26sid%3Dliteratum%253Aachs%26aulast%3DGross%26aufirst%3DS.%26aulast%3DCairns%26aufirst%3DR.%2BA.%26aulast%3DMinden%26aufirst%3DM.%2BD.%26aulast%3DDriggers%26aufirst%3DE.%2BM.%26aulast%3DBittinger%26aufirst%3DM.%2BA.%26aulast%3DJang%26aufirst%3DH.%2BG.%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DSchenkein%26aufirst%3DD.%2BP.%26aulast%3DSu%26aufirst%3DS.%2BM.%26aulast%3DDang%26aufirst%3DL.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DCancer-associated%2520metabolite%25202-hydroxyglutarate%2520accumulates%2520in%2520acute%2520myelogenous%2520leukemia%2520with%2520isocitrate%2520dehydrogenase%25201%2520and%25202%2520mutations%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2010%26volume%3D207%26spage%3D339%26epage%3D344%26doi%3D10.1084%2Fjem.20092506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stein, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K.</span></span> <span> </span><span class="NLM_article-title">Targeted differentiation therapy with mutant IDH inhibitors: early experiences and parallels with other differentiation agents</span>. <i>Annu. Rev. Cancer Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1146/annurev-cancerbio-050216-122051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1146%2Fannurev-cancerbio-050216-122051" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2017&pages=379-401&author=E.+Steinauthor=K.+Yen&title=Targeted+differentiation+therapy+with+mutant+IDH+inhibitors%3A+early+experiences+and+parallels+with+other+differentiation+agents&doi=10.1146%2Fannurev-cancerbio-050216-122051"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1146%2Fannurev-cancerbio-050216-122051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-cancerbio-050216-122051%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DE.%26aulast%3DYen%26aufirst%3DK.%26atitle%3DTargeted%2520differentiation%2520therapy%2520with%2520mutant%2520IDH%2520inhibitors%253A%2520early%2520experiences%2520and%2520parallels%2520with%2520other%2520differentiation%2520agents%26jtitle%3DAnnu.%2520Rev.%2520Cancer%2520Biol.%26date%3D2017%26volume%3D1%26spage%3D379%26epage%3D401%26doi%3D10.1146%2Fannurev-cancerbio-050216-122051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Menendez, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alarcón, T.</span></span> <span> </span><span class="NLM_article-title">Metabostemness: a new cancer hallmark</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">262</span>, <span class="refDoi"> DOI: 10.3389/fonc.2014.00262</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.3389%2Ffonc.2014.00262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=25325014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A280%3ADC%252BC2M3hsFegtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=262&author=J.+A.+Menendezauthor=T.+Alarc%C3%B3n&title=Metabostemness%3A+a+new+cancer+hallmark&doi=10.3389%2Ffonc.2014.00262"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Metabostemness: a new cancer hallmark</span></div><div class="casAuthors">Menendez Javier A; Alarcon Tomas</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">262</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">The acquisition of and departure from stemness in cancer tissues might not only be hardwired by genetic controllers, but also by the pivotal regulatory role of the cellular metabotype, which may act as a "starter dough" for cancer stemness traits.  We have coined the term metabostemness to refer to the metabolic parameters causally controlling or functionally substituting the epitranscriptional orchestration of the genetic reprograming that redirects normal and tumor cells toward less-differentiated cancer stem cell (CSC) cellular states.  Certain metabotypic alterations might operate as pivotal molecular events rendering a cell of origin susceptible to epigenetic rewiring required for the acquisition of aberrant stemness and, concurrently, of refractoriness to differentiation.  The metabostemness attribute can remove, diminish, or modify the nature of molecular barriers present in Waddington's epigenetic landscapes, thus allowing differentiated cells to more easily (re)-enter into CSC cellular macrostates.  Activation of the metabostemness trait can poise cells with chromatin states competent for rapid dedifferentiation while concomitantly setting the idoneous metabolic stage for later reprograming stimuli to finish the journey from non-cancerous into tumor-initiating cells.  Because only a few permitted metabotypes will be compatible with the operational properties owned by CSC cellular states, the metabostemness property provides a new framework through which to pharmacologically resolve the apparently impossible problem of discovering drugs aimed to target the molecular biology of the cancer stemness itself.  The metabostemness cancer hallmark generates a shifting oncology theory that should guide a new era of metabolo-epigenetic cancer precision medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTh5KwHvDODHhgd2Wuil24tfW6udTcc2eYpWwilnZJYSLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3hsFegtQ%253D%253D&md5=6e9b19cc3eaaaf39a515182bdf441ea3</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2014.00262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2014.00262%26sid%3Dliteratum%253Aachs%26aulast%3DMenendez%26aufirst%3DJ.%2BA.%26aulast%3DAlarc%25C3%25B3n%26aufirst%3DT.%26atitle%3DMetabostemness%253A%2520a%2520new%2520cancer%2520hallmark%26jtitle%3DFront.%2520Oncol.%26date%3D2014%26volume%3D4%26spage%3D262%26doi%3D10.3389%2Ffonc.2014.00262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noushmehr, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisenberger, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diefes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berman, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelloski, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulman, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhaak, R. G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoadley, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perou, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Berg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bengtsson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuvial, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cope, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baylin, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laird, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldape, K.</span></span> <span> </span><span class="NLM_article-title">Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">510</span>– <span class="NLM_lpage">522</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2010.03.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1016%2Fj.ccr.2010.03.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=510-522&author=H.+Noushmehrauthor=D.+J.+Weisenbergerauthor=K.+Diefesauthor=H.+S.+Phillipsauthor=K.+Pujaraauthor=B.+P.+Bermanauthor=F.+Panauthor=C.+E.+Pelloskiauthor=E.+P.+Sulmanauthor=K.+P.+Bhatauthor=R.+G.+W.+Verhaakauthor=K.+A.+Hoadleyauthor=D.+N.+Hayesauthor=C.+M.+Perouauthor=H.+K.+Schmidtauthor=L.+Dingauthor=R.+K.+Wilsonauthor=D.+Van+Den+Bergauthor=H.+Shenauthor=H.+Bengtssonauthor=P.+Neuvialauthor=L.+M.+Copeauthor=J.+Buckleyauthor=J.+G.+Hermanauthor=S.+B.+Baylinauthor=P.+W.+Lairdauthor=K.+Aldape&title=Identification+of+a+CpG+island+methylator+phenotype+that+defines+a+distinct+subgroup+of+glioma&doi=10.1016%2Fj.ccr.2010.03.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2010.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2010.03.017%26sid%3Dliteratum%253Aachs%26aulast%3DNoushmehr%26aufirst%3DH.%26aulast%3DWeisenberger%26aufirst%3DD.%2BJ.%26aulast%3DDiefes%26aufirst%3DK.%26aulast%3DPhillips%26aufirst%3DH.%2BS.%26aulast%3DPujara%26aufirst%3DK.%26aulast%3DBerman%26aufirst%3DB.%2BP.%26aulast%3DPan%26aufirst%3DF.%26aulast%3DPelloski%26aufirst%3DC.%2BE.%26aulast%3DSulman%26aufirst%3DE.%2BP.%26aulast%3DBhat%26aufirst%3DK.%2BP.%26aulast%3DVerhaak%26aufirst%3DR.%2BG.%2BW.%26aulast%3DHoadley%26aufirst%3DK.%2BA.%26aulast%3DHayes%26aufirst%3DD.%2BN.%26aulast%3DPerou%26aufirst%3DC.%2BM.%26aulast%3DSchmidt%26aufirst%3DH.%2BK.%26aulast%3DDing%26aufirst%3DL.%26aulast%3DWilson%26aufirst%3DR.%2BK.%26aulast%3DVan%2BDen%2BBerg%26aufirst%3DD.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DBengtsson%26aufirst%3DH.%26aulast%3DNeuvial%26aufirst%3DP.%26aulast%3DCope%26aufirst%3DL.%2BM.%26aulast%3DBuckley%26aufirst%3DJ.%26aulast%3DHerman%26aufirst%3DJ.%2BG.%26aulast%3DBaylin%26aufirst%3DS.%2BB.%26aulast%3DLaird%26aufirst%3DP.%2BW.%26aulast%3DAldape%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520a%2520CpG%2520island%2520methylator%2520phenotype%2520that%2520defines%2520a%2520distinct%2520subgroup%2520of%2520glioma%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D17%26spage%3D510%26epage%3D522%26doi%3D10.1016%2Fj.ccr.2010.03.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travins, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLaBarre, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penard-Lacronique, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schalm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kernytsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gliser, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saada, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mylonas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quivoron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovici-Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salituro, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agresta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkein, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biller, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Botton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K. E.</span></span> <span> </span><span class="NLM_article-title">Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>340</i></span>,  <span class="NLM_fpage">622</span>– <span class="NLM_lpage">626</span>, <span class="refDoi"> DOI: 10.1126/science.1234769</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1126%2Fscience.1234769" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=23558173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslWksbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2013&pages=622-626&author=F.+Wangauthor=J.+Travinsauthor=B.+DeLaBarreauthor=V.+Penard-Lacroniqueauthor=S.+Schalmauthor=E.+Hansenauthor=K.+Straleyauthor=A.+Kernytskyauthor=W.+Liuauthor=C.+Gliserauthor=H.+Yangauthor=S.+Grossauthor=E.+Artinauthor=V.+Saadaauthor=E.+Mylonasauthor=C.+Quivoronauthor=J.+Popovici-Mullerauthor=J.+O.+Saundersauthor=F.+G.+Salituroauthor=S.+Yanauthor=S.+Murrayauthor=W.+Weiauthor=Y.+Gaoauthor=L.+Dangauthor=M.+Dorschauthor=S.+Agrestaauthor=D.+P.+Schenkeinauthor=S.+A.+Billerauthor=S.+M.+Suauthor=S.+de+Bottonauthor=K.+E.+Yen&title=Targeted+inhibition+of+mutant+IDH2+in+leukemia+cells+induces+cellular+differentiation&doi=10.1126%2Fscience.1234769"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation</span></div><div class="casAuthors">Wang, Fang; Travins, Jeremy; De La Barre, Byron; Penard-Lacronique, Virginie; Schalm, Stefanie; Hansen, Erica; Straley, Kimberly; Kernytsky, Andrew; Liu, Wei; Gliser, Camelia; Yang, Hua; Gross, Stefan; Artin, Erin; Saada, Veronique; Mylonas, Elena; Quivoron, Cyril; Popovici-Muller, Janeta; Saunders, Jeffrey O.; Salituro, Francesco G.; Yan, Shunqi; Murray, Stuart; Wei, Wentao; Gao, Yi; Dang, Lenny; Dorsch, Marion; Agresta, Sam; Schenkein, David P.; Biller, Scott A.; Su, Shinsan M.; de Botton, Stephane; Yen, Katharine E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">6132</span>),
    <span class="NLM_cas:pages">622-626</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A no. of human cancers harbor somatic point mutations in the genes encoding isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2).  These mutations alter residues in the enzyme active sites and confer a gain-of-function in cancer cells, resulting in the accumulation and secretion of the oncometabolite (R)-2-hydroxyglutarate (2HG).  We developed a small mol., AGI-6780, that potently and selectively inhibits the tumor-assocd. mutant IDH2/R140Q.  A crystal structure of AGI-6780 complexed with IDH2/R140Q revealed that the inhibitor binds in an allosteric manner at the dimer interface.  The results of steady-state enzymol. anal. were consistent with allostery and slow-tight binding by AGI-6780.  Treatment with AGI-6780 induced differentiation of TF-1 erythroleukemia and primary human acute myelogenous leukemia cells in vitro.  These data provide proof-of-concept that inhibitors targeting mutant IDH2/R140Q could have potential applications as a differentiation therapy for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAdwmeRjaBrLVg90H21EOLACvtfcHk0lgIJ3g4znT_rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslWksbs%253D&md5=fe3db6b043a8b31fb661d0bdbd75e19f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1126%2Fscience.1234769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1234769%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DF.%26aulast%3DTravins%26aufirst%3DJ.%26aulast%3DDeLaBarre%26aufirst%3DB.%26aulast%3DPenard-Lacronique%26aufirst%3DV.%26aulast%3DSchalm%26aufirst%3DS.%26aulast%3DHansen%26aufirst%3DE.%26aulast%3DStraley%26aufirst%3DK.%26aulast%3DKernytsky%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DGliser%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DArtin%26aufirst%3DE.%26aulast%3DSaada%26aufirst%3DV.%26aulast%3DMylonas%26aufirst%3DE.%26aulast%3DQuivoron%26aufirst%3DC.%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DSaunders%26aufirst%3DJ.%2BO.%26aulast%3DSalituro%26aufirst%3DF.%2BG.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DMurray%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DDang%26aufirst%3DL.%26aulast%3DDorsch%26aufirst%3DM.%26aulast%3DAgresta%26aufirst%3DS.%26aulast%3DSchenkein%26aufirst%3DD.%2BP.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DSu%26aufirst%3DS.%2BM.%26aulast%3Dde%2BBotton%26aufirst%3DS.%26aulast%3DYen%26aufirst%3DK.%2BE.%26atitle%3DTargeted%2520inhibition%2520of%2520mutant%2520IDH2%2520in%2520leukemia%2520cells%2520induces%2520cellular%2520differentiation%26jtitle%3DScience%26date%3D2013%26volume%3D340%26spage%3D622%26epage%3D626%26doi%3D10.1126%2Fscience.1234769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pusch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Deimling, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zha, X.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel selective inhibitor of mutant isocitrate dehydrogenase 1 at allosteric site by docking-based virtual screening</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">96735</span>– <span class="NLM_lpage">96742</span>, <span class="refDoi"> DOI: 10.1039/C6RA21617J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1039%2FC6RA21617J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFGqs7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=96735-96742&author=F.+Zouauthor=S.+Puschauthor=J.+Eiselauthor=T.+Maauthor=Q.+Zhuauthor=D.+Dengauthor=Y.+Guauthor=Y.+Xuauthor=A.+von+Deimlingauthor=X.+Zha&title=Identification+of+a+novel+selective+inhibitor+of+mutant+isocitrate+dehydrogenase+1+at+allosteric+site+by+docking-based+virtual+screening&doi=10.1039%2FC6RA21617J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel selective inhibitor of mutant isocitrate dehydrogenase 1 at allosteric site by docking-based virtual screening</span></div><div class="casAuthors">Zou, Fangxia; Pusch, Stefan; Eisel, Jessica; Ma, Tianfang; Zhu, Qihua; Deng, Dawei; Gu, Yueqing; Xu, Yungen; von Deimling, Andreas; Zha, Xiaoming</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">99</span>),
    <span class="NLM_cas:pages">96735-96742</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Isocitrate dehydrogenase 1 (IDH1), catalyzing oxidative decarboxylation of isocitrate to provide energy for aerobic organisms, is an essential enzyme in the tricarboxylic acid cycle.  However, mutant IDH1 (mIDH1) produces oncometabolite D-2-hydroxyglutarate (D2HG) and has recently been confirmed in several types of cancers, particularly in glioma and acute myeloid leukemia.  Herein a docking-based virtual screening (VS) of SPECS library was conducted for the allosteric site of mIDH1.  The cellular evaluation of the hit compds. led to the identification of FX-03 as a novel selective mIDH1 inhibitor at allosteric site with IC50 values of 55.50 μM and 68.38 μM in HEK-293T cells transfected with IDH1 R132H and IDH1 R132C, resp.  Importantly, FX-03 owned significant selectivity with no inhibition in HEK-293T cells transfected with IDH1 WT.  These findings indicate that VS of mIDH1's allosteric site represents a useful strategy for discovery of selective mIDH1 inhibitors and FX-03 deserves further optimization as a lead compd. in future study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopLsGrqqr5ZbVg90H21EOLACvtfcHk0lgIJ3g4znT_rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFGqs7jP&md5=65307afede4de3fa7ac412b8c874cb4e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1039%2FC6RA21617J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6RA21617J%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DF.%26aulast%3DPusch%26aufirst%3DS.%26aulast%3DEisel%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DQ.%26aulast%3DDeng%26aufirst%3DD.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26aulast%3DZha%26aufirst%3DX.%26atitle%3DIdentification%2520of%2520a%2520novel%2520selective%2520inhibitor%2520of%2520mutant%2520isocitrate%2520dehydrogenase%25201%2520at%2520allosteric%2520site%2520by%2520docking-based%2520virtual%2520screening%26jtitle%3DRSC%2520Adv.%26date%3D2016%26volume%3D6%26spage%3D96735%26epage%3D96742%26doi%3D10.1039%2FC6RA21617J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Komori, T.</span></span> <span> </span><span class="NLM_article-title">Pathology and genetics of diffuse gliomas in adults</span>. <i>Neurol. Med. Chir.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">28</span>– <span class="NLM_lpage">37</span>, <span class="refDoi"> DOI: 10.2176/nmc.ra.2014-0229</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.2176%2Fnmc.ra.2014-0229" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=28-37&author=T.+Komori&title=Pathology+and+genetics+of+diffuse+gliomas+in+adults&doi=10.2176%2Fnmc.ra.2014-0229"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2176%2Fnmc.ra.2014-0229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2176%252Fnmc.ra.2014-0229%26sid%3Dliteratum%253Aachs%26aulast%3DKomori%26aufirst%3DT.%26atitle%3DPathology%2520and%2520genetics%2520of%2520diffuse%2520gliomas%2520in%2520adults%26jtitle%3DNeurol.%2520Med.%2520Chir.%26date%3D2015%26volume%3D55%26spage%3D28%26epage%3D37%26doi%3D10.2176%2Fnmc.ra.2014-0229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Louis, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reifenberger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Deimling, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figarella-Branger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavenee, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohgaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiestler, O. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleihues, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellison, D. W.</span></span> <span> </span><span class="NLM_article-title">The 2016 world health organization classification of tumors of the central nervous system: a summary</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">803</span>– <span class="NLM_lpage">820</span>, <span class="refDoi"> DOI: 10.1007/s00401-016-1545-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1007%2Fs00401-016-1545-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=27157931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A280%3ADC%252BC28bnsVektA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2016&pages=803-820&author=D.+N.+Louisauthor=A.+Perryauthor=G.+Reifenbergerauthor=A.+von+Deimlingauthor=D.+Figarella-Brangerauthor=W.+K.+Caveneeauthor=H.+Ohgakiauthor=O.+D.+Wiestlerauthor=P.+Kleihuesauthor=D.+W.+Ellison&title=The+2016+world+health+organization+classification+of+tumors+of+the+central+nervous+system%3A+a+summary&doi=10.1007%2Fs00401-016-1545-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary</span></div><div class="casAuthors">Louis David N; Perry Arie; Reifenberger Guido; Reifenberger Guido; von Deimling Andreas; von Deimling Andreas; Figarella-Branger Dominique; Cavenee Webster K; Ohgaki Hiroko; Wiestler Otmar D; Kleihues Paul; Ellison David W</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">803-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The 2016 World Health Organization Classification of Tumors of the Central Nervous System is both a conceptual and practical advance over its 2007 predecessor.  For the first time, the WHO classification of CNS tumors uses molecular parameters in addition to histology to define many tumor entities, thus formulating a concept for how CNS tumor diagnoses should be structured in the molecular era.  As such, the 2016 CNS WHO presents major restructuring of the diffuse gliomas, medulloblastomas and other embryonal tumors, and incorporates new entities that are defined by both histology and molecular features, including glioblastoma, IDH-wildtype and glioblastoma, IDH-mutant; diffuse midline glioma, H3 K27M-mutant; RELA fusion-positive ependymoma; medulloblastoma, WNT-activated and medulloblastoma, SHH-activated; and embryonal tumour with multilayered rosettes, C19MC-altered.  The 2016 edition has added newly recognized neoplasms, and has deleted some entities, variants and patterns that no longer have diagnostic and/or biological relevance.  Other notable changes include the addition of brain invasion as a criterion for atypical meningioma and the introduction of a soft tissue-type grading system for the now combined entity of solitary fibrous tumor / hemangiopericytoma-a departure from the manner by which other CNS tumors are graded.  Overall, it is hoped that the 2016 CNS WHO will facilitate clinical, experimental and epidemiological studies that will lead to improvements in the lives of patients with brain tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS7YzqOXqWReQqdek-gHSrIfW6udTcc2eblG-HU_1aUYbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bnsVektA%253D%253D&md5=f9ac51999bf1b171477b20ea0085c9e8</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs00401-016-1545-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-016-1545-1%26sid%3Dliteratum%253Aachs%26aulast%3DLouis%26aufirst%3DD.%2BN.%26aulast%3DPerry%26aufirst%3DA.%26aulast%3DReifenberger%26aufirst%3DG.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26aulast%3DFigarella-Branger%26aufirst%3DD.%26aulast%3DCavenee%26aufirst%3DW.%2BK.%26aulast%3DOhgaki%26aufirst%3DH.%26aulast%3DWiestler%26aufirst%3DO.%2BD.%26aulast%3DKleihues%26aufirst%3DP.%26aulast%3DEllison%26aufirst%3DD.%2BW.%26atitle%3DThe%25202016%2520world%2520health%2520organization%2520classification%2520of%2520tumors%2520of%2520the%2520central%2520nervous%2520system%253A%2520a%2520summary%26jtitle%3DActa%2520Neuropathol.%26date%3D2016%26volume%3D131%26spage%3D803%26epage%3D820%26doi%3D10.1007%2Fs00401-016-1545-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hentschel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wick, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capper, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felsberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westphal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schackert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyermann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietsch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reifenberger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loeffler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Deimling, A.</span></span> <span> </span><span class="NLM_article-title">Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher Age: implications for classification of gliomas</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">707</span>– <span class="NLM_lpage">718</span>, <span class="refDoi"> DOI: 10.1007/s00401-010-0781-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1007%2Fs00401-010-0781-z" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2010&pages=707-718&author=C.+Hartmannauthor=B.+Hentschelauthor=W.+Wickauthor=D.+Capperauthor=J.+Felsbergauthor=M.+Simonauthor=M.+Westphalauthor=G.+Schackertauthor=R.+Meyermannauthor=T.+Pietschauthor=G.+Reifenbergerauthor=M.+Wellerauthor=M.+Loefflerauthor=A.+von+Deimling&title=Patients+with+IDH1+wild+type+anaplastic+astrocytomas+exhibit+worse+prognosis+than+IDH1-mutated+glioblastomas%2C+and+IDH1+mutation+status+accounts+for+the+unfavorable+prognostic+effect+of+higher+Age%3A+implications+for+classification+of+gliomas&doi=10.1007%2Fs00401-010-0781-z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1007%2Fs00401-010-0781-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-010-0781-z%26sid%3Dliteratum%253Aachs%26aulast%3DHartmann%26aufirst%3DC.%26aulast%3DHentschel%26aufirst%3DB.%26aulast%3DWick%26aufirst%3DW.%26aulast%3DCapper%26aufirst%3DD.%26aulast%3DFelsberg%26aufirst%3DJ.%26aulast%3DSimon%26aufirst%3DM.%26aulast%3DWestphal%26aufirst%3DM.%26aulast%3DSchackert%26aufirst%3DG.%26aulast%3DMeyermann%26aufirst%3DR.%26aulast%3DPietsch%26aufirst%3DT.%26aulast%3DReifenberger%26aufirst%3DG.%26aulast%3DWeller%26aufirst%3DM.%26aulast%3DLoeffler%26aufirst%3DM.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26atitle%3DPatients%2520with%2520IDH1%2520wild%2520type%2520anaplastic%2520astrocytomas%2520exhibit%2520worse%2520prognosis%2520than%2520IDH1-mutated%2520glioblastomas%252C%2520and%2520IDH1%2520mutation%2520status%2520accounts%2520for%2520the%2520unfavorable%2520prognostic%2520effect%2520of%2520higher%2520Age%253A%2520implications%2520for%2520classification%2520of%2520gliomas%26jtitle%3DActa%2520Neuropathol.%26date%3D2010%26volume%3D120%26spage%3D707%26epage%3D718%26doi%3D10.1007%2Fs00401-010-0781-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, C.</span></span> <span> </span><span class="NLM_article-title">The new WHO 2016 classification of brain tumors-what neurosurgeons need to know</span>. <i>Acta Neurochir.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">403</span>– <span class="NLM_lpage">418</span>, <span class="refDoi"> DOI: 10.1007/s00701-016-3062-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1007%2Fs00701-016-3062-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=28093610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A280%3ADC%252BC1c7mtlGquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2017&pages=403-418&author=R.+Bananauthor=C.+Hartmann&title=The+new+WHO+2016+classification+of+brain+tumors-what+neurosurgeons+need+to+know&doi=10.1007%2Fs00701-016-3062-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The new WHO 2016 classification of brain tumors-what neurosurgeons need to know</span></div><div class="casAuthors">Banan Rouzbeh; Hartmann Christian</div><div class="citationInfo"><span class="NLM_cas:title">Acta neurochirurgica</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">403-418</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The understanding of molecular alterations of tumors has severely changed the concept of classification in all fields of pathology.  The availability of high-throughput technologies such as next-generation sequencing allows for a much more precise definition of tumor entities.  Also in the field of brain tumors a dramatic increase of knowledge has occurred over the last years partially calling into question the purely morphologically based concepts that were used as exclusive defining criteria in the WHO 2007 classification.  METHODS:  Review of the WHO 2016 classification of brain tumors as well as a search and review of publications in the literature relevant for brain tumor classification from 2007 up to now.  RESULTS:  The idea of incorporating the molecular features in classifying tumors of the central nervous system led the authors of the new WHO 2016 classification to encounter inevitable conceptual problems, particularly with respect to linking morphology to molecular alterations.  As a solution they introduced the concept of a "layered diagnosis" to the classification of brain tumors that still allows at a lower level a purely morphologically based diagnosis while partially forcing the incorporation of molecular characteristics for an "integrated diagnosis" at the highest diagnostic level.  In this context the broad availability of molecular assays was debated.  On the one hand molecular antibodies specifically targeting mutated proteins should be available in nearly all neuropathological laboratories.  On the other hand, different high-throughput assays are accessible only in few first-world neuropathological institutions.  As examples oligodendrogliomas are now primarily defined by molecular characteristics since the required assays are generally established, whereas molecular grouping of ependymomas, found to clearly outperform morphologically based tumor interpretation, was rejected from inclusion in the WHO 2016 classification because the required assays are currently only established in a small number of institutions.  CONCLUSION:  In summary, while neuropathologists have now encountered various challenges in the transitional phase from the previous WHO 2007 version to the new WHO 2016 classification of brain tumors, clinical neurooncologists now face many new diagnoses allowing a clearly improved understanding that could offer them more effective therapeutic opportunities in neurooncological treatment.  The new WHO 2016 classification presumably presents the highest number of modifications since the initial WHO classification of 1979 and thereby forces all professionals in the field of neurooncology to intensively understand the new concepts.  This review article aims to present the basic concepts of the new WHO 2016 brain tumor classification for neurosurgeons with a focus on neurooncology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTjanB76ivI2vEeosoOnpOLfW6udTcc2eZZS_0tXJFf3Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7mtlGquw%253D%253D&md5=e11e8c94b94f7d0ddfe6cb01a81d764f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1007%2Fs00701-016-3062-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00701-016-3062-3%26sid%3Dliteratum%253Aachs%26aulast%3DBanan%26aufirst%3DR.%26aulast%3DHartmann%26aufirst%3DC.%26atitle%3DThe%2520new%2520WHO%25202016%2520classification%2520of%2520brain%2520tumors-what%2520neurosurgeons%2520need%2520to%2520know%26jtitle%3DActa%2520Neurochir.%26date%3D2017%26volume%3D159%26spage%3D403%26epage%3D418%26doi%3D10.1007%2Fs00701-016-3062-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eckel-Passow, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachance, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinaro, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicotte, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pekmezci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosel, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smirnov, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollmeyer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Praska, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chada, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracci, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pico, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckner, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huse, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tihan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prados, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiemels, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiencke, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrensch, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, R. B.</span></span> <span> </span><span class="NLM_article-title">Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>372</i></span>,  <span class="NLM_fpage">2499</span>– <span class="NLM_lpage">2508</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1407279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1056%2FNEJMoa1407279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=26061753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFyrsbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2015&pages=2499-2508&author=J.+E.+Eckel-Passowauthor=D.+H.+Lachanceauthor=A.+M.+Molinaroauthor=K.+M.+Walshauthor=P.+A.+Deckerauthor=H.+Sicotteauthor=M.+Pekmezciauthor=T.+Riceauthor=M.+L.+Koselauthor=I.+V.+Smirnovauthor=G.+Sarkarauthor=A.+A.+Caronauthor=T.+M.+Kollmeyerauthor=C.+Praskaauthor=A.+R.+Chadaauthor=C.+Halderauthor=H.+M.+Hansenauthor=L.+S.+McCoyauthor=P.+M.+Bracciauthor=R.+Marshallauthor=S.+Zhengauthor=G.+F.+Reisauthor=A.+R.+Picoauthor=B.+P.+O%E2%80%99Neillauthor=J.+C.+Bucknerauthor=C.+Gianniniauthor=J.+T.+Huseauthor=A.+Perryauthor=T.+Tihanauthor=M.+S.+Bergerauthor=S.+M.+Changauthor=M.+D.+Pradosauthor=J.+Wiemelsauthor=J.+K.+Wienckeauthor=M.+R.+Wrenschauthor=R.+B.+Jenkins&title=Glioma+groups+based+on+1p%2F19q%2C+IDH%2C+and+TERT+promoter+mutations+in+tumors&doi=10.1056%2FNEJMoa1407279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors</span></div><div class="casAuthors">Eckel-Passow, Jeanette E.; Lachance, Daniel H.; Molinaro, Annette M.; Walsh, Kyle M.; Decker, Paul A.; Sicotte, Hugues; Pekmezci, Melike; Rice, Terri; Kosel, Matt L.; Smirnov, Ivan V.; Sarkar, Gobinda; Caron, Alissa A.; Kollmeyer, Thomas M.; Praska, Corinne E.; Chada, Anisha R.; Halder, Chandralekha; Hansen, Helen M.; McCoy, Lucie S.; Bracci, Paige M.; Marshall, Roxanne; Zheng, Shichun; Reis, Gerald F.; Pico, Alexander R.; O'Neill, Brian P.; Buckner, Jan C.; Giannini, Caterina; Huse, Jason T.; Perry, Arie; Tihan, Tarik; Berger, Mitchell S.; Chang, Susan M.; Prados, Michael D.; Wiemels, Joseph; Wiencke, John K.; Wrensch, Margaret R.; Jenkins, Robert B.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2499-2508</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background The prediction of clin. behavior, response to therapy, and outcome of infiltrative glioma is challenging.  On the basis of previous studies of tumor biol., we defined five glioma mol. groups with the use of three alterations: mutations in the TERT promoter, mutations in IDH, and codeletion of chromosome arms 1p and 19q (1p/19q codeletion).  We tested the hypothesis that within groups based on these features, tumors would have similar clin. variables, acquired somatic alterations, and germline variants. methods We scored tumors as neg. or pos. for each of these markers in 1087 gliomas and compared acquired alterations and patient characteristics among the five primary mol. groups.  Using 11,590 controls, we assessed assocns. between these groups and known glioma germline variants. results Among 615 grade II or III gliomas, 29% had all three alterations (i.e., were triple-pos.), 5% had TERT and IDH mutations, 45% had only IDH mutations, 7% were triple-neg., and 10% had only TERT mutations; 5% had other combinations.  Among 472 grade IV gliomas, less than 1% were triple-pos., 2% had TERT and IDH mutations, 7% had only IDH mutations, 17% were triple-neg., and 74% had only TERT mutations.  The mean age at diagnosis was lowest (37 years) among patients who had gliomas with only IDH mutations and was highest (59 years) among patients who had gliomas with only TERT mutations.  The mol. groups were independently assocd. with overall survival among patients with grade II or III gliomas but not among patients with grade IV gliomas.  The mol. groups were assocd. with specific germline variants. conclusions Gliomas were classified into five principal groups on the basis of three tumor markers.  The groups had different ages at onset, overall survival, and assocns. with germline variants, which implies that they are characterized by distinct mechanisms of pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8ytJLCkPFMrVg90H21EOLACvtfcHk0lgDGYMea0wosQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFyrsbvO&md5=940207df9fe93ba0c094f089746e1652</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1407279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1407279%26sid%3Dliteratum%253Aachs%26aulast%3DEckel-Passow%26aufirst%3DJ.%2BE.%26aulast%3DLachance%26aufirst%3DD.%2BH.%26aulast%3DMolinaro%26aufirst%3DA.%2BM.%26aulast%3DWalsh%26aufirst%3DK.%2BM.%26aulast%3DDecker%26aufirst%3DP.%2BA.%26aulast%3DSicotte%26aufirst%3DH.%26aulast%3DPekmezci%26aufirst%3DM.%26aulast%3DRice%26aufirst%3DT.%26aulast%3DKosel%26aufirst%3DM.%2BL.%26aulast%3DSmirnov%26aufirst%3DI.%2BV.%26aulast%3DSarkar%26aufirst%3DG.%26aulast%3DCaron%26aufirst%3DA.%2BA.%26aulast%3DKollmeyer%26aufirst%3DT.%2BM.%26aulast%3DPraska%26aufirst%3DC.%26aulast%3DChada%26aufirst%3DA.%2BR.%26aulast%3DHalder%26aufirst%3DC.%26aulast%3DHansen%26aufirst%3DH.%2BM.%26aulast%3DMcCoy%26aufirst%3DL.%2BS.%26aulast%3DBracci%26aufirst%3DP.%2BM.%26aulast%3DMarshall%26aufirst%3DR.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DReis%26aufirst%3DG.%2BF.%26aulast%3DPico%26aufirst%3DA.%2BR.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BP.%26aulast%3DBuckner%26aufirst%3DJ.%2BC.%26aulast%3DGiannini%26aufirst%3DC.%26aulast%3DHuse%26aufirst%3DJ.%2BT.%26aulast%3DPerry%26aufirst%3DA.%26aulast%3DTihan%26aufirst%3DT.%26aulast%3DBerger%26aufirst%3DM.%2BS.%26aulast%3DChang%26aufirst%3DS.%2BM.%26aulast%3DPrados%26aufirst%3DM.%2BD.%26aulast%3DWiemels%26aufirst%3DJ.%26aulast%3DWiencke%26aufirst%3DJ.%2BK.%26aulast%3DWrensch%26aufirst%3DM.%2BR.%26aulast%3DJenkins%26aufirst%3DR.%2BB.%26atitle%3DGlioma%2520groups%2520based%2520on%25201p%252F19q%252C%2520IDH%252C%2520and%2520TERT%2520promoter%2520mutations%2520in%2520tumors%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D372%26spage%3D2499%26epage%3D2508%26doi%3D10.1056%2FNEJMoa1407279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korshunov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Deimling, A.</span></span> <span> </span><span class="NLM_article-title">Analysis of the IDH1 codon 132 mutation in brain tumors</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">597</span>– <span class="NLM_lpage">602</span>, <span class="refDoi"> DOI: 10.1007/s00401-008-0455-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1007%2Fs00401-008-0455-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=18985363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlyhsbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2008&pages=597-602&author=J.+Balssauthor=J.+Meyerauthor=W.+Muellerauthor=A.+Korshunovauthor=C.+Hartmannauthor=A.+von+Deimling&title=Analysis+of+the+IDH1+codon+132+mutation+in+brain+tumors&doi=10.1007%2Fs00401-008-0455-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of the IDH1 codon 132 mutation in brain tumors</span></div><div class="casAuthors">Balss, Joerg; Meyer, Jochen; Mueller, Wolf; Korshunov, Andrey; Hartmann, Christian; Deimling, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">597-602</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A recent study reported on mutations in the active site of the isocitrate dehydrogenase (IDH1) gene in 12% of glioblastomas.  All mutations detected resulted in an amino acid exchange in position 132.  We analyzed the genomic region spanning wild type R132 of IDH1 by direct sequencing in 685 brain tumors including 41 pilocytic astrocytomas, 12 subependymal giant cell astrocytomas, 7 pleomorphic xanthoastrocytomas, 93 diffuse astrocytomas, 120 adult glioblastomas, 14 pediatric glioblastomas, 105 oligodendrogliomas, 83 oligoastrocytomas, 31 ependymomas, 58 medulloblastomas, 9 supratentorial primitive neuroectodermal tumors, 17 schwannomas, 72 meningiomas and 23 pituitary adenomas.  A total of 221 somatic IDH1 mutations were detected and the highest frequencies occurred in diffuse astrocytomas (68%), oligodendrogliomas (69%), oligoastrocytomas (78%) and secondary glioblastomas (88%).  Primary glioblastomas and other entities were characterized by a low frequency or absence of mutations in amino acid position 132 of IDH1.  The very high frequency of IDH1 mutations in WHO grade II astrocytic and oligodendroglial gliomas suggests a role in early tumor development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6yX24ZGaBg7Vg90H21EOLACvtfcHk0lg4PWXH9jBnDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlyhsbfN&md5=3e36ffca189233b12d0e81e9e3a4da9c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs00401-008-0455-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-008-0455-2%26sid%3Dliteratum%253Aachs%26aulast%3DBalss%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DJ.%26aulast%3DMueller%26aufirst%3DW.%26aulast%3DKorshunov%26aufirst%3DA.%26aulast%3DHartmann%26aufirst%3DC.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26atitle%3DAnalysis%2520of%2520the%2520IDH1%2520codon%2520132%2520mutation%2520in%2520brain%2520tumors%26jtitle%3DActa%2520Neuropathol.%26date%3D2008%26volume%3D116%26spage%3D597%26epage%3D602%26doi%3D10.1007%2Fs00401-008-0455-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Welch, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ley, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Link, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koboldt, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wartman, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamprecht, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandoth, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulton, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLellan, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dooling, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallis, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalicki-Veizer, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Laughlin, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMichael, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delehaunty, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulton, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magrini, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeter, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vickery, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hundal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alldredge, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wylie, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heath, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varghese, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagarajan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payton, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baty, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klco, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasson, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westervelt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubert, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiPersio, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mardis, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, R. K.</span></span> <span> </span><span class="NLM_article-title">The origin and evolution of mutations in acute myeloid leukemia</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">264</span>– <span class="NLM_lpage">278</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.06.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1016%2Fj.cell.2012.06.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=22817890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVyms7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2012&pages=264-278&author=J.+S.+Welchauthor=T.+J.+Leyauthor=D.+C.+Linkauthor=C.+A.+Millerauthor=D.+E.+Larsonauthor=D.+C.+Koboldtauthor=L.+D.+Wartmanauthor=T.+L.+Lamprechtauthor=F.+Liuauthor=J.+Xiaauthor=C.+Kandothauthor=R.+S.+Fultonauthor=M.+D.+McLellanauthor=D.+J.+Doolingauthor=J.+W.+Wallisauthor=K.+Chenauthor=C.+C.+Harrisauthor=H.+K.+Schmidtauthor=J.+M.+Kalicki-Veizerauthor=C.+Luauthor=Q.+Zhangauthor=L.+Linauthor=M.+D.+O%E2%80%99Laughlinauthor=J.+F.+McMichaelauthor=K.+D.+Delehauntyauthor=L.+A.+Fultonauthor=V.+J.+Magriniauthor=S.+D.+McGrathauthor=R.+T.+Demeterauthor=T.+L.+Vickeryauthor=J.+Hundalauthor=L.+L.+Cookauthor=G.+W.+Swiftauthor=J.+P.+Reedauthor=P.+A.+Alldredgeauthor=T.+N.+Wylieauthor=J.+R.+Walkerauthor=M.+A.+Watsonauthor=S.+E.+Heathauthor=W.+D.+Shannonauthor=N.+Vargheseauthor=R.+Nagarajanauthor=J.+E.+Paytonauthor=J.+D.+Batyauthor=S.+Kulkarniauthor=J.+M.+Klcoauthor=M.+H.+Tomassonauthor=P.+Westerveltauthor=M.+J.+Walterauthor=T.+A.+Graubertauthor=J.+F.+DiPersioauthor=L.+Dingauthor=E.+R.+Mardisauthor=R.+K.+Wilson&title=The+origin+and+evolution+of+mutations+in+acute+myeloid+leukemia&doi=10.1016%2Fj.cell.2012.06.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The origin and evolution of mutations in acute myeloid leukemia</span></div><div class="casAuthors">Welch, John S.; Ley, Timothy J.; Link, Daniel C.; Miller, Christopher A.; Larson, David E.; Koboldt, Daniel C.; Wartman, Lukas D.; Lamprecht, Tamara L.; Liu, Fulu; Xia, Jun; Kandoth, Cyriac; Fulton, Robert S.; McLellan, Michael D.; Dooling, David J.; Wallis, John W.; Chen, Ken; Harris, Christopher C.; Schmidt, Heather K.; Kalicki-Veizer, Joelle M.; Lu, Charles; Zhang, Qunyuan; Lin, Ling; O'Laughlin, Michelle D.; McMichael, Joshua F.; Delehaunty, Kim D.; Fulton, Lucinda A.; Magrini, Vincent J.; McGrath, Sean D.; Demeter, Ryan T.; Vickery, Tammi L.; Hundal, Jasreet; Cook, Lisa L.; Swift, Gary W.; Reed, Jerry P.; Alldredge, Patricia A.; Wylie, Todd N.; Walker, Jason R.; Watson, Mark A.; Heath, Sharon E.; Shannon, William D.; Varghese, Nobish; Nagarajan, Rakesh; Payton, Jacqueline E.; Baty, Jack D.; Kulkarni, Shashikant; Klco, Jeffery M.; Tomasson, Michael H.; Westervelt, Peter; Walter, Matthew J.; Graubert, Timothy A.; DiPersio, John F.; Ding, Li; Mardis, Elaine R.; Wilson, Richard K.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">264-278</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Most mutations in cancer genomes are thought to be acquired after the initiating event, which may cause genomic instability and drive clonal evolution.  However, for acute myeloid leukemia (AML), normal karyotypes are common, and genomic instability is unusual.  To better understand clonal evolution in AML, we sequenced the genomes of M3-AML samples with a known initiating event (PML-RARA) vs. the genomes of normal karyotype M1-AML samples and the exomes of hematopoietic stem/progenitor cells (HSPCs) from healthy people.  Collectively, the data suggest that most of the mutations found in AML genomes are actually random events that occurred in HSPCs before they acquired the initiating mutation; the mutational history of that cell is "captured" as the clone expands.  In many cases, only one or two addnl., cooperating mutations are needed to generate the malignant founding clone.  Cells from the founding clone can acquire addnl. cooperating mutations, yielding subclones that can contribute to disease progression and/or relapse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquUH22-h3l2LVg90H21EOLACvtfcHk0lg4PWXH9jBnDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVyms7jP&md5=575c8c5d3907347ca83a7f2c49b4764d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.06.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.06.023%26sid%3Dliteratum%253Aachs%26aulast%3DWelch%26aufirst%3DJ.%2BS.%26aulast%3DLey%26aufirst%3DT.%2BJ.%26aulast%3DLink%26aufirst%3DD.%2BC.%26aulast%3DMiller%26aufirst%3DC.%2BA.%26aulast%3DLarson%26aufirst%3DD.%2BE.%26aulast%3DKoboldt%26aufirst%3DD.%2BC.%26aulast%3DWartman%26aufirst%3DL.%2BD.%26aulast%3DLamprecht%26aufirst%3DT.%2BL.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DXia%26aufirst%3DJ.%26aulast%3DKandoth%26aufirst%3DC.%26aulast%3DFulton%26aufirst%3DR.%2BS.%26aulast%3DMcLellan%26aufirst%3DM.%2BD.%26aulast%3DDooling%26aufirst%3DD.%2BJ.%26aulast%3DWallis%26aufirst%3DJ.%2BW.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DHarris%26aufirst%3DC.%2BC.%26aulast%3DSchmidt%26aufirst%3DH.%2BK.%26aulast%3DKalicki-Veizer%26aufirst%3DJ.%2BM.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Laughlin%26aufirst%3DM.%2BD.%26aulast%3DMcMichael%26aufirst%3DJ.%2BF.%26aulast%3DDelehaunty%26aufirst%3DK.%2BD.%26aulast%3DFulton%26aufirst%3DL.%2BA.%26aulast%3DMagrini%26aufirst%3DV.%2BJ.%26aulast%3DMcGrath%26aufirst%3DS.%2BD.%26aulast%3DDemeter%26aufirst%3DR.%2BT.%26aulast%3DVickery%26aufirst%3DT.%2BL.%26aulast%3DHundal%26aufirst%3DJ.%26aulast%3DCook%26aufirst%3DL.%2BL.%26aulast%3DSwift%26aufirst%3DG.%2BW.%26aulast%3DReed%26aufirst%3DJ.%2BP.%26aulast%3DAlldredge%26aufirst%3DP.%2BA.%26aulast%3DWylie%26aufirst%3DT.%2BN.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DWatson%26aufirst%3DM.%2BA.%26aulast%3DHeath%26aufirst%3DS.%2BE.%26aulast%3DShannon%26aufirst%3DW.%2BD.%26aulast%3DVarghese%26aufirst%3DN.%26aulast%3DNagarajan%26aufirst%3DR.%26aulast%3DPayton%26aufirst%3DJ.%2BE.%26aulast%3DBaty%26aufirst%3DJ.%2BD.%26aulast%3DKulkarni%26aufirst%3DS.%26aulast%3DKlco%26aufirst%3DJ.%2BM.%26aulast%3DTomasson%26aufirst%3DM.%2BH.%26aulast%3DWestervelt%26aufirst%3DP.%26aulast%3DWalter%26aufirst%3DM.%2BJ.%26aulast%3DGraubert%26aufirst%3DT.%2BA.%26aulast%3DDiPersio%26aufirst%3DJ.%2BF.%26aulast%3DDing%26aufirst%3DL.%26aulast%3DMardis%26aufirst%3DE.%2BR.%26aulast%3DWilson%26aufirst%3DR.%2BK.%26atitle%3DThe%2520origin%2520and%2520evolution%2520of%2520mutations%2520in%2520acute%2520myeloid%2520leukemia%26jtitle%3DCell%26date%3D2012%26volume%3D150%26spage%3D264%26epage%3D278%26doi%3D10.1016%2Fj.cell.2012.06.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knobbe, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munger, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lind, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brüstle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakeham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haight, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You-Ten, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schalm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virtanen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reifenberger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figueroa, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zúñiga-Pflücker, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">IDH1 (R132H) mutation increases murine haematopoietic progenitors and alters epigenetics</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>488</i></span>,  <span class="NLM_fpage">656</span>– <span class="NLM_lpage">659</span>, <span class="refDoi"> DOI: 10.1038/nature11323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1038%2Fnature11323" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=656-659&author=M.+Sasakiauthor=C.+B.+Knobbeauthor=J.+C.+Mungerauthor=E.+F.+Lindauthor=D.+Brennerauthor=A.+Br%C3%BCstleauthor=I.+S.+Harrisauthor=R.+Holmesauthor=A.+Wakehamauthor=J.+Haightauthor=A.+You-Tenauthor=W.+Y.+Liauthor=S.+Schalmauthor=S.+M.+Suauthor=C.+Virtanenauthor=G.+Reifenbergerauthor=P.+S.+Ohashiauthor=D.+L.+Barberauthor=M.+E.+Figueroaauthor=A.+Melnickauthor=J.+C.+Z%C3%BA%C3%B1iga-Pfl%C3%BCckerauthor=T.+W.+Mak&title=IDH1+%28R132H%29+mutation+increases+murine+haematopoietic+progenitors+and+alters+epigenetics&doi=10.1038%2Fnature11323"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnature11323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11323%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DKnobbe%26aufirst%3DC.%2BB.%26aulast%3DMunger%26aufirst%3DJ.%2BC.%26aulast%3DLind%26aufirst%3DE.%2BF.%26aulast%3DBrenner%26aufirst%3DD.%26aulast%3DBr%25C3%25BCstle%26aufirst%3DA.%26aulast%3DHarris%26aufirst%3DI.%2BS.%26aulast%3DHolmes%26aufirst%3DR.%26aulast%3DWakeham%26aufirst%3DA.%26aulast%3DHaight%26aufirst%3DJ.%26aulast%3DYou-Ten%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DW.%2BY.%26aulast%3DSchalm%26aufirst%3DS.%26aulast%3DSu%26aufirst%3DS.%2BM.%26aulast%3DVirtanen%26aufirst%3DC.%26aulast%3DReifenberger%26aufirst%3DG.%26aulast%3DOhashi%26aufirst%3DP.%2BS.%26aulast%3DBarber%26aufirst%3DD.%2BL.%26aulast%3DFigueroa%26aufirst%3DM.%2BE.%26aulast%3DMelnick%26aufirst%3DA.%26aulast%3DZ%25C3%25BA%25C3%25B1iga-Pfl%25C3%25BCcker%26aufirst%3DJ.%2BC.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DIDH1%2520%2528R132H%2529%2520mutation%2520increases%2520murine%2520haematopoietic%2520progenitors%2520and%2520alters%2520epigenetics%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D656%26epage%3D659%26doi%3D10.1038%2Fnature11323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shroff, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. W.</span></span> <span> </span><span class="NLM_article-title">Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1974</span>– <span class="NLM_lpage">1985</span>, <span class="refDoi"> DOI: 10.1101/gad.226613.113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1101%2Fgad.226613.113" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=1974-1985&author=C.+Chenauthor=Y.+Liuauthor=C.+Luauthor=J.+R.+Crossauthor=J.+P.+Morrisauthor=A.+S.+Shroffauthor=P.+S.+Wardauthor=J.+E.+Bradnerauthor=C.+Thompsonauthor=S.+W.+Lowe&title=Cancer-associated+IDH2+mutants+drive+an+acute+myeloid+leukemia+that+is+susceptible+to+Brd4+inhibition&doi=10.1101%2Fgad.226613.113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1101%2Fgad.226613.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.226613.113%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DCross%26aufirst%3DJ.%2BR.%26aulast%3DMorris%26aufirst%3DJ.%2BP.%26aulast%3DShroff%26aufirst%3DA.%2BS.%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DC.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26atitle%3DCancer-associated%2520IDH2%2520mutants%2520drive%2520an%2520acute%2520myeloid%2520leukemia%2520that%2520is%2520susceptible%2520to%2520Brd4%2520inhibition%26jtitle%3DGenes%2520Dev.%26date%3D2013%26volume%3D27%26spage%3D1974%26epage%3D1985%26doi%3D10.1101%2Fgad.226613.113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fathi, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadrzadeh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borger, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballen, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amrein, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attar, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matulis, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmonds, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iafrate, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straley, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agresta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkein, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuberg, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. B.</span></span> <span> </span><span class="NLM_article-title">Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">4649</span>– <span class="NLM_lpage">4652</span>, <span class="refDoi"> DOI: 10.1182/blood-2012-06-438267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1182%2Fblood-2012-06-438267" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=4649-4652&author=A.+T.+Fathiauthor=H.+Sadrzadehauthor=D.+R.+Borgerauthor=K.+K.+Ballenauthor=P.+C.+Amreinauthor=E.+C.+Attarauthor=J.+Fosterauthor=M.+Burkeauthor=H.+U.+Lopezauthor=C.+R.+Matulisauthor=K.+M.+Edmondsauthor=A.+J.+Iafrateauthor=K.+S.+Straleyauthor=K.+E.+Yenauthor=S.+Agrestaauthor=D.+P.+Schenkeinauthor=C.+Hillauthor=A.+Emadiauthor=D.+S.+Neubergauthor=R.+M.+Stoneauthor=Y.+B.+Chen&title=Prospective+serial+evaluation+of+2-hydroxyglutarate%2C+during+treatment+of+newly+diagnosed+acute+myeloid+leukemia%2C+to+assess+disease+activity+and+therapeutic+response&doi=10.1182%2Fblood-2012-06-438267"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1182%2Fblood-2012-06-438267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2012-06-438267%26sid%3Dliteratum%253Aachs%26aulast%3DFathi%26aufirst%3DA.%2BT.%26aulast%3DSadrzadeh%26aufirst%3DH.%26aulast%3DBorger%26aufirst%3DD.%2BR.%26aulast%3DBallen%26aufirst%3DK.%2BK.%26aulast%3DAmrein%26aufirst%3DP.%2BC.%26aulast%3DAttar%26aufirst%3DE.%2BC.%26aulast%3DFoster%26aufirst%3DJ.%26aulast%3DBurke%26aufirst%3DM.%26aulast%3DLopez%26aufirst%3DH.%2BU.%26aulast%3DMatulis%26aufirst%3DC.%2BR.%26aulast%3DEdmonds%26aufirst%3DK.%2BM.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26aulast%3DStraley%26aufirst%3DK.%2BS.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DAgresta%26aufirst%3DS.%26aulast%3DSchenkein%26aufirst%3DD.%2BP.%26aulast%3DHill%26aufirst%3DC.%26aulast%3DEmadi%26aufirst%3DA.%26aulast%3DNeuberg%26aufirst%3DD.%2BS.%26aulast%3DStone%26aufirst%3DR.%2BM.%26aulast%3DChen%26aufirst%3DY.%2BB.%26atitle%3DProspective%2520serial%2520evaluation%2520of%25202-hydroxyglutarate%252C%2520during%2520treatment%2520of%2520newly%2520diagnosed%2520acute%2520myeloid%2520leukemia%252C%2520to%2520assess%2520disease%2520activity%2520and%2520therapeutic%2520response%26jtitle%3DBlood%26date%3D2012%26volume%3D120%26spage%3D4649%26epage%3D4652%26doi%3D10.1182%2Fblood-2012-06-438267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tefferi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulai, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasho, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finke, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knudson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardanani, A.</span></span> <span> </span><span class="NLM_article-title">IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">475</span>– <span class="NLM_lpage">480</span>, <span class="refDoi"> DOI: 10.1038/leu.2011.253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1038%2Fleu.2011.253" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=475-480&author=A.+Tefferiauthor=T.+Jimmaauthor=N.+H.+Sulaiauthor=T.+L.+Lashoauthor=C.+M.+Finkeauthor=R.+A.+Knudsonauthor=R.+F.+McClureauthor=A.+Pardanani&title=IDH+mutations+in+primary+myelofibrosis+predict+leukemic+transformation+and+shortened+survival%3A+clinical+evidence+for+leukemogenic+collaboration+with+JAK2V617F&doi=10.1038%2Fleu.2011.253"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fleu.2011.253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2011.253%26sid%3Dliteratum%253Aachs%26aulast%3DTefferi%26aufirst%3DA.%26aulast%3DJimma%26aufirst%3DT.%26aulast%3DSulai%26aufirst%3DN.%2BH.%26aulast%3DLasho%26aufirst%3DT.%2BL.%26aulast%3DFinke%26aufirst%3DC.%2BM.%26aulast%3DKnudson%26aufirst%3DR.%2BA.%26aulast%3DMcClure%26aufirst%3DR.%2BF.%26aulast%3DPardanani%26aufirst%3DA.%26atitle%3DIDH%2520mutations%2520in%2520primary%2520myelofibrosis%2520predict%2520leukemic%2520transformation%2520and%2520shortened%2520survival%253A%2520clinical%2520evidence%2520for%2520leukemogenic%2520collaboration%2520with%2520JAK2V617F%26jtitle%3DLeukemia%26date%3D2012%26volume%3D26%26spage%3D475%26epage%3D480%26doi%3D10.1038%2Fleu.2011.253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saha, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parachoniak, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghanta, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitamant, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Najem, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurumurthy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akbay, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornella, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miltiadous, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walesky, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshpande, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, A. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hezel, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straley, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travins, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovici-Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gliser, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrone, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apte, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llovet, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaswamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardeesy, N.</span></span> <span> </span><span class="NLM_article-title">Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>513</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1038/nature13441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1038%2Fnature13441" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=513&publication_year=2014&pages=110-114&author=S.+K.+Sahaauthor=C.+A.+Parachoniakauthor=K.+S.+Ghantaauthor=J.+Fitamantauthor=K.+N.+Rossauthor=M.+S.+Najemauthor=S.+Gurumurthyauthor=E.+A.+Akbayauthor=D.+Siaauthor=H.+Cornellaauthor=O.+Miltiadousauthor=C.+Waleskyauthor=V.+Deshpandeauthor=A.+X.+Zhuauthor=A.+F.+Hezelauthor=K.+E.+Yenauthor=K.+S.+Straleyauthor=J.+Travinsauthor=J.+Popovici-Mullerauthor=C.+Gliserauthor=C.+R.+Ferroneauthor=U.+Apteauthor=J.+M.+Llovetauthor=K.+K.+Wongauthor=S.+Ramaswamyauthor=N.+Bardeesy&title=Mutant+IDH+inhibits+HNF-4%CE%B1+to+block+hepatocyte+differentiation+and+promote+biliary+cancer&doi=10.1038%2Fnature13441"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnature13441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13441%26sid%3Dliteratum%253Aachs%26aulast%3DSaha%26aufirst%3DS.%2BK.%26aulast%3DParachoniak%26aufirst%3DC.%2BA.%26aulast%3DGhanta%26aufirst%3DK.%2BS.%26aulast%3DFitamant%26aufirst%3DJ.%26aulast%3DRoss%26aufirst%3DK.%2BN.%26aulast%3DNajem%26aufirst%3DM.%2BS.%26aulast%3DGurumurthy%26aufirst%3DS.%26aulast%3DAkbay%26aufirst%3DE.%2BA.%26aulast%3DSia%26aufirst%3DD.%26aulast%3DCornella%26aufirst%3DH.%26aulast%3DMiltiadous%26aufirst%3DO.%26aulast%3DWalesky%26aufirst%3DC.%26aulast%3DDeshpande%26aufirst%3DV.%26aulast%3DZhu%26aufirst%3DA.%2BX.%26aulast%3DHezel%26aufirst%3DA.%2BF.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DStraley%26aufirst%3DK.%2BS.%26aulast%3DTravins%26aufirst%3DJ.%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DGliser%26aufirst%3DC.%26aulast%3DFerrone%26aufirst%3DC.%2BR.%26aulast%3DApte%26aufirst%3DU.%26aulast%3DLlovet%26aufirst%3DJ.%2BM.%26aulast%3DWong%26aufirst%3DK.%2BK.%26aulast%3DRamaswamy%26aufirst%3DS.%26aulast%3DBardeesy%26aufirst%3DN.%26atitle%3DMutant%2520IDH%2520inhibits%2520HNF-4%25CE%25B1%2520to%2520block%2520hepatocyte%2520differentiation%2520and%2520promote%2520biliary%2520cancer%26jtitle%3DNature%26date%3D2014%26volume%3D513%26spage%3D110%26epage%3D114%26doi%3D10.1038%2Fnature13441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairns, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puviindran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snow, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadesan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whetstone, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gliser, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wunder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alman, B. A.</span></span> <span> </span><span class="NLM_article-title">Mutant IDH is sufficient to initiate enchondromatosis in mice</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">2829</span>– <span class="NLM_lpage">2834</span>, <span class="refDoi"> DOI: 10.1073/pnas.1424400112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1073%2Fpnas.1424400112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=25730874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFajs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=2829-2834&author=M.+Hirataauthor=M.+Sasakiauthor=R.+A.+Cairnsauthor=S.+Inoueauthor=V.+Puviindranauthor=W.+Y.+Liauthor=B.+E.+Snowauthor=L.+D.+Jonesauthor=Q.+Weiauthor=S.+Satoauthor=Y.+J.+Tangauthor=P.+Nadesanauthor=J.+Rockelauthor=H.+Whetstoneauthor=R.+Poonauthor=A.+Wengauthor=S.+Grossauthor=K.+Straleyauthor=C.+Gliserauthor=Y.+Xuauthor=J.+Wunderauthor=T.+W.+Makauthor=B.+A.+Alman&title=Mutant+IDH+is+sufficient+to+initiate+enchondromatosis+in+mice&doi=10.1073%2Fpnas.1424400112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Mutant IDH is sufficient to initiate enchondromatosis in mice</span></div><div class="casAuthors">Hirata, Makoto; Sasaki, Masato; Cairns, Rob A.; Inoue, Satoshi; Puviindran, Vijitha; Li, Wanda Y.; Snow, Bryan E.; Jones, Lisa D.; Wei, Qingxia; Sato, Shingo; Tang, Yuning J.; Nadesan, Puviindran; Rockel, Jason; Whetstone, Heather; Poon, Raymond; Weng, Angela; Gross, Stefan; Straley, Kimberly; Gliser, Camelia; Xu, Yingxia; Wunder, Jay; Mak, Tak W.; Alman, Benjamin A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2829-2834</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Enchondromas are benign cartilage tumors and precursors to malignant chondrosarcomas.  Somatic mutations in the isocitrate dehydrogenase genes (IDH1 and IDH2) are present in the majority of these tumor types.  How these mutations cause enchondromas is unclear.  Here, we identified the spectrum of IDH mutations in human enchondromas and chondrosarcomas and studied their effects in mice.  A broad range of mutations was identified, including the previously unreported IDH1-R132Q mutation.  These mutations harbored enzymic activity to catalyze α-ketoglutarate to D-2-hydroxyglutarate (d-2HG).  Mice expressing Idh1-R132Q in one allele in cells expressing type 2 collagen showed a disordered growth plate, with persistence of type X-expressing chondrocytes.  Chondrocyte cell cultures from these animals or controls showed that there was an increase in proliferation and expression of genes characteristic of hypertrophic chondrocytes with expression of Idh1-R132Q or 2HG treatment.  Col2a1-Cre;Idh1-R132Q mutant knock-in mice (mutant allele expressed in chondrocytes) did not survive after the neonatal stage.  Col2a1-Cre/ERT2;Idh1-R132 mutant conditional knock-in mice, in which Cre was induced by tamoxifen after weaning, developed multiple enchondroma-like lesions.  Taken together, these data show that mutant IDH or d-2HG causes persistence of chondrocytes, giving rise to rests of growth-plate cells that persist in the bone as enchondromas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1s2uRLFom1bVg90H21EOLACvtfcHk0liZjWMILRNndA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFajs7s%253D&md5=4f3cb2cf33b52cb18442b629bcffdc02</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1424400112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1424400112%26sid%3Dliteratum%253Aachs%26aulast%3DHirata%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DCairns%26aufirst%3DR.%2BA.%26aulast%3DInoue%26aufirst%3DS.%26aulast%3DPuviindran%26aufirst%3DV.%26aulast%3DLi%26aufirst%3DW.%2BY.%26aulast%3DSnow%26aufirst%3DB.%2BE.%26aulast%3DJones%26aufirst%3DL.%2BD.%26aulast%3DWei%26aufirst%3DQ.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DY.%2BJ.%26aulast%3DNadesan%26aufirst%3DP.%26aulast%3DRockel%26aufirst%3DJ.%26aulast%3DWhetstone%26aufirst%3DH.%26aulast%3DPoon%26aufirst%3DR.%26aulast%3DWeng%26aufirst%3DA.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DStraley%26aufirst%3DK.%26aulast%3DGliser%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DWunder%26aufirst%3DJ.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DAlman%26aufirst%3DB.%2BA.%26atitle%3DMutant%2520IDH%2520is%2520sufficient%2520to%2520initiate%2520enchondromatosis%2520in%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D2829%26epage%3D2834%26doi%3D10.1073%2Fpnas.1424400112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittinger, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driggers, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantin, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keenan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prins, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liau, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vander Heiden, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S. M.</span></span> <span> </span><span class="NLM_article-title">Cancer-associated IDH1 mutations produce 2-hydroxyglutarate</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>465</i></span>,  <span class="NLM_fpage">966</span>– <span class="NLM_lpage">966</span>, <span class="refDoi"> DOI: 10.1038/nature09132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1038%2Fnature09132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=20559394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsVymu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=966-966&author=L.+Dangauthor=D.+W.+Whiteauthor=S.+Grossauthor=B.+D.+Bennettauthor=M.+A.+Bittingerauthor=E.+M.+Driggersauthor=V.+R.+Fantinauthor=H.+G.+Jangauthor=S.+Jinauthor=M.+C.+Keenanauthor=K.+M.+Marksauthor=R.+M.+Prinsauthor=P.+S.+Wardauthor=K.+E.+Yenauthor=L.+M.+Liauauthor=J.+D.+Rabinowitzauthor=L.+C.+Cantleyauthor=C.+B.+Thompsonauthor=M.+G.+Vander+Heidenauthor=S.+M.+Su&title=Cancer-associated+IDH1+mutations+produce+2-hydroxyglutarate&doi=10.1038%2Fnature09132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. [Erratum to document cited in CA152:054793]</span></div><div class="casAuthors">Dang, Lenny; White, David W.; Gross, Stefan; Bennett, Bryson D.; Bittinger, Mark A.; Driggers, Edward M.; Fantin, Valeria R.; Jang, Hyun Gyung; Jin, Shengfang; Keenan, Marie C.; Marks, Kevin M.; Prins, Robert M.; Ward, Patrick S.; Yen, Katharine E.; Liau, Linda M.; Rabinowitz, Joshua D.; Cantley, Lewis C.; Thompson, Craig B.; Vander Heiden, Matthew G.; Su, Shinsan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7300</span>),
    <span class="NLM_cas:pages">966</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The authors acknowledge that there are other mechanisms by which R(-)<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="361b767e71">[email protected]</a> may promote tumor formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiVTMGVGxJmLVg90H21EOLACvtfcHk0liZjWMILRNndA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsVymu7c%253D&md5=9564cf6bbfad7eae449f110e2613d426</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnature09132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09132%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DD.%2BW.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBittinger%26aufirst%3DM.%2BA.%26aulast%3DDriggers%26aufirst%3DE.%2BM.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DJang%26aufirst%3DH.%2BG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKeenan%26aufirst%3DM.%2BC.%26aulast%3DMarks%26aufirst%3DK.%2BM.%26aulast%3DPrins%26aufirst%3DR.%2BM.%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DLiau%26aufirst%3DL.%2BM.%26aulast%3DRabinowitz%26aufirst%3DJ.%2BD.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DSu%26aufirst%3DS.%2BM.%26atitle%3DCancer-associated%2520IDH1%2520mutations%2520produce%25202-hydroxyglutarate%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D966%26epage%3D966%26doi%3D10.1038%2Fnature09132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairns, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puviindran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snow, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadesan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whetstone, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gliser, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wunder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alman, B. A.</span></span> <span> </span><span class="NLM_article-title">Mutant IDH is sufficient to initiate enchondromatosis in mice</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">2829</span>– <span class="NLM_lpage">2834</span>, <span class="refDoi"> DOI: 10.1073/pnas.1424400112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1073%2Fpnas.1424400112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=25730874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFajs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=2829-2834&author=M.+Hirataauthor=M.+Sasakiauthor=R.+A.+Cairnsauthor=S.+Inoueauthor=V.+Puviindranauthor=W.+Y.+Liauthor=B.+E.+Snowauthor=L.+D.+Jonesauthor=Q.+Weiauthor=S.+Satoauthor=Y.+J.+Tangauthor=P.+Nadesanauthor=J.+Rockelauthor=H.+Whetstoneauthor=R.+Poonauthor=A.+Wengauthor=S.+Grossauthor=K.+Straleyauthor=C.+Gliserauthor=Y.+Xuauthor=J.+Wunderauthor=T.+W.+Makauthor=B.+A.+Alman&title=Mutant+IDH+is+sufficient+to+initiate+enchondromatosis+in+mice&doi=10.1073%2Fpnas.1424400112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Mutant IDH is sufficient to initiate enchondromatosis in mice</span></div><div class="casAuthors">Hirata, Makoto; Sasaki, Masato; Cairns, Rob A.; Inoue, Satoshi; Puviindran, Vijitha; Li, Wanda Y.; Snow, Bryan E.; Jones, Lisa D.; Wei, Qingxia; Sato, Shingo; Tang, Yuning J.; Nadesan, Puviindran; Rockel, Jason; Whetstone, Heather; Poon, Raymond; Weng, Angela; Gross, Stefan; Straley, Kimberly; Gliser, Camelia; Xu, Yingxia; Wunder, Jay; Mak, Tak W.; Alman, Benjamin A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2829-2834</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Enchondromas are benign cartilage tumors and precursors to malignant chondrosarcomas.  Somatic mutations in the isocitrate dehydrogenase genes (IDH1 and IDH2) are present in the majority of these tumor types.  How these mutations cause enchondromas is unclear.  Here, we identified the spectrum of IDH mutations in human enchondromas and chondrosarcomas and studied their effects in mice.  A broad range of mutations was identified, including the previously unreported IDH1-R132Q mutation.  These mutations harbored enzymic activity to catalyze α-ketoglutarate to D-2-hydroxyglutarate (d-2HG).  Mice expressing Idh1-R132Q in one allele in cells expressing type 2 collagen showed a disordered growth plate, with persistence of type X-expressing chondrocytes.  Chondrocyte cell cultures from these animals or controls showed that there was an increase in proliferation and expression of genes characteristic of hypertrophic chondrocytes with expression of Idh1-R132Q or 2HG treatment.  Col2a1-Cre;Idh1-R132Q mutant knock-in mice (mutant allele expressed in chondrocytes) did not survive after the neonatal stage.  Col2a1-Cre/ERT2;Idh1-R132 mutant conditional knock-in mice, in which Cre was induced by tamoxifen after weaning, developed multiple enchondroma-like lesions.  Taken together, these data show that mutant IDH or d-2HG causes persistence of chondrocytes, giving rise to rests of growth-plate cells that persist in the bone as enchondromas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1s2uRLFom1bVg90H21EOLACvtfcHk0lhn8U9_xAIv2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFajs7s%253D&md5=4f3cb2cf33b52cb18442b629bcffdc02</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1424400112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1424400112%26sid%3Dliteratum%253Aachs%26aulast%3DHirata%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DCairns%26aufirst%3DR.%2BA.%26aulast%3DInoue%26aufirst%3DS.%26aulast%3DPuviindran%26aufirst%3DV.%26aulast%3DLi%26aufirst%3DW.%2BY.%26aulast%3DSnow%26aufirst%3DB.%2BE.%26aulast%3DJones%26aufirst%3DL.%2BD.%26aulast%3DWei%26aufirst%3DQ.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DY.%2BJ.%26aulast%3DNadesan%26aufirst%3DP.%26aulast%3DRockel%26aufirst%3DJ.%26aulast%3DWhetstone%26aufirst%3DH.%26aulast%3DPoon%26aufirst%3DR.%26aulast%3DWeng%26aufirst%3DA.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DStraley%26aufirst%3DK.%26aulast%3DGliser%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DWunder%26aufirst%3DJ.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DAlman%26aufirst%3DB.%2BA.%26atitle%3DMutant%2520IDH%2520is%2520sufficient%2520to%2520initiate%2520enchondromatosis%2520in%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D2829%26epage%3D2834%26doi%3D10.1073%2Fpnas.1424400112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pansuriya, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Eijk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Adamo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Ruler, M. A. J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuijjer, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oosting, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleton-Jansen, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Oosterwijk, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbeke, S. L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Wezel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nord, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangiorgi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toker, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liegl-Atzwanger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">San-Julian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciot, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limaye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kindblom, L.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daugaard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godfraind, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boon, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vikkula, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurek, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szuhai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bovée, J. V. M. G.</span></span> <span> </span><span class="NLM_article-title">Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in ollier disease and maffucci syndrome</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1256</span>– <span class="NLM_lpage">1261</span>, <span class="refDoi"> DOI: 10.1038/ng.1004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1038%2Fng.1004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=22057234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVagurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2011&pages=1256-1261&author=T.+C.+Pansuriyaauthor=R.+van+Eijkauthor=P.+D%E2%80%99Adamoauthor=M.+A.+J.+H.+van+Rulerauthor=M.+L.+Kuijjerauthor=J.+Oostingauthor=A.-M.+Cleton-Jansenauthor=J.+G.+van+Oosterwijkauthor=S.+L.+J.+Verbekeauthor=D.+Meijerauthor=T.+van+Wezelauthor=K.+H.+Nordauthor=L.+Sangiorgiauthor=B.+Tokerauthor=B.+Liegl-Atzwangerauthor=M.+San-Julianauthor=R.+Sciotauthor=N.+Limayeauthor=L.-G.+Kindblomauthor=S.+Daugaardauthor=C.+Godfraindauthor=L.+M.+Boonauthor=M.+Vikkulaauthor=K.+C.+Kurekauthor=K.+Szuhaiauthor=P.+J.+Frenchauthor=J.+V.+M.+G.+Bov%C3%A9e&title=Somatic+mosaic+IDH1+and+IDH2+mutations+are+associated+with+enchondroma+and+spindle+cell+hemangioma+in+ollier+disease+and+maffucci+syndrome&doi=10.1038%2Fng.1004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome</span></div><div class="casAuthors">Pansuriya, Twinkal C.; van Eijk, Ronald; d'Adamo, Pio; van Ruler, Maayke A. J. H.; Kuijjer, Marieke L.; Oosting, Jan; Cleton-Jansen, Anne-Marie; van Oosterwijk, Jolieke G.; Verbeke, Sofie L. J.; Meijer, Danielle; van Wezel, Tom; Nord, Karolin H.; Sangiorgi, Luca; Toker, Berkin; Liegl-Atzwanger, Bernadette; San-Julian, Mikel; Sciot, Raf; Limaye, Nisha; Kindblom, Lars-Gunnar; Daugaard, Soeren; Godfraind, Catherine; Boon, Laurence M.; Vikkula, Miikka; Kurek, Kyle C.; Szuhai, Karoly; French, Pim J.; Bovee, Judith V. M. G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1256-1261</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ollier disease and Maffucci syndrome are non-hereditary skeletal disorders characterized by multiple enchondromas (Ollier disease) combined with spindle cell hemangiomas (Maffucci syndrome).  We report somatic heterozygous mutations in IDH1 (c.394C>T encoding an R132C substitution and c.395G>A encoding an R132H substitution) or IDH2 (c.516G>C encoding R172S) in 87% of enchondromas (benign cartilage tumors) and in 70% of spindle cell hemangiomas (benign vascular lesions).  In total, 35 of 43 (81%) subjects with Ollier disease and 10 of 13 (77%) with Maffucci syndrome carried IDH1 (98%) or IDH2 (2%) mutations in their tumors.  Fourteen of 16 subjects had identical mutations in sep. lesions.  Immunohistochem. to detect mutant IDH1 R132H protein suggested intraneoplastic and somatic mosaicism.  IDH1 mutations in cartilage tumors were assocd. with hypermethylation and downregulated expression of several genes.  Mutations were also found in 40% of solitary central cartilaginous tumors and in four chondrosarcoma cell lines, which will enable functional studies to assess the role of IDH1 and IDH2 mutations in tumor formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQkb5_RfkGnLVg90H21EOLACvtfcHk0lhn8U9_xAIv2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVagurrO&md5=0a501826c538de8832403c0cd99030fa</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fng.1004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.1004%26sid%3Dliteratum%253Aachs%26aulast%3DPansuriya%26aufirst%3DT.%2BC.%26aulast%3Dvan%2BEijk%26aufirst%3DR.%26aulast%3DD%25E2%2580%2599Adamo%26aufirst%3DP.%26aulast%3Dvan%2BRuler%26aufirst%3DM.%2BA.%2BJ.%2BH.%26aulast%3DKuijjer%26aufirst%3DM.%2BL.%26aulast%3DOosting%26aufirst%3DJ.%26aulast%3DCleton-Jansen%26aufirst%3DA.-M.%26aulast%3Dvan%2BOosterwijk%26aufirst%3DJ.%2BG.%26aulast%3DVerbeke%26aufirst%3DS.%2BL.%2BJ.%26aulast%3DMeijer%26aufirst%3DD.%26aulast%3Dvan%2BWezel%26aufirst%3DT.%26aulast%3DNord%26aufirst%3DK.%2BH.%26aulast%3DSangiorgi%26aufirst%3DL.%26aulast%3DToker%26aufirst%3DB.%26aulast%3DLiegl-Atzwanger%26aufirst%3DB.%26aulast%3DSan-Julian%26aufirst%3DM.%26aulast%3DSciot%26aufirst%3DR.%26aulast%3DLimaye%26aufirst%3DN.%26aulast%3DKindblom%26aufirst%3DL.-G.%26aulast%3DDaugaard%26aufirst%3DS.%26aulast%3DGodfraind%26aufirst%3DC.%26aulast%3DBoon%26aufirst%3DL.%2BM.%26aulast%3DVikkula%26aufirst%3DM.%26aulast%3DKurek%26aufirst%3DK.%2BC.%26aulast%3DSzuhai%26aufirst%3DK.%26aulast%3DFrench%26aufirst%3DP.%2BJ.%26aulast%3DBov%25C3%25A9e%26aufirst%3DJ.%2BV.%2BM.%2BG.%26atitle%3DSomatic%2520mosaic%2520IDH1%2520and%2520IDH2%2520mutations%2520are%2520associated%2520with%2520enchondroma%2520and%2520spindle%2520cell%2520hemangioma%2520in%2520ollier%2520disease%2520and%2520maffucci%2520syndrome%26jtitle%3DNat.%2520Genet.%26date%3D2011%26volume%3D43%26spage%3D1256%26epage%3D1261%26doi%3D10.1038%2Fng.1004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Figueroa, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Wahab, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhagwat, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasanthakumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolniak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peeters, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantin, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paietta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Löwenberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Licht, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godley, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delwel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valk, P. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnick, A.</span></span> <span> </span><span class="NLM_article-title">Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">553</span>– <span class="NLM_lpage">567</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2010.11.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1016%2Fj.ccr.2010.11.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=21130701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGhsbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=553-567&author=M.+E.+Figueroaauthor=O.+Abdel-Wahabauthor=C.+Luauthor=P.+S.+Wardauthor=J.+Patelauthor=A.+Shihauthor=Y.+Liauthor=N.+Bhagwatauthor=A.+Vasanthakumarauthor=H.+F.+Fernandezauthor=M.+S.+Tallmanauthor=Z.+Sunauthor=K.+Wolniakauthor=J.+K.+Peetersauthor=W.+Liuauthor=S.+E.+Choeauthor=V.+R.+Fantinauthor=E.+Paiettaauthor=B.+L%C3%B6wenbergauthor=J.+D.+Lichtauthor=L.+A.+Godleyauthor=R.+Delwelauthor=P.+J.+M.+Valkauthor=C.+B.+Thompsonauthor=R.+L.+Levineauthor=A.+Melnick&title=Leukemic+IDH1+and+IDH2+mutations+result+in+a+hypermethylation+phenotype%2C+disrupt+TET2+function%2C+and+impair+hematopoietic+differentiation&doi=10.1016%2Fj.ccr.2010.11.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation</span></div><div class="casAuthors">Figueroa, Maria E.; Abdel-Wahab, Omar; Lu, Chao; Ward, Patrick S.; Patel, Jay; Shih, Alan; Li, Yushan; Bhagwat, Neha; Vasanthakumar, Aparna; Fernandez, Hugo F.; Tallman, Martin S.; Sun, Zhuoxin; Wolniak, Kristy; Peeters, Justine K.; Liu, Wei; Choe, Sung E.; Fantin, Valeria R.; Paietta, Elisabeth; Loewenberg, Bob; Licht, Jonathan D.; Godley, Lucy A.; Delwel, Ruud; Valk, Peter J. M.; Thompson, Craig B.; Levine, Ross L.; Melnick, Ari</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">553-567</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Cancer-assocd. IDH mutations are characterized by neomorphic enzyme activity and resultant 2-hydroxyglutarate (2HG) prodn.  Mutational and epigenetic profiling of a large acute myeloid leukemia (AML) patient cohort revealed that IDH1/2-mutant AMLs display global DNA hypermethylation and a specific hypermethylation signature.  Furthermore, expression of 2HG-producing IDH alleles in cells induced global DNA hypermethylation.  In the AML cohort, IDH1/2 mutations were mutually exclusive with mutations in the α-ketoglutarate-dependent enzyme TET2, and TET2 loss-of-function mutations were assocd. with similar epigenetic defects as IDH1/2 mutants.  Consistent with these genetic and epigenetic data, expression of IDH mutants impaired TET2 catalytic function in cells.  Finally, either expression of mutant IDH1/2 or Tet2 depletion impaired hematopoietic differentiation and increased stem/progenitor cell marker expression, suggesting a shared proleukemogenic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5mMhJR64Z4rVg90H21EOLACvtfcHk0lgiQO58k96V1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGhsbvJ&md5=f058c7dbd2efd6a25f4044506b5a2ef3</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2010.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2010.11.015%26sid%3Dliteratum%253Aachs%26aulast%3DFigueroa%26aufirst%3DM.%2BE.%26aulast%3DAbdel-Wahab%26aufirst%3DO.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DPatel%26aufirst%3DJ.%26aulast%3DShih%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DBhagwat%26aufirst%3DN.%26aulast%3DVasanthakumar%26aufirst%3DA.%26aulast%3DFernandez%26aufirst%3DH.%2BF.%26aulast%3DTallman%26aufirst%3DM.%2BS.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DWolniak%26aufirst%3DK.%26aulast%3DPeeters%26aufirst%3DJ.%2BK.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DChoe%26aufirst%3DS.%2BE.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DPaietta%26aufirst%3DE.%26aulast%3DL%25C3%25B6wenberg%26aufirst%3DB.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26aulast%3DGodley%26aufirst%3DL.%2BA.%26aulast%3DDelwel%26aufirst%3DR.%26aulast%3DValk%26aufirst%3DP.%2BJ.%2BM.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DMelnick%26aufirst%3DA.%26atitle%3DLeukemic%2520IDH1%2520and%2520IDH2%2520mutations%2520result%2520in%2520a%2520hypermethylation%2520phenotype%252C%2520disrupt%2520TET2%2520function%252C%2520and%2520impair%2520hematopoietic%2520differentiation%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D18%26spage%3D553%26epage%3D567%26doi%3D10.1016%2Fj.ccr.2010.11.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Popovici-Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salituro, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straley, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunii, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantin, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biller, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of the first potent inhibitors of mutant IDH1 that lower tumor 2-HG in vivo</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">850</span>– <span class="NLM_lpage">855</span>, <span class="refDoi"> DOI: 10.1021/ml300225h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300225h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGkurnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=850-855&author=J.+Popovici-Mullerauthor=J.+O.+Saundersauthor=F.+G.+Salituroauthor=J.+M.+Travinsauthor=S.+Yanauthor=F.+Zhaoauthor=S.+Grossauthor=L.+Dangauthor=K.+E.+Yenauthor=H.+Yangauthor=K.+S.+Straleyauthor=S.+Jinauthor=K.+Kuniiauthor=V.+R.+Fantinauthor=S.+Zhangauthor=Q.+Panauthor=D.+Shiauthor=S.+A.+Billerauthor=S.+M.+Su&title=Discovery+of+the+first+potent+inhibitors+of+mutant+IDH1+that+lower+tumor+2-HG+in+vivo&doi=10.1021%2Fml300225h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo</span></div><div class="casAuthors">Popovici-Muller, Janeta; Saunders, Jeffrey O.; Salituro, Francesco G.; Travins, Jeremy M.; Yan, Shunqi; Zhao, Fang; Gross, Stefan; Dang, Lenny; Yen, Katharine E.; Yang, Hua; Straley, Kimberly S.; Jin, Shengfang; Kunii, Kaiko; Fantin, Valeria R.; Zhang, Shunan; Pan, Qiongqun; Shi, Derek; Biller, Scott A.; Su, Shinsan M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">850-855</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optimization of a series of R132H IDH1 inhibitors from a high throughput screen led to the first potent mols. that show robust tumor 2-HG inhibition in a xenograft model.  Compd. 35 shows good potency in the U87 R132H cell based assay and ∼90% tumor 2-HG inhibition in the corresponding mouse xenograft model following BID dosing.  The magnitude and duration of tumor 2-HG inhibition correlates with free plasma concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprvfJ98f1ns7Vg90H21EOLACvtfcHk0lgiQO58k96V1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGkurnE&md5=eabdaa3351155971ed3feceace0d17c4</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fml300225h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300225h%26sid%3Dliteratum%253Aachs%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DSaunders%26aufirst%3DJ.%2BO.%26aulast%3DSalituro%26aufirst%3DF.%2BG.%26aulast%3DTravins%26aufirst%3DJ.%2BM.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DDang%26aufirst%3DL.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DStraley%26aufirst%3DK.%2BS.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKunii%26aufirst%3DK.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DQ.%26aulast%3DShi%26aufirst%3DD.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DSu%26aufirst%3DS.%2BM.%26atitle%3DDiscovery%2520of%2520the%2520first%2520potent%2520inhibitors%2520of%2520mutant%2520IDH1%2520that%2520lower%2520tumor%25202-HG%2520in%2520vivo%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D850%26epage%3D855%26doi%3D10.1021%2Fml300225h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cairns, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">Oncogenic isocitrate dehydrogenase mutations: mechanisms, models, and clinical opportunities</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">730</span>– <span class="NLM_lpage">741</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-13-0083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1158%2F2159-8290.CD-13-0083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=23796461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSrtLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=730-741&author=R.+A.+Cairnsauthor=T.+W.+Mak&title=Oncogenic+isocitrate+dehydrogenase+mutations%3A+mechanisms%2C+models%2C+and+clinical+opportunities&doi=10.1158%2F2159-8290.CD-13-0083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic Isocitrate Dehydrogenase Mutations: Mechanisms, Models, and Clinical Opportunities</span></div><div class="casAuthors">Cairns, Rob A.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">730-741</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Heterozygous mutations in catalytic arginine residues of isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) are common in glioma, acute myeloid leukemia, chondrosarcoma, cholangiocarcinoma, and angioimmunoblastic T-cell lymphoma.  The mutant enzymes acquire a neomorphic activity that converts α-ketoglutarate (α-KG) to D-2-hydroxyglutarate (D2HG), a rare metabolite.  In cells and tissues expressing mutant IDH, D2HG concns. are highly elevated.  D2HG may act as an "oncometabolite" by inhibiting a class of α-KG-dependent enzymes involved in epigenetic regulation, collagen synthesis, and cell signaling.  Knock-in mouse models of IDH1 mutations have shed light on these mechanisms and will provide valuable animal models for further investigation.  Significance: Mutations in IDH1 and IDH2 promote the development of a no. of malignancies.  These active site mutations cause a gain-of-function leading to the accumulation of the rare metabolite D2HG.  Mouse models of these mutations should provide insights into the mechanisms driving tumorigenesis and facilitate evaluation of new treatments.  Cancer Discov; 3(7); 730-41. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh83ISAiWVdrVg90H21EOLACvtfcHk0lieowTEYPTQDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSrtLnL&md5=536f30c7ae2761a3de801e8213522d23</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-13-0083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-13-0083%26sid%3Dliteratum%253Aachs%26aulast%3DCairns%26aufirst%3DR.%2BA.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DOncogenic%2520isocitrate%2520dehydrogenase%2520mutations%253A%2520mechanisms%252C%2520models%252C%2520and%2520clinical%2520opportunities%26jtitle%3DCancer%2520Discovery%26date%3D2013%26volume%3D3%26spage%3D730%26epage%3D741%26doi%3D10.1158%2F2159-8290.CD-13-0083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rohle, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovici-Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palaskas, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turcan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grommes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsoi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldrini, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komisopoulou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunii, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedraza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schalm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kernytsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblum, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biller, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graeber, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellinghoff, I. K.</span></span> <span> </span><span class="NLM_article-title">An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>340</i></span>,  <span class="NLM_fpage">626</span>– <span class="NLM_lpage">630</span>, <span class="refDoi"> DOI: 10.1126/science.1236062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1126%2Fscience.1236062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=23558169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslWksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2013&pages=626-630&author=D.+Rohleauthor=J.+Popovici-Mullerauthor=N.+Palaskasauthor=S.+Turcanauthor=C.+Grommesauthor=C.+Camposauthor=J.+Tsoiauthor=O.+Clarkauthor=B.+Oldriniauthor=E.+Komisopoulouauthor=K.+Kuniiauthor=A.+Pedrazaauthor=S.+Schalmauthor=L.+Silvermanauthor=A.+Millerauthor=F.+Wangauthor=H.+Yangauthor=Y.+Chenauthor=A.+Kernytskyauthor=M.+K.+Rosenblumauthor=W.+Liuauthor=S.+A.+Billerauthor=S.+M.+Suauthor=C.+W.+Brennanauthor=T.+A.+Chanauthor=T.+G.+Graeberauthor=K.+E.+Yenauthor=I.+K.+Mellinghoff&title=An+inhibitor+of+mutant+IDH1+delays+growth+and+promotes+differentiation+of+glioma+cells&doi=10.1126%2Fscience.1236062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells</span></div><div class="casAuthors">Rohle, Dan; Popovici-Muller, Janeta; Palaskas, Nicolaos; Turcan, Sevin; Grommes, Christian; Campos, Carl; Tsoi, Jennifer; Clark, Owen; Oldrini, Barbara; Komisopoulou, Evangelia; Kunii, Kaiko; Pedraza, Alicia; Schalm, Stefanie; Silverman, Lee; Miller, Alexandra; Wang, Fang; Yang, Hua; Chen, Yue; Kernytsky, Andrew; Rosenblum, Marc K.; Liu, Wei; Biller, Scott A.; Su, Shinsan M.; Brennan, Cameron W.; Chan, Timothy A.; Graeber, Thomas G.; Yen, Katharine E.; Mellinghoff, Ingo K.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">6132</span>),
    <span class="NLM_cas:pages">626-630</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The recent discovery of mutations in metabolic enzymes has rekindled interest in harnessing the altered metab. of cancer cells for cancer therapy.  One potential drug target is isocitrate dehydrogenase 1 (IDH1), which is mutated in multiple human cancers.  Here, we examine the role of mutant IDH1 in fully transformed cells with endogenous IDH1 mutations.  A selective R132H-IDH1 inhibitor (AGI-5198) identified through a high-throughput screen blocked, in a dose-dependent manner, the ability of the mutant enzyme (mIDH1) to produce R-2-hydroxyglutarate (R-2HG).  Under conditions of near-complete R-2HG inhibition, the mIDH1 inhibitor induced demethylation of histone H3K9me3 and expression of genes assocd. with gliogenic differentiation.  Blockade of mIDH1 impaired the growth of IDH1-mutant-but not IDH1-wild-type-glioma cells without appreciable changes in genome-wide DNA methylation.  These data suggest that mIDH1 may promote glioma growth through mechanisms beyond its well-characterized epigenetic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz81Au_Pr-4rVg90H21EOLACvtfcHk0lieowTEYPTQDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslWksbg%253D&md5=c4499103628349dcf9866c44924acf3c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1126%2Fscience.1236062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1236062%26sid%3Dliteratum%253Aachs%26aulast%3DRohle%26aufirst%3DD.%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DPalaskas%26aufirst%3DN.%26aulast%3DTurcan%26aufirst%3DS.%26aulast%3DGrommes%26aufirst%3DC.%26aulast%3DCampos%26aufirst%3DC.%26aulast%3DTsoi%26aufirst%3DJ.%26aulast%3DClark%26aufirst%3DO.%26aulast%3DOldrini%26aufirst%3DB.%26aulast%3DKomisopoulou%26aufirst%3DE.%26aulast%3DKunii%26aufirst%3DK.%26aulast%3DPedraza%26aufirst%3DA.%26aulast%3DSchalm%26aufirst%3DS.%26aulast%3DSilverman%26aufirst%3DL.%26aulast%3DMiller%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DKernytsky%26aufirst%3DA.%26aulast%3DRosenblum%26aufirst%3DM.%2BK.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DSu%26aufirst%3DS.%2BM.%26aulast%3DBrennan%26aufirst%3DC.%2BW.%26aulast%3DChan%26aufirst%3DT.%2BA.%26aulast%3DGraeber%26aufirst%3DT.%2BG.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DMellinghoff%26aufirst%3DI.%2BK.%26atitle%3DAn%2520inhibitor%2520of%2520mutant%2520IDH1%2520delays%2520growth%2520and%2520promotes%2520differentiation%2520of%2520glioma%2520cells%26jtitle%3DScience%26date%3D2013%26volume%3D340%26spage%3D626%26epage%3D630%26doi%3D10.1126%2Fscience.1236062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paz, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilky, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galoian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinoco, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodamer, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trent, J. C.</span></span> <span> </span><span class="NLM_article-title">Treatment with a small molecule mutant IDH1 inhibitor suppresses tumorigenic activity and decreases production of the oncometabolite 2-hydroxyglutarate in human chondrosarcoma cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0133813</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0133813</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1371%2Fjournal.pone.0133813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=26368816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC28XosVWjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0133813&author=L.+Liauthor=A.+C.+Pazauthor=B.+A.+Wilkyauthor=B.+Johnsonauthor=K.+Galoianauthor=A.+Rosenbergauthor=G.+Huauthor=G.+Tinocoauthor=O.+Bodamerauthor=J.+C.+Trent&title=Treatment+with+a+small+molecule+mutant+IDH1+inhibitor+suppresses+tumorigenic+activity+and+decreases+production+of+the+oncometabolite+2-hydroxyglutarate+in+human+chondrosarcoma+cells&doi=10.1371%2Fjournal.pone.0133813"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment with a small molecule mutant IDH1 inhibitor suppresses tumorigenic activity and decreases production of the oncometabolite 2-hydroxyglutarate in human chondrosarcoma cells</span></div><div class="casAuthors">Li, Luyuan; Paz, Ana C.; Wilky, Breelyn A.; Johnson, Britt; Galoian, Karina; Rosenberg, Andrew; Hu, Guozhi; Tinoco, Gabriel; Bodamer, Olaf; Trent, Jonathan C.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e0133813/1-e0133813/19</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Chondrosarcomas are malignant bone tumors that produce cartilaginousmatrix.  Mutations in isocitrate dehydrogenase enzymes (IDH1/2) were recently described in several cancers including chondrosarcomas.  The IDH1 inhibitor AGI-5198 abrogates the ability of mutant IDH1 to produce the oncometabolite D-2 hydroxyglutarate (D-2HG) in gliomas.We sought to det. if treatment with AGI-5198 would similarly inhibit tumorigenic activity and D-2HG prodn. in IDH1-mutant human chondrosarcoma cells.  Two human chondrosarcoma cell lines, JJ012 and HT1080 with endogenous IDH1 mutations and a human chondrocyte cell line C28 with wild type IDH1 were employed in our study.  Mutation anal. of IDH was performed by PCR-based DNA sequencing, and D-2HG was detected using tandem mass spectrometry.We confirmed that JJ012 and HT1080 harbor IDH1 R132G and R132C mutation, resp., while C28 has no mutation.  D-2HG was detectable in cell pellets and media of JJ012 and HT1080 cells, as well as plasma and urine from an IDH-mutant chondrosarcoma patient, which decreased after tumor resection.  AGI-5198 treatment decreased D-2HG levels in JJ012 and HT1080 cells in a dose-dependent manner, and dramatically inhibited colony formation and migration, interrupted cell cycling, and induced apoptosis.  In conclusion, our study demonstrates anti-tumor activity of amutant IDH1 inhibitor in human chondrosarcoma cell lines, and suggests that D-2HG is a potential biomarker for IDH mutations in chondrosarcoma cells.  Thus, clin. trials of mutant IDH inhibitors are warranted for patients with IDH-mutant chondrosarcomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodi9R8fnoFPrVg90H21EOLACvtfcHk0lieowTEYPTQDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosVWjuw%253D%253D&md5=5d7d934b46f2f92dd7f99121ba07623f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0133813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0133813%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DPaz%26aufirst%3DA.%2BC.%26aulast%3DWilky%26aufirst%3DB.%2BA.%26aulast%3DJohnson%26aufirst%3DB.%26aulast%3DGaloian%26aufirst%3DK.%26aulast%3DRosenberg%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DTinoco%26aufirst%3DG.%26aulast%3DBodamer%26aufirst%3DO.%26aulast%3DTrent%26aufirst%3DJ.%2BC.%26atitle%3DTreatment%2520with%2520a%2520small%2520molecule%2520mutant%2520IDH1%2520inhibitor%2520suppresses%2520tumorigenic%2520activity%2520and%2520decreases%2520production%2520of%2520the%2520oncometabolite%25202-hydroxyglutarate%2520in%2520human%2520chondrosarcoma%2520cells%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0133813%26doi%3D10.1371%2Fjournal.pone.0133813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodado, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lita, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowdy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larion, M.</span></span> <span> </span><span class="NLM_article-title">Abstract 2508: profiling the metabolic effects of AGI-5198 treatment on IDH1-mutated gliomas</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">2508</span>– <span class="NLM_lpage">2508</span>, <span class="refDoi"> DOI: 10.1158/1538-7445.AM2017-2508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1158%2F1538-7445.AM2017-2508" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=2508-2508&author=V.+R.+Rodadoauthor=A.+Litaauthor=T.+Dowdyauthor=M.+R.+Gilbertauthor=M.+Larion&title=Abstract+2508%3A+profiling+the+metabolic+effects+of+AGI-5198+treatment+on+IDH1-mutated+gliomas&doi=10.1158%2F1538-7445.AM2017-2508"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2017-2508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2017-2508%26sid%3Dliteratum%253Aachs%26aulast%3DRodado%26aufirst%3DV.%2BR.%26aulast%3DLita%26aufirst%3DA.%26aulast%3DDowdy%26aufirst%3DT.%26aulast%3DGilbert%26aufirst%3DM.%2BR.%26aulast%3DLarion%26aufirst%3DM.%26atitle%3DAbstract%25202508%253A%2520profiling%2520the%2520metabolic%2520effects%2520of%2520AGI-5198%2520treatment%2520on%2520IDH1-mutated%2520gliomas%26jtitle%3DCancer%2520Res.%26date%3D2017%26volume%3D77%26spage%3D2508%26epage%3D2508%26doi%3D10.1158%2F1538-7445.AM2017-2508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Popovici-Muller, J.</span>; <span class="NLM_string-name">Salituro, F. G.</span>; <span class="NLM_string-name">Saunders, J.</span>; <span class="NLM_string-name">Travins, J.</span>; <span class="NLM_string-name">Yan, S.</span></span> <span> </span><span class="NLM_article-title">Therapeutically Active Compounds and Their Methods of Use</span>. <span class="NLM_patent">WO/2012009678 A8</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+Popovici-Muller&author=F.+G.+Salituro&author=J.+Saunders&author=J.+Travins&author=S.+Yan&title=Therapeutically+Active+Compounds+and+Their+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26atitle%3DTherapeutically%2520Active%2520Compounds%2520and%2520Their%2520Methods%2520of%2520Use%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, Y.</span>; <span class="NLM_string-name">Sigel, C.</span>; <span class="NLM_string-name">Lowery, M. A.</span>; <span class="NLM_string-name">Goyal, L.</span>; <span class="NLM_string-name">Gliser, G.</span>; <span class="NLM_string-name">Jiang, L.</span>; <span class="NLM_string-name">Pandya, S.</span>; <span class="NLM_string-name">Wu, B.</span>; <span class="NLM_string-name">Choe, S.</span>; <span class="NLM_string-name">Deshpande, V.</span></span> <span> </span><span class="NLM_article-title">AG-120 (Ivosidenib), a First-in-Class Mutant IDH1 Inhibitor, Promotes Morphologic Changes and Upregulates Liver-Specific Genes in IDH1 Mutant Cholangiocarcinoma</span>.  <i>Abstracts of Papers</i>, AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, Philadelphia, PA, Oct 26–30 <span class="NLM_year">2017</span>; Abstract A071.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=Y.+Ishii&author=C.+Sigel&author=M.+A.+Lowery&author=L.+Goyal&author=G.+Gliser&author=L.+Jiang&author=S.+Pandya&author=B.+Wu&author=S.+Choe&author=V.+Deshpande&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DIshii%26aufirst%3DY.%26atitle%3DAG-120%2520%2528Ivosidenib%2529%252C%2520a%2520First-in-Class%2520Mutant%2520IDH1%2520Inhibitor%252C%2520Promotes%2520Morphologic%2520Changes%2520and%2520Upregulates%2520Liver-Specific%2520Genes%2520in%2520IDH1%2520Mutant%2520Cholangiocarcinoma%26btitle%3DAbstracts%2520of%2520Papers%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quivoron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemieux, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovici-Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadrzadeh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fathi, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gliser, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saada, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micol, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agresta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Botton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penard-Lacronique, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K.</span></span> <span> </span><span class="NLM_article-title">AG-120, an oral, selective, first-in-class, potent inhibitor of mutant IDH1, reduces intracellular 2-HG and induces cellular differentiation in TF-1 R132H cells and primary human IDH1 mutant AML patient samples treated <i>ex vivo</i></span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">3734</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=3734&author=E.+Hansenauthor=C.+Quivoronauthor=K.+Straleyauthor=R.+M.+Lemieuxauthor=J.+Popovici-Mullerauthor=H.+Sadrzadehauthor=A.+T.+Fathiauthor=C.+Gliserauthor=M.+Davidauthor=V.+Saadaauthor=J.-B.+Micolauthor=O.+Bernardauthor=M.+Dorschauthor=H.+Yangauthor=M.+Suauthor=S.+Agrestaauthor=S.+de+Bottonauthor=V.+Penard-Lacroniqueauthor=K.+Yen&title=AG-120%2C+an+oral%2C+selective%2C+first-in-class%2C+potent+inhibitor+of+mutant+IDH1%2C+reduces+intracellular+2-HG+and+induces+cellular+differentiation+in+TF-1+R132H+cells+and+primary+human+IDH1+mutant+AML+patient+samples+treated+ex+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DE.%26aulast%3DQuivoron%26aufirst%3DC.%26aulast%3DStraley%26aufirst%3DK.%26aulast%3DLemieux%26aufirst%3DR.%2BM.%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DSadrzadeh%26aufirst%3DH.%26aulast%3DFathi%26aufirst%3DA.%2BT.%26aulast%3DGliser%26aufirst%3DC.%26aulast%3DDavid%26aufirst%3DM.%26aulast%3DSaada%26aufirst%3DV.%26aulast%3DMicol%26aufirst%3DJ.-B.%26aulast%3DBernard%26aufirst%3DO.%26aulast%3DDorsch%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DAgresta%26aufirst%3DS.%26aulast%3Dde%2BBotton%26aufirst%3DS.%26aulast%3DPenard-Lacronique%26aufirst%3DV.%26aulast%3DYen%26aufirst%3DK.%26atitle%3DAG-120%252C%2520an%2520oral%252C%2520selective%252C%2520first-in-class%252C%2520potent%2520inhibitor%2520of%2520mutant%2520IDH1%252C%2520reduces%2520intracellular%25202-HG%2520and%2520induces%2520cellular%2520differentiation%2520in%2520TF-1%2520R132H%2520cells%2520and%2520primary%2520human%2520IDH1%2520mutant%2520AML%2520patient%2520samples%2520treated%2520ex%2520vivo%26jtitle%3DBlood%26date%3D2014%26volume%3D124%26spage%3D3734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pollyea, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Botton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fathi, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agresta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowden, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, R. M.</span></span> <span> </span><span class="NLM_article-title">1LBA clinical safety and activity in a phase I trial of AG-120, a first in class, selective, potent inhibitor of the IDH1-mutant protein, in patients with IDH1 mutant positive advanced hematologic malignancies</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">195</span>, <span class="refDoi"> DOI: 10.1016/S0959-8049(14)70722-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1016%2FS0959-8049%2814%2970722-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=195&author=D.+A.+Pollyeaauthor=S.+de+Bottonauthor=A.+T.+Fathiauthor=E.+M.+Steinauthor=M.+S.+Tallmanauthor=S.+Agrestaauthor=C.+Bowdenauthor=B.+Fanauthor=M.+Prahauthor=H.+Yangauthor=K.+Yenauthor=R.+M.+Stone&title=1LBA+clinical+safety+and+activity+in+a+phase+I+trial+of+AG-120%2C+a+first+in+class%2C+selective%2C+potent+inhibitor+of+the+IDH1-mutant+protein%2C+in+patients+with+IDH1+mutant+positive+advanced+hematologic+malignancies&doi=10.1016%2FS0959-8049%2814%2970722-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0959-8049%2814%2970722-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-8049%252814%252970722-1%26sid%3Dliteratum%253Aachs%26aulast%3DPollyea%26aufirst%3DD.%2BA.%26aulast%3Dde%2BBotton%26aufirst%3DS.%26aulast%3DFathi%26aufirst%3DA.%2BT.%26aulast%3DStein%26aufirst%3DE.%2BM.%26aulast%3DTallman%26aufirst%3DM.%2BS.%26aulast%3DAgresta%26aufirst%3DS.%26aulast%3DBowden%26aufirst%3DC.%26aulast%3DFan%26aufirst%3DB.%26aulast%3DPrah%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DYen%26aufirst%3DK.%26aulast%3DStone%26aufirst%3DR.%2BM.%26atitle%3D1LBA%2520clinical%2520safety%2520and%2520activity%2520in%2520a%2520phase%2520I%2520trial%2520of%2520AG-120%252C%2520a%2520first%2520in%2520class%252C%2520selective%252C%2520potent%2520inhibitor%2520of%2520the%2520IDH1-mutant%2520protein%252C%2520in%2520patients%2520with%2520IDH1%2520mutant%2520positive%2520advanced%2520hematologic%2520malignancies%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2014%26volume%3D50%26spage%3D195%26doi%3D10.1016%2FS0959-8049%2814%2970722-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nassereddine, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lap, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haroun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabbara, I.</span></span> <span> </span><span class="NLM_article-title">The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia</span>. <i>Ann. Hematol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">1983</span>– <span class="NLM_lpage">1991</span>, <span class="refDoi"> DOI: 10.1007/s00277-017-3161-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1007%2Fs00277-017-3161-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=29090344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslCmtrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2017&pages=1983-1991&author=S.+Nassereddineauthor=C.+J.+Lapauthor=F.+Harounauthor=I.+Tabbara&title=The+role+of+mutant+IDH1+and+IDH2+inhibitors+in+the+treatment+of+acute+myeloid+leukemia&doi=10.1007%2Fs00277-017-3161-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia</span></div><div class="casAuthors">Nassereddine, Samah; Lap, Coen J.; Haroun, Faysal; Tabbara, Imad</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Hematology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1983-1991</span>CODEN:
                <span class="NLM_cas:coden">ANHEE8</span>;
        ISSN:<span class="NLM_cas:issn">0939-5555</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">For decades, researchers have looked into the pathophysiol. of acute myeloid leukemia (AML).  With the advances in mol. techniques, the two-hit hypothesis was replaced by a multi-hit model, which also emphasizes the importance of aberrant epigenetic regulation in the pathogenesis of AML.  IDH1 and IDH2 are two isoforms of isocitrate dehydrogenase that perform crucial roles in cellular metab.  Somatic mutations in either of these two genes impart a neomorphic enzymic activity upon the encoded enzymes resulting in the ability to convert α-ketoglutarate (αKG) into the oncometabolite R2-hydroxyglutarate (R2-HG), which can competitively inhibit multiple αKG-dependent dioxygenases.  Inhibition of various classes of αKG-dependent dioxygenases results in dramatic epigenetic changes in hematopoietic cells, which has been found to directly impair differentiation.  In addn. to a global dysregulation of gene expression, other mechanisms have been described through which R2-HG promotes leukemic transformation including the induction of B cell lymphoma 2 dependency and stimulation of the EglN family of prolyl 4-hydroxylases (EglN).  Due to the fact that mutations in IDH1 and IDH2 are acquired early during AML clonal evolution as well as because these mutations tend to remain stable during AML progression, the pharmaceutical industry has prompted the development of specific mutant IDH enzyme inhibitors.  More recently, the FDA approved the first mutant IDH2 inhibitor, enasidenib (AG-221), for patients with relapsed or refractory IDH2-mutated AML (RR-AML).  This has brought a lot of excitement to researchers, clinicians, and patients, esp. because the treatment of AML remains challenging and is still assocd. with a high mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0MoaTYhzKz7Vg90H21EOLACvtfcHk0ljhRgr5ioR_6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslCmtrrL&md5=8b84f1581f0beef64cf14e6bf9f1a7c0</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2Fs00277-017-3161-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00277-017-3161-0%26sid%3Dliteratum%253Aachs%26aulast%3DNassereddine%26aufirst%3DS.%26aulast%3DLap%26aufirst%3DC.%2BJ.%26aulast%3DHaroun%26aufirst%3DF.%26aulast%3DTabbara%26aufirst%3DI.%26atitle%3DThe%2520role%2520of%2520mutant%2520IDH1%2520and%2520IDH2%2520inhibitors%2520in%2520the%2520treatment%2520of%2520acute%2520myeloid%2520leukemia%26jtitle%3DAnn.%2520Hematol.%26date%3D2017%26volume%3D96%26spage%3D1983%26epage%3D1991%26doi%3D10.1007%2Fs00277-017-3161-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lemieux, R. M.</span>; <span class="NLM_string-name">Popovici-Muller, J.</span>; <span class="NLM_string-name">Travins, J.</span>; <span class="NLM_string-name">Cai, Z.</span>; <span class="NLM_string-name">Cui, D.</span>; <span class="NLM_string-name">Zhou, D.</span></span> <span> </span><span class="NLM_article-title">Therapeutically Active Compounds and Their Methods of Use</span>. <span class="NLM_patent">WO/2013107291 A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=R.+M.+Lemieux&author=J.+Popovici-Muller&author=J.+Travins&author=Z.+Cai&author=D.+Cui&author=D.+Zhou&title=Therapeutically+Active+Compounds+and+Their+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLemieux%26aufirst%3DR.%2BM.%26atitle%3DTherapeutically%2520Active%2520Compounds%2520and%2520Their%2520Methods%2520of%2520Use%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gu, C.</span></span> <span> </span><span class="NLM_article-title">Pharmaceutical Compositions of Therapeutically Active Compounds</span>. <span class="NLM_patent">WO/2015138837 A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=C.+Gu&title=Pharmaceutical+Compositions+of+Therapeutically+Active+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DC.%26atitle%3DPharmaceutical%2520Compositions%2520of%2520Therapeutically%2520Active%2520Compounds%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gu, C.</span></span> <span> </span><span class="NLM_article-title">Pharmaceutical Compositions of Therapeutically Active Compounds</span>. <span class="NLM_patent">WO/2015138839 A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=C.+Gu&title=Pharmaceutical+Compositions+of+Therapeutically+Active+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DC.%26atitle%3DPharmaceutical%2520Compositions%2520of%2520Therapeutically%2520Active%2520Compounds%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemieux, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovici-Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agresta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkein, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span> <span> </span><span class="NLM_article-title">IDH1 mutant inhibitor induces cellular differentiation and offers a combination benefit with Ara-C in a primary human IDH1 mutant AML xenograft model</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">3946</span>– <span class="NLM_lpage">3946</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2013&pages=3946-3946&author=K.+Yenauthor=R.+Lemieuxauthor=J.+Popovici-Mullerauthor=Y.+Chenauthor=H.+Yangauthor=K.+Straleyauthor=S.+Choeauthor=M.+Dorschauthor=S.+Agrestaauthor=D.+P.+Schenkeinauthor=S.+Billerauthor=M.+Suauthor=F.+Wang&title=IDH1+mutant+inhibitor+induces+cellular+differentiation+and+offers+a+combination+benefit+with+Ara-C+in+a+primary+human+IDH1+mutant+AML+xenograft+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYen%26aufirst%3DK.%26aulast%3DLemieux%26aufirst%3DR.%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DStraley%26aufirst%3DK.%26aulast%3DChoe%26aufirst%3DS.%26aulast%3DDorsch%26aufirst%3DM.%26aulast%3DAgresta%26aufirst%3DS.%26aulast%3DSchenkein%26aufirst%3DD.%2BP.%26aulast%3DBiller%26aufirst%3DS.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DF.%26atitle%3DIDH1%2520mutant%2520inhibitor%2520induces%2520cellular%2520differentiation%2520and%2520offers%2520a%2520combination%2520benefit%2520with%2520Ara-C%2520in%2520a%2520primary%2520human%2520IDH1%2520mutant%2520AML%2520xenograft%2520model%26jtitle%3DBlood%26date%3D2013%26volume%3D122%26spage%3D3946%26epage%3D3946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larkin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, W.</span></span> <span> </span><span class="NLM_article-title">Novel therapies in AML: reason for hope or just hype?</span>. <i>Am. Soc. Clin. Oncol. Educ. B</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">e341</span>– <span class="NLM_lpage">e351</span>, <span class="refDoi"> DOI: 10.14694/EdBook_AM.2014.34.e341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.14694%2FEdBook_AM.2014.34.e341" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=e341-e351&author=K.+Larkinauthor=W.+Blum&title=Novel+therapies+in+AML%3A+reason+for+hope+or+just+hype%3F&doi=10.14694%2FEdBook_AM.2014.34.e341"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.14694%2FEdBook_AM.2014.34.e341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14694%252FEdBook_AM.2014.34.e341%26sid%3Dliteratum%253Aachs%26aulast%3DLarkin%26aufirst%3DK.%26aulast%3DBlum%26aufirst%3DW.%26atitle%3DNovel%2520therapies%2520in%2520AML%253A%2520reason%2520for%2520hope%2520or%2520just%2520hype%253F%26jtitle%3DAm.%2520Soc.%2520Clin.%2520Oncol.%2520Educ.%2520B%26date%3D2014%26volume%3D34%26spage%3De341%26epage%3De351%26doi%3D10.14694%2FEdBook_AM.2014.34.e341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellwood-Yen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemieux, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovici-Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agresta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.</span></span> <span> </span><span class="NLM_article-title">Abstract 1194: IDH1 mutant inhibitor induces cellular differentiation and offers a combination benefit with Ara-C in a primary human IDH1 mutant AML xenograft model</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">1194</span>– <span class="NLM_lpage">1194</span>, <span class="refDoi"> DOI: 10.1158/1538-7445.AM2014-1194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1158%2F1538-7445.AM2014-1194" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=1194-1194&author=K.+Ellwood-Yenauthor=Y.+Chenauthor=F.+Wangauthor=R.+Lemieuxauthor=J.+Popovici-Mullerauthor=H.+Yangauthor=K.+Straleyauthor=S.+Choeauthor=M.+Dorschauthor=S.+Agrestaauthor=D.+Schenkeinauthor=S.+Billerauthor=M.+Su&title=Abstract+1194%3A+IDH1+mutant+inhibitor+induces+cellular+differentiation+and+offers+a+combination+benefit+with+Ara-C+in+a+primary+human+IDH1+mutant+AML+xenograft+model&doi=10.1158%2F1538-7445.AM2014-1194"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2014-1194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2014-1194%26sid%3Dliteratum%253Aachs%26aulast%3DEllwood-Yen%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DLemieux%26aufirst%3DR.%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DStraley%26aufirst%3DK.%26aulast%3DChoe%26aufirst%3DS.%26aulast%3DDorsch%26aufirst%3DM.%26aulast%3DAgresta%26aufirst%3DS.%26aulast%3DSchenkein%26aufirst%3DD.%26aulast%3DBiller%26aufirst%3DS.%26aulast%3DSu%26aufirst%3DM.%26atitle%3DAbstract%25201194%253A%2520IDH1%2520mutant%2520inhibitor%2520induces%2520cellular%2520differentiation%2520and%2520offers%2520a%2520combination%2520benefit%2520with%2520Ara-C%2520in%2520a%2520primary%2520human%2520IDH1%2520mutant%2520AML%2520xenograft%2520model%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26spage%3D1194%26epage%3D1194%26doi%3D10.1158%2F1538-7445.AM2014-1194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Konig, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levis, M.</span></span> <span> </span><span class="NLM_article-title">Is targeted therapy feasible in acute myelogenous leukemia?</span>. <i>Curr. Hematol. Malig. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.1007/s11899-014-0198-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1007%2Fs11899-014-0198-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=24599573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A280%3ADC%252BC2crhtVWrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=118-127&author=H.+Konigauthor=M.+Levis&title=Is+targeted+therapy+feasible+in+acute+myelogenous+leukemia%3F&doi=10.1007%2Fs11899-014-0198-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Is targeted therapy feasible in acute myelogenous leukemia?</span></div><div class="casAuthors">Konig Heiko; Levis Mark</div><div class="citationInfo"><span class="NLM_cas:title">Current hematologic malignancy reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">118-27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The prognosis for patients with acute myeloid leukemia (AML) is determined to a large degree by the biology of the leukemic cell.  In recent years, the identification and characterization of genetic aberrations has vastly improved our understanding of the pathogenesis of AML.  In contrast, however, there has been a lack of clinically meaningful therapeutic advances.  The same chemotherapeutic strategies have been applied to AML for several decades now, and while these regimens are effective in inducing remission, most patients relapse within months after initial treatment.  Hence, there is an urgent need for novel therapies.  We review herein a number of lines of laboratory and clinical trial data supporting the clinical value of targeted treatment approaches that will likely result in improved outcomes for patients with AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRA3Z2jpwOm0lUIs6wFK5xJfW6udTcc2eYMHRRjhNTXFrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crhtVWrtA%253D%253D&md5=e0ed4bdacd9424789c2255c8f2861eca</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1007%2Fs11899-014-0198-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11899-014-0198-1%26sid%3Dliteratum%253Aachs%26aulast%3DKonig%26aufirst%3DH.%26aulast%3DLevis%26aufirst%3DM.%26atitle%3DIs%2520targeted%2520therapy%2520feasible%2520in%2520acute%2520myelogenous%2520leukemia%253F%26jtitle%3DCurr.%2520Hematol.%2520Malig.%2520Rep.%26date%3D2014%26volume%3D9%26spage%3D118%26epage%3D127%26doi%3D10.1007%2Fs11899-014-0198-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M.</span>; <span class="NLM_string-name">Pragani, R.</span>; <span class="NLM_string-name">Popovici-Muller, J.</span>; <span class="NLM_string-name">Gross, S.</span>; <span class="NLM_string-name">Thorne, N.</span>; <span class="NLM_string-name">Salituro, F.</span>; <span class="NLM_string-name">Fantin, V.</span>; <span class="NLM_string-name">Straley, K.</span>; <span class="NLM_string-name">Su, M.</span>; <span class="NLM_string-name">Dang, L.</span>; <span class="NLM_string-name">Simeonov, A.</span>; <span class="NLM_string-name">Shen, M.</span>; <span class="NLM_string-name">Boxer, M. B.</span></span> <span> </span><span class="NLM_article-title">ML309: A Potent Inhibitor of R132H Mutant IDH1 Capable of Reducing 2-Hydroxyglutarate Production in U87 MG Glioblastoma Cells</span>.  <i>Probe Reports from the NIH Molecular Libraries Program</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, K.</span></span>, Ed.; <span class="NLM_publisher-name">National Center for Biotechnology Information</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=M.+Davis&author=R.+Pragani&author=J.+Popovici-Muller&author=S.+Gross&author=N.+Thorne&author=F.+Salituro&author=V.+Fantin&author=K.+Straley&author=M.+Su&author=L.+Dang&author=A.+Simeonov&author=M.+Shen&author=M.+B.+Boxerauthor=K.+Mills&title=Probe+Reports+from+the+NIH+Molecular+Libraries+Program"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%26atitle%3DML309%253A%2520A%2520Potent%2520Inhibitor%2520of%2520R132H%2520Mutant%2520IDH1%2520Capable%2520of%2520Reducing%25202-Hydroxyglutarate%2520Production%2520in%2520U87%2520MG%2520Glioblastoma%2520Cells%26btitle%3DProbe%2520Reports%2520from%2520the%2520NIH%2520Molecular%2520Libraries%2520Program%26aulast%3DMills%26aufirst%3DK.%26pub%3DNational%2520Center%2520for%2520Biotechnology%2520Information%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straley, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pragani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lea, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovici-Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLaBarre, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorne, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auld, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boxer, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span> <span> </span><span class="NLM_article-title">Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate dehydrogenase IDH1</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">13717</span>– <span class="NLM_lpage">13725</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.511030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1074%2Fjbc.M113.511030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=13717-13725&author=M.+I.+Davisauthor=S.+Grossauthor=M.+Shenauthor=K.+S.+Straleyauthor=R.+Praganiauthor=W.+A.+Leaauthor=J.+Popovici-Mullerauthor=B.+DeLaBarreauthor=E.+Artinauthor=N.+Thorneauthor=D.+S.+Auldauthor=Z.+Liauthor=L.+Dangauthor=M.+B.+Boxerauthor=A.+Simeonov&title=Biochemical%2C+cellular%2C+and+biophysical+characterization+of+a+potent+inhibitor+of+mutant+isocitrate+dehydrogenase+IDH1&doi=10.1074%2Fjbc.M113.511030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.511030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.511030%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DStraley%26aufirst%3DK.%2BS.%26aulast%3DPragani%26aufirst%3DR.%26aulast%3DLea%26aufirst%3DW.%2BA.%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DDeLaBarre%26aufirst%3DB.%26aulast%3DArtin%26aufirst%3DE.%26aulast%3DThorne%26aufirst%3DN.%26aulast%3DAuld%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DDang%26aufirst%3DL.%26aulast%3DBoxer%26aufirst%3DM.%2BB.%26aulast%3DSimeonov%26aufirst%3DA.%26atitle%3DBiochemical%252C%2520cellular%252C%2520and%2520biophysical%2520characterization%2520of%2520a%2520potent%2520inhibitor%2520of%2520mutant%2520isocitrate%2520dehydrogenase%2520IDH1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D13717%26epage%3D13725%26doi%3D10.1074%2Fjbc.M113.511030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Merk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartesaghi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falconieri, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pragani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boxer, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Earl, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milne, J. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramaniam, S.</span></span> <span> </span><span class="NLM_article-title">Breaking cryo-EM resolution barriers to facilitate drug discovery</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>165</i></span>,  <span class="NLM_fpage">1698</span>– <span class="NLM_lpage">1707</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.05.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1016%2Fj.cell.2016.05.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=27238019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC28XptVSlsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2016&pages=1698-1707&author=A.+Merkauthor=A.+Bartesaghiauthor=S.+Banerjeeauthor=V.+Falconieriauthor=P.+Raoauthor=M.+I.+Davisauthor=R.+Praganiauthor=M.+B.+Boxerauthor=L.+A.+Earlauthor=J.+L.+S.+Milneauthor=S.+Subramaniam&title=Breaking+cryo-EM+resolution+barriers+to+facilitate+drug+discovery&doi=10.1016%2Fj.cell.2016.05.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Breaking Cryo-EM Resolution Barriers to Facilitate Drug Discovery</span></div><div class="casAuthors">Merk, Alan; Bartesaghi, Alberto; Banerjee, Soojay; Falconieri, Veronica; Rao, Prashant; Davis, Mindy I.; Pragani, Rajan; Boxer, Matthew B.; Earl, Lesley A.; Milne, Jacqueline L. S.; Subramaniam, Sriram</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1698-1707</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Recent advances in single-particle cryo-electron microscopy (cryo-EM) are enabling generation of numerous near-at. resoln. structures for well-ordered protein complexes with sizes ≥ ∼200 kDa.  Whether cryo-EM methods are equally useful for high-resoln. structural anal. of smaller, dynamic protein complexes such as those involved in cellular metab. remains an important question.  Here, we present 3.8 Å resoln. cryo-EM structures of the cancer target isocitrate dehydrogenase (93 kDa) and identify the nature of conformational changes induced by binding of the allosteric small-mol. inhibitor ML309.  We also report 2.8-Å- and 1.8-Å-resoln. structures of lactate dehydrogenase (145 kDa) and glutamate dehydrogenase (334 kDa), resp.  With these results, two perceived barriers in single-particle cryo-EM are overcome: (1) crossing 2 Å resoln. and (2) obtaining structures of proteins with sizes < 100 kDa, demonstrating that cryo-EM can be used to investigate a broad spectrum of drug-target interactions and dynamic conformational states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSVJ4hXEIN07Vg90H21EOLACvtfcHk0ljVv_0JxZwrhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptVSlsb8%253D&md5=8457195c1f1724244caa9f90e0ba4682</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.05.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.05.040%26sid%3Dliteratum%253Aachs%26aulast%3DMerk%26aufirst%3DA.%26aulast%3DBartesaghi%26aufirst%3DA.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DFalconieri%26aufirst%3DV.%26aulast%3DRao%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DPragani%26aufirst%3DR.%26aulast%3DBoxer%26aufirst%3DM.%2BB.%26aulast%3DEarl%26aufirst%3DL.%2BA.%26aulast%3DMilne%26aufirst%3DJ.%2BL.%2BS.%26aulast%3DSubramaniam%26aufirst%3DS.%26atitle%3DBreaking%2520cryo-EM%2520resolution%2520barriers%2520to%2520facilitate%2520drug%2520discovery%26jtitle%3DCell%26date%3D2016%26volume%3D165%26spage%3D1698%26epage%3D1707%26doi%3D10.1016%2Fj.cell.2016.05.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Popovici-Muller, J.</span>; <span class="NLM_string-name">Saunders, J.</span>; <span class="NLM_string-name">Salituro, F. G.</span>; <span class="NLM_string-name">Cai, Z.</span>; <span class="NLM_string-name">Yan, S.</span>; <span class="NLM_string-name">Zhou, D.</span></span> <span> </span><span class="NLM_article-title">Therapeutically Active Compounds and Their Methods of Use</span>. <span class="NLM_patent">WO/2013107405 A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=J.+Popovici-Muller&author=J.+Saunders&author=F.+G.+Salituro&author=Z.+Cai&author=S.+Yan&author=D.+Zhou&title=Therapeutically+Active+Compounds+and+Their+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26atitle%3DTherapeutically%2520Active%2520Compounds%2520and%2520Their%2520Methods%2520of%2520Use%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okoye-Okafor, U. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartholdy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietrak, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rominger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smallwood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiggall, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reif, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joberty, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faelth-Savitski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantscheff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duraiswami, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brady, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanagari, S.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antony-Debre, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kao, Y.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopeit, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvajal, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreyro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paietta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makishima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Will, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Concha, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCabe, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maciejewski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steidl, U.</span></span> <span> </span><span class="NLM_article-title">New IDH1 mutant inhibitors for treatment of acute myeloid leukemia</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">878</span>– <span class="NLM_lpage">886</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1930</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1038%2Fnchembio.1930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=26436839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFKqu7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=878-886&author=U.+C.+Okoye-Okaforauthor=B.+Bartholdyauthor=J.+Cartierauthor=E.+N.+Gaoauthor=B.+Pietrakauthor=A.+R.+Rendinaauthor=C.+Romingerauthor=C.+Quinnauthor=A.+Smallwoodauthor=K.+J.+Wiggallauthor=A.+J.+Reifauthor=S.+J.+Schmidtauthor=H.+Qiauthor=H.+Zhaoauthor=G.+Jobertyauthor=M.+Faelth-Savitskiauthor=M.+Bantscheffauthor=G.+Drewesauthor=C.+Duraiswamiauthor=P.+Bradyauthor=A.+Groyauthor=S.-R.+Narayanagariauthor=I.+Antony-Debreauthor=K.+Mitchellauthor=H.+R.+Wangauthor=Y.-R.+Kaoauthor=M.+Christopeitauthor=L.+Carvajalauthor=L.+Barreyroauthor=E.+Paiettaauthor=H.+Makishimaauthor=B.+Willauthor=N.+Conchaauthor=N.+D.+Adamsauthor=B.+Schwartzauthor=M.+T.+McCabeauthor=J.+Maciejewskiauthor=A.+Vermaauthor=U.+Steidl&title=New+IDH1+mutant+inhibitors+for+treatment+of+acute+myeloid+leukemia&doi=10.1038%2Fnchembio.1930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">New IDH1 mutant inhibitors for treatment of acute myeloid leukemia</span></div><div class="casAuthors">Okoye-Okafor, Ujunwa C.; Bartholdy, Boris; Cartier, Jessy; Gao, Enoch N.; Pietrak, Beth; Rendina, Alan R.; Rominger, Cynthia; Quinn, Chad; Smallwood, Angela; Wiggall, Kenneth J.; Reif, Alexander J.; Schmidt, Stanley J.; Qi, Hongwei; Zhao, Huizhen; Joberty, Gerard; Faelth-Savitski, Maria; Bantscheff, Marcus; Drewes, Gerard; Duraiswami, Chaya; Brady, Pat; Groy, Arthur; Narayanagari, Swathi-Rao; Antony-Debre, Ileana; Mitchell, Kelly; Wang, Heng Rui; Kao, Yun-Ruei; Christopeit, Maximilian; Carvajal, Luis; Barreyro, Laura; Paietta, Elisabeth; Makishima, Hideki; Will, Britta; Concha, Nestor; Adams, Nicholas D.; Schwartz, Benjamin; McCabe, Michael T.; Maciejewski, Jaroslav; Verma, Amit; Steidl, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">878-886</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neomorphic mutations in isocitrate dehydrogenase 1 (IDH1) are driver mutations in acute myeloid leukemia (AML) and other cancers.  The authors report the development of new allosteric inhibitors of mutant IDH1.  Crystallog. and biochem. results demonstrated that compds. of this chem. series bind to an allosteric site and lock the enzyme in a catalytically inactive conformation, thereby enabling inhibition of different clin. relevant IDH1 mutants.  Treatment of IDH1 mutant primary AML cells uniformly led to a decrease in intracellular 2-HG, abrogation of the myeloid differentiation block and induction of granulocytic differentiation at the level of leukemic blasts and more immature stem-like cells, in vitro and in vivo.  Molecularly, treatment with the inhibitors led to a reversal of the DNA cytosine hypermethylation patterns caused by mutant IDH1 in the cells of individuals with AML.  The authors' study provides proof of concept for the mol. and biol. activity of novel allosteric inhibitors for targeting different mutant forms of IDH1 in leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiVGxt4CfctrVg90H21EOLACvtfcHk0lg4Ield7VE-ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFKqu7vE&md5=96634bed9a8355145dd3e1bce58cc13b</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1930%26sid%3Dliteratum%253Aachs%26aulast%3DOkoye-Okafor%26aufirst%3DU.%2BC.%26aulast%3DBartholdy%26aufirst%3DB.%26aulast%3DCartier%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DE.%2BN.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DRominger%26aufirst%3DC.%26aulast%3DQuinn%26aufirst%3DC.%26aulast%3DSmallwood%26aufirst%3DA.%26aulast%3DWiggall%26aufirst%3DK.%2BJ.%26aulast%3DReif%26aufirst%3DA.%2BJ.%26aulast%3DSchmidt%26aufirst%3DS.%2BJ.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DJoberty%26aufirst%3DG.%26aulast%3DFaelth-Savitski%26aufirst%3DM.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DDuraiswami%26aufirst%3DC.%26aulast%3DBrady%26aufirst%3DP.%26aulast%3DGroy%26aufirst%3DA.%26aulast%3DNarayanagari%26aufirst%3DS.-R.%26aulast%3DAntony-Debre%26aufirst%3DI.%26aulast%3DMitchell%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DH.%2BR.%26aulast%3DKao%26aufirst%3DY.-R.%26aulast%3DChristopeit%26aufirst%3DM.%26aulast%3DCarvajal%26aufirst%3DL.%26aulast%3DBarreyro%26aufirst%3DL.%26aulast%3DPaietta%26aufirst%3DE.%26aulast%3DMakishima%26aufirst%3DH.%26aulast%3DWill%26aufirst%3DB.%26aulast%3DConcha%26aufirst%3DN.%26aulast%3DAdams%26aufirst%3DN.%2BD.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DMcCabe%26aufirst%3DM.%2BT.%26aulast%3DMaciejewski%26aufirst%3DJ.%26aulast%3DVerma%26aufirst%3DA.%26aulast%3DSteidl%26aufirst%3DU.%26atitle%3DNew%2520IDH1%2520mutant%2520inhibitors%2520for%2520treatment%2520of%2520acute%2520myeloid%2520leukemia%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D878%26epage%3D886%26doi%3D10.1038%2Fnchembio.1930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms of “off-on switch” of activities of human IDH1 by tumor-associated mutation R132H</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1188</span>– <span class="NLM_lpage">1200</span>, <span class="refDoi"> DOI: 10.1038/cr.2010.145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1038%2Fcr.2010.145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=20975740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKjtbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1188-1200&author=B.+Yangauthor=C.+Zhongauthor=Y.+Pengauthor=Z.+Laiauthor=J.+Ding&title=Molecular+mechanisms+of+%E2%80%9Coff-on+switch%E2%80%9D+of+activities+of+human+IDH1+by+tumor-associated+mutation+R132H&doi=10.1038%2Fcr.2010.145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of "off-on switch" of activities of human IDH1 by tumor-associated mutation R132H</span></div><div class="casAuthors">Yang, Bei; Zhong, Chen; Peng, Yingjie; Lai, Zheng; Ding, Jianping</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1188-1200</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Human cytosolic NADP-IDH (IDH1) has recently been found to be involved in tumorigenesis.  Notably, the tumor-derived IDH1 mutations identified so far mainly occur at Arg132, and mutation R132H is the most prevalent one.  This mutation impairs the oxidative IDH activity of the enzyme, but renders a new redn. function of converting α-ketoglutarate (αKG) to 2-hydroxyglutarate.  Here, we report the structures of the R132H mutant IDH1 with and without isocitrate (ICT) bound.  The structural data together with mutagenesis and biochem. data reveal a previously undefined initial ICT-binding state and demonstrate that IDH activity requires a conformational change to a closed pre-transition state.  Arg132 plays multiple functional roles in the catalytic reaction; in particular, the R132H mutation hinders the conformational changes from the initial ICT-binding state to the pre-transition state, leading to the impairment of the IDH activity.  Our results describe for the first time that there is an intermediate conformation that corresponds to an initial ICT-binding state and that the R132H mutation can trap the enzyme in this conformation, therefore shedding light on the mol. mechanism of the "off switch" of the potentially tumor-suppressive IDH activity.  Furthermore, we proved the necessity of Tyr139 for the gained αKG redn. activity and propose that Tyr139 may play a vital role by compensating the increased neg. charge on the C2 atom of αKG during the transfer of a hydride anion from NADPH to αKG, which provides new insights into the mechanism of the "on switch" of the hypothetically oncogenic redn. activity of IDH1 by this mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpory1c32RonLVg90H21EOLACvtfcHk0lg4Ield7VE-ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKjtbfI&md5=04d83e2a90480837c09eb8c0140ecc88</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fcr.2010.145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2010.145%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DB.%26aulast%3DZhong%26aufirst%3DC.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DZ.%26aulast%3DDing%26aufirst%3DJ.%26atitle%3DMolecular%2520mechanisms%2520of%2520%25E2%2580%259Coff-on%2520switch%25E2%2580%259D%2520of%2520activities%2520of%2520human%2520IDH1%2520by%2520tumor-associated%2520mutation%2520R132H%26jtitle%3DCell%2520Res.%26date%3D2010%26volume%3D20%26spage%3D1188%26epage%3D1200%26doi%3D10.1038%2Fcr.2010.145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, G. Q.</span></span> <span> </span><span class="NLM_article-title">Rearrangements in the second intron of the RARA gene are present in a large majority of patients with acute promyelocytic leukemia and are used as molecular marker for retinoic acid-induced leukemic cell differentiation</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">2696</span>– <span class="NLM_lpage">2701</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1991&pages=2696-2701&author=S.+J.+Chenauthor=Y.+J.+Zhuauthor=J.+H.+Tongauthor=S.+Dongauthor=W.+Huangauthor=Y.+Chenauthor=W.+M.+Xiangauthor=L.+Zhangauthor=X.+S.+Liauthor=G.+Q.+Qian&title=Rearrangements+in+the+second+intron+of+the+RARA+gene+are+present+in+a+large+majority+of+patients+with+acute+promyelocytic+leukemia+and+are+used+as+molecular+marker+for+retinoic+acid-induced+leukemic+cell+differentiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%2BJ.%26aulast%3DZhu%26aufirst%3DY.%2BJ.%26aulast%3DTong%26aufirst%3DJ.%2BH.%26aulast%3DDong%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DXiang%26aufirst%3DW.%2BM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%2BS.%26aulast%3DQian%26aufirst%3DG.%2BQ.%26atitle%3DRearrangements%2520in%2520the%2520second%2520intron%2520of%2520the%2520RARA%2520gene%2520are%2520present%2520in%2520a%2520large%2520majority%2520of%2520patients%2520with%2520acute%2520promyelocytic%2520leukemia%2520and%2520are%2520used%2520as%2520molecular%2520marker%2520for%2520retinoic%2520acid-induced%2520leukemic%2520cell%2520differentiation%26jtitle%3DBlood%26date%3D1991%26volume%3D78%26spage%3D2696%26epage%3D2701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kogiso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span> <span> </span><span class="NLM_article-title">Inhibition of cancer-associated mutant isocitrate dehydrogenases by 2-thiohydantoin compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6899</span>– <span class="NLM_lpage">6908</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00684</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00684" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlequ7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6899-6908&author=F.+Wuauthor=H.+Jiangauthor=B.+Zhengauthor=M.+Kogisoauthor=Y.+Yaoauthor=C.+Zhouauthor=X.+N.+Liauthor=Y.+Song&title=Inhibition+of+cancer-associated+mutant+isocitrate+dehydrogenases+by+2-thiohydantoin+compounds&doi=10.1021%2Facs.jmedchem.5b00684"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds</span></div><div class="casAuthors">Wu, Fangrui; Jiang, Hong; Zheng, Baisong; Kogiso, Mari; Yao, Yuan; Zhou, Chao; Li, Xiao-Nan; Song, Yongcheng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6899-6908</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Somatic mutations of isocitrate dehydrogenase 1 (IDH1) at R132 are frequently found in certain cancers such as glioma.  With losing the activity of wild-type IDH1, the R132H and R132C mutant proteins can reduce α-ketoglutaric acid (α-KG) to D-2-hydroxyglutaric acid (D2HG).  The resulting high concn. of D2HG inhibits many α-KG-dependent dioxygenases, including histone demethylases, to cause broad histone hypermethylation.  These aberrant epigenetic changes are responsible for the initiation of these cancers.  The authors report the synthesis, structure-activity relationships, enzyme kinetics, and binding thermodn. of a novel series of 2-thiohydantoin and related compds. I [R1 = H, Me, Ph, etc.; R2 = 3,4-(HO)2C6H3, pyridin-3-yl, 2-pyridinone-5-yl, etc.], among which several compds. are potent inhibitors of mutant IDH1 with Ki as low as 420 nM.  X-ray crystal structures of IDH1(R132H) in complex with two inhibitors are reported, showing their inhibitor-protein interactions.  These compds. can decrease the cellular concn. of D2HG, reduce the levels of histone methylation, and suppress the proliferation of stem-like cancer cells in BT142 glioma with IDH1 R132H mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHlhXpk4PcnbVg90H21EOLACvtfcHk0lgN9-ezeAZIgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlequ7nI&md5=57dd47bcd29b65244b33e564910419de</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00684%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DF.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DKogiso%26aufirst%3DM.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DX.%2BN.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DInhibition%2520of%2520cancer-associated%2520mutant%2520isocitrate%2520dehydrogenases%2520by%25202-thiohydantoin%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6899%26epage%3D6908%26doi%3D10.1021%2Facs.jmedchem.5b00684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anglin, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, B. V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span> <span> </span><span class="NLM_article-title">Crystallographic investigation and selective inhibition of mutant isocitrate dehydrogenase</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">542</span>– <span class="NLM_lpage">546</span>, <span class="refDoi"> DOI: 10.1021/ml400036z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400036z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVWrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=542-546&author=B.+Zhengauthor=Y.+Yaoauthor=Z.+Liuauthor=L.+Dengauthor=J.+L.+Anglinauthor=H.+Jiangauthor=B.+V.+V.+Prasadauthor=Y.+Song&title=Crystallographic+investigation+and+selective+inhibition+of+mutant+isocitrate+dehydrogenase&doi=10.1021%2Fml400036z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase</span></div><div class="casAuthors">Zheng, Baisong; Yao, Yuan; Liu, Zhen; Deng, Lisheng; Anglin, Justin L.; Jiang, Hong; Prasad, B. V. Venkataram; Song, Yongcheng</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">542-546</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mutations in isocitrate dehydrogenase (IDH), a key enzyme in the tricarboxylic acid cycle, have recently been found in ∼75% glioma and ∼20% acute myeloid leukemia.  Different from the wild-type enzyme, mutant IDH1 catalyzes the redn. of α-ketoglutaric acid to D-2-hydroxyglutaric acid.  Strong evidence has shown mutant IDH1 represents a novel target for this type of cancer.  We found two 1-hydroxypyridin-2-one compds. that are potent inhibitors of R132H and R132C IDH1 mutants with Ki values as low as 120 nM.  These compds. exhibit >60-fold selectivity against wild-type IDH1 and can inhibit the prodn. of D-2-hydroxyglutaric acid in IDH1 mutated cells, representing novel chem. probes for cancer biol. studies.  We also report the first inhibitor-bound crystal structures of IDH1(R132H), showing these inhibitors have H-bond, electrostatic, and hydrophobic interactions with the mutant enzyme.  Comparison with the substrate-bound IDH1 structures revealed the structural basis for the high enzyme selectivity of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH0vzVLGCPZLVg90H21EOLACvtfcHk0lgN9-ezeAZIgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVWrtLg%253D&md5=c34c67949fe816bdf151525a578535f3</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fml400036z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400036z%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DAnglin%26aufirst%3DJ.%2BL.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DPrasad%26aufirst%3DB.%2BV.%2BV.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DCrystallographic%2520investigation%2520and%2520selective%2520inhibition%2520of%2520mutant%2520isocitrate%2520dehydrogenase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D542%26epage%3D546%26doi%3D10.1021%2Fml400036z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kogiso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span> <span> </span><span class="NLM_article-title">Inhibition of cancer-associated mutant isocitrate dehydrogenases: synthesis, structure–activity relationship and selective antitumor activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">8307</span>– <span class="NLM_lpage">8318</span>, <span class="refDoi"> DOI: 10.1021/jm500660f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500660f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8307-8318&author=Z.+Liuauthor=Y.+Yaoauthor=M.+Kogisoauthor=B.+Zhengauthor=L.+Dengauthor=J.+J.+Qiuauthor=S.+Dongauthor=H.+Lvauthor=J.+M.+Galloauthor=X.+N.+Liauthor=Y.+Song&title=Inhibition+of+cancer-associated+mutant+isocitrate+dehydrogenases%3A+synthesis%2C+structure%E2%80%93activity+relationship+and+selective+antitumor+activity&doi=10.1021%2Fjm500660f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm500660f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500660f%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DKogiso%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DJ.%2BJ.%26aulast%3DDong%26aufirst%3DS.%26aulast%3DLv%26aufirst%3DH.%26aulast%3DGallo%26aufirst%3DJ.%2BM.%26aulast%3DLi%26aufirst%3DX.%2BN.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DInhibition%2520of%2520cancer-associated%2520mutant%2520isocitrate%2520dehydrogenases%253A%2520synthesis%252C%2520structure%25E2%2580%2593activity%2520relationship%2520and%2520selective%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8307%26epage%3D8318%26doi%3D10.1021%2Fjm500660f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pusch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krausert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrimpf, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capper, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahm, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, A.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jugold, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eichwald, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaulfuss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panknin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehwinkel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillig, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenther, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toschi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haegebart, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess-Stumpp, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wick, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unterberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold-Mende, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platten, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Deimling, A.</span></span> <span> </span><span class="NLM_article-title">Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">629</span>– <span class="NLM_lpage">644</span>, <span class="refDoi"> DOI: 10.1007/s00401-017-1677-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1007%2Fs00401-017-1677-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=28124097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFKitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2017&pages=629-644&author=S.+Puschauthor=S.+Krausertauthor=V.+Fischerauthor=J.+Balssauthor=M.+Ottauthor=D.+Schrimpfauthor=D.+Capperauthor=F.+Sahmauthor=J.+Eiselauthor=A.-C.+Beckauthor=M.+Jugoldauthor=V.+Eichwaldauthor=S.+Kaulfussauthor=O.+Pankninauthor=H.+Rehwinkelauthor=K.+Zimmermannauthor=R.+C.+Hilligauthor=J.+Guentherauthor=L.+Toschiauthor=R.+Neuhausauthor=A.+Haegebartauthor=H.+Hess-Stumppauthor=M.+Bauserauthor=W.+Wickauthor=A.+Unterbergauthor=C.+Herold-Mendeauthor=M.+Plattenauthor=A.+von+Deimling&title=Pan-mutant+IDH1+inhibitor+BAY+1436032+for+effective+treatment+of+IDH1+mutant+astrocytoma+in+vivo&doi=10.1007%2Fs00401-017-1677-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo</span></div><div class="casAuthors">Pusch, Stefan; Krausert, Sonja; Fischer, Viktoria; Balss, Joerg; Ott, Martina; Schrimpf, Daniel; Capper, David; Sahm, Felix; Eisel, Jessica; Beck, Ann-Christin; Jugold, Manfred; Eichwald, Viktoria; Kaulfuss, Stefan; Panknin, Olaf; Rehwinkel, Hartmut; Zimmermann, Katja; Hillig, Roman C.; Guenther, Judith; Toschi, Luisella; Neuhaus, Roland; Haegebart, Andrea; Hess-Stumpp, Holger; Bauser, Markus; Wick, Wolfgang; Unterberg, Andreas; Herold-Mende, Christel; Platten, Michael; von Deimling, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">629-644</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Mutations in codon 132 of isocitrate dehydrogenase (IDH) 1 are frequent in diffuse glioma, acute myeloid leukemia, chondrosarcoma and intrahepatic cholangiocarcinoma.  These mutations result in a neomorphic enzyme specificity which leads to a dramatic increase of intracellular D-2-hydroxyglutarate (2-HG) in tumor cells.  Therefore, mutant IDH1 protein is a highly attractive target for inhibitory drugs.  Here, we describe the development and properties of BAY 1436032, a pan-inhibitor of IDH1 protein with different codon 132 mutations.  BAY 1436032 strongly reduces 2-HG levels in cells carrying IDH1-R132H, -R132C, -R132G, -R132S and -R132L mutations.  Cells not carrying IDH mutations were unaffected.  BAY 1436032 did not exhibit toxicity in vitro or in vivo.  The pharmacokinetic properties of BAY 1436032 allow for oral administration.  In two independent expts., BAY 1436032 has been shown to significantly prolong survival of mice intracerebrally transplanted with human astrocytoma carrying the IDH1R132H mutation.  In conclusion, we developed a pan-inhibitor targeting tumors with different IDH1R132 mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOmrHN_rsuT7Vg90H21EOLACvtfcHk0li2N3sLHnDTrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFKitbc%253D&md5=e5a60357948c458ff6644f53575e0c6f</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1007%2Fs00401-017-1677-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-017-1677-y%26sid%3Dliteratum%253Aachs%26aulast%3DPusch%26aufirst%3DS.%26aulast%3DKrausert%26aufirst%3DS.%26aulast%3DFischer%26aufirst%3DV.%26aulast%3DBalss%26aufirst%3DJ.%26aulast%3DOtt%26aufirst%3DM.%26aulast%3DSchrimpf%26aufirst%3DD.%26aulast%3DCapper%26aufirst%3DD.%26aulast%3DSahm%26aufirst%3DF.%26aulast%3DEisel%26aufirst%3DJ.%26aulast%3DBeck%26aufirst%3DA.-C.%26aulast%3DJugold%26aufirst%3DM.%26aulast%3DEichwald%26aufirst%3DV.%26aulast%3DKaulfuss%26aufirst%3DS.%26aulast%3DPanknin%26aufirst%3DO.%26aulast%3DRehwinkel%26aufirst%3DH.%26aulast%3DZimmermann%26aufirst%3DK.%26aulast%3DHillig%26aufirst%3DR.%2BC.%26aulast%3DGuenther%26aufirst%3DJ.%26aulast%3DToschi%26aufirst%3DL.%26aulast%3DNeuhaus%26aufirst%3DR.%26aulast%3DHaegebart%26aufirst%3DA.%26aulast%3DHess-Stumpp%26aufirst%3DH.%26aulast%3DBauser%26aufirst%3DM.%26aulast%3DWick%26aufirst%3DW.%26aulast%3DUnterberg%26aufirst%3DA.%26aulast%3DHerold-Mende%26aufirst%3DC.%26aulast%3DPlatten%26aufirst%3DM.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26atitle%3DPan-mutant%2520IDH1%2520inhibitor%2520BAY%25201436032%2520for%2520effective%2520treatment%2520of%2520IDH1%2520mutant%2520astrocytoma%2520in%2520vivo%26jtitle%3DActa%2520Neuropathol.%26date%3D2017%26volume%3D133%26spage%3D629%26epage%3D644%26doi%3D10.1007%2Fs00401-017-1677-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbst, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pusch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klett, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goparaju, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stichel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaulfuss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panknin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toschi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haegebarth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehwinkel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess-Stumpp, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bochtler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struys, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakkali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geffers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araujo-Cruz, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thol, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabdoulline, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Deimling, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rippe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krämer, A.</span></span> <span> </span><span class="NLM_article-title">Pan-mutant-IDH1 inhibitor BAY- 1436032 is highly effective against human IDH1 mutant acute myeloid leukemia <i>in vivo</i></span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">2020</span>– <span class="NLM_lpage">2028</span>, <span class="refDoi"> DOI: 10.1038/leu.2017.46</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1038%2Fleu.2017.46" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=2020-2028&author=A.+Chaturvediauthor=L.+Herbstauthor=S.+Puschauthor=L.+Klettauthor=R.+Goparajuauthor=D.+Stichelauthor=S.+Kaulfussauthor=O.+Pankninauthor=K.+Zimmermannauthor=L.+Toschiauthor=R.+Neuhausauthor=A.+Haegebarthauthor=H.+Rehwinkelauthor=H.+Hess-Stumppauthor=M.+Bauserauthor=T.+Bochtlerauthor=E.+A.+Struysauthor=A.+Sharmaauthor=A.+Bakkaliauthor=R.+Geffersauthor=M.+M.+Araujo-Cruzauthor=F.+Tholauthor=R.+Gabdoullineauthor=A.+Ganserauthor=A.+D.+Hoauthor=A.+von+Deimlingauthor=K.+Rippeauthor=M.+Heuserauthor=A.+Kr%C3%A4mer&title=Pan-mutant-IDH1+inhibitor+BAY-+1436032+is+highly+effective+against+human+IDH1+mutant+acute+myeloid+leukemia+in+vivo&doi=10.1038%2Fleu.2017.46"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fleu.2017.46&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2017.46%26sid%3Dliteratum%253Aachs%26aulast%3DChaturvedi%26aufirst%3DA.%26aulast%3DHerbst%26aufirst%3DL.%26aulast%3DPusch%26aufirst%3DS.%26aulast%3DKlett%26aufirst%3DL.%26aulast%3DGoparaju%26aufirst%3DR.%26aulast%3DStichel%26aufirst%3DD.%26aulast%3DKaulfuss%26aufirst%3DS.%26aulast%3DPanknin%26aufirst%3DO.%26aulast%3DZimmermann%26aufirst%3DK.%26aulast%3DToschi%26aufirst%3DL.%26aulast%3DNeuhaus%26aufirst%3DR.%26aulast%3DHaegebarth%26aufirst%3DA.%26aulast%3DRehwinkel%26aufirst%3DH.%26aulast%3DHess-Stumpp%26aufirst%3DH.%26aulast%3DBauser%26aufirst%3DM.%26aulast%3DBochtler%26aufirst%3DT.%26aulast%3DStruys%26aufirst%3DE.%2BA.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DBakkali%26aufirst%3DA.%26aulast%3DGeffers%26aufirst%3DR.%26aulast%3DAraujo-Cruz%26aufirst%3DM.%2BM.%26aulast%3DThol%26aufirst%3DF.%26aulast%3DGabdoulline%26aufirst%3DR.%26aulast%3DGanser%26aufirst%3DA.%26aulast%3DHo%26aufirst%3DA.%2BD.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26aulast%3DRippe%26aufirst%3DK.%26aulast%3DHeuser%26aufirst%3DM.%26aulast%3DKr%25C3%25A4mer%26aufirst%3DA.%26atitle%3DPan-mutant-IDH1%2520inhibitor%2520BAY-%25201436032%2520is%2520highly%2520effective%2520against%2520human%2520IDH1%2520mutant%2520acute%2520myeloid%2520leukemia%2520in%2520vivo%26jtitle%3DLeukemia%26date%3D2017%26volume%3D31%26spage%3D2020%26epage%3D2028%26doi%3D10.1038%2Fleu.2017.46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heuser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbst, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pusch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klett, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goparaju, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stichel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaulfuss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panknin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toschi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haegebarth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehwinkel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess-Stumpp, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bochtler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struys, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdellatif, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceffers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruz, M. M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thol, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaboulline, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Deimling, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rippe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraemer, A.</span></span> <span> </span><span class="NLM_article-title">Pan-mutant-IDH1 inhibitor BAY-1436032 is highly effective against human IDH1 mutant acute myeloid leukemia <i>in vivo</i></span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">745</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2016&pages=745&author=M.+Heuserauthor=L.+Herbstauthor=S.+Puschauthor=L.+Klettauthor=R.+Goparajuauthor=D.+Stichelauthor=S.+Kaulfussauthor=O.+Pankninauthor=K.+Zimmermannauthor=L.+Toschiauthor=R.+Neuhausauthor=A.+Haegebarthauthor=H.+Rehwinkelauthor=H.+Hess-Stumppauthor=M.+Bauserauthor=T.+Bochtlerauthor=E.+A.+Struysauthor=A.+Sharmaauthor=A.+Abdellatifauthor=R.+Ceffersauthor=M.+M.+A.+Cruzauthor=F.+Tholauthor=R.+Gaboullineauthor=A.+Ganserauthor=A.+D.+Hoauthor=A.+von+Deimlingauthor=K.+Rippeauthor=A.+Chaturvediauthor=A.+Kraemer&title=Pan-mutant-IDH1+inhibitor+BAY-1436032+is+highly+effective+against+human+IDH1+mutant+acute+myeloid+leukemia+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeuser%26aufirst%3DM.%26aulast%3DHerbst%26aufirst%3DL.%26aulast%3DPusch%26aufirst%3DS.%26aulast%3DKlett%26aufirst%3DL.%26aulast%3DGoparaju%26aufirst%3DR.%26aulast%3DStichel%26aufirst%3DD.%26aulast%3DKaulfuss%26aufirst%3DS.%26aulast%3DPanknin%26aufirst%3DO.%26aulast%3DZimmermann%26aufirst%3DK.%26aulast%3DToschi%26aufirst%3DL.%26aulast%3DNeuhaus%26aufirst%3DR.%26aulast%3DHaegebarth%26aufirst%3DA.%26aulast%3DRehwinkel%26aufirst%3DH.%26aulast%3DHess-Stumpp%26aufirst%3DH.%26aulast%3DBauser%26aufirst%3DM.%26aulast%3DBochtler%26aufirst%3DT.%26aulast%3DStruys%26aufirst%3DE.%2BA.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DAbdellatif%26aufirst%3DA.%26aulast%3DCeffers%26aufirst%3DR.%26aulast%3DCruz%26aufirst%3DM.%2BM.%2BA.%26aulast%3DThol%26aufirst%3DF.%26aulast%3DGaboulline%26aufirst%3DR.%26aulast%3DGanser%26aufirst%3DA.%26aulast%3DHo%26aufirst%3DA.%2BD.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26aulast%3DRippe%26aufirst%3DK.%26aulast%3DChaturvedi%26aufirst%3DA.%26aulast%3DKraemer%26aufirst%3DA.%26atitle%3DPan-mutant-IDH1%2520inhibitor%2520BAY-1436032%2520is%2520highly%2520effective%2520against%2520human%2520IDH1%2520mutant%2520acute%2520myeloid%2520leukemia%2520in%2520vivo%26jtitle%3DBlood%26date%3D2016%26volume%3D128%26spage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rehwinkel, H.</span>; <span class="NLM_string-name">Panknin, O.</span>; <span class="NLM_string-name">Ring, S.</span>; <span class="NLM_string-name">Anlauf, S.</span>; <span class="NLM_string-name">Siebeneicher, H.</span>; <span class="NLM_string-name">Nguyen, D.</span>; <span class="NLM_string-name">Schwede, W.</span>; <span class="NLM_string-name">Bauser, M.</span>; <span class="NLM_string-name">Zimmermann, K.</span>; <span class="NLM_string-name">Kaulfuss, S.</span>; <span class="NLM_string-name">Neuhaus, R.</span>; <span class="NLM_string-name">Blaney, P. M.</span></span> <span> </span><span class="NLM_article-title">Benzimidazol-2-amines as mIDH1 Inhibitors</span>. <span class="NLM_patent">WO/2015121210 A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.+Rehwinkel&author=O.+Panknin&author=S.+Ring&author=S.+Anlauf&author=H.+Siebeneicher&author=D.+Nguyen&author=W.+Schwede&author=M.+Bauser&author=K.+Zimmermann&author=S.+Kaulfuss&author=R.+Neuhaus&author=P.+M.+Blaney&title=Benzimidazol-2-amines+as+mIDH1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRehwinkel%26aufirst%3DH.%26atitle%3DBenzimidazol-2-amines%2520as%2520mIDH1%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schirmer, H.</span></span> <span> </span><span class="NLM_article-title">Inhibitor of the Mutated Isocitrate Dehydrogenase IDH1 R132H</span>. <span class="NLM_patent">WO/2017016992 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=H.+Schirmer&title=Inhibitor+of+the+Mutated+Isocitrate+Dehydrogenase+IDH1+R132H"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchirmer%26aufirst%3DH.%26atitle%3DInhibitor%2520of%2520the%2520Mutated%2520Isocitrate%2520Dehydrogenase%2520IDH1%2520R132H%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McManus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathieu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gee, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLean, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le-Strat, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquette, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooney, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassort, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Englaro, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adrian, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiederschain, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Licht, S.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of mutant isocitrate dehydrogenase 1(IDH1) via disruption of a metal binding network by an allosteric small molecule</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>290</i></span>,  <span class="NLM_fpage">762</span>– <span class="NLM_lpage">774</span>, <span class="refDoi"> DOI: 10.1074/jbc.M114.608497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1074%2Fjbc.M114.608497" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=762-774&author=G.+Dengauthor=J.+Shenauthor=M.+Yinauthor=J.+McManusauthor=M.+Mathieuauthor=P.+Geeauthor=T.+Heauthor=C.+Shiauthor=O.+Bedelauthor=L.+R.+McLeanauthor=F.+Le-Stratauthor=Y.+Zhangauthor=J.+P.+Marquetteauthor=Q.+Gaoauthor=B.+Zhangauthor=A.+Rakauthor=D.+Hoffmannauthor=E.+Rooneyauthor=A.+Vassortauthor=W.+Englaroauthor=Y.+Liauthor=V.+Patelauthor=F.+Adrianauthor=S.+Grossauthor=D.+Wiederschainauthor=H.+Chengauthor=S.+Licht&title=Selective+inhibition+of+mutant+isocitrate+dehydrogenase+1%28IDH1%29+via+disruption+of+a+metal+binding+network+by+an+allosteric+small+molecule&doi=10.1074%2Fjbc.M114.608497"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.608497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.608497%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DG.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DYin%26aufirst%3DM.%26aulast%3DMcManus%26aufirst%3DJ.%26aulast%3DMathieu%26aufirst%3DM.%26aulast%3DGee%26aufirst%3DP.%26aulast%3DHe%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DBedel%26aufirst%3DO.%26aulast%3DMcLean%26aufirst%3DL.%2BR.%26aulast%3DLe-Strat%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMarquette%26aufirst%3DJ.%2BP.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DRak%26aufirst%3DA.%26aulast%3DHoffmann%26aufirst%3DD.%26aulast%3DRooney%26aufirst%3DE.%26aulast%3DVassort%26aufirst%3DA.%26aulast%3DEnglaro%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DAdrian%26aufirst%3DF.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DWiederschain%26aufirst%3DD.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DLicht%26aufirst%3DS.%26atitle%3DSelective%2520inhibition%2520of%2520mutant%2520isocitrate%2520dehydrogenase%25201%2528IDH1%2529%2520via%2520disruption%2520of%2520a%2520metal%2520binding%2520network%2520by%2520an%2520allosteric%2520small%2520molecule%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D762%26epage%3D774%26doi%3D10.1074%2Fjbc.M114.608497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Law, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leiendecker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verho, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamji, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of 8-membered ring sulfonamides as inhibitors of oncogenic mutant isocitrate dehydrogenase 1</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">944</span>– <span class="NLM_lpage">949</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00264</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00264" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOgtrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=944-949&author=J.+M.+Lawauthor=S.+C.+Starkauthor=K.+Liuauthor=N.+E.+Liangauthor=M.+M.+Hussainauthor=M.+Leiendeckerauthor=D.+Itoauthor=O.+Verhoauthor=A.+M.+Sternauthor=S.+E.+Johnstonauthor=Y.+Zhangauthor=G.+P.+Dunnauthor=A.+F.+Shamjiauthor=S.+L.+Schreiber&title=Discovery+of+8-membered+ring+sulfonamides+as+inhibitors+of+oncogenic+mutant+isocitrate+dehydrogenase+1&doi=10.1021%2Facsmedchemlett.6b00264"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 8-Membered Ring Sulfonamides as Inhibitors of Oncogenic Mutant Isocitrate Dehydrogenase 1</span></div><div class="casAuthors">Law, Jason M.; Stark, Sebastian C.; Liu, Ke; Liang, Norah E.; Hussain, Mahmud M.; Leiendecker, Matthias; Ito, Daisuke; Verho, Oscar; Stern, Andrew M.; Johnston, Stephen E.; Zhang, Yan-Ling; Dunn, Gavin P.; Shamji, Alykhan F.; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">944-949</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Evidence suggests that specific mutations of isocitrate dehydrogenases 1 and 2 (IDH1/2) are crit. for the initiation and maintenance of certain tumor types, and that inhibiting these mutant enzymes with small mols. may be therapeutically beneficial.  In order to discover mutant-allele-selective IDH1 inhibitors with chem. features distinct from existing probes, the authors screened a collection of small mols. derived from diversity-oriented synthesis.  The assay identified compds. that inhibit the IDH1-R132H mutant allele commonly found in glioma.  Here, the authors report the discovery of a potent (IC50 = 50 nM) series of IDH1-R132H inhibitors having 8-membered ring sulfonamides as exemplified by the compd. I.  The inhibitors suppress (R)-2-hydroxyglutarate prodn. in cells without apparent toxicity.  Although the soly. and pharmacokinetic properties of the specific inhibitor I prevent its use in vivo, the scaffold presents a validated starting point for the synthesis of future IDH1-R132H inhibitors having improved biol. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVJ2KnOXtLdLVg90H21EOLACvtfcHk0lixM6CqIKMLag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOgtrfF&md5=aed428e21b3e3de5937fedbd2a7c4b45</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00264%26sid%3Dliteratum%253Aachs%26aulast%3DLaw%26aufirst%3DJ.%2BM.%26aulast%3DStark%26aufirst%3DS.%2BC.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DLiang%26aufirst%3DN.%2BE.%26aulast%3DHussain%26aufirst%3DM.%2BM.%26aulast%3DLeiendecker%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DD.%26aulast%3DVerho%26aufirst%3DO.%26aulast%3DStern%26aufirst%3DA.%2BM.%26aulast%3DJohnston%26aufirst%3DS.%2BE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDunn%26aufirst%3DG.%2BP.%26aulast%3DShamji%26aufirst%3DA.%2BF.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DDiscovery%2520of%25208-membered%2520ring%2520sulfonamides%2520as%2520inhibitors%2520of%2520oncogenic%2520mutant%2520isocitrate%2520dehydrogenase%25201%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D944%26epage%3D949%26doi%3D10.1021%2Facsmedchemlett.6b00264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayton, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ball, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cockerill, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairweather, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitchin, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plant, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinclair, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somervaille, T. C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Small, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waddell, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waszkowycz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigglesworth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiseman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, D. J.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of allosteric inhibitors of mutant isocitrate dehydrogenase 1 (IDH1 R132H) displaying activity in human acute myeloid leukemia cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">11120</span>– <span class="NLM_lpage">11137</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01320</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01320" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=11120-11137&author=S.+Jonesauthor=J.+Ahmetauthor=K.+Aytonauthor=M.+D.+Ballauthor=M.+Cockerillauthor=E.+E.+Fairweatherauthor=N.+Hamiltonauthor=P.+Harperauthor=J.+R.+Hitchinauthor=A.+M.+Jordanauthor=C.+W.+Levyauthor=R.+Lopezauthor=E.+McKenzieauthor=M.+J.+Packerauthor=D.+Plantauthor=L.+Simpsonauthor=P.+Simpsonauthor=L.+Sinclairauthor=T.+C.+P.+Somervailleauthor=H.+Smallauthor=G.+J.+Spencerauthor=G.+J.+Thomsonauthor=M.+Tongeauthor=L.+D.+Waddellauthor=J.+Walshauthor=B.+Waszkowyczauthor=M.+Wigglesworthauthor=D.+Wisemanauthor=D.+J.+Ogilvie&title=Discovery+and+optimization+of+allosteric+inhibitors+of+mutant+isocitrate+dehydrogenase+1+%28IDH1+R132H%29+displaying+activity+in+human+acute+myeloid+leukemia+cells&doi=10.1021%2Facs.jmedchem.6b01320"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01320%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DS.%26aulast%3DAhmet%26aufirst%3DJ.%26aulast%3DAyton%26aufirst%3DK.%26aulast%3DBall%26aufirst%3DM.%2BD.%26aulast%3DCockerill%26aufirst%3DM.%26aulast%3DFairweather%26aufirst%3DE.%2BE.%26aulast%3DHamilton%26aufirst%3DN.%26aulast%3DHarper%26aufirst%3DP.%26aulast%3DHitchin%26aufirst%3DJ.%2BR.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DLevy%26aufirst%3DC.%2BW.%26aulast%3DLopez%26aufirst%3DR.%26aulast%3DMcKenzie%26aufirst%3DE.%26aulast%3DPacker%26aufirst%3DM.%2BJ.%26aulast%3DPlant%26aufirst%3DD.%26aulast%3DSimpson%26aufirst%3DL.%26aulast%3DSimpson%26aufirst%3DP.%26aulast%3DSinclair%26aufirst%3DL.%26aulast%3DSomervaille%26aufirst%3DT.%2BC.%2BP.%26aulast%3DSmall%26aufirst%3DH.%26aulast%3DSpencer%26aufirst%3DG.%2BJ.%26aulast%3DThomson%26aufirst%3DG.%2BJ.%26aulast%3DTonge%26aufirst%3DM.%26aulast%3DWaddell%26aufirst%3DL.%2BD.%26aulast%3DWalsh%26aufirst%3DJ.%26aulast%3DWaszkowycz%26aufirst%3DB.%26aulast%3DWigglesworth%26aufirst%3DM.%26aulast%3DWiseman%26aufirst%3DD.%26aulast%3DOgilvie%26aufirst%3DD.%2BJ.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520allosteric%2520inhibitors%2520of%2520mutant%2520isocitrate%2520dehydrogenase%25201%2520%2528IDH1%2520R132H%2529%2520displaying%2520activity%2520in%2520human%2520acute%2520myeloid%2520leukemia%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D11120%26epage%3D11137%26doi%3D10.1021%2Facs.jmedchem.6b01320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. S.</span>; <span class="NLM_string-name">Levell, J. R.</span>; <span class="NLM_string-name">Liu, G.</span>; <span class="NLM_string-name">Shultz, M. D.</span>; <span class="NLM_string-name">Van Der Plas, S. C.</span></span> <span> </span><span class="NLM_article-title">3-Pyrimidin-4-yl-oxazolidin-2-ones as Inhibitors of Mutant IDH</span>. <span class="NLM_patent">WO/2014141153 A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=Y.+S.+Cho&author=J.+R.+Levell&author=G.+Liu&author=M.+D.+Shultz&author=S.+C.+Van+Der+Plas&title=3-Pyrimidin-4-yl-oxazolidin-2-ones+as+Inhibitors+of+Mutant+IDH"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DY.%2BS.%26atitle%3D3-Pyrimidin-4-yl-oxazolidin-2-ones%2520as%2520Inhibitors%2520of%2520Mutant%2520IDH%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Levell, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caferro, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chenail, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dix, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dooley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giraldes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Growney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulathila, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Plas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slocum, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terranova, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toure, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagliarini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. S.</span></span> <span> </span><span class="NLM_article-title">Optimization of 3-pyrimidin-4-yl-oxazolidin-2-ones as allosteric and mutant specific inhibitors of IDH1</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">156</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00334</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00334" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFSgu7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=151-156&author=J.+R.+Levellauthor=T.+Caferroauthor=G.+Chenailauthor=I.+Dixauthor=J.+Dooleyauthor=B.+Firestoneauthor=P.+D.+Fortinauthor=J.+Giraldesauthor=T.+Gouldauthor=J.+D.+Growneyauthor=M.+D.+Jonesauthor=R.+Kulathilaauthor=F.+Linauthor=G.+Liuauthor=A.+Muellerauthor=S.+van+der+Plasauthor=K.+Slocumauthor=T.+Smithauthor=R.+Terranovaauthor=B.+B.+Toureauthor=V.+Tyagiauthor=T.+Wagnerauthor=X.+Xieauthor=M.+Xuauthor=F.+S.+Yangauthor=L.+X.+Zhouauthor=R.+Pagliariniauthor=Y.+S.+Cho&title=Optimization+of+3-pyrimidin-4-yl-oxazolidin-2-ones+as+allosteric+and+mutant+specific+inhibitors+of+IDH1&doi=10.1021%2Facsmedchemlett.6b00334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Allosteric and Mutant Specific Inhibitors of IDH1</span></div><div class="casAuthors">Levell, Julian R.; Caferro, Thomas; Chenail, Gregg; Dix, Ina; Dooley, Julia; Firestone, Brant; Fortin, Pascal D.; Giraldes, John; Gould, Ty; Growney, Joseph D.; Jones, Michael D.; Kulathila, Raviraj; Lin, Fallon; Liu, Gang; Mueller, Arne; van der Plas, Simon; Slocum, Kelly; Smith, Troy; Terranova, Remi; Toure, B. Barry; Tyagi, Viraj; Wagner, Trixie; Xie, Xiaoling; Xu, Ming; Yang, Fan S.; Zhou, Liping X.; Pagliarini, Raymond; Cho, Young Shin</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-156</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">High throughput screening and subsequent hit validation identified 4-isopropyl-3-(2-((1-phenylethyl)amino)pyrimidin-4-yl)oxazolidin-2-one as a potent inhibitor of IDH1R132H.  Synthesis of the four sep. stereomers identified the (S,S)-diastereomer (IDH125, 1f) as the most potent isomer.  This also showed reasonable cellular activity and excellent selectivity vs. IDH1wt.  Initial SAR exploration identified the key tolerances and potential for optimization.  X-ray crystallog. identified a functionally relevant allosteric binding site amenable to inhibitors which can penetrate the blood-brain barrier, and aided rational optimization.  Potency improvement and modulation of the physico-chem. properties identified (S,S)-oxazolidinone IDH889 (5x) with good exposure and 2-HG inhibitory activity in a mutant IDH1 xenograft mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdfShR2C4h0LVg90H21EOLACvtfcHk0lixM6CqIKMLag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFSgu7jK&md5=9f754dba792b77c9c64fcac474dc1f0f</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00334%26sid%3Dliteratum%253Aachs%26aulast%3DLevell%26aufirst%3DJ.%2BR.%26aulast%3DCaferro%26aufirst%3DT.%26aulast%3DChenail%26aufirst%3DG.%26aulast%3DDix%26aufirst%3DI.%26aulast%3DDooley%26aufirst%3DJ.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26aulast%3DGiraldes%26aufirst%3DJ.%26aulast%3DGould%26aufirst%3DT.%26aulast%3DGrowney%26aufirst%3DJ.%2BD.%26aulast%3DJones%26aufirst%3DM.%2BD.%26aulast%3DKulathila%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DMueller%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BPlas%26aufirst%3DS.%26aulast%3DSlocum%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DT.%26aulast%3DTerranova%26aufirst%3DR.%26aulast%3DToure%26aufirst%3DB.%2BB.%26aulast%3DTyagi%26aufirst%3DV.%26aulast%3DWagner%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DF.%2BS.%26aulast%3DZhou%26aufirst%3DL.%2BX.%26aulast%3DPagliarini%26aufirst%3DR.%26aulast%3DCho%26aufirst%3DY.%2BS.%26atitle%3DOptimization%2520of%25203-pyrimidin-4-yl-oxazolidin-2-ones%2520as%2520allosteric%2520and%2520mutant%2520specific%2520inhibitors%2520of%2520IDH1%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D151%26epage%3D156%26doi%3D10.1021%2Facsmedchemlett.6b00334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baird, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capka, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chenail, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dooley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farsidjani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohls, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulathila, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sage, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touré, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Plas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagliarini, R. A.</span></span> <span> </span><span class="NLM_article-title">Allosteric mutant IDH1 inhibitors reveal mechanisms for IDH1 mutant and isoform selectivity</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">506</span>– <span class="NLM_lpage">513</span>, <span class="refDoi"> DOI: 10.1016/j.str.2016.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1016%2Fj.str.2016.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=28132785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1KnsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=506-513&author=X.+Xieauthor=D.+Bairdauthor=K.+Bowenauthor=V.+Capkaauthor=J.+Chenauthor=G.+Chenailauthor=Y.+Choauthor=J.+Dooleyauthor=A.+Farsidjaniauthor=P.+Fortinauthor=D.+Kohlsauthor=R.+Kulathilaauthor=F.+Linauthor=D.+McKayauthor=L.+Rodriguesauthor=D.+Sageauthor=B.+B.+Tour%C3%A9author=S.+van+der+Plasauthor=K.+Wrightauthor=M.+Xuauthor=H.+Yinauthor=J.+Levellauthor=R.+A.+Pagliarini&title=Allosteric+mutant+IDH1+inhibitors+reveal+mechanisms+for+IDH1+mutant+and+isoform+selectivity&doi=10.1016%2Fj.str.2016.12.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Mutant IDH1 Inhibitors Reveal Mechanisms for IDH1 Mutant and Isoform Selectivity</span></div><div class="casAuthors">Xie, Xiaoling; Baird, Daniel; Bowen, Kimberly; Capka, Vladimir; Chen, Jinyun; Chenail, Gregg; Cho, Young Shin; Dooley, Julia; Farsidjani, Ali; Fortin, Pascal; Kohls, Darcy; Kulathila, Raviraj; Lin, Fallon; McKay, Daniel; Rodrigues, Lindsey; Sage, David; van der Plas, Simon; Wright, Kirk; Xu, Ming; Yin, Hong; Levell, Julian; Pagliarini, Raymond A.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">506-513</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Oncogenic IDH1 and IDH2 mutations contribute to cancer via prodn. of R-2-hydroxyglutarate (2-HG).  Here, we characterize two structurally distinct mutant- and isoform-selective IDH1 inhibitors that inhibit 2-HG prodn.  Both bind to an allosteric pocket on IDH1, yet shape it differently, highlighting the plasticity of this site.  Oncogenic IDH1R132H mutation destabilizes an IDH1 "regulatory segment," which otherwise restricts compd. access to the allosteric pocket.  Regulatory segment destabilization in wild-type IDH1 promotes inhibitor binding, suggesting that destabilization is crit. for mutant selectivity.  We also report crystal structures of oncogenic IDH2 mutant isoforms, highlighting the fact that the analogous segment of IDH2 is not similarly destabilized.  This intrinsic stability of IDH2 may contribute to obsd. inhibitor IDH1 isoform selectivity.  Moreover, discrete residues in the IDH1 allosteric pocket that differ from IDH2 may also guide IDH1 isoform selectivity.  These data provide a deeper understanding of how IDH1 inhibitors achieve mutant and isoform selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLhnq8F-J4DbVg90H21EOLACvtfcHk0lhNettzcwIJjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1KnsbY%253D&md5=58532ad82b6baca40717bbe1c3834ecc</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2016.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2016.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DX.%26aulast%3DBaird%26aufirst%3DD.%26aulast%3DBowen%26aufirst%3DK.%26aulast%3DCapka%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DChenail%26aufirst%3DG.%26aulast%3DCho%26aufirst%3DY.%26aulast%3DDooley%26aufirst%3DJ.%26aulast%3DFarsidjani%26aufirst%3DA.%26aulast%3DFortin%26aufirst%3DP.%26aulast%3DKohls%26aufirst%3DD.%26aulast%3DKulathila%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DMcKay%26aufirst%3DD.%26aulast%3DRodrigues%26aufirst%3DL.%26aulast%3DSage%26aufirst%3DD.%26aulast%3DTour%25C3%25A9%26aufirst%3DB.%2BB.%26aulast%3Dvan%2Bder%2BPlas%26aufirst%3DS.%26aulast%3DWright%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DLevell%26aufirst%3DJ.%26aulast%3DPagliarini%26aufirst%3DR.%2BA.%26atitle%3DAllosteric%2520mutant%2520IDH1%2520inhibitors%2520reveal%2520mechanisms%2520for%2520IDH1%2520mutant%2520and%2520isoform%2520selectivity%26jtitle%3DStructure%26date%3D2017%26volume%3D25%26spage%3D506%26epage%3D513%26doi%3D10.1016%2Fj.str.2016.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khawaja, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiNardo, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janku, F.</span></span> <span> </span><span class="NLM_article-title">Targeting isocitrate dehydrogenase (IDH) in cancer</span>. <i>Discovery Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">380</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=27355333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A280%3ADC%252BC2s7ltFKmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=373-380&author=T.+Fujiiauthor=M.+R.+Khawajaauthor=C.+D.+DiNardoauthor=J.+T.+Atkinsauthor=F.+Janku&title=Targeting+isocitrate+dehydrogenase+%28IDH%29+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting isocitrate dehydrogenase (IDH) in cancer</span></div><div class="casAuthors">Fujii Takeo; Khawaja Muhammad Rizwan; Atkins Johnique T; Janku Filip; Fujii Takeo; Khawaja Muhammad Rizwan; DiNardo Courtney D</div><div class="citationInfo"><span class="NLM_cas:title">Discovery medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">117</span>),
    <span class="NLM_cas:pages">373-80</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Isocitrate dehydrogenase (IDH) is an essential enzyme for cellular respiration in the tricarboxylic acid (TCA) cycle.  Recurrent mutations in IDH1 or IDH2 are prevalent in several cancers including glioma, acute myeloid leukemia (AML), cholangiocarcinoma and chondrosarcoma.  The mutated IDH1 and IDH2 proteins have a gain-of-function, neomorphic activity, catalyzing the reduction of α-ketoglutarate (α-KG) to 2-hydroxyglutarate (2-HG) by NADPH.  Cancer-associated IDH mutations block normal cellular differentiation and promote tumorigenesis via the abnormal production of the oncometabolite 2-HG.  High levels of 2-HG have been shown to inhibit α-KG dependent dioxygenases, including histone and deoxyribonucleic acid (DNA) demethylases, which play a key role in regulating the epigenetic state of cells.  Current targeted inhibitors of IDH1 (AG120, IDH305), IDH2 (AG221), and pan-IDH1/2 (AG881) selectively inhibit mutant IDH protein and induce cell differentiation in in vitro and in vivo models.  Preliminary results from phase I clinical trials with IDH inhibitors in patients with advanced hematologic malignancies have demonstrated an objective response rate ranging from 31% to 40% with durable responses (>1 year) observed.  Furthermore, the IDH inhibitors have demonstrated early signals of activity in solid tumors with IDH mutations, including cholangiocarcinomas and low grade gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSuJxrwgJ7KGmbXvSEQle5fW6udTcc2ebgO2ADB6pYOrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7ltFKmtQ%253D%253D&md5=e7297950531e645cff014cd011230d12</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujii%26aufirst%3DT.%26aulast%3DKhawaja%26aufirst%3DM.%2BR.%26aulast%3DDiNardo%26aufirst%3DC.%2BD.%26aulast%3DAtkins%26aufirst%3DJ.%2BT.%26aulast%3DJanku%26aufirst%3DF.%26atitle%3DTargeting%2520isocitrate%2520dehydrogenase%2520%2528IDH%2529%2520in%2520cancer%26jtitle%3DDiscovery%2520Med.%26date%3D2016%26volume%3D21%26spage%3D373%26epage%3D380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levell, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caferro, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shafer, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costales, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sendzik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chenail, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dooley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalba, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farsidjani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulathila, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heimbach, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slocum, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagliarini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Growney, J. D.</span></span> <span> </span><span class="NLM_article-title">Discovery and evaluation of clinical candidate IDH305, a brain penetrant mutant IDH1 inhibitor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1116</span>– <span class="NLM_lpage">1121</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00342</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00342" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFWjtrbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1116-1121&author=Y.+S.+Choauthor=J.+R.+Levellauthor=G.+Liuauthor=T.+Caferroauthor=J.+Suttonauthor=C.+M.+Shaferauthor=A.+Costalesauthor=J.+R.+Manningauthor=Q.+Zhaoauthor=M.+Sendzikauthor=M.+Shultzauthor=G.+Chenailauthor=J.+Dooleyauthor=B.+Villalbaauthor=A.+Farsidjaniauthor=J.+Chenauthor=R.+Kulathilaauthor=X.+Xieauthor=S.+Doddauthor=T.+Gouldauthor=G.+Liangauthor=T.+Heimbachauthor=K.+Slocumauthor=B.+Firestoneauthor=M.+Puauthor=R.+Pagliariniauthor=J.+D.+Growney&title=Discovery+and+evaluation+of+clinical+candidate+IDH305%2C+a+brain+penetrant+mutant+IDH1+inhibitor&doi=10.1021%2Facsmedchemlett.7b00342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 Inhibitor</span></div><div class="casAuthors">Cho, Young Shin; Levell, Julian R.; Liu, Gang; Caferro, Thomas; Sutton, James; Shafer, Cynthia M.; Costales, Abran; Manning, James R.; Zhao, Qian; Sendzik, Martin; Shultz, Michael; Chenail, Gregg; Dooley, Julia; Villalba, Brian; Farsidjani, Ali; Chen, Jinyun; Kulathila, Raviraj; Xie, Xiaoling; Dodd, Stephanie; Gould, Ty; Liang, Guiqing; Heimbach, Tycho; Slocum, Kelly; Firestone, Brant; Pu, Minying; Pagliarini, Raymond; Growney, Joseph D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1116-1121</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of mutant IDH1 is being evaluated clin. as a promising treatment option for various cancers with hotspot mutation at Arg132.  Having identified an allosteric, induced pocket of IDH1R132H, we have explored 3-pyrimidin-4-yl-oxazolidin-2-ones as mutant IDH1 inhibitors for in vivo modulation of 2-HG prodn. and potential brain penetration.  We report here optimization efforts toward the identification of clin. candidate IDH305 (I), a potent and selective mutant IDH1 inhibitor that has demonstrated brain exposure in rodents.  Preclin. characterization of this compd. exhibited in vivo correlation of 2-HG redn. and efficacy in a patient-derived IDH1 mutant xenograft tumor model.  IDH305 (13) has progressed into human clin. trials for the treatment of cancers with IDH1 mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbHEgOqdDh6bVg90H21EOLACvtfcHk0ljkM5D6KXvOUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFWjtrbL&md5=ab3900c2499e847f7db3ccb0d41f2236</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00342%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DY.%2BS.%26aulast%3DLevell%26aufirst%3DJ.%2BR.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DCaferro%26aufirst%3DT.%26aulast%3DSutton%26aufirst%3DJ.%26aulast%3DShafer%26aufirst%3DC.%2BM.%26aulast%3DCostales%26aufirst%3DA.%26aulast%3DManning%26aufirst%3DJ.%2BR.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DSendzik%26aufirst%3DM.%26aulast%3DShultz%26aufirst%3DM.%26aulast%3DChenail%26aufirst%3DG.%26aulast%3DDooley%26aufirst%3DJ.%26aulast%3DVillalba%26aufirst%3DB.%26aulast%3DFarsidjani%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DKulathila%26aufirst%3DR.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DDodd%26aufirst%3DS.%26aulast%3DGould%26aufirst%3DT.%26aulast%3DLiang%26aufirst%3DG.%26aulast%3DHeimbach%26aufirst%3DT.%26aulast%3DSlocum%26aufirst%3DK.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DPagliarini%26aufirst%3DR.%26aulast%3DGrowney%26aufirst%3DJ.%2BD.%26atitle%3DDiscovery%2520and%2520evaluation%2520of%2520clinical%2520candidate%2520IDH305%252C%2520a%2520brain%2520penetrant%2520mutant%2520IDH1%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D1116%26epage%3D1121%26doi%3D10.1021%2Facsmedchemlett.7b00342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DiNardo, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schimmer, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yee, K. W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochhaus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraemer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvajal, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janku, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schöffski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Bent, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’keeffe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagliarini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuck, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, A.</span></span> <span> </span><span class="NLM_article-title">A phase I study of IDH 305 in patients with advanced malignancies including relapsed/refractory AML and MDS that harbor IDH1 R132 mutations</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">1073</span>– <span class="NLM_lpage">1073</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2016&pages=1073-1073&author=C.+D.+DiNardoauthor=A.+D.+Schimmerauthor=K.+W.+L.+Yeeauthor=A.+Hochhausauthor=A.+Kraemerauthor=R.+D.+Carvajalauthor=F.+Jankuauthor=P.+Bedardauthor=C.+Carpioauthor=A.+Wickauthor=G.+K.+Schwartzauthor=P.+Sch%C3%B6ffskiauthor=P.+Wenauthor=M.+J.+van+den+Bentauthor=M.+Rosenthalauthor=J.+O%E2%80%99keeffeauthor=X.+Chenauthor=R.+Pagliariniauthor=V.+Schuckauthor=A.+Myersauthor=A.+Wei&title=A+phase+I+study+of+IDH+305+in+patients+with+advanced+malignancies+including+relapsed%2Frefractory+AML+and+MDS+that+harbor+IDH1+R132+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiNardo%26aufirst%3DC.%2BD.%26aulast%3DSchimmer%26aufirst%3DA.%2BD.%26aulast%3DYee%26aufirst%3DK.%2BW.%2BL.%26aulast%3DHochhaus%26aufirst%3DA.%26aulast%3DKraemer%26aufirst%3DA.%26aulast%3DCarvajal%26aufirst%3DR.%2BD.%26aulast%3DJanku%26aufirst%3DF.%26aulast%3DBedard%26aufirst%3DP.%26aulast%3DCarpio%26aufirst%3DC.%26aulast%3DWick%26aufirst%3DA.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26aulast%3DSch%25C3%25B6ffski%26aufirst%3DP.%26aulast%3DWen%26aufirst%3DP.%26aulast%3Dvan%2Bden%2BBent%26aufirst%3DM.%2BJ.%26aulast%3DRosenthal%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599keeffe%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DPagliarini%26aufirst%3DR.%26aulast%3DSchuck%26aufirst%3DV.%26aulast%3DMyers%26aufirst%3DA.%26aulast%3DWei%26aufirst%3DA.%26atitle%3DA%2520phase%2520I%2520study%2520of%2520IDH%2520305%2520in%2520patients%2520with%2520advanced%2520malignancies%2520including%2520relapsed%252Frefractory%2520AML%2520and%2520MDS%2520that%2520harbor%2520IDH1%2520R132%2520mutations%26jtitle%3DBlood%26date%3D2016%26volume%3D128%26spage%3D1073%26epage%3D1073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. S.</span>; <span class="NLM_string-name">Levell, J. R.</span>; <span class="NLM_string-name">Shafer, C.</span>; <span class="NLM_string-name">Shultz, M. D.</span></span> <span> </span><span class="NLM_article-title">1-(2-(Ethylamino)pyrimidin-4-yl)pyrrolidin-2-ones as Inhibitors of Mutant IDH</span>. <span class="NLM_patent">WO/2014147586 A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=Y.+S.+Cho&author=J.+R.+Levell&author=C.+Shafer&author=M.+D.+Shultz&title=1-%282-%28Ethylamino%29pyrimidin-4-yl%29pyrrolidin-2-ones+as+Inhibitors+of+Mutant+IDH"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DY.%2BS.%26atitle%3D1-%25282-%2528Ethylamino%2529pyrimidin-4-yl%2529pyrrolidin-2-ones%2520as%2520Inhibitors%2520of%2520Mutant%2520IDH%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashwell, S.</span>; <span class="NLM_string-name">Campbell, A. M.</span>; <span class="NLM_string-name">Caravella, J. A.</span>; <span class="NLM_string-name">Diebold, R. B.</span>; <span class="NLM_string-name">Ericsson, A.</span>; <span class="NLM_string-name">Gustafson, G.</span>; <span class="NLM_string-name">Lancia, D. R.</span>; <span class="NLM_string-name">Lin, J.</span>; <span class="NLM_string-name">Lu, W.</span>; <span class="NLM_string-name">Wang, Z.</span></span> <span> </span><span class="NLM_article-title">Quinolinone Pyrimidines Compositions as Mutant-Isocitrate Dehydrogenase Inhibitors</span>. <span class="NLM_patent">WO/2016044781 A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+Ashwell&author=A.+M.+Campbell&author=J.+A.+Caravella&author=R.+B.+Diebold&author=A.+Ericsson&author=G.+Gustafson&author=D.+R.+Lancia&author=J.+Lin&author=W.+Lu&author=Z.+Wang&title=Quinolinone+Pyrimidines+Compositions+as+Mutant-Isocitrate+Dehydrogenase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAshwell%26aufirst%3DS.%26atitle%3DQuinolinone%2520Pyrimidines%2520Compositions%2520as%2520Mutant-Isocitrate%2520Dehydrogenase%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashwell, S.</span>; <span class="NLM_string-name">Campbell, A. M.</span>; <span class="NLM_string-name">Caravella, J. A.</span>; <span class="NLM_string-name">Diebold, R. B.</span>; <span class="NLM_string-name">Ericsson, A.</span>; <span class="NLM_string-name">Gustafson, G.</span>; <span class="NLM_string-name">Lancia, D. R.</span>; <span class="NLM_string-name">Lin, J.</span>; <span class="NLM_string-name">Lu, W.</span>; <span class="NLM_string-name">Wang, Z.</span></span> <span> </span><span class="NLM_article-title">Phenyl Quinolinone Derivatives as Mutant-Isocitrate Dehydrogenase Inhibitors</span>. <span class="NLM_patent">WO/2016044782 A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+Ashwell&author=A.+M.+Campbell&author=J.+A.+Caravella&author=R.+B.+Diebold&author=A.+Ericsson&author=G.+Gustafson&author=D.+R.+Lancia&author=J.+Lin&author=W.+Lu&author=Z.+Wang&title=Phenyl+Quinolinone+Derivatives+as+Mutant-Isocitrate+Dehydrogenase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAshwell%26aufirst%3DS.%26atitle%3DPhenyl%2520Quinolinone%2520Derivatives%2520as%2520Mutant-Isocitrate%2520Dehydrogenase%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashwell, S.</span>; <span class="NLM_string-name">Campbell, A. M.</span>; <span class="NLM_string-name">Caravella, J. A.</span>; <span class="NLM_string-name">Diebold, R. B.</span>; <span class="NLM_string-name">Ericsson, A.</span>; <span class="NLM_string-name">Gustafson, G.</span>; <span class="NLM_string-name">Lancia, D. R.</span>; <span class="NLM_string-name">Lin, J.</span>; <span class="NLM_string-name">Lu, W.</span>; <span class="NLM_string-name">Wang, Z.</span></span> <span> </span><span class="NLM_article-title">Pyridin-2(1h)-one Quinolinone Derivatives as Mutant-Isocitrate Dehydrogenase Inhibitors</span>. <span class="NLM_patent">WO/2016044789 A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+Ashwell&author=A.+M.+Campbell&author=J.+A.+Caravella&author=R.+B.+Diebold&author=A.+Ericsson&author=G.+Gustafson&author=D.+R.+Lancia&author=J.+Lin&author=W.+Lu&author=Z.+Wang&title=Pyridin-2%281h%29-one+Quinolinone+Derivatives+as+Mutant-Isocitrate+Dehydrogenase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAshwell%26aufirst%3DS.%26atitle%3DPyridin-2%25281h%2529-one%2520Quinolinone%2520Derivatives%2520as%2520Mutant-Isocitrate%2520Dehydrogenase%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="note"><p class="first last">Daiichi Sankyo conducts Japanese phase I trial of DS-1001b in IDH1 mutated gliomas. Thomson Reuters Drug News, February 16, 2017.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palkowitz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, R. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of diverse N -acryloyl azetidines and evaluation of their enhanced thiol reactivities</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2270</span>– <span class="NLM_lpage">2273</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.7b00788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.7b00788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmt1KqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=2270-2273&author=M.+D.+Palkowitzauthor=B.+Tanauthor=H.+Huauthor=K.+Rothauthor=R.+A.+Bauer&title=Synthesis+of+diverse+N+-acryloyl+azetidines+and+evaluation+of+their+enhanced+thiol+reactivities&doi=10.1021%2Facs.orglett.7b00788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Diverse N-Acryloyl Azetidines and Evaluation of Their Enhanced Thiol Reactivities</span></div><div class="casAuthors">Palkowitz, Maximilian D.; Tan, Bo; Hu, Haitao; Roth, Kenneth; Bauer, Renato A.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2270-2273</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acyl azetidines exhibit nonplanar hybridization, leading to lower amide-like character of the corresponding (O)C-N bonds.  This impacts N-acryloyl azetidines by producing enhanced electrophilicy at appended Michael acceptors.  Herein, reactivity data are reported in the presence of glutathione (GSH) in phosphate buffer (pH 7.4) at 37 °C.  Wide reactivity ranges are obsd. by varying substitution at the Michael acceptor or by modulating the electron-withdrawing character of substituents at the C3 position of the azetidine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjUFdHgOWgc7Vg90H21EOLACvtfcHk0licFs0EKQxqKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmt1KqtLw%253D&md5=d65414bda2976c07bc76cd0df6d4a38d</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.7b00788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.7b00788%26sid%3Dliteratum%253Aachs%26aulast%3DPalkowitz%26aufirst%3DM.%2BD.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DRoth%26aufirst%3DK.%26aulast%3DBauer%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520of%2520diverse%2520N%2520-acryloyl%2520azetidines%2520and%2520evaluation%2520of%2520their%2520enhanced%2520thiol%2520reactivities%26jtitle%3DOrg.%2520Lett.%26date%3D2017%26volume%3D19%26spage%3D2270%26epage%3D2273%26doi%3D10.1021%2Facs.orglett.7b00788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, R. A.</span>; <span class="NLM_string-name">Boulet, S. L.</span>; <span class="NLM_string-name">Burkholder, T. P.</span>; <span class="NLM_string-name">Carballares Martin, S.</span>; <span class="NLM_string-name">Gillig, J. P.</span>; <span class="NLM_string-name">Gilmour, R.</span>; <span class="NLM_string-name">Lumeras Amador, W.</span>; <span class="NLM_string-name">Wu, Z.</span>; <span class="NLM_string-name">Schirmer, H.</span></span> <span> </span><span class="NLM_article-title">7-Phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one Compounds and Their Use as Mutant IDH1 Inhibitors</span>. <span class="NLM_patent">WO/2017019429 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=R.+A.+Bauer&author=S.+L.+Boulet&author=T.+P.+Burkholder&author=S.+Carballares+Martin&author=J.+P.+Gillig&author=R.+Gilmour&author=W.+Lumeras+Amador&author=Z.+Wu&author=H.+Schirmer&title=7-Phenylethylamino-4H-pyrimido%5B4%2C5-d%5D%5B1%2C3%5Doxazin-2-one+Compounds+and+Their+Use+as+Mutant+IDH1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBauer%26aufirst%3DR.%2BA.%26atitle%3D7-Phenylethylamino-4H-pyrimido%255B4%252C5-d%255D%255B1%252C3%255Doxazin-2-one%2520Compounds%2520and%2520Their%2520Use%2520as%2520Mutant%2520IDH1%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lumeras Amador, W.</span>; <span class="NLM_string-name">Bauer, R. A.</span>; <span class="NLM_string-name">Boulet, S. L.</span>; <span class="NLM_string-name">Burkholder, T. P.</span>; <span class="NLM_string-name">Gilmour, R.</span>; <span class="NLM_string-name">Hahn, P.
J.</span>; <span class="NLM_string-name">Carballares Martin, S.</span>; <span class="NLM_string-name">Pankovic, Z.</span></span> <span> </span><span class="NLM_article-title">Mutant IDH1 Inhibitors</span>. <span class="NLM_patent">WO/2017213910 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=W.+Lumeras+Amador&author=R.+A.+Bauer&author=S.+L.+Boulet&author=T.+P.+Burkholder&author=R.+Gilmour&author=P.%0AJ.+Hahn&author=S.+Carballares+Martin&author=Z.+Pankovic&title=Mutant+IDH1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLumeras%2BAmador%26aufirst%3DW.%26atitle%3DMutant%2520IDH1%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Witter, D. J.</span>; <span class="NLM_string-name">Biftu, T.</span>; <span class="NLM_string-name">Biju, P.</span>; <span class="NLM_string-name">Bogen, S. L.</span>; <span class="NLM_string-name">Hone, Q.</span>; <span class="NLM_string-name">Huang, C.</span>; <span class="NLM_string-name">Huang, X.</span>; <span class="NLM_string-name">Li, B.</span>; <span class="NLM_string-name">Park, M. K.</span>; <span class="NLM_string-name">Sloman, D. L.</span></span> <span> </span><span class="NLM_article-title">Novel Tricyclic Compounds as Inhibitors of Mutant IDH Enzymes</span>. <span class="NLM_patent">WO/2017074914 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=D.+J.+Witter&author=T.+Biftu&author=P.+Biju&author=S.+L.+Bogen&author=Q.+Hone&author=C.+Huang&author=X.+Huang&author=B.+Li&author=M.+K.+Park&author=D.+L.+Sloman&title=Novel+Tricyclic+Compounds+as+Inhibitors+of+Mutant+IDH+Enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWitter%26aufirst%3DD.%2BJ.%26atitle%3DNovel%2520Tricyclic%2520Compounds%2520as%2520Inhibitors%2520of%2520Mutant%2520IDH%2520Enzymes%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span>; <span class="NLM_string-name">Li, J.</span>; <span class="NLM_string-name">Zhou, Y.</span>; <span class="NLM_string-name">Gao, A.</span>; <span class="NLM_string-name">Gao, L.</span>; <span class="NLM_string-name">Hu, Y.</span>; <span class="NLM_string-name">Li, X.</span>; <span class="NLM_string-name">Gao, J.</span></span> <span> </span><span class="NLM_article-title">Double Aryl Maleimide Compound and Salt Pharmaceutically Accepted and Preparation Method and Application</span>. <span class="NLM_patent">CN1,057,777,51</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=Q.+Ye&author=J.+Li&author=Y.+Zhou&author=A.+Gao&author=L.+Gao&author=Y.+Hu&author=X.+Li&author=J.+Gao&title=Double+Aryl+Maleimide+Compound+and+Salt+Pharmaceutically+Accepted+and+Preparation+Method+and+Application"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DQ.%26atitle%3DDouble%2520Aryl%2520Maleimide%2520Compound%2520and%2520Salt%2520Pharmaceutically%2520Accepted%2520and%2520Preparation%2520Method%2520and%2520Application%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span>; <span class="NLM_string-name">Geng, M.</span>; <span class="NLM_string-name">Zheng, Q.</span>; <span class="NLM_string-name">Huang, M.</span>; <span class="NLM_string-name">Wan, H.</span>; <span class="NLM_string-name">Tang, S.</span>; <span class="NLM_string-name">Fu, X.</span>; <span class="NLM_string-name">Lan, X.</span>; <span class="NLM_string-name">Cao, J.</span>; <span class="NLM_string-name">Liu, F.</span>; <span class="NLM_string-name">Ding, J.</span></span> <span> </span><span class="NLM_article-title">Compound Having Mutant IDH Inhibitory Activity, Preparation Method and Use Thereof</span>. <span class="NLM_patent">WO/2017162133 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=L.+Jiang&author=M.+Geng&author=Q.+Zheng&author=M.+Huang&author=H.+Wan&author=S.+Tang&author=X.+Fu&author=X.+Lan&author=J.+Cao&author=F.+Liu&author=J.+Ding&title=Compound+Having+Mutant+IDH+Inhibitory+Activity%2C+Preparation+Method+and+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DL.%26atitle%3DCompound%2520Having%2520Mutant%2520IDH%2520Inhibitory%2520Activity%252C%2520Preparation%2520Method%2520and%2520Use%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, H.</span></span> <span> </span><span class="NLM_article-title">Discovery and structure activity relationship study of novel conformationally restricted indane analogs for mutant isocitric dehydrogenase 1 (IDH1) inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">5262</span>– <span class="NLM_lpage">5266</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1016%2Fj.bmcl.2017.10.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=5262-5266&author=Q.+Zhengauthor=S.+Tangauthor=X.+Fuauthor=Z.+Chenauthor=Y.+Yeauthor=X.+Lanauthor=L.+Jiangauthor=Y.+Huangauthor=J.+Dingauthor=M.+Gengauthor=M.+Huangauthor=H.+Wan&title=Discovery+and+structure+activity+relationship+study+of+novel+conformationally+restricted+indane+analogs+for+mutant+isocitric+dehydrogenase+1+%28IDH1%29+inhibitors&doi=10.1016%2Fj.bmcl.2017.10.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.029%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DQ.%26aulast%3DTang%26aufirst%3DS.%26aulast%3DFu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DYe%26aufirst%3DY.%26aulast%3DLan%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DH.%26atitle%3DDiscovery%2520and%2520structure%2520activity%2520relationship%2520study%2520of%2520novel%2520conformationally%2520restricted%2520indane%2520analogs%2520for%2520mutant%2520isocitric%2520dehydrogenase%25201%2520%2528IDH1%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D5262%26epage%3D5266%26doi%3D10.1016%2Fj.bmcl.2017.10.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span>; <span class="NLM_string-name">Geng, M.</span>; <span class="NLM_string-name">Zheng, Q.</span>; <span class="NLM_string-name">Huang, M.</span>; <span class="NLM_string-name">Wan, H.</span>; <span class="NLM_string-name">Tang, S.</span>; <span class="NLM_string-name">Fu, X.</span>; <span class="NLM_string-name">Lan, X.</span>; <span class="NLM_string-name">Cao, J.</span>; <span class="NLM_string-name">Ding, J.</span></span> <span> </span><span class="NLM_article-title">Compound Having Inhibitory Activity against Mutant Isocitrate Dehydrogenase, Preparation Method Therefor and Use Thereof</span>. <span class="NLM_patent">WO/2018001332 A1</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=L.+Jiang&author=M.+Geng&author=Q.+Zheng&author=M.+Huang&author=H.+Wan&author=S.+Tang&author=X.+Fu&author=X.+Lan&author=J.+Cao&author=J.+Ding&title=Compound+Having+Inhibitory+Activity+against+Mutant+Isocitrate+Dehydrogenase%2C+Preparation+Method+Therefor+and+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DL.%26atitle%3DCompound%2520Having%2520Inhibitory%2520Activity%2520against%2520Mutant%2520Isocitrate%2520Dehydrogenase%252C%2520Preparation%2520Method%2520Therefor%2520and%2520Use%2520Thereof%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span>; <span class="NLM_string-name">Duan, X.</span>; <span class="NLM_string-name">Dai, L.</span>; <span class="NLM_string-name">Yang, Z.</span>; <span class="NLM_string-name">Yang, Y.</span>; <span class="NLM_string-name">Zhang, H.</span>; <span class="NLM_string-name">Hu, Y.</span>; <span class="NLM_string-name">Peng, Y.</span>; <span class="NLM_string-name">Han, Y.</span>; <span class="NLM_string-name">Zhao, R.</span>; <span class="NLM_string-name">Tian, X.</span>; <span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Sultam Compound and Application Method Thereof</span>. <span class="NLM_patent">WO/2017162157 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=L.+Zhu&author=X.+Duan&author=L.+Dai&author=Z.+Yang&author=Y.+Yang&author=H.+Zhang&author=Y.+Hu&author=Y.+Peng&author=Y.+Han&author=R.+Zhao&author=X.+Tian&author=S.+Wang&title=Sultam+Compound+and+Application+Method+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DL.%26atitle%3DSultam%2520Compound%2520and%2520Application%2520Method%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span>; <span class="NLM_string-name">Yang, Y.</span>; <span class="NLM_string-name">Dai, L.</span>; <span class="NLM_string-name">Duan, X.</span>; <span class="NLM_string-name">Yang, Z.</span>; <span class="NLM_string-name">Zhang, H.</span>; <span class="NLM_string-name">Hu, Y.</span>; <span class="NLM_string-name">Peng, Y.</span>; <span class="NLM_string-name">Han, Y.</span>; <span class="NLM_string-name">Zhao, R.</span>; <span class="NLM_string-name">Tian, X.</span>; <span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Iridinesulfonamide Compound and Use Method Thereof</span>. <span class="NLM_patent">WO/2017162156 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=L.+Zhu&author=Y.+Yang&author=L.+Dai&author=X.+Duan&author=Z.+Yang&author=H.+Zhang&author=Y.+Hu&author=Y.+Peng&author=Y.+Han&author=R.+Zhao&author=X.+Tian&author=S.+Wang&title=Iridinesulfonamide+Compound+and+Use+Method+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DL.%26atitle%3DIridinesulfonamide%2520Compound%2520and%2520Use%2520Method%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boxer, M. B.</span>; <span class="NLM_string-name">Wang, X.</span>; <span class="NLM_string-name">Brimacombe, K. R.</span>; <span class="NLM_string-name">Emily Davis, M. I.</span>; <span class="NLM_string-name">Fang, Y.</span>; <span class="NLM_string-name">Hall, M.</span>; <span class="NLM_string-name">Jadhav, A.</span>; <span class="NLM_string-name">Karavadhi, S.</span>; <span class="NLM_string-name">Liu, L.</span>; <span class="NLM_string-name">Martinez, N.</span>; <span class="NLM_string-name">Mciver, A. L.</span>; <span class="NLM_string-name">Pragani, R.</span>; <span class="NLM_string-name">Rohde, J. M.</span>; <span class="NLM_string-name">Simeonov, A.</span>; <span class="NLM_string-name">Zhao, W.</span>; <span class="NLM_string-name">Shen, M.</span></span> <span> </span><span class="NLM_article-title">Thiazole Derivatives Useful as Mutant IDH1 Inhibitors for Treating Cancer</span>. <span class="NLM_patent">WO/2017223202 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=M.+B.+Boxer&author=X.+Wang&author=K.+R.+Brimacombe&author=M.+I.+Emily+Davis&author=Y.+Fang&author=M.+Hall&author=A.+Jadhav&author=S.+Karavadhi&author=L.+Liu&author=N.+Martinez&author=A.+L.+Mciver&author=R.+Pragani&author=J.+M.+Rohde&author=A.+Simeonov&author=W.+Zhao&author=M.+Shen&title=Thiazole+Derivatives+Useful+as+Mutant+IDH1+Inhibitors+for+Treating+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoxer%26aufirst%3DM.%2BB.%26atitle%3DThiazole%2520Derivatives%2520Useful%2520as%2520Mutant%2520IDH1%2520Inhibitors%2520for%2520Treating%2520Cancer%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruz, M. M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goparaju, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jyotsana, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baehre, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goerlich, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schottmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struys, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kloos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaever, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thol, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuser, M.</span></span> <span> </span><span class="NLM_article-title">A novel inhibitor of mutant IDH1 induces differentiation in vivo and prolongs survival in a mouse model of leukemia</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">3598</span>– <span class="NLM_lpage">3598</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=3598-3598&author=A.+Chaturvediauthor=M.+M.+A.+Cruzauthor=R.+Goparajuauthor=N.+Jyotsanaauthor=H.+Baehreauthor=K.+Goerlichauthor=R.+Schottmannauthor=M.+Prellerauthor=E.+A.+Struysauthor=A.+Kloosauthor=V.+Kaeverauthor=A.+Ganserauthor=F.+Tholauthor=M.+Heuser&title=A+novel+inhibitor+of+mutant+IDH1+induces+differentiation+in+vivo+and+prolongs+survival+in+a+mouse+model+of+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChaturvedi%26aufirst%3DA.%26aulast%3DCruz%26aufirst%3DM.%2BM.%2BA.%26aulast%3DGoparaju%26aufirst%3DR.%26aulast%3DJyotsana%26aufirst%3DN.%26aulast%3DBaehre%26aufirst%3DH.%26aulast%3DGoerlich%26aufirst%3DK.%26aulast%3DSchottmann%26aufirst%3DR.%26aulast%3DPreller%26aufirst%3DM.%26aulast%3DStruys%26aufirst%3DE.%2BA.%26aulast%3DKloos%26aufirst%3DA.%26aulast%3DKaever%26aufirst%3DV.%26aulast%3DGanser%26aufirst%3DA.%26aulast%3DThol%26aufirst%3DF.%26aulast%3DHeuser%26aufirst%3DM.%26atitle%3DA%2520novel%2520inhibitor%2520of%2520mutant%2520IDH1%2520induces%2520differentiation%2520in%2520vivo%2520and%2520prolongs%2520survival%2520in%2520a%2520mouse%2520model%2520of%2520leukemia%26jtitle%3DBlood%26date%3D2014%26volume%3D124%26spage%3D3598%26epage%3D3598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span> <span> </span><span class="NLM_article-title">Structure based discovery of clomifene as a potent inhibitor of cancer-associated mutant IDH1</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">44255</span>– <span class="NLM_lpage">44265</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.17464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.18632%2Foncotarget.17464" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=44255-44265&author=M.+Zhengauthor=W.+Sunauthor=S.+Gaoauthor=S.+Luanauthor=D.+Liauthor=R.+Chenauthor=Q.+Zhangauthor=L.+Chenauthor=J.+Huangauthor=H.+Li&title=Structure+based+discovery+of+clomifene+as+a+potent+inhibitor+of+cancer-associated+mutant+IDH1&doi=10.18632%2Foncotarget.17464"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.17464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.17464%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DS.%26aulast%3DLuan%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26atitle%3DStructure%2520based%2520discovery%2520of%2520clomifene%2520as%2520a%2520potent%2520inhibitor%2520of%2520cancer-associated%2520mutant%2520IDH1%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D44255%26epage%3D44265%26doi%3D10.18632%2Foncotarget.17464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pusch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Deimling, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zha, X.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological activity of 3-pyrazine-2-yl-oxazolidin-2-ones as novel, potent and selective inhibitors of mutant isocitrate dehydrogenase 1</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">6379</span>– <span class="NLM_lpage">6387</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.10.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1016%2Fj.bmc.2017.10.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=6379-6387&author=T.+Maauthor=F.+Zouauthor=S.+Puschauthor=L.+Yangauthor=Q.+Zhuauthor=Y.+Xuauthor=Y.+Guauthor=A.+von+Deimlingauthor=X.+Zha&title=Design%2C+synthesis+and+biological+activity+of+3-pyrazine-2-yl-oxazolidin-2-ones+as+novel%2C+potent+and+selective+inhibitors+of+mutant+isocitrate+dehydrogenase+1&doi=10.1016%2Fj.bmc.2017.10.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DT.%26aulast%3DZou%26aufirst%3DF.%26aulast%3DPusch%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DGu%26aufirst%3DY.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26aulast%3DZha%26aufirst%3DX.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520activity%2520of%25203-pyrazine-2-yl-oxazolidin-2-ones%2520as%2520novel%252C%2520potent%2520and%2520selective%2520inhibitors%2520of%2520mutant%2520isocitrate%2520dehydrogenase%25201%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D6379%26epage%3D6387%26doi%3D10.1016%2Fj.bmc.2017.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feliciano, P.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of mutant IDH1 and IDH2</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">477</span>, <span class="refDoi"> DOI: 10.1038/ng.2630</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1038%2Fng.2630" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2013&pages=477-477&author=P.+Feliciano&title=Inhibitors+of+mutant+IDH1+and+IDH2&doi=10.1038%2Fng.2630"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1038%2Fng.2630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.2630%26sid%3Dliteratum%253Aachs%26aulast%3DFeliciano%26aufirst%3DP.%26atitle%3DInhibitors%2520of%2520mutant%2520IDH1%2520and%2520IDH2%26jtitle%3DNat.%2520Genet.%26date%3D2013%26volume%3D45%26spage%3D477%26epage%3D477%26doi%3D10.1038%2Fng.2630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. Y.C.</span></span> <span> </span><span class="NLM_article-title">Potential mitochondrial isocitrate dehydrogenase R140Q mutant inhibitor from traditional Chinese medicine against cancers</span>. <i>BioMed Res. Int.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2014</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1155/2014/364625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1155%2F2014%2F364625" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2014&publication_year=2014&pages=1-10&author=W.+Y.+Leeauthor=K.+C.+Chenauthor=H.+Y.+Chenauthor=C.+Y.C.+Chen&title=Potential+mitochondrial+isocitrate+dehydrogenase+R140Q+mutant+inhibitor+from+traditional+Chinese+medicine+against+cancers&doi=10.1155%2F2014%2F364625"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1155%2F2014%2F364625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2014%252F364625%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DW.%2BY.%26aulast%3DChen%26aufirst%3DK.%2BC.%26aulast%3DChen%26aufirst%3DH.%2BY.%26aulast%3DChen%26aufirst%3DC.%2BY.C.%26atitle%3DPotential%2520mitochondrial%2520isocitrate%2520dehydrogenase%2520R140Q%2520mutant%2520inhibitor%2520from%2520traditional%2520Chinese%2520medicine%2520against%2520cancers%26jtitle%3DBioMed%2520Res.%2520Int.%26date%3D2014%26volume%3D2014%26spage%3D1%26epage%3D10%26doi%3D10.1155%2F2014%2F364625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E.</span></span> <span> </span><span class="NLM_article-title">Enasidenib: first global approval</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">1705</span>– <span class="NLM_lpage">1711</span>, <span class="refDoi"> DOI: 10.1007/s40265-017-0813-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1007%2Fs40265-017-0813-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=28879540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVyrt7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=1705-1711&author=E.+Kim&title=Enasidenib%3A+first+global+approval&doi=10.1007%2Fs40265-017-0813-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Enasidenib: First Global Approval</span></div><div class="casAuthors">Kim, Esther S.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1705-1711</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Enasidenib (Idhifa) is an oral isocitrate dehydrogenase-2 (IDH2) inhibitor developed by Celgene Corporation under a global, exclusive license from Agios Pharmaceuticals.  Enasidenib has been approved in the USA for the treatment of adults with relapsed or refractory acute myeloid leukemia (AML) and an IDH2 mutation as detected by an FDA-approved test.  It is at various stages of development in other countries for AML, myelodysplastic syndromes and solid tumors.  This article summarizes the milestones in the development of enasidenib leading to this first global approval in the USA for the treatment of adults with relapsed or refractory IDH2-mutated AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQY_z0s-7qX7Vg90H21EOLACvtfcHk0lgpH9DAMlj4dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVyrt7zJ&md5=337b677cfaab46eccea63b91b16ebf40</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1007%2Fs40265-017-0813-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-017-0813-2%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DE.%26atitle%3DEnasidenib%253A%2520first%2520global%2520approval%26jtitle%3DDrugs%26date%3D2017%26volume%3D77%26spage%3D1705%26epage%3D1711%26doi%3D10.1007%2Fs40265-017-0813-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travins, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padyana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLaBarre, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagaraja, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konteatis, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianchetta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salituro, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quivoron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opolon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saada, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broutin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Botton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marteyn, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilichowska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penard-Lacronique, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biller, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S. S. M.</span></span> <span> </span><span class="NLM_article-title">AG-221, a first-in-class therapy targeting acute myeloid leukemia harboring oncogenic IDH2 mutations</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">478</span>– <span class="NLM_lpage">493</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-16-1034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1158%2F2159-8290.CD-16-1034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=28193778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFemurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=478-493&author=K.+Yenauthor=J.+Travinsauthor=F.+Wangauthor=M.+D.+Davidauthor=E.+Artinauthor=K.+Straleyauthor=A.+Padyanaauthor=S.+Grossauthor=B.+DeLaBarreauthor=E.+Tobinauthor=Y.+Chenauthor=R.+Nagarajaauthor=S.+Choeauthor=L.+Jinauthor=Z.+Konteatisauthor=G.+Cianchettaauthor=J.+O.+Saundersauthor=F.+G.+Salituroauthor=C.+Quivoronauthor=P.+Opolonauthor=O.+Bawaauthor=V.+Saadaauthor=A.+Paciauthor=S.+Broutinauthor=O.+A.+Bernardauthor=S.+de+Bottonauthor=B.+S.+Marteynauthor=M.+Pilichowskaauthor=Y.+Xuauthor=C.+Fangauthor=F.+Jiangauthor=W.+Weiauthor=S.+Jinauthor=L.+Silvermanauthor=W.+Liuauthor=H.+Yangauthor=L.+Dangauthor=M.+Dorschauthor=V.+Penard-Lacroniqueauthor=S.+A.+Billerauthor=S.+S.+M.+Su&title=AG-221%2C+a+first-in-class+therapy+targeting+acute+myeloid+leukemia+harboring+oncogenic+IDH2+mutations&doi=10.1158%2F2159-8290.CD-16-1034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations</span></div><div class="casAuthors">Yen, Katharine; Travins, Jeremy; Wang, Fang; David, Muriel D.; Artin, Erin; Straley, Kimberly; Padyana, Anil; Gross, Stefan; De La Barre, Byron; Tobin, Erica; Chen, Yue; Nagaraja, Raj; Choe, Sung; Jin, Lei; Konteatis, Zenon; Cianchetta, Giovanni; Saunders, Jeffrey O.; Salituro, Francesco G.; Quivoron, Cyril; Opolon, Paule; Bawa, Olivia; Saada, Veronique; Paci, Angelo; Broutin, Sophie; Bernard, Olivier A.; de Botton, Stephane; Marteyn, Benoit S.; Pilichowska, Monika; Xu, Ying Xia; Fang, Cheng; Jiang, Fan; Wei, Wentao; Jin, Shengfang; Silverman, Lee; Liu, Wei; Yang, Hua; Dang, Lenny; Dorsch, Marion; Penard-Lacronique, Virginie; Biller, Scott A.; Su, Shin-San Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">478-493</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Somatic gain-of-function mutations in isocitrate dehydrogenases (IDH) 1 and 2 are found in multiple hematol. and solid tumors, leading to accumulation of the oncometabolite (R)-2-hydroxyglutarate (2HG).  2HG competitively inhibits α-ketoglutarate-dependent dioxygenases, including histone demethylases and methylcytosine dioxygenases of the TET family, causing epigenetic dysregulation and a block in cellular differentiation.  In vitro studies have provided proof of concept for mutant IDH inhibition as a therapeutic approach.  We report the discovery and characterization of AG-221, an orally available, selective, potent inhibitor of the mutant IDH2 enzyme.  AG-221 suppressed 2HG prodn. and induced cellular differentiation in primary human IDH2 mutation-pos. acute myeloid leukemia (AML) cells ex vivo and in xenograft mouse models.  AG-221 also provided a statistically significant survival benefit in an aggressive IDH2R140Q-mutant AML xenograft mouse model.  These findings supported initiation of the ongoing clin. trials of AG-221 in patients with IDH2 mutation-pos. advanced hematol. malignancies.  Significance: Mutations in IDH1/2 are identified in approx. 20% of patients with AML and contribute to leukemia via a block in hematopoietic cell differentiation.  We have shown that the targeted inhibitor AG-221 suppresses the mutant IDH2 enzyme in multiple preclin. models and induces differentiation of malignant blasts, supporting its clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD2cujlZfayrVg90H21EOLACvtfcHk0lgpH9DAMlj4dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFemurY%253D&md5=b83b3d82491d02befbde03aa392a6914</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-16-1034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-16-1034%26sid%3Dliteratum%253Aachs%26aulast%3DYen%26aufirst%3DK.%26aulast%3DTravins%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DDavid%26aufirst%3DM.%2BD.%26aulast%3DArtin%26aufirst%3DE.%26aulast%3DStraley%26aufirst%3DK.%26aulast%3DPadyana%26aufirst%3DA.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DDeLaBarre%26aufirst%3DB.%26aulast%3DTobin%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DNagaraja%26aufirst%3DR.%26aulast%3DChoe%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DKonteatis%26aufirst%3DZ.%26aulast%3DCianchetta%26aufirst%3DG.%26aulast%3DSaunders%26aufirst%3DJ.%2BO.%26aulast%3DSalituro%26aufirst%3DF.%2BG.%26aulast%3DQuivoron%26aufirst%3DC.%26aulast%3DOpolon%26aufirst%3DP.%26aulast%3DBawa%26aufirst%3DO.%26aulast%3DSaada%26aufirst%3DV.%26aulast%3DPaci%26aufirst%3DA.%26aulast%3DBroutin%26aufirst%3DS.%26aulast%3DBernard%26aufirst%3DO.%2BA.%26aulast%3Dde%2BBotton%26aufirst%3DS.%26aulast%3DMarteyn%26aufirst%3DB.%2BS.%26aulast%3DPilichowska%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DFang%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DSilverman%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DDang%26aufirst%3DL.%26aulast%3DDorsch%26aufirst%3DM.%26aulast%3DPenard-Lacronique%26aufirst%3DV.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DSu%26aufirst%3DS.%2BS.%2BM.%26atitle%3DAG-221%252C%2520a%2520first-in-class%2520therapy%2520targeting%2520acute%2520myeloid%2520leukemia%2520harboring%2520oncogenic%2520IDH2%2520mutations%26jtitle%3DCancer%2520Discovery%26date%3D2017%26volume%3D7%26spage%3D478%26epage%3D493%26doi%3D10.1158%2F2159-8290.CD-16-1034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stein, E. M.</span></span> <span> </span><span class="NLM_article-title">IDH2 inhibition in AML: finally progress?</span>. <i>Best Pract. Res. Clin. Haematol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.1016/j.beha.2015.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1016%2Fj.beha.2015.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=26590767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A280%3ADC%252BC28vktVGisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=112-115&author=E.+M.+Stein&title=IDH2+inhibition+in+AML%3A+finally+progress%3F&doi=10.1016%2Fj.beha.2015.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">IDH2 inhibition in AML: Finally progress?</span></div><div class="casAuthors">Stein Eytan M</div><div class="citationInfo"><span class="NLM_cas:title">Best practice & research. Clinical haematology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">112-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Isocitrate dehydrogenase (IDH) catalyzes the conversion of isocitrate to alpha ketoglutarate.  IDH occurs in three isoforms, IDH1, located in the cytoplasm, IDH2 located in the mitochondria, and IDH3, which functions as part of the TCA cycle.  Mutations in the active site of IDH1 at position R132 and an analogous mutation in the IDH2 gene at position R172 have been discovered.  Notably, many cases of acute myeloid leukemia (AML) have mutations in R172 and R140.  The impact of these mutations and early results of inhibiting mutant IDH2 with the reversible inhibitor AG-221 are discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSk-4M09PezakloaUqgkFHkfW6udTcc2ebXDIechPyd_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28vktVGisw%253D%253D&md5=0c0f529709d296c926e5ce700cb55ba4</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.beha.2015.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.beha.2015.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DE.%2BM.%26atitle%3DIDH2%2520inhibition%2520in%2520AML%253A%2520finally%2520progress%253F%26jtitle%3DBest%2520Pract.%2520Res.%2520Clin.%2520Haematol.%26date%3D2015%26volume%3D28%26spage%3D112%26epage%3D115%26doi%3D10.1016%2Fj.beha.2015.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cianchetta, G.</span>; <span class="NLM_string-name">Delabarre, B.</span>; <span class="NLM_string-name">Popovici-Muller, J.</span>; <span class="NLM_string-name">Salituro, F. G.</span>; <span class="NLM_string-name">Saunders, J. O.</span>; <span class="NLM_string-name">Travins, J.</span>; <span class="NLM_string-name">Yan, S.</span>; <span class="NLM_string-name">Guo, T.</span>; <span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">Therapeutically Active Compounds and Their Methods of Use</span>. <span class="NLM_patent">WO/2013102431 A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=G.+Cianchetta&author=B.+Delabarre&author=J.+Popovici-Muller&author=F.+G.+Salituro&author=J.+O.+Saunders&author=J.+Travins&author=S.+Yan&author=T.+Guo&author=L.+Zhang&title=Therapeutically+Active+Compounds+and+Their+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCianchetta%26aufirst%3DG.%26atitle%3DTherapeutically%2520Active%2520Compounds%2520and%2520Their%2520Methods%2520of%2520Use%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stein, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altman, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeAngelo, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fathi, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flinn, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medeiros, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollyea, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roboz, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swords, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agresta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Botton, S.</span></span> <span> </span><span class="NLM_article-title">AG-221, an oral, selective, first-in-class, potent inhibitor of the IDH2 mutant metabolic enzyme, induces durable remissions in a phase I study in patients with IDH2 mutation positive advanced hematologic malignancies</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">115</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=115-115&author=E.+M.+Steinauthor=J.+K.+Altmanauthor=R.+Collinsauthor=D.+J.+DeAngeloauthor=A.+T.+Fathiauthor=I.+Flinnauthor=A.+Frankelauthor=R.+L.+Levineauthor=B.+C.+Medeirosauthor=M.+Patelauthor=D.+A.+Pollyeaauthor=G.+J.+Robozauthor=R.+M.+Stoneauthor=R.+T.+Swordsauthor=M.+S.+Tallmanauthor=S.+Agrestaauthor=B.+Fanauthor=H.+Yangauthor=K.+Yenauthor=S.+de+Botton&title=AG-221%2C+an+oral%2C+selective%2C+first-in-class%2C+potent+inhibitor+of+the+IDH2+mutant+metabolic+enzyme%2C+induces+durable+remissions+in+a+phase+I+study+in+patients+with+IDH2+mutation+positive+advanced+hematologic+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DE.%2BM.%26aulast%3DAltman%26aufirst%3DJ.%2BK.%26aulast%3DCollins%26aufirst%3DR.%26aulast%3DDeAngelo%26aufirst%3DD.%2BJ.%26aulast%3DFathi%26aufirst%3DA.%2BT.%26aulast%3DFlinn%26aufirst%3DI.%26aulast%3DFrankel%26aufirst%3DA.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DMedeiros%26aufirst%3DB.%2BC.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DPollyea%26aufirst%3DD.%2BA.%26aulast%3DRoboz%26aufirst%3DG.%2BJ.%26aulast%3DStone%26aufirst%3DR.%2BM.%26aulast%3DSwords%26aufirst%3DR.%2BT.%26aulast%3DTallman%26aufirst%3DM.%2BS.%26aulast%3DAgresta%26aufirst%3DS.%26aulast%3DFan%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DYen%26aufirst%3DK.%26aulast%3Dde%2BBotton%26aufirst%3DS.%26atitle%3DAG-221%252C%2520an%2520oral%252C%2520selective%252C%2520first-in-class%252C%2520potent%2520inhibitor%2520of%2520the%2520IDH2%2520mutant%2520metabolic%2520enzyme%252C%2520induces%2520durable%2520remissions%2520in%2520a%2520phase%2520I%2520study%2520in%2520patients%2520with%2520IDH2%2520mutation%2520positive%2520advanced%2520hematologic%2520malignancies%26jtitle%3DBlood%26date%3D2014%26volume%3D124%26spage%3D115%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stein, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiNardo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altman, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeAngelo, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantarjian, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekeres, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fathi, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flinn, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankel, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medeiros, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollyea, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roboz, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swords, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attar, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tosolini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakurta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Botton, S.</span></span> <span> </span><span class="NLM_article-title">Safety and efficacy of AG-221, a potent inhibitor of mutant IDH2 that promotes differentiation of myeloid cells in patients with advanced hematologic malignancies: results of a phase 1/2 trial</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">323</span>– <span class="NLM_lpage">323</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2015&pages=323-323&author=E.+M.+Steinauthor=C.+DiNardoauthor=J.+K.+Altmanauthor=R.+Collinsauthor=D.+J.+DeAngeloauthor=H.+M.+Kantarjianauthor=M.+A.+Sekeresauthor=A.+T.+Fathiauthor=W.+Flinnauthor=A.+E.+Frankelauthor=R.+L.+Levineauthor=B.+C.+Medeirosauthor=M.+R.+Patelauthor=D.+Pollyeaauthor=G.+J.+Robozauthor=R.+M.+Stoneauthor=R.+T.+Swordsauthor=M.+S.+Tallmanauthor=K.+Yenauthor=E.+C.+Attarauthor=Q.+Xuauthor=A.+Tosoliniauthor=J.+M.+Meiauthor=A.+Thakurtaauthor=R.+D.+Knightauthor=S.+De+Botton&title=Safety+and+efficacy+of+AG-221%2C+a+potent+inhibitor+of+mutant+IDH2+that+promotes+differentiation+of+myeloid+cells+in+patients+with+advanced+hematologic+malignancies%3A+results+of+a+phase+1%2F2+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DE.%2BM.%26aulast%3DDiNardo%26aufirst%3DC.%26aulast%3DAltman%26aufirst%3DJ.%2BK.%26aulast%3DCollins%26aufirst%3DR.%26aulast%3DDeAngelo%26aufirst%3DD.%2BJ.%26aulast%3DKantarjian%26aufirst%3DH.%2BM.%26aulast%3DSekeres%26aufirst%3DM.%2BA.%26aulast%3DFathi%26aufirst%3DA.%2BT.%26aulast%3DFlinn%26aufirst%3DW.%26aulast%3DFrankel%26aufirst%3DA.%2BE.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DMedeiros%26aufirst%3DB.%2BC.%26aulast%3DPatel%26aufirst%3DM.%2BR.%26aulast%3DPollyea%26aufirst%3DD.%26aulast%3DRoboz%26aufirst%3DG.%2BJ.%26aulast%3DStone%26aufirst%3DR.%2BM.%26aulast%3DSwords%26aufirst%3DR.%2BT.%26aulast%3DTallman%26aufirst%3DM.%2BS.%26aulast%3DYen%26aufirst%3DK.%26aulast%3DAttar%26aufirst%3DE.%2BC.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DTosolini%26aufirst%3DA.%26aulast%3DMei%26aufirst%3DJ.%2BM.%26aulast%3DThakurta%26aufirst%3DA.%26aulast%3DKnight%26aufirst%3DR.%2BD.%26aulast%3DDe%2BBotton%26aufirst%3DS.%26atitle%3DSafety%2520and%2520efficacy%2520of%2520AG-221%252C%2520a%2520potent%2520inhibitor%2520of%2520mutant%2520IDH2%2520that%2520promotes%2520differentiation%2520of%2520myeloid%2520cells%2520in%2520patients%2520with%2520advanced%2520hematologic%2520malignancies%253A%2520results%2520of%2520a%2520phase%25201%252F2%2520trial%26jtitle%3DBlood%26date%3D2015%26volume%3D126%26spage%3D323%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Utley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agresta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span> <span> </span><span class="NLM_article-title">Evaluation of pharmacokinetic-pharmacodynamic (PK-PD) relationship of an oral, selective, first-in-class, potent IDH2 inhibitor, AG-221, from a phase 1 trial in patients with advanced IDH2 mutant positive hematologic malignancies</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">3737</span>– <span class="NLM_lpage">3737</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=3737-3737&author=B.+Fanauthor=Y.+Chenauthor=F.+Wangauthor=K.+Yenauthor=L.+Utleyauthor=C.+Almonauthor=S.+Billerauthor=S.+Agrestaauthor=H.+Yang&title=Evaluation+of+pharmacokinetic-pharmacodynamic+%28PK-PD%29+relationship+of+an+oral%2C+selective%2C+first-in-class%2C+potent+IDH2+inhibitor%2C+AG-221%2C+from+a+phase+1+trial+in+patients+with+advanced+IDH2+mutant+positive+hematologic+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DYen%26aufirst%3DK.%26aulast%3DUtley%26aufirst%3DL.%26aulast%3DAlmon%26aufirst%3DC.%26aulast%3DBiller%26aufirst%3DS.%26aulast%3DAgresta%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DH.%26atitle%3DEvaluation%2520of%2520pharmacokinetic-pharmacodynamic%2520%2528PK-PD%2529%2520relationship%2520of%2520an%2520oral%252C%2520selective%252C%2520first-in-class%252C%2520potent%2520IDH2%2520inhibitor%252C%2520AG-221%252C%2520from%2520a%2520phase%25201%2520trial%2520in%2520patients%2520with%2520advanced%2520IDH2%2520mutant%2520positive%2520hematologic%2520malignancies%26jtitle%3DBlood%26date%3D2014%26volume%3D124%26spage%3D3737%26epage%3D3737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xia, X.</span>; <span class="NLM_string-name">Zhang, D.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic Compounds as IDH2 Inhibitors</span>. <span class="NLM_patent">WO/2016177347 A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=X.+Xia&author=D.+Zhang&title=Heterocyclic+Compounds+as+IDH2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DX.%26atitle%3DHeterocyclic%2520Compounds%2520as%2520IDH2%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span>; <span class="NLM_string-name">Cheng, C.</span></span> <span> </span><span class="NLM_article-title">Deuterated Compounds for Treating Hematologic Malignancies, and Compositions and Methods Thereof</span>. <span class="NLM_patent">WO/2017069878 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=C.+Huang&author=C.+Cheng&title=Deuterated+Compounds+for+Treating+Hematologic+Malignancies%2C+and+Compositions+and+Methods+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%26atitle%3DDeuterated%2520Compounds%2520for%2520Treating%2520Hematologic%2520Malignancies%252C%2520and%2520Compositions%2520and%2520Methods%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, N.</span>; <span class="NLM_string-name">Wang, S.</span>; <span class="NLM_string-name">Liu, S.</span>; <span class="NLM_string-name">Hu, Y.</span>; <span class="NLM_string-name">Zhang, H.</span>; <span class="NLM_string-name">Luo, H.</span>; <span class="NLM_string-name">Peng, Y.</span>; <span class="NLM_string-name">Han, Y.</span>; <span class="NLM_string-name">Zhang, X.</span>; <span class="NLM_string-name">Xu, H.</span></span> <span> </span><span class="NLM_article-title">1,3,5-Triazine Derivative and Method of Using Same</span>. <span class="NLM_patent">WO/2017016513 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=N.+Zhao&author=S.+Wang&author=S.+Liu&author=Y.+Hu&author=H.+Zhang&author=H.+Luo&author=Y.+Peng&author=Y.+Han&author=X.+Zhang&author=H.+Xu&title=1%2C3%2C5-Triazine+Derivative+and+Method+of+Using+Same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DN.%26atitle%3D1%252C3%252C5-Triazine%2520Derivative%2520and%2520Method%2520of%2520Using%2520Same%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, P.</span>; <span class="NLM_string-name">Chen, J.</span>; <span class="NLM_string-name">Yang, J.</span></span> <span> </span><span class="NLM_article-title">IDH2 Mutant Inhibitors and Uses Thereof</span>. <span class="NLM_patent">CN 1,068,105,12</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=P.+Cao&author=J.+Chen&author=J.+Yang&title=IDH2+Mutant+Inhibitors+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DP.%26atitle%3DIDH2%2520Mutant%2520Inhibitors%2520and%2520Uses%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel class of pyridine derivatives that selectively inhibits mutant isocitrate dehydrogenase 2</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">1087</span>– <span class="NLM_lpage">1093</span>, <span class="refDoi"> DOI: 10.1111/cbdd.13139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1111%2Fcbdd.13139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=29120536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsVKisrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2018&pages=1087-1093&author=F.+Wangauthor=Z.+Liauthor=T.+Zhangauthor=G.+Yanauthor=M.+Huauthor=L.+Zhaoauthor=Y.+Zhaoauthor=Y.+Chen&title=Discovery+of+a+novel+class+of+pyridine+derivatives+that+selectively+inhibits+mutant+isocitrate+dehydrogenase+2&doi=10.1111%2Fcbdd.13139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a novel class of pyridine derivatives that selectively inhibits mutant isocitrate dehydrogenase 2</span></div><div class="casAuthors">Wang, Fangying; Li, Zhuoling; Zhang, Tao; Yan, Guoyi; Hu, Mingxing; Zhao, Lifeng; Zhao, Yinglan; Chen, Yuanwei</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1087-1093</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">This paper presents synthesis and structure-activity relationship of pyridine derivs. as inhibitors of mutant isocitrate dehydrogenase 2 (IDH2).  A series of 2,4,6-trisubstituted pyridine derivs. have been prepd. and evaluated in vitro.  Among these compds., 14n (N4-isopropyl-6-phenyl-N2-(4-(trifluoromethyl)pyridin-2-yl)pyridine-2,4-diamine) exhibited excellent inhibition activity with the IC50 of 54.6 nM, which is approx. onefold improvement compared to drug candidate AG-221 (Enasidenib) that is in Phase III trial.  Exquisite selectivity of 14n for IDH2 R140Q mutant isoform was demonstrated by the poor activity against the wild-type IDH1 and IDH2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCOGkXBP02arVg90H21EOLACvtfcHk0lj0v6zpU-2ZRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsVKisrk%253D&md5=c59997ac5c3fca4854f8af6de4bd39be</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.13139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.13139%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DYan%26aufirst%3DG.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520class%2520of%2520pyridine%2520derivatives%2520that%2520selectively%2520inhibits%2520mutant%2520isocitrate%2520dehydrogenase%25202%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2018%26volume%3D91%26spage%3D1087%26epage%3D1093%26doi%3D10.1111%2Fcbdd.13139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span>; <span class="NLM_string-name">Wang, F.
Y.</span>; <span class="NLM_string-name">Chen, Y.
W.</span>; <span class="NLM_string-name">Wei, Y. Q.</span></span> <span> </span><span class="NLM_article-title">Pyridine Compounds and Their Use as IDH Function Variant Mutant Inhibitor Medicine Use</span>. <span class="NLM_patent">CN 1,073,828,40</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=T.+Zhang&author=F.%0AY.+Wang&author=Y.%0AW.+Chen&author=Y.+Q.+Wei&title=Pyridine+Compounds+and+Their+Use+as+IDH+Function+Variant+Mutant+Inhibitor+Medicine+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26atitle%3DPyridine%2520Compounds%2520and%2520Their%2520Use%2520as%2520IDH%2520Function%2520Variant%2520Mutant%2520Inhibitor%2520Medicine%2520Use%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K.</span>; <span class="NLM_string-name">Konteatis, Z.</span>; <span class="NLM_string-name">Straley, K.</span>; <span class="NLM_string-name">Artin, E.</span>; <span class="NLM_string-name">David, M.</span>; <span class="NLM_string-name">Quivoron, C.</span>; <span class="NLM_string-name">Dang, L.</span>; <span class="NLM_string-name">Tobin, E.</span>; <span class="NLM_string-name">Campos, C.</span>; <span class="NLM_string-name">Yang, H.</span>; <span class="NLM_string-name">Nagaraja, R.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Sui, Z.</span>; <span class="NLM_string-name">Kim, H.</span>; <span class="NLM_string-name">Gliser, C.</span>; <span class="NLM_string-name">Nicolay, B.</span>; <span class="NLM_string-name">Olaharski, A.</span>; <span class="NLM_string-name">Silverman, L.</span>; <span class="NLM_string-name">Penard-Lacronique, V.</span>; <span class="NLM_string-name">de Botton, S.</span>; <span class="NLM_string-name">Biller, S.</span>; <span class="NLM_string-name">Su, S. M.</span>; <span class="NLM_string-name">Mellinghoff, I.</span>; <span class="NLM_string-name">Popovici-Muller, J.</span></span> <span> </span><span class="NLM_article-title">AG-881, a brain penetrant, potent, pan-mutant IDH (mIDH) inhibitor for use in mIDH solid and hematologic malignancies</span>.  <i>Abstracts of Papers</i>, AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, Philadelphia, PA, Oct 26–30, <span class="NLM_year">2017</span>; Abstract B126.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=K.+Yen&author=Z.+Konteatis&author=K.+Straley&author=E.+Artin&author=M.+David&author=C.+Quivoron&author=L.+Dang&author=E.+Tobin&author=C.+Campos&author=H.+Yang&author=R.+Nagaraja&author=Y.+Chen&author=Z.+Sui&author=H.+Kim&author=C.+Gliser&author=B.+Nicolay&author=A.+Olaharski&author=L.+Silverman&author=V.+Penard-Lacronique&author=S.+de+Botton&author=S.+Biller&author=S.+M.+Su&author=I.+Mellinghoff&author=J.+Popovici-Muller&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DYen%26aufirst%3DK.%26atitle%3DAG-881%252C%2520a%2520brain%2520penetrant%252C%2520potent%252C%2520pan-mutant%2520IDH%2520%2528mIDH%2529%2520inhibitor%2520for%2520use%2520in%2520mIDH%2520solid%2520and%2520hematologic%2520malignancies%26btitle%3DAbstracts%2520of%2520Papers%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Konteatis, Z. D.</span>; <span class="NLM_string-name">Popovici-Muller, J.</span>; <span class="NLM_string-name">Travins, J. M.</span>; <span class="NLM_string-name">Zahler, R.</span>; <span class="NLM_string-name">Cai, Z.</span>; <span class="NLM_string-name">Zhou, D.</span></span> <span> </span><span class="NLM_article-title">Therapeutically Active Compounds and Their Methods of Use</span>. <span class="NLM_patent">WO/2015003640 A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Z.+D.+Konteatis&author=J.+Popovici-Muller&author=J.+M.+Travins&author=R.+Zahler&author=Z.+Cai&author=D.+Zhou&title=Therapeutically+Active+Compounds+and+Their+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKonteatis%26aufirst%3DZ.%2BD.%26atitle%3DTherapeutically%2520Active%2520Compounds%2520and%2520Their%2520Methods%2520of%2520Use%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hay, D.</span>; <span class="NLM_string-name">Mccarthy, C.</span>; <span class="NLM_string-name">Chappell, R.</span></span> <span> </span><span class="NLM_article-title">Derivatives of 2-Amino-4-(2-oxazolidinon-3-yl)-pyrimidine Fused with a Five-membered Heteroaromatic Ring in 5,6-Position Which Are Useful for the Treatment of Various Cancers</span>. <span class="NLM_patent">WO/2017140758 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=D.+Hay&author=C.+Mccarthy&author=R.+Chappell&title=Derivatives+of+2-Amino-4-%282-oxazolidinon-3-yl%29-pyrimidine+Fused+with+a+Five-membered+Heteroaromatic+Ring+in+5%2C6-Position+Which+Are+Useful+for+the+Treatment+of+Various+Cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHay%26aufirst%3DD.%26atitle%3DDerivatives%2520of%25202-Amino-4-%25282-oxazolidinon-3-yl%2529-pyrimidine%2520Fused%2520with%2520a%2520Five-membered%2520Heteroaromatic%2520Ring%2520in%25205%252C6-Position%2520Which%2520Are%2520Useful%2520for%2520the%2520Treatment%2520of%2520Various%2520Cancers%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travins, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padyana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLaBarre, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagaraja, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konteatis, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianchetta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salituro, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quivoron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opolon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saada, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broutin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Botton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marteyn, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilichowska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penard-Lacronique, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biller, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S.-S. M.</span></span> <span> </span><span class="NLM_article-title">AG-221, a first-in-class therapy targeting acute myeloid leukemia harboring oncogenic IDH2 mutations</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">478</span>– <span class="NLM_lpage">493</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-16-1034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1158%2F2159-8290.CD-16-1034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=28193778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFemurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=478-493&author=K.+Yenauthor=J.+Travinsauthor=F.+Wangauthor=M.+D.+Davidauthor=E.+Artinauthor=K.+Straleyauthor=A.+Padyanaauthor=S.+Grossauthor=B.+DeLaBarreauthor=E.+Tobinauthor=Y.+Chenauthor=R.+Nagarajaauthor=S.+Choeauthor=L.+Jinauthor=Z.+Konteatisauthor=G.+Cianchettaauthor=J.+O.+Saundersauthor=F.+G.+Salituroauthor=C.+Quivoronauthor=P.+Opolonauthor=O.+Bawaauthor=V.+Saadaauthor=A.+Paciauthor=S.+Broutinauthor=O.+A.+Bernardauthor=S.+de+Bottonauthor=B.+S.+Marteynauthor=M.+Pilichowskaauthor=Y.+Xuauthor=C.+Fangauthor=F.+Jiangauthor=W.+Weiauthor=S.+Jinauthor=L.+Silvermanauthor=W.+Liuauthor=H.+Yangauthor=L.+Dangauthor=M.+Dorschauthor=V.+Penard-Lacroniqueauthor=S.+A.+Billerauthor=S.-S.+M.+Su&title=AG-221%2C+a+first-in-class+therapy+targeting+acute+myeloid+leukemia+harboring+oncogenic+IDH2+mutations&doi=10.1158%2F2159-8290.CD-16-1034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations</span></div><div class="casAuthors">Yen, Katharine; Travins, Jeremy; Wang, Fang; David, Muriel D.; Artin, Erin; Straley, Kimberly; Padyana, Anil; Gross, Stefan; De La Barre, Byron; Tobin, Erica; Chen, Yue; Nagaraja, Raj; Choe, Sung; Jin, Lei; Konteatis, Zenon; Cianchetta, Giovanni; Saunders, Jeffrey O.; Salituro, Francesco G.; Quivoron, Cyril; Opolon, Paule; Bawa, Olivia; Saada, Veronique; Paci, Angelo; Broutin, Sophie; Bernard, Olivier A.; de Botton, Stephane; Marteyn, Benoit S.; Pilichowska, Monika; Xu, Ying Xia; Fang, Cheng; Jiang, Fan; Wei, Wentao; Jin, Shengfang; Silverman, Lee; Liu, Wei; Yang, Hua; Dang, Lenny; Dorsch, Marion; Penard-Lacronique, Virginie; Biller, Scott A.; Su, Shin-San Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">478-493</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Somatic gain-of-function mutations in isocitrate dehydrogenases (IDH) 1 and 2 are found in multiple hematol. and solid tumors, leading to accumulation of the oncometabolite (R)-2-hydroxyglutarate (2HG).  2HG competitively inhibits α-ketoglutarate-dependent dioxygenases, including histone demethylases and methylcytosine dioxygenases of the TET family, causing epigenetic dysregulation and a block in cellular differentiation.  In vitro studies have provided proof of concept for mutant IDH inhibition as a therapeutic approach.  We report the discovery and characterization of AG-221, an orally available, selective, potent inhibitor of the mutant IDH2 enzyme.  AG-221 suppressed 2HG prodn. and induced cellular differentiation in primary human IDH2 mutation-pos. acute myeloid leukemia (AML) cells ex vivo and in xenograft mouse models.  AG-221 also provided a statistically significant survival benefit in an aggressive IDH2R140Q-mutant AML xenograft mouse model.  These findings supported initiation of the ongoing clin. trials of AG-221 in patients with IDH2 mutation-pos. advanced hematol. malignancies.  Significance: Mutations in IDH1/2 are identified in approx. 20% of patients with AML and contribute to leukemia via a block in hematopoietic cell differentiation.  We have shown that the targeted inhibitor AG-221 suppresses the mutant IDH2 enzyme in multiple preclin. models and induces differentiation of malignant blasts, supporting its clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD2cujlZfayrVg90H21EOLACvtfcHk0lgGuigjx66drg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFemurY%253D&md5=b83b3d82491d02befbde03aa392a6914</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-16-1034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-16-1034%26sid%3Dliteratum%253Aachs%26aulast%3DYen%26aufirst%3DK.%26aulast%3DTravins%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DDavid%26aufirst%3DM.%2BD.%26aulast%3DArtin%26aufirst%3DE.%26aulast%3DStraley%26aufirst%3DK.%26aulast%3DPadyana%26aufirst%3DA.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DDeLaBarre%26aufirst%3DB.%26aulast%3DTobin%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DNagaraja%26aufirst%3DR.%26aulast%3DChoe%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DKonteatis%26aufirst%3DZ.%26aulast%3DCianchetta%26aufirst%3DG.%26aulast%3DSaunders%26aufirst%3DJ.%2BO.%26aulast%3DSalituro%26aufirst%3DF.%2BG.%26aulast%3DQuivoron%26aufirst%3DC.%26aulast%3DOpolon%26aufirst%3DP.%26aulast%3DBawa%26aufirst%3DO.%26aulast%3DSaada%26aufirst%3DV.%26aulast%3DPaci%26aufirst%3DA.%26aulast%3DBroutin%26aufirst%3DS.%26aulast%3DBernard%26aufirst%3DO.%2BA.%26aulast%3Dde%2BBotton%26aufirst%3DS.%26aulast%3DMarteyn%26aufirst%3DB.%2BS.%26aulast%3DPilichowska%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DFang%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DSilverman%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DDang%26aufirst%3DL.%26aulast%3DDorsch%26aufirst%3DM.%26aulast%3DPenard-Lacronique%26aufirst%3DV.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DSu%26aufirst%3DS.-S.%2BM.%26atitle%3DAG-221%252C%2520a%2520first-in-class%2520therapy%2520targeting%2520acute%2520myeloid%2520leukemia%2520harboring%2520oncogenic%2520IDH2%2520mutations%26jtitle%3DCancer%2520Discovery%26date%3D2017%26volume%3D7%26spage%3D478%26epage%3D493%26doi%3D10.1158%2F2159-8290.CD-16-1034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gusyatiner, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegi, M. E.</span></span> <span> </span><span class="NLM_article-title">Glioma epigenetics: from subclassification to novel treatment options</span>. <i>Semin. Cancer Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">1983</span>– <span class="NLM_lpage">1991</span>, <span class="refDoi"> DOI: 10.1016/j.semcancer.2017.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1016%2Fj.semcancer.2017.11.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2017&pages=1983-1991&author=O.+Gusyatinerauthor=M.+E.+Hegi&title=Glioma+epigenetics%3A+from+subclassification+to+novel+treatment+options&doi=10.1016%2Fj.semcancer.2017.11.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2017.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2017.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DGusyatiner%26aufirst%3DO.%26aulast%3DHegi%26aufirst%3DM.%2BE.%26atitle%3DGlioma%2520epigenetics%253A%2520from%2520subclassification%2520to%2520novel%2520treatment%2520options%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2017%26volume%3D96%26spage%3D1983%26epage%3D1991%26doi%3D10.1016%2Fj.semcancer.2017.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nassereddine, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lap, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haroun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabbara, I.</span></span> <span> </span><span class="NLM_article-title">The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia</span>. <i>Ann. Hematol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">1983</span>– <span class="NLM_lpage">1991</span>, <span class="refDoi"> DOI: 10.1007/s00277-017-3161-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1007%2Fs00277-017-3161-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=29090344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslCmtrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2017&pages=1983-1991&author=S.+Nassereddineauthor=C.+J.+Lapauthor=F.+Harounauthor=I.+Tabbara&title=The+role+of+mutant+IDH1+and+IDH2+inhibitors+in+the+treatment+of+acute+myeloid+leukemia&doi=10.1007%2Fs00277-017-3161-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia</span></div><div class="casAuthors">Nassereddine, Samah; Lap, Coen J.; Haroun, Faysal; Tabbara, Imad</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Hematology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1983-1991</span>CODEN:
                <span class="NLM_cas:coden">ANHEE8</span>;
        ISSN:<span class="NLM_cas:issn">0939-5555</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">For decades, researchers have looked into the pathophysiol. of acute myeloid leukemia (AML).  With the advances in mol. techniques, the two-hit hypothesis was replaced by a multi-hit model, which also emphasizes the importance of aberrant epigenetic regulation in the pathogenesis of AML.  IDH1 and IDH2 are two isoforms of isocitrate dehydrogenase that perform crucial roles in cellular metab.  Somatic mutations in either of these two genes impart a neomorphic enzymic activity upon the encoded enzymes resulting in the ability to convert α-ketoglutarate (αKG) into the oncometabolite R2-hydroxyglutarate (R2-HG), which can competitively inhibit multiple αKG-dependent dioxygenases.  Inhibition of various classes of αKG-dependent dioxygenases results in dramatic epigenetic changes in hematopoietic cells, which has been found to directly impair differentiation.  In addn. to a global dysregulation of gene expression, other mechanisms have been described through which R2-HG promotes leukemic transformation including the induction of B cell lymphoma 2 dependency and stimulation of the EglN family of prolyl 4-hydroxylases (EglN).  Due to the fact that mutations in IDH1 and IDH2 are acquired early during AML clonal evolution as well as because these mutations tend to remain stable during AML progression, the pharmaceutical industry has prompted the development of specific mutant IDH enzyme inhibitors.  More recently, the FDA approved the first mutant IDH2 inhibitor, enasidenib (AG-221), for patients with relapsed or refractory IDH2-mutated AML (RR-AML).  This has brought a lot of excitement to researchers, clinicians, and patients, esp. because the treatment of AML remains challenging and is still assocd. with a high mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0MoaTYhzKz7Vg90H21EOLACvtfcHk0lgGuigjx66drg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslCmtrrL&md5=8b84f1581f0beef64cf14e6bf9f1a7c0</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1007%2Fs00277-017-3161-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00277-017-3161-0%26sid%3Dliteratum%253Aachs%26aulast%3DNassereddine%26aufirst%3DS.%26aulast%3DLap%26aufirst%3DC.%2BJ.%26aulast%3DHaroun%26aufirst%3DF.%26aulast%3DTabbara%26aufirst%3DI.%26atitle%3DThe%2520role%2520of%2520mutant%2520IDH1%2520and%2520IDH2%2520inhibitors%2520in%2520the%2520treatment%2520of%2520acute%2520myeloid%2520leukemia%26jtitle%3DAnn.%2520Hematol.%26date%3D2017%26volume%3D96%26spage%3D1983%26epage%3D1991%26doi%3D10.1007%2Fs00277-017-3161-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tateishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koerner, M. V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lelic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankar, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batchelor, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iafrate, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cahill, D. P.</span></span> <span> </span><span class="NLM_article-title">The alkylating chemotherapeutic temozolomide induces metabolic stress in IDH1-mutant cancers and potentiates NAD<sup>+</sup> depletion-mediated cytotoxicity</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">4102</span>– <span class="NLM_lpage">4115</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-16-2263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1158%2F0008-5472.CAN-16-2263" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=4102-4115&author=K.+Tateishiauthor=F.+Higuchiauthor=J.+J.+Millerauthor=M.+V.+A.+Koernerauthor=N.+Lelicauthor=G.+M.+Shankarauthor=S.+Tanakaauthor=D.+E.+Fisherauthor=T.+T.+Batchelorauthor=A.+J.+Iafrateauthor=H.+Wakimotoauthor=A.+S.+Chiauthor=D.+P.+Cahill&title=The+alkylating+chemotherapeutic+temozolomide+induces+metabolic+stress+in+IDH1-mutant+cancers+and+potentiates+NAD%2B+depletion-mediated+cytotoxicity&doi=10.1158%2F0008-5472.CAN-16-2263"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-16-2263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-16-2263%26sid%3Dliteratum%253Aachs%26aulast%3DTateishi%26aufirst%3DK.%26aulast%3DHiguchi%26aufirst%3DF.%26aulast%3DMiller%26aufirst%3DJ.%2BJ.%26aulast%3DKoerner%26aufirst%3DM.%2BV.%2BA.%26aulast%3DLelic%26aufirst%3DN.%26aulast%3DShankar%26aufirst%3DG.%2BM.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DFisher%26aufirst%3DD.%2BE.%26aulast%3DBatchelor%26aufirst%3DT.%2BT.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26aulast%3DWakimoto%26aufirst%3DH.%26aulast%3DChi%26aufirst%3DA.%2BS.%26aulast%3DCahill%26aufirst%3DD.%2BP.%26atitle%3DThe%2520alkylating%2520chemotherapeutic%2520temozolomide%2520induces%2520metabolic%2520stress%2520in%2520IDH1-mutant%2520cancers%2520and%2520potentiates%2520NAD%252B%2520depletion-mediated%2520cytotoxicity%26jtitle%3DCancer%2520Res.%26date%3D2017%26volume%3D77%26spage%3D4102%26epage%3D4115%26doi%3D10.1158%2F0008-5472.CAN-16-2263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span> <span> </span><span class="NLM_article-title">Metabolism, activity, and targeting of D- and L-2-hydroxyglutarates</span>. <i>Trends in Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1016/j.trecan.2017.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1016%2Fj.trecan.2017.12.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=151-165&author=D.+Yeauthor=K.+L.+Guanauthor=Y.+Xiong&title=Metabolism%2C+activity%2C+and+targeting+of+D-+and+L-2-hydroxyglutarates&doi=10.1016%2Fj.trecan.2017.12.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.trecan.2017.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trecan.2017.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DD.%26aulast%3DGuan%26aufirst%3DK.%2BL.%26aulast%3DXiong%26aufirst%3DY.%26atitle%3DMetabolism%252C%2520activity%252C%2520and%2520targeting%2520of%2520D-%2520and%2520L-2-hydroxyglutarates%26jtitle%3DTrends%2520in%2520Cancer%26date%3D2018%26volume%3D4%26spage%3D151%26epage%3D165%26doi%3D10.1016%2Fj.trecan.2017.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tateishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iafrate, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loebel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lelic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiederschain, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerszten, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, J.-R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundaram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nigim, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koerner, M. V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roider, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemeny, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuels, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaherty, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batchelor, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cahill, D. P.</span></span> <span> </span><span class="NLM_article-title">Extreme vulnerability of IDH1 mutant cancers to NAD<sup>+</sup> depletion</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">773</span>– <span class="NLM_lpage">784</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2015.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1016%2Fj.ccell.2015.11.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=773-784&author=K.+Tateishiauthor=H.+Wakimotoauthor=A.+J.+Iafrateauthor=S.+Tanakaauthor=F.+Loebelauthor=N.+Lelicauthor=D.+Wiederschainauthor=O.+Bedelauthor=G.+Dengauthor=B.+Zhangauthor=T.+Heauthor=X.+Shiauthor=R.+E.+Gersztenauthor=Y.+Zhangauthor=J.-R.+J.+Yehauthor=W.+T.+Curryauthor=D.+Zhaoauthor=S.+Sundaramauthor=F.+Nigimauthor=M.+V.+A.+Koernerauthor=Q.+Hoauthor=D.+E.+Fisherauthor=E.+M.+Roiderauthor=L.+V.+Kemenyauthor=Y.+Samuelsauthor=K.+T.+Flahertyauthor=T.+T.+Batchelorauthor=A.+S.+Chiauthor=D.+P.+Cahill&title=Extreme+vulnerability+of+IDH1+mutant+cancers+to+NAD%2B+depletion&doi=10.1016%2Fj.ccell.2015.11.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2015.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2015.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DTateishi%26aufirst%3DK.%26aulast%3DWakimoto%26aufirst%3DH.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DLoebel%26aufirst%3DF.%26aulast%3DLelic%26aufirst%3DN.%26aulast%3DWiederschain%26aufirst%3DD.%26aulast%3DBedel%26aufirst%3DO.%26aulast%3DDeng%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DGerszten%26aufirst%3DR.%2BE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYeh%26aufirst%3DJ.-R.%2BJ.%26aulast%3DCurry%26aufirst%3DW.%2BT.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DSundaram%26aufirst%3DS.%26aulast%3DNigim%26aufirst%3DF.%26aulast%3DKoerner%26aufirst%3DM.%2BV.%2BA.%26aulast%3DHo%26aufirst%3DQ.%26aulast%3DFisher%26aufirst%3DD.%2BE.%26aulast%3DRoider%26aufirst%3DE.%2BM.%26aulast%3DKemeny%26aufirst%3DL.%2BV.%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DFlaherty%26aufirst%3DK.%2BT.%26aulast%3DBatchelor%26aufirst%3DT.%2BT.%26aulast%3DChi%26aufirst%3DA.%2BS.%26aulast%3DCahill%26aufirst%3DD.%2BP.%26atitle%3DExtreme%2520vulnerability%2520of%2520IDH1%2520mutant%2520cancers%2520to%2520NAD%252B%2520depletion%26jtitle%3DCancer%2520Cell%26date%3D2015%26volume%3D28%26spage%3D773%26epage%3D784%26doi%3D10.1016%2Fj.ccell.2015.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peterse, E. F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Akker, B. E. W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niessen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oosting, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suijker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danen, E. H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleton-Jansen, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bovée, J. V. M. G.</span></span> <span> </span><span class="NLM_article-title">NAD synthesis pathway interference is a viable therapeutic strategy for chondrosarcoma</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1714</span>– <span class="NLM_lpage">1721</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-17-0293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1158%2F1541-7786.MCR-17-0293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=28860121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWht73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=1714-1721&author=E.+F.+P.+Peterseauthor=B.+E.+W.+M.+van+den+Akkerauthor=B.+Niessenauthor=J.+Oostingauthor=J.+Suijkerauthor=Y.+de+Jongauthor=E.+H.+J.+Danenauthor=A.-M.+Cleton-Jansenauthor=J.+V.+M.+G.+Bov%C3%A9e&title=NAD+synthesis+pathway+interference+is+a+viable+therapeutic+strategy+for+chondrosarcoma&doi=10.1158%2F1541-7786.MCR-17-0293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">NAD Synthesis Pathway Interference Is a Viable Therapeutic Strategy for Chondrosarcoma</span></div><div class="casAuthors">Peterse, Elisabeth F. P.; van den Akker, Brendy E. W. M.; Niessen, Bertine; Oosting, Jan; Suijker, Johnny; de Jong, Yvonne; Danen, Erik H. J.; Cleton-Jansen, Anne-Marie; Bovee, Judith V. M. G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1714-1721</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (NAMPT) and nicotinic acid phosphoribosyltransferase (NAPRT) are rate-limiting enzymes in the NAD+ synthesis pathway.  Chondrosarcoma is a malignant cartilage forming bone tumor, in which mutations altering isocitrate dehydrogenase-1 and -2 (IDH1 and IDH2) activity have been identified as potential driver mutations.  Vulnerability for NAD+ depletion has been reported for IDH1/2-mutant cells.  Here, the potency of NAMPT inhibitors as a treatment of chondrosarcoma was explored.  Eleven chondrosarcoma cell lines were treated with NAMPT inhibitors, in which the effect on cell viability, colony formation, and 3D collagen invasion was assessed.  The expression level of NAMPT and NAPRT transcripts in chondrosarcoma cells was detd. by qRT-PCR.  Methylation of the NAPRT promoter was evaluated using a previously published dataset of genome-wide methylation.  In addn., a methylation dataset was used to det. methylation of the NAPRT promoter in 20 IDH1/2-mutated cartilage tumors.  Chondrosarcoma cells showed a dose-dependent decrease in cell viability, 3D collagen invasion, and colony formation upon treatment with NAMPT inhibitors, in which nearly half of the cell lines demonstrated abs. IC50s in the low nanomolar range.  Increasing IC50s correlated to increasing NAPRT expression levels and decreasing NAPRT promoter methylation.  No correlation between IDH1/2 mutation status and sensitivity for NAMPT inhibitors was obsd.  Strikingly, higher methylation of the NAPRT promoter was obsd. in high-grade vs. low-grade chondrosarcomas.  In conclusion, this study identified NAMPT as a potential target for treatment of chondrosarcoma.  Implications: Chondrosarcoma patients, esp. those of high histol. grade with lower expression and hypermethylation of NAPRT, may benefit from inhibition of the NAD synthesis pathway.  Mol Cancer Res; 15(12); 1714-21. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL556PcRo1p7Vg90H21EOLACvtfcHk0li7eoa6_LF13A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWht73E&md5=612a76e211bcbcbdbf2e0c4029744699</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-17-0293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-17-0293%26sid%3Dliteratum%253Aachs%26aulast%3DPeterse%26aufirst%3DE.%2BF.%2BP.%26aulast%3Dvan%2Bden%2BAkker%26aufirst%3DB.%2BE.%2BW.%2BM.%26aulast%3DNiessen%26aufirst%3DB.%26aulast%3DOosting%26aufirst%3DJ.%26aulast%3DSuijker%26aufirst%3DJ.%26aulast%3Dde%2BJong%26aufirst%3DY.%26aulast%3DDanen%26aufirst%3DE.%2BH.%2BJ.%26aulast%3DCleton-Jansen%26aufirst%3DA.-M.%26aulast%3DBov%25C3%25A9e%26aufirst%3DJ.%2BV.%2BM.%2BG.%26atitle%3DNAD%2520synthesis%2520pathway%2520interference%2520is%2520a%2520viable%2520therapeutic%2520strategy%2520for%2520chondrosarcoma%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2017%26volume%3D15%26spage%3D1714%26epage%3D1721%26doi%3D10.1158%2F1541-7786.MCR-17-0293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karpel-Massler, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchetti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujiuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banu, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canoll, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegelin, M. D.</span></span> <span> </span><span class="NLM_article-title">Induction of Synthetic Lethality in IDH1-Mutated Gliomas through Inhibition of Bcl-xL</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1067</span>– <span class="NLM_lpage">1080</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-00984-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1038%2Fs41467-017-00984-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=29057925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A280%3ADC%252BC1M7jt1yhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1067-1080&author=G.+Karpel-Masslerauthor=C.+T.+Ishidaauthor=E.+Bianchettiauthor=Y.+Zhangauthor=C.+Shuauthor=T.+Tsujiuchiauthor=M.+A.+Banuauthor=F.+Garciaauthor=K.+A.+Rothauthor=J.+N.+Bruceauthor=P.+Canollauthor=M.+D.+Siegelin&title=Induction+of+Synthetic+Lethality+in+IDH1-Mutated+Gliomas+through+Inhibition+of+Bcl-xL&doi=10.1038%2Fs41467-017-00984-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xL</span></div><div class="casAuthors">Karpel-Massler Georg; Ishida Chiaki Tsuge; Bianchetti Elena; Zhang Yiru; Shu Chang; Garcia Franklin; Roth Kevin A; Canoll Peter; Siegelin Markus D; Karpel-Massler Georg; Tsujiuchi Takashi; Banu Matei A; Bruce Jeffrey N</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1067</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Certain gliomas often harbor a mutation in the activity center of IDH1 (R132H), which leads to the production of the oncometabolite 2-R-2-hydroxyglutarate (2-HG).  In six model systems, including patient-derived stem cell-like glioblastoma cultures, inhibition of Bcl-xL induces significantly more apoptosis in IDH1-mutated cells than in wild-type IDH1 cells.  Anaplastic astrocytoma samples with mutated IDH1 display lower levels of Mcl-1 than IDH1 wild-type tumors and specific knockdown of Mcl-1 broadly sensitizes glioblastoma cells to Bcl-xL inhibition-mediated apoptosis.  Addition of 2-HG to glioblastoma cultures recapitulates the effects of the IDH mutation on intrinsic apoptosis, shuts down oxidative phosphorylation and reduces ATP levels in glioblastoma cells. 2-HG-mediated energy depletion activates AMPK (Threonine 172), blunting protein synthesis and mTOR signaling, culminating in a decline of Mcl-1.  In an orthotopic glioblastoma xenograft model expressing mutated IDH1, Bcl-xL inhibition leads to long-term survival.  These results demonstrate that IDH1-mutated gliomas are particularly vulnerable to Bcl-xL inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLKkCUWpX6UhFwe7cAcrfPfW6udTcc2ebYgEt1UJ-MHrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7jt1yhsw%253D%253D&md5=b4fbe4439e265d2f9b456bb1f33fc05e</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-00984-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-00984-9%26sid%3Dliteratum%253Aachs%26aulast%3DKarpel-Massler%26aufirst%3DG.%26aulast%3DIshida%26aufirst%3DC.%2BT.%26aulast%3DBianchetti%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DShu%26aufirst%3DC.%26aulast%3DTsujiuchi%26aufirst%3DT.%26aulast%3DBanu%26aufirst%3DM.%2BA.%26aulast%3DGarcia%26aufirst%3DF.%26aulast%3DRoth%26aufirst%3DK.%2BA.%26aulast%3DBruce%26aufirst%3DJ.%2BN.%26aulast%3DCanoll%26aufirst%3DP.%26aulast%3DSiegelin%26aufirst%3DM.%2BD.%26atitle%3DInduction%2520of%2520Synthetic%2520Lethality%2520in%2520IDH1-Mutated%2520Gliomas%2520through%2520Inhibition%2520of%2520Bcl-xL%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D1067%26epage%3D1080%26doi%3D10.1038%2Fs41467-017-00984-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':[],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Zhong</span>, <span class="hlFld-ContribAuthor ">Yueshan  Li</span>, <span class="hlFld-ContribAuthor ">Liang  Xiong</span>, <span class="hlFld-ContribAuthor ">Wenjing  Wang</span>, <span class="hlFld-ContribAuthor ">Ming  Wu</span>, <span class="hlFld-ContribAuthor ">Ting  Yuan</span>, <span class="hlFld-ContribAuthor ">Wei  Yang</span>, <span class="hlFld-ContribAuthor ">Chenyu  Tian</span>, <span class="hlFld-ContribAuthor ">Zhuang  Miao</span>, <span class="hlFld-ContribAuthor ">Tianqi  Wang</span>, <span class="hlFld-ContribAuthor ">Shengyong  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. </span><span class="cited-content_cbyCitation_journal-name">Signal Transduction and Targeted Therapy</span><span> <strong>2021,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41392-021-00572-w" title="DOI URL">https://doi.org/10.1038/s41392-021-00572-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41392-021-00572-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41392-021-00572-w%26sid%3Dliteratum%253Aachs%26jtitle%3DSignal%2520Transduction%2520and%2520Targeted%2520Therapy%26atitle%3DSmall%252Bmolecules%252Bin%252Btargeted%252Bcancer%252Btherapy%25253A%252Badvances%25252C%252Bchallenges%25252C%252Band%252Bfuture%252Bperspectives%26aulast%3DZhong%26aufirst%3DLei%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinxin  Che</span>, <span class="hlFld-ContribAuthor ">Feng  Huang</span>, <span class="hlFld-ContribAuthor ">Mengmeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Gaoya  Xu</span>, <span class="hlFld-ContribAuthor ">Bingxue  Qu</span>, <span class="hlFld-ContribAuthor ">Jian  Gao</span>, <span class="hlFld-ContribAuthor ">Binhui  Chen</span>, <span class="hlFld-ContribAuthor ">Jianjun  Zhang</span>, <span class="hlFld-ContribAuthor ">Huazhou  Ying</span>, <span class="hlFld-ContribAuthor ">Yongzhou  Hu</span>, <span class="hlFld-ContribAuthor ">Xiaobei  Hu</span>, <span class="hlFld-ContribAuthor ">Yubo  Zhou</span>, <span class="hlFld-ContribAuthor ">Anhui  Gao</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Xiaowu  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design, synthesis and bioactivity evaluation of macrocyclic inhibitors of mutant isocitrate dehydrogenase 2 (IDH2) displaying activity in acute myeloid leukemia cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>203 </em>, 112491. <a href="https://doi.org/10.1016/j.ejmech.2020.112491" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112491</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112491%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bdesign%25252C%252Bsynthesis%252Band%252Bbioactivity%252Bevaluation%252Bof%252Bmacrocyclic%252Binhibitors%252Bof%252Bmutant%252Bisocitrate%252Bdehydrogenase%252B2%252B%252528IDH2%252529%252Bdisplaying%252Bactivity%252Bin%252Bacute%252Bmyeloid%252Bleukemia%252Bcells%26aulast%3DChe%26aufirst%3DJinxin%26date%3D2020%26volume%3D203%26spage%3D112491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Drug Targets. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 1-96. <a href="https://doi.org/10.1002/9781119607311.ch1" title="DOI URL">https://doi.org/10.1002/9781119607311.ch1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119607311.ch1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119607311.ch1%26sid%3Dliteratum%253Aachs%26atitle%3DDrug%252BTargets%26date%3D2020%26date%3D2020%26spage%3D1%26epage%3D96%26pub%3DWiley%26atitle%3DMedicinal%252BChemistry%252Bfor%252BPractitioners%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2020%26date%3D2020%26volume%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kun  Yao</span>, <span class="hlFld-ContribAuthor ">Haipeng  Liu</span>, <span class="hlFld-ContribAuthor ">Pengyu  Liu</span>, <span class="hlFld-ContribAuthor ">Wenbin  Liu</span>, <span class="hlFld-ContribAuthor ">Jie  Yang</span>, <span class="hlFld-ContribAuthor ">Qingyun  Wei</span>, <span class="hlFld-ContribAuthor ">Peng  Cao</span>, <span class="hlFld-ContribAuthor ">Yisheng  Lai</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular modeling studies to discover novel mIDH2 inhibitors with high selectivity for the primary and secondary mutants. </span><span class="cited-content_cbyCitation_journal-name">Computational Biology and Chemistry</span><span> <strong>2020,</strong> <em>86 </em>, 107261. <a href="https://doi.org/10.1016/j.compbiolchem.2020.107261" title="DOI URL">https://doi.org/10.1016/j.compbiolchem.2020.107261</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiolchem.2020.107261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiolchem.2020.107261%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Biology%2520and%2520Chemistry%26atitle%3DMolecular%252Bmodeling%252Bstudies%252Bto%252Bdiscover%252Bnovel%252BmIDH2%252Binhibitors%252Bwith%252Bhigh%252Bselectivity%252Bfor%252Bthe%252Bprimary%252Band%252Bsecondary%252Bmutants%26aulast%3DYao%26aufirst%3DKun%26date%3D2020%26volume%3D86%26spage%3D107261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David B.  Altshuler</span>, <span class="hlFld-ContribAuthor ">Padma  Kadiyala</span>, <span class="hlFld-ContribAuthor ">Felipe J.  Nuñez</span>, <span class="hlFld-ContribAuthor ">Fernando M.  Nuñez</span>, <span class="hlFld-ContribAuthor ">Stephen  Carney</span>, <span class="hlFld-ContribAuthor ">Mahmoud S.  Alghamri</span>, <span class="hlFld-ContribAuthor ">Maria B.  Garcia-Fabiani</span>, <span class="hlFld-ContribAuthor ">Antonela S.  Asad</span>, <span class="hlFld-ContribAuthor ">Alejandro J.  Nicola Candia</span>, <span class="hlFld-ContribAuthor ">Marianela  Candolfi</span>, <span class="hlFld-ContribAuthor ">Joerg  Lahann</span>, <span class="hlFld-ContribAuthor ">James J.  Moon</span>, <span class="hlFld-ContribAuthor ">Anna  Schwendeman</span>, <span class="hlFld-ContribAuthor ">Pedro R.  Lowenstein</span>, <span class="hlFld-ContribAuthor ">Maria G.  Castro</span>. </span><span class="cited-content_cbyCitation_article-title">Prospects of biological and synthetic pharmacotherapies for glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Biological Therapy</span><span> <strong>2020,</strong> <em>20 </em>
                                    (3)
                                     , 305-317. <a href="https://doi.org/10.1080/14712598.2020.1713085" title="DOI URL">https://doi.org/10.1080/14712598.2020.1713085</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14712598.2020.1713085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14712598.2020.1713085%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Biological%2520Therapy%26atitle%3DProspects%252Bof%252Bbiological%252Band%252Bsynthetic%252Bpharmacotherapies%252Bfor%252Bglioblastoma%26aulast%3DAltshuler%26aufirst%3DDavid%2BB.%26date%3D2020%26date%3D2020%26volume%3D20%26issue%3D3%26spage%3D305%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaoyong  Lu</span>, <span class="hlFld-ContribAuthor ">Yuran  Qiu</span>, <span class="hlFld-ContribAuthor ">Duan  Ni</span>, <span class="hlFld-ContribAuthor ">Xinheng  He</span>, <span class="hlFld-ContribAuthor ">Jun  Pu</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Emergence of allosteric drug-resistance mutations: new challenges for allosteric drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2020,</strong> <em>25 </em>
                                    (1)
                                     , 177-184. <a href="https://doi.org/10.1016/j.drudis.2019.10.006" title="DOI URL">https://doi.org/10.1016/j.drudis.2019.10.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2019.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2019.10.006%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DEmergence%252Bof%252Ballosteric%252Bdrug-resistance%252Bmutations%25253A%252Bnew%252Bchallenges%252Bfor%252Ballosteric%252Bdrug%252Bdiscovery%26aulast%3DLu%26aufirst%3DShaoyong%26date%3D2020%26volume%3D25%26issue%3D1%26spage%3D177%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Panli  Jia</span>, <span class="hlFld-ContribAuthor ">Yao  Wu</span>, <span class="hlFld-ContribAuthor ">Hongzhi  Du</span>, <span class="hlFld-ContribAuthor ">Lijun  Yang</span>, <span class="hlFld-ContribAuthor ">Zhibo  Zhang</span>, <span class="hlFld-ContribAuthor ">Tianfang  Ma</span>, <span class="hlFld-ContribAuthor ">Sun  Li</span>, <span class="hlFld-ContribAuthor ">Shengtao  Yuan</span>, <span class="hlFld-ContribAuthor ">Ligong  Lu</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Zha</span>. </span><span class="cited-content_cbyCitation_article-title">I-8, a novel inhibitor of mutant IDH1, inhibits cancer progression in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2019,</strong> <em>140 </em>, 105072. <a href="https://doi.org/10.1016/j.ejps.2019.105072" title="DOI URL">https://doi.org/10.1016/j.ejps.2019.105072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2019.105072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2019.105072%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DI-8%25252C%252Ba%252Bnovel%252Binhibitor%252Bof%252Bmutant%252BIDH1%25252C%252Binhibits%252Bcancer%252Bprogression%252Bin%252Bvitro%252Band%252Bin%252Bvivo%26aulast%3DJia%26aufirst%3DPanli%26date%3D2019%26volume%3D140%26spage%3D105072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kun  Yao</span>, <span class="hlFld-ContribAuthor ">Pengyu  Liu</span>, <span class="hlFld-ContribAuthor ">Haipeng  Liu</span>, <span class="hlFld-ContribAuthor ">Qingyun  Wei</span>, <span class="hlFld-ContribAuthor ">Jie  Yang</span>, <span class="hlFld-ContribAuthor ">Peng  Cao</span>, <span class="hlFld-ContribAuthor ">Yisheng  Lai</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR, molecular docking and molecular dynamics simulations study of 3-pyrimidin-4-yl-oxazolidin-2-one derivatives to explore the structure requirements of mutant IDH1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2019,</strong> <em>1189 </em>, 187-202. <a href="https://doi.org/10.1016/j.molstruc.2019.03.092" title="DOI URL">https://doi.org/10.1016/j.molstruc.2019.03.092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2019.03.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2019.03.092%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3D3D-QSAR%25252C%252Bmolecular%252Bdocking%252Band%252Bmolecular%252Bdynamics%252Bsimulations%252Bstudy%252Bof%252B3-pyrimidin-4-yl-oxazolidin-2-one%252Bderivatives%252Bto%252Bexplore%252Bthe%252Bstructure%252Brequirements%252Bof%252Bmutant%252BIDH1%252Binhibitors%26aulast%3DYao%26aufirst%3DKun%26date%3D2019%26volume%3D1189%26spage%3D187%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William P  Katt</span>, <span class="hlFld-ContribAuthor ">Richard A  Cerione</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of cancer metabolism: a patent landscape. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Patent Analyst</span><span> <strong>2019,</strong> <em>8 </em>
                                    (4)
                                     , 117-138. <a href="https://doi.org/10.4155/ppa-2019-0012" title="DOI URL">https://doi.org/10.4155/ppa-2019-0012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/ppa-2019-0012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fppa-2019-0012%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Patent%2520Analyst%26atitle%3DInhibition%252Bof%252Bcancer%252Bmetabolism%25253A%252Ba%252Bpatent%252Blandscape%26aulast%3DKatt%26aufirst%3DWilliam%2BP%26date%3D2019%26volume%3D8%26issue%3D4%26spage%3D117%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bozena  Kaminska</span>, <span class="hlFld-ContribAuthor ">Bartosz  Czapski</span>, <span class="hlFld-ContribAuthor ">Rafal  Guzik</span>, <span class="hlFld-ContribAuthor ">Sylwia  Król</span>, <span class="hlFld-ContribAuthor ">Bartlomiej  Gielniewski</span>. </span><span class="cited-content_cbyCitation_article-title">Consequences of IDH1/2 Mutations in Gliomas and an Assessment of Inhibitors Targeting Mutated IDH Proteins. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (5)
                                     , 968. <a href="https://doi.org/10.3390/molecules24050968" title="DOI URL">https://doi.org/10.3390/molecules24050968</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24050968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24050968%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DConsequences%252Bof%252BIDH1%25252F2%252BMutations%252Bin%252BGliomas%252Band%252Ban%252BAssessment%252Bof%252BInhibitors%252BTargeting%252BMutated%252BIDH%252BProteins%26aulast%3DKaminska%26aufirst%3DBozena%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D5%26spage%3D968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0035.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Functions of normal and mutated IDH.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures of compounds <b>1</b>–<b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Chemical structures of compounds <b>4</b>–<b>9</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Chemical structure of compound <b>10</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Chemical structures of compounds <b>11</b>–<b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Chemical structures of compounds <b>14</b> and <b>15</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Chemical structures of compounds <b>16</b>–<b>18</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. X-ray crystal structure of IDH1 R132H and <b>16</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I3L">4I3L</a>). The yellow dotted lines represent hydrogen bonds interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Chemical structures of compounds <b>19</b>–<b>23</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Chemical structures of compounds <b>24</b>–<b>26</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Chemical structures of compounds <b>27</b>–<b>31</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Chemical structure of compound <b>32</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Chemical structure of compound <b>33</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Chemical structures of compounds <b>34</b>–<b>38</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Chemical structures of compounds <b>39</b>–<b>47</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Chemical structures of compounds <b>48</b>–<b>53</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Chemical structures of compounds <b>55</b>–<b>57</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Chemical structures of compounds <b>58</b>–<b>61</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Chemical structure of compound <b>62</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Chemical structures of compounds <b>63</b>–<b>66</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0021.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Chemical structures of compounds <b>67</b> and <b>68</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0022.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Chemical structures of compounds <b>69</b> and <b>70</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0023.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Chemical structures of compounds <b>71</b>–<b>73</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0024.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Chemical structures of compounds <b>74</b>–<b>77</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0025.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Chemical structure of compound <b>78</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0026.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Chemical structures of compounds <b>79</b>–<b>84</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0027.jpeg" id="rightTab-gr27" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Chemical structures of compounds <b>85</b> and <b>86</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0028.jpeg" id="rightTab-gr28" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Chemical structures of compounds <b>87</b>–<b>90</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0029.jpeg" id="rightTab-gr29" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Chemical structures of compounds <b>91</b>–<b>96</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig30" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0030.jpeg" id="rightTab-gr30" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Chemical structure of compound <b>97</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig31" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0031.jpeg" id="rightTab-gr31" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. Chemical structures of compounds <b>98</b>–<b>102</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig32" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Figure 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0032.jpeg" id="rightTab-gr32" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 32. Chemical structures of compounds <b>103</b>–<b>106</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig32"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig33" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Figure 33</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0033.jpeg" id="rightTab-gr33" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 33. The mIDH1 active sites are depicted in purple, red, blue, green, and yellow. Around the active sites, different inhibitors (SYC-435 (<b>16</b>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I3L">4I3L</a>), VVS (<b>24</b>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UMX">4UMX</a>), GSK321 (<b>14</b>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5DE1">5DE1</a>), IDH889 (<b>29</b>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TQH">5TQH</a>), IDH146 and <b>26</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L57">5L57</a>)) are shown and color-coded by their corresponding binding sites. The specific drug–target interactions between these inhibitors and mIDH1 are shown below, in which the green solid lines represent the π–π interactions and the yellow dotted lines represent the hydrogen bond interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig33"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig34" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Figure 34</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/medium/jm-2018-00159t_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0034.jpeg" id="rightTab-gr34" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 34. An allosteric site in IDH2 R140Q is depicted in the purple circle. Around it, two mIDH2 inhibitors AGI-6780 (<b>78</b>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JA8">4JA8</a>) and AG-221 (<b>79</b>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5I96">5I96</a>) are shown. The specific drug–target interactions between these inhibitors and mIDH1 are shown below, in which the yellow dotted lines represent the hydrogen bond interactions and the green dotted lines represent the halogen bond interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00159/20181019/images/large/jm-2018-00159t_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00159&amp;id=fig34"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i63">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54417" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54417" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 123 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reitman, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span> <span> </span><span class="NLM_article-title">Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism</span>. <i>J. Natl. Cancer. Inst</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">932</span>– <span class="NLM_lpage">941</span>, <span class="refDoi"> DOI: 10.1093/jnci/djq187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1093%2Fjnci%2Fdjq187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=20513808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptlegs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2010&pages=932-941&author=Z.+J.+Reitmanauthor=H.+Yan&title=Isocitrate+dehydrogenase+1+and+2+mutations+in+cancer%3A+alterations+at+a+crossroads+of+cellular+metabolism&doi=10.1093%2Fjnci%2Fdjq187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Isocitrate Dehydrogenase 1 and 2 Mutations in Cancer: Alterations at a Crossroads of Cellular Metabolism</span></div><div class="casAuthors">Reitman, Zachary J.; Yan, Hai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">932-941</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Dysregulation of metab. is a common phenomenon in cancer cells.  The NADP+-dependent isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) function at a crossroads of cellular metab. in lipid synthesis, cellular defense against oxidative stress, oxidative respiration, and oxygen-sensing signal transduction.  We review the normal functions of the encoded enzymes, frequent mutations of IDH1 and IDH2 recently found in human cancers, and possible roles for the mutated enzymes in human disease.  IDH1 and IDH2 mutations occur frequently in some types of World Health Organization grades 2-4 gliomas and in acute myeloid leukemias with normal karyotype.  IDH1 and IDH2 mutations are remarkably specific to codons that encode conserved functionally important arginines in the active site of each enzyme.  To date, all IDH1 mutations have been identified at the Arg132 codon.  Mutations in IDH2 have been identified at the Arg140 codon, as well as at Arg172, which is aligned with IDH1 Arg132.  IDH1 and IDH2 mutations are usually heterozygous in cancer, and they appear to confer a neomorphic enzyme activity for the enzymes to catalyze the prodn. of D-2-hydroxyglutarate.  Study of alterations in these metabolic enzymes may provide insights into the metab. of cancer cells and uncover novel avenues for development of anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaDJbCVLIvebVg90H21EOLACvtfcHk0ljHqwaTcoqdfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptlegs7c%253D&md5=09b5d48e9c10d5e103f73b4a74e0327b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjq187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjq187%26sid%3Dliteratum%253Aachs%26aulast%3DReitman%26aufirst%3DZ.%2BJ.%26aulast%3DYan%26aufirst%3DH.%26atitle%3DIsocitrate%2520dehydrogenase%25201%2520and%25202%2520mutations%2520in%2520cancer%253A%2520alterations%2520at%2520a%2520crossroads%2520of%2520cellular%2520metabolism%26jtitle%3DJ.%2520Natl.%2520Cancer.%2520Inst%26date%3D2010%26volume%3D102%26spage%3D932%26epage%3D941%26doi%3D10.1093%2Fjnci%2Fdjq187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attar, E. C.</span></span> <span> </span><span class="NLM_article-title">IDH mutations in cancer and progress toward development of targeted therapeutics</span>. <i>Ann. Oncol</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1093/annonc/mdw013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1093%2Fannonc%2Fmdw013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=27005468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A280%3ADC%252BC28fjtFGntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=599-608&author=L.+Dangauthor=K.+Yenauthor=E.+C.+Attar&title=IDH+mutations+in+cancer+and+progress+toward+development+of+targeted+therapeutics&doi=10.1093%2Fannonc%2Fmdw013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">IDH mutations in cancer and progress toward development of targeted therapeutics</span></div><div class="casAuthors">Dang L; Yen K; Attar E C</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">599-608</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) are key metabolic enzymes, converting isocitrate to α-ketoglutarate (αKG).IDH1 and IDH2 mutations have been identified in multiple tumor types, including gliomas and myeloid malignancies such as acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).  Here we provide an overview of the function of normal and mutated IDH, discuss the role of IDH mutations in tumorigenesis and progression and review the key clinical considerations when treating IDH-mutated tumors based on emerging clinical data from mutant IDH1/2 inhibitor trials.  IDH1 and IDH2 mutations confer neomorphic activity in the mutant protein, resulting in the conversion of αKG to the oncometabolite, D-2-hydroxyglutarate (2-HG).  The subsequent accumulation of 2-HG results in epigenetic dysregulation via inhibition of αKG-dependent histone and DNA demethylases, and a block in cellular differentiation.  There is growing preclinical and clinical evidence suggesting that IDHmutations are involved in neoplasia.  Furthermore, preclinical studies assessing small molecule inhibitors of mutant IDH1/2 enzymes have provided proof of concept that this approach decreases intracellular 2-HG levels, reverses epigenetic dysregulation and induces cellular differentiation.  Phase I studies of mutant IDH inhibitors are currently ongoing in patients with IDH-mutant hematologic and solid tumors, with early data in hematologic tumors suggesting a manageable safety profile as well as clinical benefit, with a mechanism of action based on differentiation of malignant cells.  Inhibition of mutant IDH shows promise as a treatment approach in hematologic malignancies, with further development ongoing in solid tumors and glioma.  The mutant IDH inhibitors may have clinical utility both as single agents and in combination strategies that target additional oncogenic pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5w5RykA08B0HdcurJClFcfW6udTcc2eZWqz_wGZHIa7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fjtFGntg%253D%253D&md5=676354660c8d5ff27487d50b1ba80218</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdw013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdw013%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DL.%26aulast%3DYen%26aufirst%3DK.%26aulast%3DAttar%26aufirst%3DE.%2BC.%26atitle%3DIDH%2520mutations%2520in%2520cancer%2520and%2520progress%2520toward%2520development%2520of%2520targeted%2520therapeutics%26jtitle%3DAnn.%2520Oncol%26date%3D2016%26volume%3D27%26spage%3D599%26epage%3D608%26doi%3D10.1093%2Fannonc%2Fmdw013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span> <span> </span><span class="NLM_article-title">IDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectives</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">5562</span>– <span class="NLM_lpage">5571</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-1773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1158%2F1078-0432.CCR-12-1773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=23071358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFahu73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=5562-5571&author=H.+Yangauthor=D.+Yeauthor=K.+L.+Guanauthor=Y.+Xiong&title=IDH1+and+IDH2+mutations+in+tumorigenesis%3A+mechanistic+insights+and+clinical+perspectives&doi=10.1158%2F1078-0432.CCR-12-1773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">IDH1 and IDH2 Mutations in Tumorigenesis: Mechanistic Insights and Clinical Perspectives</span></div><div class="casAuthors">Yang, Hui; Ye, Dan; Guan, Kun-Liang; Xiong, Yue</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5562-5571</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Genes encoding for isocitrate dehydrogenases 1 and 2, IDH1 and IDH2, are frequently mutated in multiple types of human cancer.  Mutations targeting IDH1 and IDH2 result in simultaneous loss of their normal catalytic activity, the prodn. of α-ketoglutarate (α-KG), and gain of a new function, the prodn. of 2-hydroxyglutarate (2-HG). 2-HG is structurally similar to α-KG, and acts as an α-KG antagonist to competitively inhibit multiple α-KG-dependent dioxygenases, including both lysine histone demethylases and the ten-eleven translocation family of DNA hydroxylases.  Abnormal histone and DNA methylation are emerging as a common feature of tumors with IDH1 and IDH2 mutations and may cause altered stem cell differentiation and eventual tumorigenesis.  Therapeutically, unique features of IDH1 and IDH2 mutations make them good biomarkers and potential drug targets.  Clin Cancer Res; 18(20); 5562-71. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLxU4GOoxoYLVg90H21EOLACvtfcHk0ljoVxrKd1vDvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFahu73E&md5=248a8579316f9942e684669e6cedb594</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-1773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-1773%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DYe%26aufirst%3DD.%26aulast%3DGuan%26aufirst%3DK.%2BL.%26aulast%3DXiong%26aufirst%3DY.%26atitle%3DIDH1%2520and%2520IDH2%2520mutations%2520in%2520tumorigenesis%253A%2520mechanistic%2520insights%2520and%2520clinical%2520perspectives%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D5562%26epage%3D5571%26doi%3D10.1158%2F1078-0432.CCR-12-1773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Voelxen, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walenta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proescholdt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dettmer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pusch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller-Klieser, W.</span></span> <span> </span><span class="NLM_article-title">Quantitative imaging of D-2-hydroxyglutarate in selected histological tissue areas by a novel bioluminescence technique</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.3389/fonc.2016.00046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.3389%2Ffonc.2016.00046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=27014623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A280%3ADC%252BC28fjvFKksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=46-46&author=N.+F.+Voelxenauthor=S.+Walentaauthor=M.+Proescholdtauthor=K.+Dettmerauthor=S.+Puschauthor=W.+Mueller-Klieser&title=Quantitative+imaging+of+D-2-hydroxyglutarate+in+selected+histological+tissue+areas+by+a+novel+bioluminescence+technique&doi=10.3389%2Ffonc.2016.00046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative Imaging of D-2-Hydroxyglutarate in Selected Histological Tissue Areas by a Novel Bioluminescence Technique</span></div><div class="casAuthors">Voelxen Nadine F; Walenta Stefan; Mueller-Klieser Wolfgang; Proescholdt Martin; Dettmer Katja; Pusch Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">46</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">Patients with malignant gliomas have a poor prognosis with average survival of less than 1 year.  Whereas in other tumor entities the characteristics of tumor metabolism are successfully used for therapeutic approaches, such developments are very rare in brain tumors, notably in gliomas.  One metabolic feature characteristic of gliomas, in particular diffuse astrocytomas and oligodendroglial tumors, is the variable content of D-2-hydroxyglutarate (D2HG), a metabolite that was discovered first in this tumor entity.  D2HG is generated in large amounts due to various "gain-of-function" mutations in the isocitrate dehydrogenases IDH1 and IDH2.  Meanwhile, D2HG has been detected in several other tumor entities, including intrahepatic bile-duct cancer, chondrosarcoma, acute myeloid leukemia, and angioimmunoblastic T-cell lymphoma.  D2HG is barely detectable in healthy tissue (<0.1 mM), but its concentration increases up to 35 mM in malignant tumor tissues.  Consequently, the "oncometabolite" D2HG has gained increasing interest in the field of tumor metabolism.  To facilitate its quantitative measurement without loss of spatial resolution at a microscopical level, we have developed a novel bioluminescence assay for determining D2HG in sections of snap-frozen tissue.  The assay was verified independently by photometric tests and liquid chromatography/mass spectrometry.  The novel technique allows the microscopically resolved determination of D2HG in a concentration range of 0-10 μmol/g tissue (wet weight).  In combination with the already established bioluminescence imaging techniques for ATP, glucose, pyruvate, and lactate, the novel D2HG assay enables a comparative characterization of the metabolic profile of individual tumors in a further dimension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT704covJK7BCXXDYhVZBdlfW6udTcc2eZZo29wB-NLRbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fjvFKksQ%253D%253D&md5=dcd74cbcdc3a502b1b5d9a0fa44e6686</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2016.00046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2016.00046%26sid%3Dliteratum%253Aachs%26aulast%3DVoelxen%26aufirst%3DN.%2BF.%26aulast%3DWalenta%26aufirst%3DS.%26aulast%3DProescholdt%26aufirst%3DM.%26aulast%3DDettmer%26aufirst%3DK.%26aulast%3DPusch%26aufirst%3DS.%26aulast%3DMueller-Klieser%26aufirst%3DW.%26atitle%3DQuantitative%2520imaging%2520of%2520D-2-hydroxyglutarate%2520in%2520selected%2520histological%2520tissue%2520areas%2520by%2520a%2520novel%2520bioluminescence%2520technique%26jtitle%3DFront.%2520Oncol.%26date%3D2016%26volume%3D6%26spage%3D46%26epage%3D46%26doi%3D10.3389%2Ffonc.2016.00046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knobbe, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itsumi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elia, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chio, I. I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairns, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCracken, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakeham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haight, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ten, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snow, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2038</span>– <span class="NLM_lpage">2049</span>, <span class="refDoi"> DOI: 10.1101/gad.198200.112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1101%2Fgad.198200.112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=2038-2049&author=M.+Sasakiauthor=C.+B.+Knobbeauthor=M.+Itsumiauthor=A.+J.+Eliaauthor=I.+S.+Harrisauthor=I.+I.+C.+Chioauthor=R.+A.+Cairnsauthor=S.+McCrackenauthor=A.+Wakehamauthor=J.+Haightauthor=A.+Y.+Tenauthor=B.+Snowauthor=T.+Uedaauthor=S.+Inoueauthor=K.+Yamamotoauthor=M.+Koauthor=A.+Raoauthor=K.+E.+Yenauthor=S.+M.+Suauthor=T.+W.+Mak&title=D-2-hydroxyglutarate+produced+by+mutant+IDH1+perturbs+collagen+maturation+and+basement+membrane+function&doi=10.1101%2Fgad.198200.112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1101%2Fgad.198200.112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.198200.112%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DKnobbe%26aufirst%3DC.%2BB.%26aulast%3DItsumi%26aufirst%3DM.%26aulast%3DElia%26aufirst%3DA.%2BJ.%26aulast%3DHarris%26aufirst%3DI.%2BS.%26aulast%3DChio%26aufirst%3DI.%2BI.%2BC.%26aulast%3DCairns%26aufirst%3DR.%2BA.%26aulast%3DMcCracken%26aufirst%3DS.%26aulast%3DWakeham%26aufirst%3DA.%26aulast%3DHaight%26aufirst%3DJ.%26aulast%3DTen%26aufirst%3DA.%2BY.%26aulast%3DSnow%26aufirst%3DB.%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DS.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DKo%26aufirst%3DM.%26aulast%3DRao%26aufirst%3DA.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DSu%26aufirst%3DS.%2BM.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DD-2-hydroxyglutarate%2520produced%2520by%2520mutant%2520IDH1%2520perturbs%2520collagen%2520maturation%2520and%2520basement%2520membrane%2520function%26jtitle%3DGenes%2520Dev.%26date%3D2012%26volume%3D26%26spage%3D2038%26epage%3D2049%26doi%3D10.1101%2Fgad.198200.112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellinghoff, I. K.</span></span> <span> </span><span class="NLM_article-title">Molecular pathways: isocitrate dehydrogenase mutations in cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1837</span>– <span class="NLM_lpage">1842</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-1333</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1158%2F1078-0432.CCR-13-1333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=26819452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsFeqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=1837-1842&author=O.+Clarkauthor=K.+Yenauthor=I.+K.+Mellinghoff&title=Molecular+pathways%3A+isocitrate+dehydrogenase+mutations+in+cancer&doi=10.1158%2F1078-0432.CCR-13-1333"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Pathways: Isocitrate Dehydrogenase Mutations in Cancer</span></div><div class="casAuthors">Clark, Owen; Yen, Katharine; Mellinghoff, Ingo K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1837-1842</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">IDH1 and IDH2 are homodimeric enzymes that catalyze the conversion of isocitrate to α-ketoglutarate (α-KG) and concomitantly produce reduced NADPH from NADP+.  Mutations in the genes encoding IDH1 and IDH2 have recently been found in a variety of human cancers, most commonly glioma, acute myeloid leukemia (AML), chondrosarcoma, and intrahepatic cholangiocarcinoma.  The mutant protein loses its normal enzymic activity and gains a new ability to produce the "oncometabolite" R(-)-2-hydroxyglutarate (R-2-HG).  R-2-HG competitively inhibits α-KG-dependent enzymes which play crucial roles in gene regulation and tissue homeostasis.  Expression of mutant IDH impairs cellular differentiation in various cell lineages and promotes tumor development in cooperation with other cancer genes.  First-generation inhibitors of mutant IDH have entered clin. trials, and have shown encouraging results in patients with IDH-mutant AML.  This article summarizes recent progress in our understanding of the role of mutant IDH in tumorigenesis.  Clin Cancer Res; 22(8); 1837-42. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRe25vsB2yx7Vg90H21EOLACvtfcHk0ljoVxrKd1vDvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsFeqsrg%253D&md5=ba94ff8b176c87efe75df99646c13564</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-1333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-1333%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DO.%26aulast%3DYen%26aufirst%3DK.%26aulast%3DMellinghoff%26aufirst%3DI.%2BK.%26atitle%3DMolecular%2520pathways%253A%2520isocitrate%2520dehydrogenase%2520mutations%2520in%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2016%26volume%3D22%26spage%3D1837%26epage%3D1842%26doi%3D10.1158%2F1078-0432.CCR-13-1333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, P.</span></span> <span> </span><span class="NLM_article-title">The evolving landscape in the development of isocitrate dehydrogenase mutant inhibitors,</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1344</span>– <span class="NLM_lpage">1358</span>, <span class="refDoi"> DOI: 10.2174/1389557516666160609085520</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.2174%2F1389557516666160609085520" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=1344-1358&author=J.+Chenauthor=J.+Yangauthor=P.+Cao&title=The+evolving+landscape+in+the+development+of+isocitrate+dehydrogenase+mutant+inhibitors%2C&doi=10.2174%2F1389557516666160609085520"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F1389557516666160609085520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557516666160609085520%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DP.%26atitle%3DThe%2520evolving%2520landscape%2520in%2520the%2520development%2520of%2520isocitrate%2520dehydrogenase%2520mutant%2520inhibitors%252C%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D1344%26epage%3D1358%26doi%3D10.2174%2F1389557516666160609085520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pusch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahm, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mittelbronn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Deimling, A.</span></span> <span> </span><span class="NLM_article-title">Scientific correspondence</span>. <i>Neuropathol. Appl. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">430</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2990.2010.01127.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1111%2Fj.1365-2990.2010.01127.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=20874727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3MXot1Cqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2011&pages=428-430&author=S.+Puschauthor=F.+Sahmauthor=J.+Meyerauthor=M.+Mittelbronnauthor=C.+Hartmannauthor=A.+von+Deimling&title=Scientific+correspondence&doi=10.1111%2Fj.1365-2990.2010.01127.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Glioma IDH1 mutation patterns off the beaten track</span></div><div class="casAuthors">Pusch, S.; Sahm, F.; Meyer, J.; Mittelbronn, M.; Hartmann, C.; von Deimling, A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropathology and Applied Neurobiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">428-430</span>CODEN:
                <span class="NLM_cas:coden">NANEDL</span>;
        ISSN:<span class="NLM_cas:issn">0305-1846</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Up to now, IDH1 mutations were described in gliomas only affecting codon 132, however, three cases of a predicted, but so far never described mutation in codon 100 of IDH1 in gliomas, IDH1R100-Q, have been identified, affecting two anaplastic oligodendrogliomas WHO grade III and an astrocytoma WHO grade II.  The IDH1R100-Q mutation demonstrates that substitution of either one of the two homolog arginines by certain other amino acids lead to the same gain of function in both proteins.  Interestingly, the third conserved arginine, which is also involved in substrate binding, has never been reported to be mutated.  To obtain insights into the potential mechanism that leads to a focal loss of an IDH1 mutation in the sGBM sample, five flanking microsatellite markers (D2S322, D2S2274, D2S2208, D2S2242, and D2S2321, were analyzed in both portions.  It was obsd. in the tumor area without IDH1 mutation in all informative markers a loss of heterozygosity compared with the tumor portions with IDH1 mutation.  The observation of this sGBM with focal loss of the mutated IDH1 allele implies that is malignant gliomas other mutations may substitute for the role of mutated IDH1 protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSh1o8xTv6srVg90H21EOLACvtfcHk0lgBxAM40OAyzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXot1Cqsr8%253D&md5=adb89e895671e4a2309c07ce8286c6d5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2990.2010.01127.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2990.2010.01127.x%26sid%3Dliteratum%253Aachs%26aulast%3DPusch%26aufirst%3DS.%26aulast%3DSahm%26aufirst%3DF.%26aulast%3DMeyer%26aufirst%3DJ.%26aulast%3DMittelbronn%26aufirst%3DM.%26aulast%3DHartmann%26aufirst%3DC.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26atitle%3DScientific%2520correspondence%26jtitle%3DNeuropathol.%2520Appl.%2520Neurobiol.%26date%3D2011%26volume%3D37%26spage%3D428%26epage%3D430%26doi%3D10.1111%2Fj.1365-2990.2010.01127.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capper, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christians, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felsberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mawrin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wick, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold-Mende, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unterberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeuken, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesseling, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reifenberger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Deimling, A.</span></span> <span> </span><span class="NLM_article-title">Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1010 diffuse gliomas</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">469</span>– <span class="NLM_lpage">474</span>, <span class="refDoi"> DOI: 10.1007/s00401-009-0561-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1007%2Fs00401-009-0561-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2009&pages=469-474&author=C.+Hartmannauthor=J.+Meyerauthor=J.+Balssauthor=D.+Capperauthor=W.+Muellerauthor=A.+Christiansauthor=J.+Felsbergauthor=M.+Wolterauthor=C.+Mawrinauthor=W.+Wickauthor=M.+Wellerauthor=C.+Herold-Mendeauthor=A.+Unterbergauthor=J.+W.+Jeukenauthor=P.+Wesselingauthor=G.+Reifenbergerauthor=A.+von+Deimling&title=Type+and+frequency+of+IDH1+and+IDH2+mutations+are+related+to+astrocytic+and+oligodendroglial+differentiation+and+age%3A+a+study+of+1010+diffuse+gliomas&doi=10.1007%2Fs00401-009-0561-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs00401-009-0561-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-009-0561-9%26sid%3Dliteratum%253Aachs%26aulast%3DHartmann%26aufirst%3DC.%26aulast%3DMeyer%26aufirst%3DJ.%26aulast%3DBalss%26aufirst%3DJ.%26aulast%3DCapper%26aufirst%3DD.%26aulast%3DMueller%26aufirst%3DW.%26aulast%3DChristians%26aufirst%3DA.%26aulast%3DFelsberg%26aufirst%3DJ.%26aulast%3DWolter%26aufirst%3DM.%26aulast%3DMawrin%26aufirst%3DC.%26aulast%3DWick%26aufirst%3DW.%26aulast%3DWeller%26aufirst%3DM.%26aulast%3DHerold-Mende%26aufirst%3DC.%26aulast%3DUnterberg%26aufirst%3DA.%26aulast%3DJeuken%26aufirst%3DJ.%2BW.%26aulast%3DWesseling%26aufirst%3DP.%26aulast%3DReifenberger%26aufirst%3DG.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26atitle%3DType%2520and%2520frequency%2520of%2520IDH1%2520and%2520IDH2%2520mutations%2520are%2520related%2520to%2520astrocytic%2520and%2520oligodendroglial%2520differentiation%2520and%2520age%253A%2520a%2520study%2520of%25201010%2520diffuse%2520gliomas%26jtitle%3DActa%2520Neuropathol.%26date%3D2009%26volume%3D118%26spage%3D469%26epage%3D474%26doi%3D10.1007%2Fs00401-009-0561-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paschka, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlenk, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaidzik, V. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habdank, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krönke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bullinger, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Späth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zucknick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Götze, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horst, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germing, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Döhner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Döhner, K.</span></span> <span> </span><span class="NLM_article-title">IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3636</span>– <span class="NLM_lpage">3643</span>, <span class="refDoi"> DOI: 10.1200/JCO.2010.28.3762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1200%2FJCO.2010.28.3762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=20567020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSksb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=3636-3643&author=P.+Paschkaauthor=R.+F.+Schlenkauthor=V.+I.+Gaidzikauthor=M.+Habdankauthor=J.+Kr%C3%B6nkeauthor=L.+Bullingerauthor=D.+Sp%C3%A4thauthor=S.+Kayserauthor=M.+Zucknickauthor=K.+G%C3%B6tzeauthor=H.+A.+Horstauthor=U.+Germingauthor=H.+D%C3%B6hnerauthor=K.+D%C3%B6hner&title=IDH1+and+IDH2+mutations+are+frequent+genetic+alterations+in+acute+myeloid+leukemia+and+confer+adverse+prognosis+in+cytogenetically+normal+acute+myeloid+leukemia+with+NPM1+mutation+without+FLT3+internal+tandem+duplication&doi=10.1200%2FJCO.2010.28.3762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication</span></div><div class="casAuthors">Paschka, Peter; Schlenk, Richard F.; Gaidzik, Verena I.; Habdank, Marianne; Kroenke, Jan; Bullinger, Lars; Spaeth, Daniela; Kayser, Sabine; Zucknick, Manuela; Goetze, Katharina; Horst, Heinz-A.; Germing, Ulrich; Doehner, Hartmut; Doehner, Konstanze</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3636-3643</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose To analyze the frequency and prognostic impact of isocitrate dehydrogenase 1 (IDH1) and isocitrate dehydrogenase 2 (IDH2) mutations in acute myeloid leukemia (AML).  Patients and Methods We studied 805 adults (age range, 16 to 60 years) with AML enrolled on German-Austrian AML Study Group (AMLSG) treatment trials AML HD98A and APL HD95 for mutations in exon 4 of IDH1 and IDH2.  Patients were also studied for NPM1, FLT3, MLL, and CEBPA mutations.  The median follow-up for survival was 6.3 years.  Results IDH mutations were found in 129 patients (16.0%) -IDH1 in 61 patients (7.6%), and IDH2 in 70 patients (8.7%).  Two patients had both IDH1 and IDH2 mutations.  All but one IDH1 mutation caused substitutions of residue R132; IDH2 mutations caused changes of R140 (n = 48) or R172 (n = 22).  IDH mutations were assocd. with older age (P <.001; effect conferred by IDH2 only); lower WBC (P =.04); higher platelets (P <.001); cytogenetically normal (CN) -AML (P<.001); and NPM1 mutations, in particular with the genotype of mutated NPM1 without FLT3 internal tandem duplication (ITD; P <.001).  In patients with CN-AML with the latter genotype, IDH mutations adversely impacted relapse-free survival (RFS; P =.02) and overall survival (P =.03), whereas outcome was not affected in patients with CN-AML who lacked this genotype.  In CN-AML, multivariable analyses revealed a significant interaction between IDH mutation and the genotype of mutated NPM1 without FLT3-ITD (ie, the adverse impact of IDH mutation [RFS]; P =.046 was restricted to this patient subset).  Conclusion IDH1 and IDH2 mutations are recurring genetic changes in AML.  They constitute a poor prognostic factor in CN-AML with mutated NPM1 without FLT3-ITD, which allows refined risk stratification of this AML subset.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocyoeI6L8VjrVg90H21EOLACvtfcHk0lgBxAM40OAyzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSksb3K&md5=18a4e6fe5f64a67e52d340e7aa34cdc1</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1200%2FJCO.2010.28.3762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2010.28.3762%26sid%3Dliteratum%253Aachs%26aulast%3DPaschka%26aufirst%3DP.%26aulast%3DSchlenk%26aufirst%3DR.%2BF.%26aulast%3DGaidzik%26aufirst%3DV.%2BI.%26aulast%3DHabdank%26aufirst%3DM.%26aulast%3DKr%25C3%25B6nke%26aufirst%3DJ.%26aulast%3DBullinger%26aufirst%3DL.%26aulast%3DSp%25C3%25A4th%26aufirst%3DD.%26aulast%3DKayser%26aufirst%3DS.%26aulast%3DZucknick%26aufirst%3DM.%26aulast%3DG%25C3%25B6tze%26aufirst%3DK.%26aulast%3DHorst%26aufirst%3DH.%2BA.%26aulast%3DGerming%26aufirst%3DU.%26aulast%3DD%25C3%25B6hner%26aufirst%3DH.%26aulast%3DD%25C3%25B6hner%26aufirst%3DK.%26atitle%3DIDH1%2520and%2520IDH2%2520mutations%2520are%2520frequent%2520genetic%2520alterations%2520in%2520acute%2520myeloid%2520leukemia%2520and%2520confer%2520adverse%2520prognosis%2520in%2520cytogenetically%2520normal%2520acute%2520myeloid%2520leukemia%2520with%2520NPM1%2520mutation%2520without%2520FLT3%2520internal%2520tandem%2520duplication%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2010%26volume%3D28%26spage%3D3636%26epage%3D3643%26doi%3D10.1200%2FJCO.2010.28.3762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mardis, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dooling, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLellan, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koboldt, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulton, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delehaunty, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulton, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locke, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magrini, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vickery, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wylie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmichael, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eldred, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peck, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukes, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brummett, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMichael, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schindler, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohl, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallis, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haipek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiechert, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivy, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalicki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ries, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payton, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westervelt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasson, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baty, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagarajan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Link, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubert, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiPersio, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ley, T. J.</span></span> <span> </span><span class="NLM_article-title">Recurring mutations found by sequencing an acute myeloid leukemia genome</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>361</i></span>,  <span class="NLM_fpage">1058</span>– <span class="NLM_lpage">1066</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa0903840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1056%2FNEJMoa0903840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=19657110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFaltLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2009&pages=1058-1066&author=E.+R.+Mardisauthor=L.+Dingauthor=D.+J.+Doolingauthor=D.+E.+Larsonauthor=M.+D.+McLellanauthor=K.+Chenauthor=D.+C.+Koboldtauthor=R.+S.+Fultonauthor=K.+D.+Delehauntyauthor=S.+D.+McGrathauthor=L.+A.+Fultonauthor=D.+P.+Lockeauthor=V.+J.+Magriniauthor=R.+M.+Abbottauthor=T.+L.+Vickeryauthor=J.+S.+Reedauthor=J.+S.+Robinsonauthor=T.+Wylieauthor=S.+M.+Smithauthor=L.+Carmichaelauthor=J.+M.+Eldredauthor=C.+C.+Harrisauthor=J.+Walkerauthor=J.+B.+Peckauthor=F.+Duauthor=A.+F.+Dukesauthor=G.+E.+Sandersonauthor=A.+M.+Brummettauthor=E.+Clarkauthor=J.+F.+McMichaelauthor=R.+J.+Meyerauthor=J.+K.+Schindlerauthor=C.+S.+Pohlauthor=J.+W.+Wallisauthor=X.+Shiauthor=L.+Linauthor=H.+Schmidtauthor=Y.+Tangauthor=C.+Haipekauthor=M.+E.+Wiechertauthor=J.+V.+Ivyauthor=J.+Kalickiauthor=G.+Elliottauthor=R.+E.+Riesauthor=J.+E.+Paytonauthor=P.+Westerveltauthor=M.+H.+Tomassonauthor=M.+A.+Watsonauthor=J.+Batyauthor=S.+Heathauthor=W.+D.+Shannonauthor=R.+Nagarajanauthor=D.+C.+Linkauthor=M.+J.+Walterauthor=T.+A.+Graubertauthor=J.+F.+DiPersioauthor=R.+K.+Wilsonauthor=T.+J.+Ley&title=Recurring+mutations+found+by+sequencing+an+acute+myeloid+leukemia+genome&doi=10.1056%2FNEJMoa0903840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Recurring mutations found by sequencing an acute myeloid leukemia genome</span></div><div class="casAuthors">Mardis, Elaine R.; Ding, Li; Dooling, David J.; Larson, David E.; McLellan, Michael D.; Chen, Ken; Koboldt, Daniel C.; Fulton, Robert S.; Delehaunty, Kim D.; McGrath, Sean D.; Fulton, Lucinda A.; Locke, Devin P.; Magrini, Vincent J.; Abbott, Rachel M.; Vickery, Tammi L.; Reed, Jerry S.; Robinson, Jody S.; Wylie, Todd; Smith, Scott M.; Carmichael, Lynn; Eldred, James M.; Harris, Christopher C.; Walker, Jason; Peck, Joshua B.; Du, Feiyu; Dukes, Adam F.; Sanderson, Gabriel E.; Brummett, Anthony M.; Clark, Eric; McMichael, Joshua F.; Meyer, Rick J.; Schindler, Jonathan K.; Pohl, Craig S.; Wallis, John W.; Shi, Xiaoqi; Lin, Ling; Schmidt, Heather; Tang, Yuzhu; Haipek, Carrie; Wiechert, Madeline E.; Ivy, Jolynda V.; Kalicki, Joelle; Elliott, Glendoria; Ries, Rhonda E.; Payton, Jacqueline E.; Westervelt, Peter; Tomasson, Michael H.; Watson, Mark A.; Baty, Jack; Heath, Sharon; Shannon, William D.; Nagarajan, Rakesh; Link, Daniel C.; Walter, Matthew J.; Graubert, Timothy A.; Dipersio, John F.; Wilson, Richard K.; Ley, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1058-1066</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND The full complement of DNA mutations that are responsible for the pathogenesis of acute myeloid leukemia (AML) is not yet known.  METHODS We used massively parallel DNA sequencing to obtain a very high level of coverage (approx. 98%) of a primary, cytogenetically normal, de novo genome for AML with minimal maturation (AML-M1) and a matched normal skin genome.  RESULTS We identified 12 acquired (somatic) mutations within the coding sequences of genes and 52 somatic point mutations in conserved or regulatory portions of the genome.  All mutations appeared to be heterozygous and present in nearly all cells in the tumor sample.  Four of the 64 mutations occurred in at least 1 addnl. AML sample in 188 samples that were tested.  Mutations in NRAS and NPM1 had been identified previously in patients with AML, but two other mutations had not been identified.  One of these mutations, in the IDH1 gene, was present in 15 of 187 addnl. AML genomes tested and was strongly assocd. with normal cytogenetic status; it was present in 13 of 80 cytogenetically normal samples (16%).  The other was a nongenic mutation in a genomic region with regulatory potential and conservation in higher mammals; we detected it in one addnl. AML tumor.  The AML genome that we sequenced contains approx. 750 point mutations, of which only a small fraction are likely to be relevant to pathogenesis.  CONCLUSIONS By comparing the sequences of tumor and skin genomes of a patient with AML-M1, we have identified recurring mutations that may be relevant for pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1qF271txIDrVg90H21EOLACvtfcHk0ljUSDufap1peQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFaltLvL&md5=8ed6e59ccc06b690d4855d65cb5757b8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0903840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0903840%26sid%3Dliteratum%253Aachs%26aulast%3DMardis%26aufirst%3DE.%2BR.%26aulast%3DDing%26aufirst%3DL.%26aulast%3DDooling%26aufirst%3DD.%2BJ.%26aulast%3DLarson%26aufirst%3DD.%2BE.%26aulast%3DMcLellan%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DKoboldt%26aufirst%3DD.%2BC.%26aulast%3DFulton%26aufirst%3DR.%2BS.%26aulast%3DDelehaunty%26aufirst%3DK.%2BD.%26aulast%3DMcGrath%26aufirst%3DS.%2BD.%26aulast%3DFulton%26aufirst%3DL.%2BA.%26aulast%3DLocke%26aufirst%3DD.%2BP.%26aulast%3DMagrini%26aufirst%3DV.%2BJ.%26aulast%3DAbbott%26aufirst%3DR.%2BM.%26aulast%3DVickery%26aufirst%3DT.%2BL.%26aulast%3DReed%26aufirst%3DJ.%2BS.%26aulast%3DRobinson%26aufirst%3DJ.%2BS.%26aulast%3DWylie%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DS.%2BM.%26aulast%3DCarmichael%26aufirst%3DL.%26aulast%3DEldred%26aufirst%3DJ.%2BM.%26aulast%3DHarris%26aufirst%3DC.%2BC.%26aulast%3DWalker%26aufirst%3DJ.%26aulast%3DPeck%26aufirst%3DJ.%2BB.%26aulast%3DDu%26aufirst%3DF.%26aulast%3DDukes%26aufirst%3DA.%2BF.%26aulast%3DSanderson%26aufirst%3DG.%2BE.%26aulast%3DBrummett%26aufirst%3DA.%2BM.%26aulast%3DClark%26aufirst%3DE.%26aulast%3DMcMichael%26aufirst%3DJ.%2BF.%26aulast%3DMeyer%26aufirst%3DR.%2BJ.%26aulast%3DSchindler%26aufirst%3DJ.%2BK.%26aulast%3DPohl%26aufirst%3DC.%2BS.%26aulast%3DWallis%26aufirst%3DJ.%2BW.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DSchmidt%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DHaipek%26aufirst%3DC.%26aulast%3DWiechert%26aufirst%3DM.%2BE.%26aulast%3DIvy%26aufirst%3DJ.%2BV.%26aulast%3DKalicki%26aufirst%3DJ.%26aulast%3DElliott%26aufirst%3DG.%26aulast%3DRies%26aufirst%3DR.%2BE.%26aulast%3DPayton%26aufirst%3DJ.%2BE.%26aulast%3DWestervelt%26aufirst%3DP.%26aulast%3DTomasson%26aufirst%3DM.%2BH.%26aulast%3DWatson%26aufirst%3DM.%2BA.%26aulast%3DBaty%26aufirst%3DJ.%26aulast%3DHeath%26aufirst%3DS.%26aulast%3DShannon%26aufirst%3DW.%2BD.%26aulast%3DNagarajan%26aufirst%3DR.%26aulast%3DLink%26aufirst%3DD.%2BC.%26aulast%3DWalter%26aufirst%3DM.%2BJ.%26aulast%3DGraubert%26aufirst%3DT.%2BA.%26aulast%3DDiPersio%26aufirst%3DJ.%2BF.%26aulast%3DWilson%26aufirst%3DR.%2BK.%26aulast%3DLey%26aufirst%3DT.%2BJ.%26atitle%3DRecurring%2520mutations%2520found%2520by%2520sequencing%2520an%2520acute%2520myeloid%2520leukemia%2520genome%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D1058%26epage%3D1066%26doi%3D10.1056%2FNEJMoa0903840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLendon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasheed, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kos, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batinic-Haberle, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riggins, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reardon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herndon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzler, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velculescu, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigner, D. D.</span></span> <span> </span><span class="NLM_article-title">IDH1 and IDH2 mutations in gliomas</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>360</i></span>,  <span class="NLM_fpage">765</span>– <span class="NLM_lpage">773</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa0808710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1056%2FNEJMoa0808710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=19228619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitFWru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2009&pages=765-773&author=H.+Yanauthor=D.+W.+Parsonsauthor=G.+Jinauthor=R.+McLendonauthor=B.+A.+Rasheedauthor=W.+Yuanauthor=I.+Kosauthor=I.+Batinic-Haberleauthor=S.+Jonesauthor=G.+J.+Rigginsauthor=H.+Friedmanauthor=A.+Friedmanauthor=D.+Reardonauthor=J.+Herndonauthor=K.+W.+Kinzlerauthor=V.+E.+Velculescuauthor=B.+Vogelsteinauthor=D.+D.+Bigner&title=IDH1+and+IDH2+mutations+in+gliomas&doi=10.1056%2FNEJMoa0808710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">IDH1 and IDH2 mutations in gliomas</span></div><div class="casAuthors">Yan, Hai; Parsons, D. Williams; Jin, Genglin; McLendon, Roger; Ahmed Rasheed, B.; Yuan, Weishi; Kos, Ivan; Batinic-Haberle, Ines; Jones, Sian; Riggins, Gregory J.; Friedman, Henry; Friedman, Allan; Reardon, David; Herndon, James; Kinzler, Kenneth W.; Velculescu, Victor E.; Vogelstein, Bert; Bigner, Darell D.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">765-773</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: A recent genomewide mutational anal. of glioblastomas (World Health Organization [WHO] grade IV glioma) revealed somatic mutations of the isocitrate dehydrogenase 1 gene (IDH1) in a fraction of such tumors, most frequently in tumors that were known to have evolved from lower-grade gliomas (secondary glioblastomas).  METHODS: We detd. the sequence of the IDH1 gene and the related IDH2 gene in 445 central nervous system (CNS) tumors and 494 non-CNS tumors.  The enzymic activity of the proteins that were produced from normal and mutant IDH1 and IDH2 genes was detd. in cultured glioma cells that were transfected with these genes.  RESULTS: We identified mutations that affected amino acid 132 of IDH1 in more than 70% of WHO grade II and III astrocytomas and oligodendrogliomas and in glioblastomas that developed from these lower-grade lesions.  Tumors without mutations in IDH1 often had mutations affecting the analogous amino acid (R172) of the IDH2 gene.  Tumors with IDH1 or IDH2 mutations had distinctive genetic and clin. characteristics, and patients with such tumors had a better outcome than those with wild-type IDH genes.  Each of four tested IDH1 and IDH2 mutations reduced the enzymic activity of the encoded protein.  CONCLUSIONS: Mutations of NADP+-dependent isocitrate dehydrogenases encoded by IDH1 and IDH2 occur in a majority of several types of malignant gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMldYfHJnRn7Vg90H21EOLACvtfcHk0lgRY05XyjUxAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitFWru7o%253D&md5=2b3b5db5e16f3714f3ed6cab86939031</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0808710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0808710%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DH.%26aulast%3DParsons%26aufirst%3DD.%2BW.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DMcLendon%26aufirst%3DR.%26aulast%3DRasheed%26aufirst%3DB.%2BA.%26aulast%3DYuan%26aufirst%3DW.%26aulast%3DKos%26aufirst%3DI.%26aulast%3DBatinic-Haberle%26aufirst%3DI.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DFriedman%26aufirst%3DH.%26aulast%3DFriedman%26aufirst%3DA.%26aulast%3DReardon%26aufirst%3DD.%26aulast%3DHerndon%26aufirst%3DJ.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26atitle%3DIDH1%2520and%2520IDH2%2520mutations%2520in%2520gliomas%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D360%26spage%3D765%26epage%3D773%26doi%3D10.1056%2FNEJMoa0808710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawlik, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anders, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selaru, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streppel, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niknafs, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guthrie, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argani, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offerhaus, G. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roa, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gores, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popescu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandrescu, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fassan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simbolo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mafficini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capelli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawlor, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzenente, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guglielmi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortora, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Braud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarnagin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klimstra, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karchin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velculescu, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruban, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzler, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulos, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, L. D.</span></span> <span> </span><span class="NLM_article-title">Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1470</span>– <span class="NLM_lpage">1473</span>, <span class="refDoi"> DOI: 10.1038/ng.2813</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1038%2Fng.2813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=24185509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWjtb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2013&pages=1470-1473&author=Y.+Jiaoauthor=T.+M.+Pawlikauthor=R.+A.+Andersauthor=F.+M.+Selaruauthor=M.+M.+Streppelauthor=D.+J.+Lucasauthor=N.+Niknafsauthor=V.+B.+Guthrieauthor=A.+Maitraauthor=P.+Arganiauthor=G.+J.+A.+Offerhausauthor=J.+C.+Roaauthor=L.+R.+Robertsauthor=G.+J.+Goresauthor=I.+Popescuauthor=S.+T.+Alexandrescuauthor=S.+Dimaauthor=M.+Fassanauthor=M.+Simboloauthor=A.+Mafficiniauthor=P.+Capelliauthor=R.+T.+Lawlorauthor=A.+Ruzzenenteauthor=A.+Guglielmiauthor=G.+Tortoraauthor=F.+de+Braudauthor=A.+Scarpaauthor=W.+Jarnaginauthor=D.+Klimstraauthor=R.+Karchinauthor=V.+E.+Velculescuauthor=R.+H.+Hrubanauthor=B.+Vogelsteinauthor=K.+W.+Kinzlerauthor=N.+Papadopoulosauthor=L.+D.+Wood&title=Exome+sequencing+identifies+frequent+inactivating+mutations+in+BAP1%2C+ARID1A+and+PBRM1+in+intrahepatic+cholangiocarcinomas&doi=10.1038%2Fng.2813"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas</span></div><div class="casAuthors">Jiao, Yuchen; Pawlik, Timothy M.; Anders, Robert A.; Selaru, Florin M.; Streppel, Mirte M.; Lucas, Donald J.; Niknafs, Noushin; Guthrie, Violeta Beleva; Maitra, Anirban; Argani, Pedram; Offerhaus, G. Johan A.; Roa, Juan Carlos; Roberts, Lewis R.; Gores, Gregory J.; Popescu, Irinel; Alexandrescu, Sorin T.; Dima, Simona; Fassan, Matteo; Simbolo, Michele; Mafficini, Andrea; Capelli, Paola; Lawlor, Rita T.; Ruzzenente, Andrea; Guglielmi, Alfredo; Tortora, Giampaolo; de Braud, Filippo; Scarpa, Aldo; Jarnagin, William; Klimstra, David; Karchin, Rachel; Velculescu, Victor E.; Hruban, Ralph H.; Vogelstein, Bert; Kinzler, Kenneth W.; Papadopoulos, Nickolas; Wood, Laura D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1470-1473</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Through exomic sequencing of 32 intrahepatic cholangiocarcinomas, we discovered frequent inactivating mutations in multiple chromatin-remodeling genes (including BAP1, ARID1A and PBRM1), and mutation in one of these genes occurred in almost half of the carcinomas sequenced.  We also identified frequent mutations at previously reported hotspots in the IDH1 and IDH2 genes encoding metabolic enzymes in intrahepatic cholangiocarcinomas.  In contrast, TP53 was the most frequently altered gene in a series of nine gallbladder carcinomas.  These discoveries highlight the key role of dysregulated chromatin remodeling in intrahepatic cholangiocarcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8u7jSQOsIHbVg90H21EOLACvtfcHk0lgRY05XyjUxAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWjtb7J&md5=02fd339f0a64e9611c11f3e2ff0c157f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fng.2813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.2813%26sid%3Dliteratum%253Aachs%26aulast%3DJiao%26aufirst%3DY.%26aulast%3DPawlik%26aufirst%3DT.%2BM.%26aulast%3DAnders%26aufirst%3DR.%2BA.%26aulast%3DSelaru%26aufirst%3DF.%2BM.%26aulast%3DStreppel%26aufirst%3DM.%2BM.%26aulast%3DLucas%26aufirst%3DD.%2BJ.%26aulast%3DNiknafs%26aufirst%3DN.%26aulast%3DGuthrie%26aufirst%3DV.%2BB.%26aulast%3DMaitra%26aufirst%3DA.%26aulast%3DArgani%26aufirst%3DP.%26aulast%3DOfferhaus%26aufirst%3DG.%2BJ.%2BA.%26aulast%3DRoa%26aufirst%3DJ.%2BC.%26aulast%3DRoberts%26aufirst%3DL.%2BR.%26aulast%3DGores%26aufirst%3DG.%2BJ.%26aulast%3DPopescu%26aufirst%3DI.%26aulast%3DAlexandrescu%26aufirst%3DS.%2BT.%26aulast%3DDima%26aufirst%3DS.%26aulast%3DFassan%26aufirst%3DM.%26aulast%3DSimbolo%26aufirst%3DM.%26aulast%3DMafficini%26aufirst%3DA.%26aulast%3DCapelli%26aufirst%3DP.%26aulast%3DLawlor%26aufirst%3DR.%2BT.%26aulast%3DRuzzenente%26aufirst%3DA.%26aulast%3DGuglielmi%26aufirst%3DA.%26aulast%3DTortora%26aufirst%3DG.%26aulast%3Dde%2BBraud%26aufirst%3DF.%26aulast%3DScarpa%26aufirst%3DA.%26aulast%3DJarnagin%26aufirst%3DW.%26aulast%3DKlimstra%26aufirst%3DD.%26aulast%3DKarchin%26aufirst%3DR.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DPapadopoulos%26aufirst%3DN.%26aulast%3DWood%26aufirst%3DL.%2BD.%26atitle%3DExome%2520sequencing%2520identifies%2520frequent%2520inactivating%2520mutations%2520in%2520BAP1%252C%2520ARID1A%2520and%2520PBRM1%2520in%2520intrahepatic%2520cholangiocarcinomas%26jtitle%3DNat.%2520Genet.%26date%3D2013%26volume%3D45%26spage%3D1470%26epage%3D1473%26doi%3D10.1038%2Fng.2813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittinger, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driggers, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantin, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keenan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prins, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liau, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vander Heiden, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S. M.</span></span> <span> </span><span class="NLM_article-title">Cancer-associated IDH1 mutations produce 2-hydroxyglutarate</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>462</i></span>,  <span class="NLM_fpage">739</span>– <span class="NLM_lpage">744</span>, <span class="refDoi"> DOI: 10.1038/nature08617</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1038%2Fnature08617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=19935646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGlurzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=2009&pages=739-744&author=L.+Dangauthor=D.+W.+Whiteauthor=S.+Grossauthor=B.+D.+Bennettauthor=M.+A.+Bittingerauthor=E.+M.+Driggersauthor=V.+R.+Fantinauthor=H.+G.+Jangauthor=S.+Jinauthor=M.+C.+Keenanauthor=K.+M.+Marksauthor=R.+M.+Prinsauthor=P.+S.+Wardauthor=K.+E.+Yenauthor=L.+M.+Liauauthor=J.+D.+Rabinowitzauthor=L.+C.+Cantleyauthor=C.+B.+Thompsonauthor=M.+G.+Vander+Heidenauthor=S.+M.+Su&title=Cancer-associated+IDH1+mutations+produce+2-hydroxyglutarate&doi=10.1038%2Fnature08617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer-associated IDH1 mutations produce 2-hydroxyglutarate</span></div><div class="casAuthors">Dang, Lenny; White, David W.; Gross, Stefan; Bennett, Bryson D.; Bittinger, Mark A.; Driggers, Edward M.; Fantin, Valeria R.; Jang, Hyun-Gyung; Jin, Shengfang; Keenan, Marie C.; Marks, Kevin M.; Prins, Robert M.; Ward, Patrick S.; Yen, Katharine E.; Liau, Linda M.; Rabinowitz, Joshua D.; Cantley, Lewis C.; Thompson, Craig B.; Vander Heiden, Matthew G.; Su, Shinsan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">462</span>
        (<span class="NLM_cas:issue">7274</span>),
    <span class="NLM_cas:pages">739-744</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in the enzyme cytosolic isocitrate dehydrogenase 1 (IDH1) are a common feature of a major subset of primary human brain cancers.  These mutations occur at a single amino acid residue of the IDH1 active site, resulting in loss of the enzyme's ability to catalyze conversion of isocitrate to α-ketoglutarate.  However, only a single copy of the gene is mutated in tumors, raising the possibility that the mutations do not result in a simple loss of function.  Here we show that cancer-assocd. IDH1 mutations result in a new ability of the enzyme to catalyze the NADPH-dependent redn. of α-ketoglutarate to R(-)-2-hydroxyglutarate (2HG).  Structural studies demonstrate that when arginine 132 is mutated to histidine, residues in the active site are shifted to produce structural changes consistent with reduced oxidative decarboxylation of isocitrate and acquisition of the ability to convert α-ketoglutarate to 2HG.  Excess accumulation of 2HG has been shown to lead to an elevated risk of malignant brain tumors in patients with inborn errors of 2HG metab.  Similarly, in human malignant gliomas harbouring IDH1 mutations, we find markedly elevated levels of 2HG.  These data demonstrate that the IDH1 mutations result in prodn. of the onco-metabolite 2HG, and indicate that the excess 2HG which accumulates in vivo contributes to the formation and malignant progression of gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkIgPaD-aavrVg90H21EOLACvtfcHk0ljGP5ltmTlOGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGlurzE&md5=b8661605276da5cbd92641e45c5b8c87</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnature08617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08617%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DD.%2BW.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBittinger%26aufirst%3DM.%2BA.%26aulast%3DDriggers%26aufirst%3DE.%2BM.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DJang%26aufirst%3DH.%2BG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKeenan%26aufirst%3DM.%2BC.%26aulast%3DMarks%26aufirst%3DK.%2BM.%26aulast%3DPrins%26aufirst%3DR.%2BM.%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DLiau%26aufirst%3DL.%2BM.%26aulast%3DRabinowitz%26aufirst%3DJ.%2BD.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DSu%26aufirst%3DS.%2BM.%26atitle%3DCancer-associated%2520IDH1%2520mutations%2520produce%25202-hydroxyglutarate%26jtitle%3DNature%26date%3D2009%26volume%3D462%26spage%3D739%26epage%3D744%26doi%3D10.1038%2Fnature08617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairns, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minden, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driggers, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittinger, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkein, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantin, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>207</i></span>,  <span class="NLM_fpage">339</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.1084/jem.20092506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1084%2Fjem.20092506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=20142433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFGqur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2010&pages=339-344&author=S.+Grossauthor=R.+A.+Cairnsauthor=M.+D.+Mindenauthor=E.+M.+Driggersauthor=M.+A.+Bittingerauthor=H.+G.+Jangauthor=M.+Sasakiauthor=S.+Jinauthor=D.+P.+Schenkeinauthor=S.+M.+Suauthor=L.+Dangauthor=V.+R.+Fantinauthor=T.+W.+Mak&title=Cancer-associated+metabolite+2-hydroxyglutarate+accumulates+in+acute+myelogenous+leukemia+with+isocitrate+dehydrogenase+1+and+2+mutations&doi=10.1084%2Fjem.20092506"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations</span></div><div class="casAuthors">Gross, Stefan; Cairns, Rob A.; Minden, Mark D.; Driggers, Edward M.; Bittinger, Mark A.; Jang, Hyun Gyung; Sasaki, Masato; Jin, Shengfang; Schenkein, David P.; Su, Shinsan M.; Dang, Lenny; Fantin, Valeria R.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">339-344</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Mutations in isocitrate dehydrogenase 1 and 2 (IDH1/2), are present in most gliomas and secondary glioblastomas, but are rare in other neoplasms.  IDH1/2 mutations are heterozygous, and affect a single Arg residue.  Recently, IDH1 mutations were identified in 8% of acute myelogenous leukemia (AML) patients.  A glioma study revealed that IDH1 mutations cause a gain-of-function, resulting in the prodn. and accumulation of 2-hydroxyglutarate (2-HG).  Genotyping of 145 AML biopsies identified 11 IDH1 R132 mutant samples.  Liq. chromatog.-mass spectrometry metabolite screening revealed increased 2-HG levels in IDH1 R132 mutant cells and sera, and uncovered 2 IDH2 R172K mutations.  IDH1/2 mutations were assocd. with normal karyotypes.  Recombinant IDH1 R132C and IDH2 R172K proteins catalyze the novel NADP (NADPH)-dependent redn. of α-ketoglutarate (α-KG) to 2-HG.  The IDH1 R132C mutation commonly found in AML reduces the affinity for isocitrate, and increases the affinity for NADPH and α-KG.  This prevents the oxidative decarboxylation of isocitrate to α-KG, and facilitates the conversion of α-KG to 2-HG.  IDH1/2 mutations confer an enzymic gain of function that dramatically increases 2-HG in AML.  This provides an explanation for the heterozygous acquisition of these mutations during tumorigenesis.  2-HG is a tractable metabolic biomarker of mutant IDH1/2 enzyme activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8uyv8xo4qzLVg90H21EOLACvtfcHk0ljGP5ltmTlOGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFGqur0%253D&md5=7e900e78bc4b5a715c504272d6248551</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1084%2Fjem.20092506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20092506%26sid%3Dliteratum%253Aachs%26aulast%3DGross%26aufirst%3DS.%26aulast%3DCairns%26aufirst%3DR.%2BA.%26aulast%3DMinden%26aufirst%3DM.%2BD.%26aulast%3DDriggers%26aufirst%3DE.%2BM.%26aulast%3DBittinger%26aufirst%3DM.%2BA.%26aulast%3DJang%26aufirst%3DH.%2BG.%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DSchenkein%26aufirst%3DD.%2BP.%26aulast%3DSu%26aufirst%3DS.%2BM.%26aulast%3DDang%26aufirst%3DL.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DCancer-associated%2520metabolite%25202-hydroxyglutarate%2520accumulates%2520in%2520acute%2520myelogenous%2520leukemia%2520with%2520isocitrate%2520dehydrogenase%25201%2520and%25202%2520mutations%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2010%26volume%3D207%26spage%3D339%26epage%3D344%26doi%3D10.1084%2Fjem.20092506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stein, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K.</span></span> <span> </span><span class="NLM_article-title">Targeted differentiation therapy with mutant IDH inhibitors: early experiences and parallels with other differentiation agents</span>. <i>Annu. Rev. Cancer Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1146/annurev-cancerbio-050216-122051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1146%2Fannurev-cancerbio-050216-122051" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2017&pages=379-401&author=E.+Steinauthor=K.+Yen&title=Targeted+differentiation+therapy+with+mutant+IDH+inhibitors%3A+early+experiences+and+parallels+with+other+differentiation+agents&doi=10.1146%2Fannurev-cancerbio-050216-122051"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1146%2Fannurev-cancerbio-050216-122051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-cancerbio-050216-122051%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DE.%26aulast%3DYen%26aufirst%3DK.%26atitle%3DTargeted%2520differentiation%2520therapy%2520with%2520mutant%2520IDH%2520inhibitors%253A%2520early%2520experiences%2520and%2520parallels%2520with%2520other%2520differentiation%2520agents%26jtitle%3DAnnu.%2520Rev.%2520Cancer%2520Biol.%26date%3D2017%26volume%3D1%26spage%3D379%26epage%3D401%26doi%3D10.1146%2Fannurev-cancerbio-050216-122051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Menendez, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alarcón, T.</span></span> <span> </span><span class="NLM_article-title">Metabostemness: a new cancer hallmark</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">262</span>, <span class="refDoi"> DOI: 10.3389/fonc.2014.00262</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.3389%2Ffonc.2014.00262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=25325014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A280%3ADC%252BC2M3hsFegtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=262&author=J.+A.+Menendezauthor=T.+Alarc%C3%B3n&title=Metabostemness%3A+a+new+cancer+hallmark&doi=10.3389%2Ffonc.2014.00262"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Metabostemness: a new cancer hallmark</span></div><div class="casAuthors">Menendez Javier A; Alarcon Tomas</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">262</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">The acquisition of and departure from stemness in cancer tissues might not only be hardwired by genetic controllers, but also by the pivotal regulatory role of the cellular metabotype, which may act as a "starter dough" for cancer stemness traits.  We have coined the term metabostemness to refer to the metabolic parameters causally controlling or functionally substituting the epitranscriptional orchestration of the genetic reprograming that redirects normal and tumor cells toward less-differentiated cancer stem cell (CSC) cellular states.  Certain metabotypic alterations might operate as pivotal molecular events rendering a cell of origin susceptible to epigenetic rewiring required for the acquisition of aberrant stemness and, concurrently, of refractoriness to differentiation.  The metabostemness attribute can remove, diminish, or modify the nature of molecular barriers present in Waddington's epigenetic landscapes, thus allowing differentiated cells to more easily (re)-enter into CSC cellular macrostates.  Activation of the metabostemness trait can poise cells with chromatin states competent for rapid dedifferentiation while concomitantly setting the idoneous metabolic stage for later reprograming stimuli to finish the journey from non-cancerous into tumor-initiating cells.  Because only a few permitted metabotypes will be compatible with the operational properties owned by CSC cellular states, the metabostemness property provides a new framework through which to pharmacologically resolve the apparently impossible problem of discovering drugs aimed to target the molecular biology of the cancer stemness itself.  The metabostemness cancer hallmark generates a shifting oncology theory that should guide a new era of metabolo-epigenetic cancer precision medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTh5KwHvDODHhgd2Wuil24tfW6udTcc2ea0K2qp_IDeMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3hsFegtQ%253D%253D&md5=6e9b19cc3eaaaf39a515182bdf441ea3</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2014.00262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2014.00262%26sid%3Dliteratum%253Aachs%26aulast%3DMenendez%26aufirst%3DJ.%2BA.%26aulast%3DAlarc%25C3%25B3n%26aufirst%3DT.%26atitle%3DMetabostemness%253A%2520a%2520new%2520cancer%2520hallmark%26jtitle%3DFront.%2520Oncol.%26date%3D2014%26volume%3D4%26spage%3D262%26doi%3D10.3389%2Ffonc.2014.00262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noushmehr, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisenberger, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diefes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berman, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelloski, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulman, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhaak, R. G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoadley, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perou, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Berg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bengtsson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuvial, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cope, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baylin, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laird, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldape, K.</span></span> <span> </span><span class="NLM_article-title">Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">510</span>– <span class="NLM_lpage">522</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2010.03.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1016%2Fj.ccr.2010.03.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=510-522&author=H.+Noushmehrauthor=D.+J.+Weisenbergerauthor=K.+Diefesauthor=H.+S.+Phillipsauthor=K.+Pujaraauthor=B.+P.+Bermanauthor=F.+Panauthor=C.+E.+Pelloskiauthor=E.+P.+Sulmanauthor=K.+P.+Bhatauthor=R.+G.+W.+Verhaakauthor=K.+A.+Hoadleyauthor=D.+N.+Hayesauthor=C.+M.+Perouauthor=H.+K.+Schmidtauthor=L.+Dingauthor=R.+K.+Wilsonauthor=D.+Van+Den+Bergauthor=H.+Shenauthor=H.+Bengtssonauthor=P.+Neuvialauthor=L.+M.+Copeauthor=J.+Buckleyauthor=J.+G.+Hermanauthor=S.+B.+Baylinauthor=P.+W.+Lairdauthor=K.+Aldape&title=Identification+of+a+CpG+island+methylator+phenotype+that+defines+a+distinct+subgroup+of+glioma&doi=10.1016%2Fj.ccr.2010.03.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2010.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2010.03.017%26sid%3Dliteratum%253Aachs%26aulast%3DNoushmehr%26aufirst%3DH.%26aulast%3DWeisenberger%26aufirst%3DD.%2BJ.%26aulast%3DDiefes%26aufirst%3DK.%26aulast%3DPhillips%26aufirst%3DH.%2BS.%26aulast%3DPujara%26aufirst%3DK.%26aulast%3DBerman%26aufirst%3DB.%2BP.%26aulast%3DPan%26aufirst%3DF.%26aulast%3DPelloski%26aufirst%3DC.%2BE.%26aulast%3DSulman%26aufirst%3DE.%2BP.%26aulast%3DBhat%26aufirst%3DK.%2BP.%26aulast%3DVerhaak%26aufirst%3DR.%2BG.%2BW.%26aulast%3DHoadley%26aufirst%3DK.%2BA.%26aulast%3DHayes%26aufirst%3DD.%2BN.%26aulast%3DPerou%26aufirst%3DC.%2BM.%26aulast%3DSchmidt%26aufirst%3DH.%2BK.%26aulast%3DDing%26aufirst%3DL.%26aulast%3DWilson%26aufirst%3DR.%2BK.%26aulast%3DVan%2BDen%2BBerg%26aufirst%3DD.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DBengtsson%26aufirst%3DH.%26aulast%3DNeuvial%26aufirst%3DP.%26aulast%3DCope%26aufirst%3DL.%2BM.%26aulast%3DBuckley%26aufirst%3DJ.%26aulast%3DHerman%26aufirst%3DJ.%2BG.%26aulast%3DBaylin%26aufirst%3DS.%2BB.%26aulast%3DLaird%26aufirst%3DP.%2BW.%26aulast%3DAldape%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520a%2520CpG%2520island%2520methylator%2520phenotype%2520that%2520defines%2520a%2520distinct%2520subgroup%2520of%2520glioma%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D17%26spage%3D510%26epage%3D522%26doi%3D10.1016%2Fj.ccr.2010.03.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travins, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLaBarre, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penard-Lacronique, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schalm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kernytsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gliser, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saada, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mylonas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quivoron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovici-Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salituro, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agresta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkein, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biller, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Botton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K. E.</span></span> <span> </span><span class="NLM_article-title">Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>340</i></span>,  <span class="NLM_fpage">622</span>– <span class="NLM_lpage">626</span>, <span class="refDoi"> DOI: 10.1126/science.1234769</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1126%2Fscience.1234769" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=23558173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslWksbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2013&pages=622-626&author=F.+Wangauthor=J.+Travinsauthor=B.+DeLaBarreauthor=V.+Penard-Lacroniqueauthor=S.+Schalmauthor=E.+Hansenauthor=K.+Straleyauthor=A.+Kernytskyauthor=W.+Liuauthor=C.+Gliserauthor=H.+Yangauthor=S.+Grossauthor=E.+Artinauthor=V.+Saadaauthor=E.+Mylonasauthor=C.+Quivoronauthor=J.+Popovici-Mullerauthor=J.+O.+Saundersauthor=F.+G.+Salituroauthor=S.+Yanauthor=S.+Murrayauthor=W.+Weiauthor=Y.+Gaoauthor=L.+Dangauthor=M.+Dorschauthor=S.+Agrestaauthor=D.+P.+Schenkeinauthor=S.+A.+Billerauthor=S.+M.+Suauthor=S.+de+Bottonauthor=K.+E.+Yen&title=Targeted+inhibition+of+mutant+IDH2+in+leukemia+cells+induces+cellular+differentiation&doi=10.1126%2Fscience.1234769"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation</span></div><div class="casAuthors">Wang, Fang; Travins, Jeremy; De La Barre, Byron; Penard-Lacronique, Virginie; Schalm, Stefanie; Hansen, Erica; Straley, Kimberly; Kernytsky, Andrew; Liu, Wei; Gliser, Camelia; Yang, Hua; Gross, Stefan; Artin, Erin; Saada, Veronique; Mylonas, Elena; Quivoron, Cyril; Popovici-Muller, Janeta; Saunders, Jeffrey O.; Salituro, Francesco G.; Yan, Shunqi; Murray, Stuart; Wei, Wentao; Gao, Yi; Dang, Lenny; Dorsch, Marion; Agresta, Sam; Schenkein, David P.; Biller, Scott A.; Su, Shinsan M.; de Botton, Stephane; Yen, Katharine E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">6132</span>),
    <span class="NLM_cas:pages">622-626</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A no. of human cancers harbor somatic point mutations in the genes encoding isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2).  These mutations alter residues in the enzyme active sites and confer a gain-of-function in cancer cells, resulting in the accumulation and secretion of the oncometabolite (R)-2-hydroxyglutarate (2HG).  We developed a small mol., AGI-6780, that potently and selectively inhibits the tumor-assocd. mutant IDH2/R140Q.  A crystal structure of AGI-6780 complexed with IDH2/R140Q revealed that the inhibitor binds in an allosteric manner at the dimer interface.  The results of steady-state enzymol. anal. were consistent with allostery and slow-tight binding by AGI-6780.  Treatment with AGI-6780 induced differentiation of TF-1 erythroleukemia and primary human acute myelogenous leukemia cells in vitro.  These data provide proof-of-concept that inhibitors targeting mutant IDH2/R140Q could have potential applications as a differentiation therapy for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAdwmeRjaBrLVg90H21EOLACvtfcHk0lhVY96_CeOZTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslWksbs%253D&md5=fe3db6b043a8b31fb661d0bdbd75e19f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1126%2Fscience.1234769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1234769%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DF.%26aulast%3DTravins%26aufirst%3DJ.%26aulast%3DDeLaBarre%26aufirst%3DB.%26aulast%3DPenard-Lacronique%26aufirst%3DV.%26aulast%3DSchalm%26aufirst%3DS.%26aulast%3DHansen%26aufirst%3DE.%26aulast%3DStraley%26aufirst%3DK.%26aulast%3DKernytsky%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DGliser%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DArtin%26aufirst%3DE.%26aulast%3DSaada%26aufirst%3DV.%26aulast%3DMylonas%26aufirst%3DE.%26aulast%3DQuivoron%26aufirst%3DC.%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DSaunders%26aufirst%3DJ.%2BO.%26aulast%3DSalituro%26aufirst%3DF.%2BG.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DMurray%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DDang%26aufirst%3DL.%26aulast%3DDorsch%26aufirst%3DM.%26aulast%3DAgresta%26aufirst%3DS.%26aulast%3DSchenkein%26aufirst%3DD.%2BP.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DSu%26aufirst%3DS.%2BM.%26aulast%3Dde%2BBotton%26aufirst%3DS.%26aulast%3DYen%26aufirst%3DK.%2BE.%26atitle%3DTargeted%2520inhibition%2520of%2520mutant%2520IDH2%2520in%2520leukemia%2520cells%2520induces%2520cellular%2520differentiation%26jtitle%3DScience%26date%3D2013%26volume%3D340%26spage%3D622%26epage%3D626%26doi%3D10.1126%2Fscience.1234769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pusch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Deimling, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zha, X.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel selective inhibitor of mutant isocitrate dehydrogenase 1 at allosteric site by docking-based virtual screening</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">96735</span>– <span class="NLM_lpage">96742</span>, <span class="refDoi"> DOI: 10.1039/C6RA21617J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1039%2FC6RA21617J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFGqs7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=96735-96742&author=F.+Zouauthor=S.+Puschauthor=J.+Eiselauthor=T.+Maauthor=Q.+Zhuauthor=D.+Dengauthor=Y.+Guauthor=Y.+Xuauthor=A.+von+Deimlingauthor=X.+Zha&title=Identification+of+a+novel+selective+inhibitor+of+mutant+isocitrate+dehydrogenase+1+at+allosteric+site+by+docking-based+virtual+screening&doi=10.1039%2FC6RA21617J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel selective inhibitor of mutant isocitrate dehydrogenase 1 at allosteric site by docking-based virtual screening</span></div><div class="casAuthors">Zou, Fangxia; Pusch, Stefan; Eisel, Jessica; Ma, Tianfang; Zhu, Qihua; Deng, Dawei; Gu, Yueqing; Xu, Yungen; von Deimling, Andreas; Zha, Xiaoming</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">99</span>),
    <span class="NLM_cas:pages">96735-96742</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Isocitrate dehydrogenase 1 (IDH1), catalyzing oxidative decarboxylation of isocitrate to provide energy for aerobic organisms, is an essential enzyme in the tricarboxylic acid cycle.  However, mutant IDH1 (mIDH1) produces oncometabolite D-2-hydroxyglutarate (D2HG) and has recently been confirmed in several types of cancers, particularly in glioma and acute myeloid leukemia.  Herein a docking-based virtual screening (VS) of SPECS library was conducted for the allosteric site of mIDH1.  The cellular evaluation of the hit compds. led to the identification of FX-03 as a novel selective mIDH1 inhibitor at allosteric site with IC50 values of 55.50 μM and 68.38 μM in HEK-293T cells transfected with IDH1 R132H and IDH1 R132C, resp.  Importantly, FX-03 owned significant selectivity with no inhibition in HEK-293T cells transfected with IDH1 WT.  These findings indicate that VS of mIDH1's allosteric site represents a useful strategy for discovery of selective mIDH1 inhibitors and FX-03 deserves further optimization as a lead compd. in future study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopLsGrqqr5ZbVg90H21EOLACvtfcHk0lhVY96_CeOZTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFGqs7jP&md5=65307afede4de3fa7ac412b8c874cb4e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1039%2FC6RA21617J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6RA21617J%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DF.%26aulast%3DPusch%26aufirst%3DS.%26aulast%3DEisel%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DQ.%26aulast%3DDeng%26aufirst%3DD.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26aulast%3DZha%26aufirst%3DX.%26atitle%3DIdentification%2520of%2520a%2520novel%2520selective%2520inhibitor%2520of%2520mutant%2520isocitrate%2520dehydrogenase%25201%2520at%2520allosteric%2520site%2520by%2520docking-based%2520virtual%2520screening%26jtitle%3DRSC%2520Adv.%26date%3D2016%26volume%3D6%26spage%3D96735%26epage%3D96742%26doi%3D10.1039%2FC6RA21617J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Komori, T.</span></span> <span> </span><span class="NLM_article-title">Pathology and genetics of diffuse gliomas in adults</span>. <i>Neurol. Med. Chir.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">28</span>– <span class="NLM_lpage">37</span>, <span class="refDoi"> DOI: 10.2176/nmc.ra.2014-0229</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.2176%2Fnmc.ra.2014-0229" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=28-37&author=T.+Komori&title=Pathology+and+genetics+of+diffuse+gliomas+in+adults&doi=10.2176%2Fnmc.ra.2014-0229"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2176%2Fnmc.ra.2014-0229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2176%252Fnmc.ra.2014-0229%26sid%3Dliteratum%253Aachs%26aulast%3DKomori%26aufirst%3DT.%26atitle%3DPathology%2520and%2520genetics%2520of%2520diffuse%2520gliomas%2520in%2520adults%26jtitle%3DNeurol.%2520Med.%2520Chir.%26date%3D2015%26volume%3D55%26spage%3D28%26epage%3D37%26doi%3D10.2176%2Fnmc.ra.2014-0229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Louis, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reifenberger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Deimling, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figarella-Branger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavenee, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohgaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiestler, O. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleihues, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellison, D. W.</span></span> <span> </span><span class="NLM_article-title">The 2016 world health organization classification of tumors of the central nervous system: a summary</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">803</span>– <span class="NLM_lpage">820</span>, <span class="refDoi"> DOI: 10.1007/s00401-016-1545-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1007%2Fs00401-016-1545-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=27157931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A280%3ADC%252BC28bnsVektA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2016&pages=803-820&author=D.+N.+Louisauthor=A.+Perryauthor=G.+Reifenbergerauthor=A.+von+Deimlingauthor=D.+Figarella-Brangerauthor=W.+K.+Caveneeauthor=H.+Ohgakiauthor=O.+D.+Wiestlerauthor=P.+Kleihuesauthor=D.+W.+Ellison&title=The+2016+world+health+organization+classification+of+tumors+of+the+central+nervous+system%3A+a+summary&doi=10.1007%2Fs00401-016-1545-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary</span></div><div class="casAuthors">Louis David N; Perry Arie; Reifenberger Guido; Reifenberger Guido; von Deimling Andreas; von Deimling Andreas; Figarella-Branger Dominique; Cavenee Webster K; Ohgaki Hiroko; Wiestler Otmar D; Kleihues Paul; Ellison David W</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">803-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The 2016 World Health Organization Classification of Tumors of the Central Nervous System is both a conceptual and practical advance over its 2007 predecessor.  For the first time, the WHO classification of CNS tumors uses molecular parameters in addition to histology to define many tumor entities, thus formulating a concept for how CNS tumor diagnoses should be structured in the molecular era.  As such, the 2016 CNS WHO presents major restructuring of the diffuse gliomas, medulloblastomas and other embryonal tumors, and incorporates new entities that are defined by both histology and molecular features, including glioblastoma, IDH-wildtype and glioblastoma, IDH-mutant; diffuse midline glioma, H3 K27M-mutant; RELA fusion-positive ependymoma; medulloblastoma, WNT-activated and medulloblastoma, SHH-activated; and embryonal tumour with multilayered rosettes, C19MC-altered.  The 2016 edition has added newly recognized neoplasms, and has deleted some entities, variants and patterns that no longer have diagnostic and/or biological relevance.  Other notable changes include the addition of brain invasion as a criterion for atypical meningioma and the introduction of a soft tissue-type grading system for the now combined entity of solitary fibrous tumor / hemangiopericytoma-a departure from the manner by which other CNS tumors are graded.  Overall, it is hoped that the 2016 CNS WHO will facilitate clinical, experimental and epidemiological studies that will lead to improvements in the lives of patients with brain tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS7YzqOXqWReQqdek-gHSrIfW6udTcc2ebh6zw6s54X3rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bnsVektA%253D%253D&md5=f9ac51999bf1b171477b20ea0085c9e8</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs00401-016-1545-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-016-1545-1%26sid%3Dliteratum%253Aachs%26aulast%3DLouis%26aufirst%3DD.%2BN.%26aulast%3DPerry%26aufirst%3DA.%26aulast%3DReifenberger%26aufirst%3DG.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26aulast%3DFigarella-Branger%26aufirst%3DD.%26aulast%3DCavenee%26aufirst%3DW.%2BK.%26aulast%3DOhgaki%26aufirst%3DH.%26aulast%3DWiestler%26aufirst%3DO.%2BD.%26aulast%3DKleihues%26aufirst%3DP.%26aulast%3DEllison%26aufirst%3DD.%2BW.%26atitle%3DThe%25202016%2520world%2520health%2520organization%2520classification%2520of%2520tumors%2520of%2520the%2520central%2520nervous%2520system%253A%2520a%2520summary%26jtitle%3DActa%2520Neuropathol.%26date%3D2016%26volume%3D131%26spage%3D803%26epage%3D820%26doi%3D10.1007%2Fs00401-016-1545-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hentschel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wick, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capper, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felsberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westphal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schackert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyermann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietsch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reifenberger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loeffler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Deimling, A.</span></span> <span> </span><span class="NLM_article-title">Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher Age: implications for classification of gliomas</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">707</span>– <span class="NLM_lpage">718</span>, <span class="refDoi"> DOI: 10.1007/s00401-010-0781-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1007%2Fs00401-010-0781-z" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2010&pages=707-718&author=C.+Hartmannauthor=B.+Hentschelauthor=W.+Wickauthor=D.+Capperauthor=J.+Felsbergauthor=M.+Simonauthor=M.+Westphalauthor=G.+Schackertauthor=R.+Meyermannauthor=T.+Pietschauthor=G.+Reifenbergerauthor=M.+Wellerauthor=M.+Loefflerauthor=A.+von+Deimling&title=Patients+with+IDH1+wild+type+anaplastic+astrocytomas+exhibit+worse+prognosis+than+IDH1-mutated+glioblastomas%2C+and+IDH1+mutation+status+accounts+for+the+unfavorable+prognostic+effect+of+higher+Age%3A+implications+for+classification+of+gliomas&doi=10.1007%2Fs00401-010-0781-z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1007%2Fs00401-010-0781-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-010-0781-z%26sid%3Dliteratum%253Aachs%26aulast%3DHartmann%26aufirst%3DC.%26aulast%3DHentschel%26aufirst%3DB.%26aulast%3DWick%26aufirst%3DW.%26aulast%3DCapper%26aufirst%3DD.%26aulast%3DFelsberg%26aufirst%3DJ.%26aulast%3DSimon%26aufirst%3DM.%26aulast%3DWestphal%26aufirst%3DM.%26aulast%3DSchackert%26aufirst%3DG.%26aulast%3DMeyermann%26aufirst%3DR.%26aulast%3DPietsch%26aufirst%3DT.%26aulast%3DReifenberger%26aufirst%3DG.%26aulast%3DWeller%26aufirst%3DM.%26aulast%3DLoeffler%26aufirst%3DM.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26atitle%3DPatients%2520with%2520IDH1%2520wild%2520type%2520anaplastic%2520astrocytomas%2520exhibit%2520worse%2520prognosis%2520than%2520IDH1-mutated%2520glioblastomas%252C%2520and%2520IDH1%2520mutation%2520status%2520accounts%2520for%2520the%2520unfavorable%2520prognostic%2520effect%2520of%2520higher%2520Age%253A%2520implications%2520for%2520classification%2520of%2520gliomas%26jtitle%3DActa%2520Neuropathol.%26date%3D2010%26volume%3D120%26spage%3D707%26epage%3D718%26doi%3D10.1007%2Fs00401-010-0781-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, C.</span></span> <span> </span><span class="NLM_article-title">The new WHO 2016 classification of brain tumors-what neurosurgeons need to know</span>. <i>Acta Neurochir.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">403</span>– <span class="NLM_lpage">418</span>, <span class="refDoi"> DOI: 10.1007/s00701-016-3062-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1007%2Fs00701-016-3062-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=28093610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A280%3ADC%252BC1c7mtlGquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2017&pages=403-418&author=R.+Bananauthor=C.+Hartmann&title=The+new+WHO+2016+classification+of+brain+tumors-what+neurosurgeons+need+to+know&doi=10.1007%2Fs00701-016-3062-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The new WHO 2016 classification of brain tumors-what neurosurgeons need to know</span></div><div class="casAuthors">Banan Rouzbeh; Hartmann Christian</div><div class="citationInfo"><span class="NLM_cas:title">Acta neurochirurgica</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">403-418</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The understanding of molecular alterations of tumors has severely changed the concept of classification in all fields of pathology.  The availability of high-throughput technologies such as next-generation sequencing allows for a much more precise definition of tumor entities.  Also in the field of brain tumors a dramatic increase of knowledge has occurred over the last years partially calling into question the purely morphologically based concepts that were used as exclusive defining criteria in the WHO 2007 classification.  METHODS:  Review of the WHO 2016 classification of brain tumors as well as a search and review of publications in the literature relevant for brain tumor classification from 2007 up to now.  RESULTS:  The idea of incorporating the molecular features in classifying tumors of the central nervous system led the authors of the new WHO 2016 classification to encounter inevitable conceptual problems, particularly with respect to linking morphology to molecular alterations.  As a solution they introduced the concept of a "layered diagnosis" to the classification of brain tumors that still allows at a lower level a purely morphologically based diagnosis while partially forcing the incorporation of molecular characteristics for an "integrated diagnosis" at the highest diagnostic level.  In this context the broad availability of molecular assays was debated.  On the one hand molecular antibodies specifically targeting mutated proteins should be available in nearly all neuropathological laboratories.  On the other hand, different high-throughput assays are accessible only in few first-world neuropathological institutions.  As examples oligodendrogliomas are now primarily defined by molecular characteristics since the required assays are generally established, whereas molecular grouping of ependymomas, found to clearly outperform morphologically based tumor interpretation, was rejected from inclusion in the WHO 2016 classification because the required assays are currently only established in a small number of institutions.  CONCLUSION:  In summary, while neuropathologists have now encountered various challenges in the transitional phase from the previous WHO 2007 version to the new WHO 2016 classification of brain tumors, clinical neurooncologists now face many new diagnoses allowing a clearly improved understanding that could offer them more effective therapeutic opportunities in neurooncological treatment.  The new WHO 2016 classification presumably presents the highest number of modifications since the initial WHO classification of 1979 and thereby forces all professionals in the field of neurooncology to intensively understand the new concepts.  This review article aims to present the basic concepts of the new WHO 2016 brain tumor classification for neurosurgeons with a focus on neurooncology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTjanB76ivI2vEeosoOnpOLfW6udTcc2ebh6zw6s54X3rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7mtlGquw%253D%253D&md5=e11e8c94b94f7d0ddfe6cb01a81d764f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1007%2Fs00701-016-3062-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00701-016-3062-3%26sid%3Dliteratum%253Aachs%26aulast%3DBanan%26aufirst%3DR.%26aulast%3DHartmann%26aufirst%3DC.%26atitle%3DThe%2520new%2520WHO%25202016%2520classification%2520of%2520brain%2520tumors-what%2520neurosurgeons%2520need%2520to%2520know%26jtitle%3DActa%2520Neurochir.%26date%3D2017%26volume%3D159%26spage%3D403%26epage%3D418%26doi%3D10.1007%2Fs00701-016-3062-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eckel-Passow, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachance, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinaro, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicotte, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pekmezci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosel, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smirnov, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollmeyer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Praska, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chada, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracci, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pico, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckner, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huse, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tihan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prados, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiemels, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiencke, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrensch, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, R. B.</span></span> <span> </span><span class="NLM_article-title">Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>372</i></span>,  <span class="NLM_fpage">2499</span>– <span class="NLM_lpage">2508</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1407279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1056%2FNEJMoa1407279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=26061753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFyrsbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2015&pages=2499-2508&author=J.+E.+Eckel-Passowauthor=D.+H.+Lachanceauthor=A.+M.+Molinaroauthor=K.+M.+Walshauthor=P.+A.+Deckerauthor=H.+Sicotteauthor=M.+Pekmezciauthor=T.+Riceauthor=M.+L.+Koselauthor=I.+V.+Smirnovauthor=G.+Sarkarauthor=A.+A.+Caronauthor=T.+M.+Kollmeyerauthor=C.+Praskaauthor=A.+R.+Chadaauthor=C.+Halderauthor=H.+M.+Hansenauthor=L.+S.+McCoyauthor=P.+M.+Bracciauthor=R.+Marshallauthor=S.+Zhengauthor=G.+F.+Reisauthor=A.+R.+Picoauthor=B.+P.+O%E2%80%99Neillauthor=J.+C.+Bucknerauthor=C.+Gianniniauthor=J.+T.+Huseauthor=A.+Perryauthor=T.+Tihanauthor=M.+S.+Bergerauthor=S.+M.+Changauthor=M.+D.+Pradosauthor=J.+Wiemelsauthor=J.+K.+Wienckeauthor=M.+R.+Wrenschauthor=R.+B.+Jenkins&title=Glioma+groups+based+on+1p%2F19q%2C+IDH%2C+and+TERT+promoter+mutations+in+tumors&doi=10.1056%2FNEJMoa1407279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors</span></div><div class="casAuthors">Eckel-Passow, Jeanette E.; Lachance, Daniel H.; Molinaro, Annette M.; Walsh, Kyle M.; Decker, Paul A.; Sicotte, Hugues; Pekmezci, Melike; Rice, Terri; Kosel, Matt L.; Smirnov, Ivan V.; Sarkar, Gobinda; Caron, Alissa A.; Kollmeyer, Thomas M.; Praska, Corinne E.; Chada, Anisha R.; Halder, Chandralekha; Hansen, Helen M.; McCoy, Lucie S.; Bracci, Paige M.; Marshall, Roxanne; Zheng, Shichun; Reis, Gerald F.; Pico, Alexander R.; O'Neill, Brian P.; Buckner, Jan C.; Giannini, Caterina; Huse, Jason T.; Perry, Arie; Tihan, Tarik; Berger, Mitchell S.; Chang, Susan M.; Prados, Michael D.; Wiemels, Joseph; Wiencke, John K.; Wrensch, Margaret R.; Jenkins, Robert B.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2499-2508</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background The prediction of clin. behavior, response to therapy, and outcome of infiltrative glioma is challenging.  On the basis of previous studies of tumor biol., we defined five glioma mol. groups with the use of three alterations: mutations in the TERT promoter, mutations in IDH, and codeletion of chromosome arms 1p and 19q (1p/19q codeletion).  We tested the hypothesis that within groups based on these features, tumors would have similar clin. variables, acquired somatic alterations, and germline variants. methods We scored tumors as neg. or pos. for each of these markers in 1087 gliomas and compared acquired alterations and patient characteristics among the five primary mol. groups.  Using 11,590 controls, we assessed assocns. between these groups and known glioma germline variants. results Among 615 grade II or III gliomas, 29% had all three alterations (i.e., were triple-pos.), 5% had TERT and IDH mutations, 45% had only IDH mutations, 7% were triple-neg., and 10% had only TERT mutations; 5% had other combinations.  Among 472 grade IV gliomas, less than 1% were triple-pos., 2% had TERT and IDH mutations, 7% had only IDH mutations, 17% were triple-neg., and 74% had only TERT mutations.  The mean age at diagnosis was lowest (37 years) among patients who had gliomas with only IDH mutations and was highest (59 years) among patients who had gliomas with only TERT mutations.  The mol. groups were independently assocd. with overall survival among patients with grade II or III gliomas but not among patients with grade IV gliomas.  The mol. groups were assocd. with specific germline variants. conclusions Gliomas were classified into five principal groups on the basis of three tumor markers.  The groups had different ages at onset, overall survival, and assocns. with germline variants, which implies that they are characterized by distinct mechanisms of pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8ytJLCkPFMrVg90H21EOLACvtfcHk0litT4RN8XB4oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFyrsbvO&md5=940207df9fe93ba0c094f089746e1652</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1407279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1407279%26sid%3Dliteratum%253Aachs%26aulast%3DEckel-Passow%26aufirst%3DJ.%2BE.%26aulast%3DLachance%26aufirst%3DD.%2BH.%26aulast%3DMolinaro%26aufirst%3DA.%2BM.%26aulast%3DWalsh%26aufirst%3DK.%2BM.%26aulast%3DDecker%26aufirst%3DP.%2BA.%26aulast%3DSicotte%26aufirst%3DH.%26aulast%3DPekmezci%26aufirst%3DM.%26aulast%3DRice%26aufirst%3DT.%26aulast%3DKosel%26aufirst%3DM.%2BL.%26aulast%3DSmirnov%26aufirst%3DI.%2BV.%26aulast%3DSarkar%26aufirst%3DG.%26aulast%3DCaron%26aufirst%3DA.%2BA.%26aulast%3DKollmeyer%26aufirst%3DT.%2BM.%26aulast%3DPraska%26aufirst%3DC.%26aulast%3DChada%26aufirst%3DA.%2BR.%26aulast%3DHalder%26aufirst%3DC.%26aulast%3DHansen%26aufirst%3DH.%2BM.%26aulast%3DMcCoy%26aufirst%3DL.%2BS.%26aulast%3DBracci%26aufirst%3DP.%2BM.%26aulast%3DMarshall%26aufirst%3DR.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DReis%26aufirst%3DG.%2BF.%26aulast%3DPico%26aufirst%3DA.%2BR.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BP.%26aulast%3DBuckner%26aufirst%3DJ.%2BC.%26aulast%3DGiannini%26aufirst%3DC.%26aulast%3DHuse%26aufirst%3DJ.%2BT.%26aulast%3DPerry%26aufirst%3DA.%26aulast%3DTihan%26aufirst%3DT.%26aulast%3DBerger%26aufirst%3DM.%2BS.%26aulast%3DChang%26aufirst%3DS.%2BM.%26aulast%3DPrados%26aufirst%3DM.%2BD.%26aulast%3DWiemels%26aufirst%3DJ.%26aulast%3DWiencke%26aufirst%3DJ.%2BK.%26aulast%3DWrensch%26aufirst%3DM.%2BR.%26aulast%3DJenkins%26aufirst%3DR.%2BB.%26atitle%3DGlioma%2520groups%2520based%2520on%25201p%252F19q%252C%2520IDH%252C%2520and%2520TERT%2520promoter%2520mutations%2520in%2520tumors%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D372%26spage%3D2499%26epage%3D2508%26doi%3D10.1056%2FNEJMoa1407279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korshunov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Deimling, A.</span></span> <span> </span><span class="NLM_article-title">Analysis of the IDH1 codon 132 mutation in brain tumors</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">597</span>– <span class="NLM_lpage">602</span>, <span class="refDoi"> DOI: 10.1007/s00401-008-0455-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1007%2Fs00401-008-0455-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=18985363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlyhsbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2008&pages=597-602&author=J.+Balssauthor=J.+Meyerauthor=W.+Muellerauthor=A.+Korshunovauthor=C.+Hartmannauthor=A.+von+Deimling&title=Analysis+of+the+IDH1+codon+132+mutation+in+brain+tumors&doi=10.1007%2Fs00401-008-0455-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of the IDH1 codon 132 mutation in brain tumors</span></div><div class="casAuthors">Balss, Joerg; Meyer, Jochen; Mueller, Wolf; Korshunov, Andrey; Hartmann, Christian; Deimling, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">597-602</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A recent study reported on mutations in the active site of the isocitrate dehydrogenase (IDH1) gene in 12% of glioblastomas.  All mutations detected resulted in an amino acid exchange in position 132.  We analyzed the genomic region spanning wild type R132 of IDH1 by direct sequencing in 685 brain tumors including 41 pilocytic astrocytomas, 12 subependymal giant cell astrocytomas, 7 pleomorphic xanthoastrocytomas, 93 diffuse astrocytomas, 120 adult glioblastomas, 14 pediatric glioblastomas, 105 oligodendrogliomas, 83 oligoastrocytomas, 31 ependymomas, 58 medulloblastomas, 9 supratentorial primitive neuroectodermal tumors, 17 schwannomas, 72 meningiomas and 23 pituitary adenomas.  A total of 221 somatic IDH1 mutations were detected and the highest frequencies occurred in diffuse astrocytomas (68%), oligodendrogliomas (69%), oligoastrocytomas (78%) and secondary glioblastomas (88%).  Primary glioblastomas and other entities were characterized by a low frequency or absence of mutations in amino acid position 132 of IDH1.  The very high frequency of IDH1 mutations in WHO grade II astrocytic and oligodendroglial gliomas suggests a role in early tumor development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6yX24ZGaBg7Vg90H21EOLACvtfcHk0litT4RN8XB4oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlyhsbfN&md5=3e36ffca189233b12d0e81e9e3a4da9c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs00401-008-0455-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-008-0455-2%26sid%3Dliteratum%253Aachs%26aulast%3DBalss%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DJ.%26aulast%3DMueller%26aufirst%3DW.%26aulast%3DKorshunov%26aufirst%3DA.%26aulast%3DHartmann%26aufirst%3DC.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26atitle%3DAnalysis%2520of%2520the%2520IDH1%2520codon%2520132%2520mutation%2520in%2520brain%2520tumors%26jtitle%3DActa%2520Neuropathol.%26date%3D2008%26volume%3D116%26spage%3D597%26epage%3D602%26doi%3D10.1007%2Fs00401-008-0455-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Welch, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ley, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Link, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koboldt, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wartman, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamprecht, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandoth, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulton, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLellan, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dooling, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallis, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalicki-Veizer, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Laughlin, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMichael, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delehaunty, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulton, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magrini, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeter, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vickery, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hundal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alldredge, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wylie, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heath, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varghese, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagarajan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payton, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baty, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klco, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasson, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westervelt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubert, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiPersio, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mardis, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, R. K.</span></span> <span> </span><span class="NLM_article-title">The origin and evolution of mutations in acute myeloid leukemia</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">264</span>– <span class="NLM_lpage">278</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.06.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1016%2Fj.cell.2012.06.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=22817890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVyms7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2012&pages=264-278&author=J.+S.+Welchauthor=T.+J.+Leyauthor=D.+C.+Linkauthor=C.+A.+Millerauthor=D.+E.+Larsonauthor=D.+C.+Koboldtauthor=L.+D.+Wartmanauthor=T.+L.+Lamprechtauthor=F.+Liuauthor=J.+Xiaauthor=C.+Kandothauthor=R.+S.+Fultonauthor=M.+D.+McLellanauthor=D.+J.+Doolingauthor=J.+W.+Wallisauthor=K.+Chenauthor=C.+C.+Harrisauthor=H.+K.+Schmidtauthor=J.+M.+Kalicki-Veizerauthor=C.+Luauthor=Q.+Zhangauthor=L.+Linauthor=M.+D.+O%E2%80%99Laughlinauthor=J.+F.+McMichaelauthor=K.+D.+Delehauntyauthor=L.+A.+Fultonauthor=V.+J.+Magriniauthor=S.+D.+McGrathauthor=R.+T.+Demeterauthor=T.+L.+Vickeryauthor=J.+Hundalauthor=L.+L.+Cookauthor=G.+W.+Swiftauthor=J.+P.+Reedauthor=P.+A.+Alldredgeauthor=T.+N.+Wylieauthor=J.+R.+Walkerauthor=M.+A.+Watsonauthor=S.+E.+Heathauthor=W.+D.+Shannonauthor=N.+Vargheseauthor=R.+Nagarajanauthor=J.+E.+Paytonauthor=J.+D.+Batyauthor=S.+Kulkarniauthor=J.+M.+Klcoauthor=M.+H.+Tomassonauthor=P.+Westerveltauthor=M.+J.+Walterauthor=T.+A.+Graubertauthor=J.+F.+DiPersioauthor=L.+Dingauthor=E.+R.+Mardisauthor=R.+K.+Wilson&title=The+origin+and+evolution+of+mutations+in+acute+myeloid+leukemia&doi=10.1016%2Fj.cell.2012.06.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The origin and evolution of mutations in acute myeloid leukemia</span></div><div class="casAuthors">Welch, John S.; Ley, Timothy J.; Link, Daniel C.; Miller, Christopher A.; Larson, David E.; Koboldt, Daniel C.; Wartman, Lukas D.; Lamprecht, Tamara L.; Liu, Fulu; Xia, Jun; Kandoth, Cyriac; Fulton, Robert S.; McLellan, Michael D.; Dooling, David J.; Wallis, John W.; Chen, Ken; Harris, Christopher C.; Schmidt, Heather K.; Kalicki-Veizer, Joelle M.; Lu, Charles; Zhang, Qunyuan; Lin, Ling; O'Laughlin, Michelle D.; McMichael, Joshua F.; Delehaunty, Kim D.; Fulton, Lucinda A.; Magrini, Vincent J.; McGrath, Sean D.; Demeter, Ryan T.; Vickery, Tammi L.; Hundal, Jasreet; Cook, Lisa L.; Swift, Gary W.; Reed, Jerry P.; Alldredge, Patricia A.; Wylie, Todd N.; Walker, Jason R.; Watson, Mark A.; Heath, Sharon E.; Shannon, William D.; Varghese, Nobish; Nagarajan, Rakesh; Payton, Jacqueline E.; Baty, Jack D.; Kulkarni, Shashikant; Klco, Jeffery M.; Tomasson, Michael H.; Westervelt, Peter; Walter, Matthew J.; Graubert, Timothy A.; DiPersio, John F.; Ding, Li; Mardis, Elaine R.; Wilson, Richard K.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">264-278</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Most mutations in cancer genomes are thought to be acquired after the initiating event, which may cause genomic instability and drive clonal evolution.  However, for acute myeloid leukemia (AML), normal karyotypes are common, and genomic instability is unusual.  To better understand clonal evolution in AML, we sequenced the genomes of M3-AML samples with a known initiating event (PML-RARA) vs. the genomes of normal karyotype M1-AML samples and the exomes of hematopoietic stem/progenitor cells (HSPCs) from healthy people.  Collectively, the data suggest that most of the mutations found in AML genomes are actually random events that occurred in HSPCs before they acquired the initiating mutation; the mutational history of that cell is "captured" as the clone expands.  In many cases, only one or two addnl., cooperating mutations are needed to generate the malignant founding clone.  Cells from the founding clone can acquire addnl. cooperating mutations, yielding subclones that can contribute to disease progression and/or relapse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquUH22-h3l2LVg90H21EOLACvtfcHk0lgBUHPpvt6yaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVyms7jP&md5=575c8c5d3907347ca83a7f2c49b4764d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.06.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.06.023%26sid%3Dliteratum%253Aachs%26aulast%3DWelch%26aufirst%3DJ.%2BS.%26aulast%3DLey%26aufirst%3DT.%2BJ.%26aulast%3DLink%26aufirst%3DD.%2BC.%26aulast%3DMiller%26aufirst%3DC.%2BA.%26aulast%3DLarson%26aufirst%3DD.%2BE.%26aulast%3DKoboldt%26aufirst%3DD.%2BC.%26aulast%3DWartman%26aufirst%3DL.%2BD.%26aulast%3DLamprecht%26aufirst%3DT.%2BL.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DXia%26aufirst%3DJ.%26aulast%3DKandoth%26aufirst%3DC.%26aulast%3DFulton%26aufirst%3DR.%2BS.%26aulast%3DMcLellan%26aufirst%3DM.%2BD.%26aulast%3DDooling%26aufirst%3DD.%2BJ.%26aulast%3DWallis%26aufirst%3DJ.%2BW.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DHarris%26aufirst%3DC.%2BC.%26aulast%3DSchmidt%26aufirst%3DH.%2BK.%26aulast%3DKalicki-Veizer%26aufirst%3DJ.%2BM.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Laughlin%26aufirst%3DM.%2BD.%26aulast%3DMcMichael%26aufirst%3DJ.%2BF.%26aulast%3DDelehaunty%26aufirst%3DK.%2BD.%26aulast%3DFulton%26aufirst%3DL.%2BA.%26aulast%3DMagrini%26aufirst%3DV.%2BJ.%26aulast%3DMcGrath%26aufirst%3DS.%2BD.%26aulast%3DDemeter%26aufirst%3DR.%2BT.%26aulast%3DVickery%26aufirst%3DT.%2BL.%26aulast%3DHundal%26aufirst%3DJ.%26aulast%3DCook%26aufirst%3DL.%2BL.%26aulast%3DSwift%26aufirst%3DG.%2BW.%26aulast%3DReed%26aufirst%3DJ.%2BP.%26aulast%3DAlldredge%26aufirst%3DP.%2BA.%26aulast%3DWylie%26aufirst%3DT.%2BN.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DWatson%26aufirst%3DM.%2BA.%26aulast%3DHeath%26aufirst%3DS.%2BE.%26aulast%3DShannon%26aufirst%3DW.%2BD.%26aulast%3DVarghese%26aufirst%3DN.%26aulast%3DNagarajan%26aufirst%3DR.%26aulast%3DPayton%26aufirst%3DJ.%2BE.%26aulast%3DBaty%26aufirst%3DJ.%2BD.%26aulast%3DKulkarni%26aufirst%3DS.%26aulast%3DKlco%26aufirst%3DJ.%2BM.%26aulast%3DTomasson%26aufirst%3DM.%2BH.%26aulast%3DWestervelt%26aufirst%3DP.%26aulast%3DWalter%26aufirst%3DM.%2BJ.%26aulast%3DGraubert%26aufirst%3DT.%2BA.%26aulast%3DDiPersio%26aufirst%3DJ.%2BF.%26aulast%3DDing%26aufirst%3DL.%26aulast%3DMardis%26aufirst%3DE.%2BR.%26aulast%3DWilson%26aufirst%3DR.%2BK.%26atitle%3DThe%2520origin%2520and%2520evolution%2520of%2520mutations%2520in%2520acute%2520myeloid%2520leukemia%26jtitle%3DCell%26date%3D2012%26volume%3D150%26spage%3D264%26epage%3D278%26doi%3D10.1016%2Fj.cell.2012.06.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knobbe, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munger, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lind, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brüstle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakeham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haight, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You-Ten, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schalm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virtanen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reifenberger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figueroa, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zúñiga-Pflücker, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">IDH1 (R132H) mutation increases murine haematopoietic progenitors and alters epigenetics</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>488</i></span>,  <span class="NLM_fpage">656</span>– <span class="NLM_lpage">659</span>, <span class="refDoi"> DOI: 10.1038/nature11323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1038%2Fnature11323" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=656-659&author=M.+Sasakiauthor=C.+B.+Knobbeauthor=J.+C.+Mungerauthor=E.+F.+Lindauthor=D.+Brennerauthor=A.+Br%C3%BCstleauthor=I.+S.+Harrisauthor=R.+Holmesauthor=A.+Wakehamauthor=J.+Haightauthor=A.+You-Tenauthor=W.+Y.+Liauthor=S.+Schalmauthor=S.+M.+Suauthor=C.+Virtanenauthor=G.+Reifenbergerauthor=P.+S.+Ohashiauthor=D.+L.+Barberauthor=M.+E.+Figueroaauthor=A.+Melnickauthor=J.+C.+Z%C3%BA%C3%B1iga-Pfl%C3%BCckerauthor=T.+W.+Mak&title=IDH1+%28R132H%29+mutation+increases+murine+haematopoietic+progenitors+and+alters+epigenetics&doi=10.1038%2Fnature11323"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnature11323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11323%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DKnobbe%26aufirst%3DC.%2BB.%26aulast%3DMunger%26aufirst%3DJ.%2BC.%26aulast%3DLind%26aufirst%3DE.%2BF.%26aulast%3DBrenner%26aufirst%3DD.%26aulast%3DBr%25C3%25BCstle%26aufirst%3DA.%26aulast%3DHarris%26aufirst%3DI.%2BS.%26aulast%3DHolmes%26aufirst%3DR.%26aulast%3DWakeham%26aufirst%3DA.%26aulast%3DHaight%26aufirst%3DJ.%26aulast%3DYou-Ten%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DW.%2BY.%26aulast%3DSchalm%26aufirst%3DS.%26aulast%3DSu%26aufirst%3DS.%2BM.%26aulast%3DVirtanen%26aufirst%3DC.%26aulast%3DReifenberger%26aufirst%3DG.%26aulast%3DOhashi%26aufirst%3DP.%2BS.%26aulast%3DBarber%26aufirst%3DD.%2BL.%26aulast%3DFigueroa%26aufirst%3DM.%2BE.%26aulast%3DMelnick%26aufirst%3DA.%26aulast%3DZ%25C3%25BA%25C3%25B1iga-Pfl%25C3%25BCcker%26aufirst%3DJ.%2BC.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DIDH1%2520%2528R132H%2529%2520mutation%2520increases%2520murine%2520haematopoietic%2520progenitors%2520and%2520alters%2520epigenetics%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D656%26epage%3D659%26doi%3D10.1038%2Fnature11323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shroff, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. W.</span></span> <span> </span><span class="NLM_article-title">Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1974</span>– <span class="NLM_lpage">1985</span>, <span class="refDoi"> DOI: 10.1101/gad.226613.113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1101%2Fgad.226613.113" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=1974-1985&author=C.+Chenauthor=Y.+Liuauthor=C.+Luauthor=J.+R.+Crossauthor=J.+P.+Morrisauthor=A.+S.+Shroffauthor=P.+S.+Wardauthor=J.+E.+Bradnerauthor=C.+Thompsonauthor=S.+W.+Lowe&title=Cancer-associated+IDH2+mutants+drive+an+acute+myeloid+leukemia+that+is+susceptible+to+Brd4+inhibition&doi=10.1101%2Fgad.226613.113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1101%2Fgad.226613.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.226613.113%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DCross%26aufirst%3DJ.%2BR.%26aulast%3DMorris%26aufirst%3DJ.%2BP.%26aulast%3DShroff%26aufirst%3DA.%2BS.%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DC.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26atitle%3DCancer-associated%2520IDH2%2520mutants%2520drive%2520an%2520acute%2520myeloid%2520leukemia%2520that%2520is%2520susceptible%2520to%2520Brd4%2520inhibition%26jtitle%3DGenes%2520Dev.%26date%3D2013%26volume%3D27%26spage%3D1974%26epage%3D1985%26doi%3D10.1101%2Fgad.226613.113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fathi, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadrzadeh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borger, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballen, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amrein, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attar, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matulis, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmonds, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iafrate, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straley, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agresta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkein, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuberg, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. B.</span></span> <span> </span><span class="NLM_article-title">Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">4649</span>– <span class="NLM_lpage">4652</span>, <span class="refDoi"> DOI: 10.1182/blood-2012-06-438267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1182%2Fblood-2012-06-438267" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=4649-4652&author=A.+T.+Fathiauthor=H.+Sadrzadehauthor=D.+R.+Borgerauthor=K.+K.+Ballenauthor=P.+C.+Amreinauthor=E.+C.+Attarauthor=J.+Fosterauthor=M.+Burkeauthor=H.+U.+Lopezauthor=C.+R.+Matulisauthor=K.+M.+Edmondsauthor=A.+J.+Iafrateauthor=K.+S.+Straleyauthor=K.+E.+Yenauthor=S.+Agrestaauthor=D.+P.+Schenkeinauthor=C.+Hillauthor=A.+Emadiauthor=D.+S.+Neubergauthor=R.+M.+Stoneauthor=Y.+B.+Chen&title=Prospective+serial+evaluation+of+2-hydroxyglutarate%2C+during+treatment+of+newly+diagnosed+acute+myeloid+leukemia%2C+to+assess+disease+activity+and+therapeutic+response&doi=10.1182%2Fblood-2012-06-438267"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1182%2Fblood-2012-06-438267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2012-06-438267%26sid%3Dliteratum%253Aachs%26aulast%3DFathi%26aufirst%3DA.%2BT.%26aulast%3DSadrzadeh%26aufirst%3DH.%26aulast%3DBorger%26aufirst%3DD.%2BR.%26aulast%3DBallen%26aufirst%3DK.%2BK.%26aulast%3DAmrein%26aufirst%3DP.%2BC.%26aulast%3DAttar%26aufirst%3DE.%2BC.%26aulast%3DFoster%26aufirst%3DJ.%26aulast%3DBurke%26aufirst%3DM.%26aulast%3DLopez%26aufirst%3DH.%2BU.%26aulast%3DMatulis%26aufirst%3DC.%2BR.%26aulast%3DEdmonds%26aufirst%3DK.%2BM.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26aulast%3DStraley%26aufirst%3DK.%2BS.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DAgresta%26aufirst%3DS.%26aulast%3DSchenkein%26aufirst%3DD.%2BP.%26aulast%3DHill%26aufirst%3DC.%26aulast%3DEmadi%26aufirst%3DA.%26aulast%3DNeuberg%26aufirst%3DD.%2BS.%26aulast%3DStone%26aufirst%3DR.%2BM.%26aulast%3DChen%26aufirst%3DY.%2BB.%26atitle%3DProspective%2520serial%2520evaluation%2520of%25202-hydroxyglutarate%252C%2520during%2520treatment%2520of%2520newly%2520diagnosed%2520acute%2520myeloid%2520leukemia%252C%2520to%2520assess%2520disease%2520activity%2520and%2520therapeutic%2520response%26jtitle%3DBlood%26date%3D2012%26volume%3D120%26spage%3D4649%26epage%3D4652%26doi%3D10.1182%2Fblood-2012-06-438267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tefferi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulai, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasho, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finke, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knudson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardanani, A.</span></span> <span> </span><span class="NLM_article-title">IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">475</span>– <span class="NLM_lpage">480</span>, <span class="refDoi"> DOI: 10.1038/leu.2011.253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1038%2Fleu.2011.253" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=475-480&author=A.+Tefferiauthor=T.+Jimmaauthor=N.+H.+Sulaiauthor=T.+L.+Lashoauthor=C.+M.+Finkeauthor=R.+A.+Knudsonauthor=R.+F.+McClureauthor=A.+Pardanani&title=IDH+mutations+in+primary+myelofibrosis+predict+leukemic+transformation+and+shortened+survival%3A+clinical+evidence+for+leukemogenic+collaboration+with+JAK2V617F&doi=10.1038%2Fleu.2011.253"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fleu.2011.253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2011.253%26sid%3Dliteratum%253Aachs%26aulast%3DTefferi%26aufirst%3DA.%26aulast%3DJimma%26aufirst%3DT.%26aulast%3DSulai%26aufirst%3DN.%2BH.%26aulast%3DLasho%26aufirst%3DT.%2BL.%26aulast%3DFinke%26aufirst%3DC.%2BM.%26aulast%3DKnudson%26aufirst%3DR.%2BA.%26aulast%3DMcClure%26aufirst%3DR.%2BF.%26aulast%3DPardanani%26aufirst%3DA.%26atitle%3DIDH%2520mutations%2520in%2520primary%2520myelofibrosis%2520predict%2520leukemic%2520transformation%2520and%2520shortened%2520survival%253A%2520clinical%2520evidence%2520for%2520leukemogenic%2520collaboration%2520with%2520JAK2V617F%26jtitle%3DLeukemia%26date%3D2012%26volume%3D26%26spage%3D475%26epage%3D480%26doi%3D10.1038%2Fleu.2011.253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saha, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parachoniak, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghanta, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitamant, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Najem, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurumurthy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akbay, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornella, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miltiadous, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walesky, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshpande, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, A. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hezel, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straley, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travins, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovici-Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gliser, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrone, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apte, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llovet, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaswamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardeesy, N.</span></span> <span> </span><span class="NLM_article-title">Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>513</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1038/nature13441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1038%2Fnature13441" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=513&publication_year=2014&pages=110-114&author=S.+K.+Sahaauthor=C.+A.+Parachoniakauthor=K.+S.+Ghantaauthor=J.+Fitamantauthor=K.+N.+Rossauthor=M.+S.+Najemauthor=S.+Gurumurthyauthor=E.+A.+Akbayauthor=D.+Siaauthor=H.+Cornellaauthor=O.+Miltiadousauthor=C.+Waleskyauthor=V.+Deshpandeauthor=A.+X.+Zhuauthor=A.+F.+Hezelauthor=K.+E.+Yenauthor=K.+S.+Straleyauthor=J.+Travinsauthor=J.+Popovici-Mullerauthor=C.+Gliserauthor=C.+R.+Ferroneauthor=U.+Apteauthor=J.+M.+Llovetauthor=K.+K.+Wongauthor=S.+Ramaswamyauthor=N.+Bardeesy&title=Mutant+IDH+inhibits+HNF-4%CE%B1+to+block+hepatocyte+differentiation+and+promote+biliary+cancer&doi=10.1038%2Fnature13441"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnature13441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13441%26sid%3Dliteratum%253Aachs%26aulast%3DSaha%26aufirst%3DS.%2BK.%26aulast%3DParachoniak%26aufirst%3DC.%2BA.%26aulast%3DGhanta%26aufirst%3DK.%2BS.%26aulast%3DFitamant%26aufirst%3DJ.%26aulast%3DRoss%26aufirst%3DK.%2BN.%26aulast%3DNajem%26aufirst%3DM.%2BS.%26aulast%3DGurumurthy%26aufirst%3DS.%26aulast%3DAkbay%26aufirst%3DE.%2BA.%26aulast%3DSia%26aufirst%3DD.%26aulast%3DCornella%26aufirst%3DH.%26aulast%3DMiltiadous%26aufirst%3DO.%26aulast%3DWalesky%26aufirst%3DC.%26aulast%3DDeshpande%26aufirst%3DV.%26aulast%3DZhu%26aufirst%3DA.%2BX.%26aulast%3DHezel%26aufirst%3DA.%2BF.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DStraley%26aufirst%3DK.%2BS.%26aulast%3DTravins%26aufirst%3DJ.%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DGliser%26aufirst%3DC.%26aulast%3DFerrone%26aufirst%3DC.%2BR.%26aulast%3DApte%26aufirst%3DU.%26aulast%3DLlovet%26aufirst%3DJ.%2BM.%26aulast%3DWong%26aufirst%3DK.%2BK.%26aulast%3DRamaswamy%26aufirst%3DS.%26aulast%3DBardeesy%26aufirst%3DN.%26atitle%3DMutant%2520IDH%2520inhibits%2520HNF-4%25CE%25B1%2520to%2520block%2520hepatocyte%2520differentiation%2520and%2520promote%2520biliary%2520cancer%26jtitle%3DNature%26date%3D2014%26volume%3D513%26spage%3D110%26epage%3D114%26doi%3D10.1038%2Fnature13441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairns, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puviindran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snow, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadesan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whetstone, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gliser, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wunder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alman, B. A.</span></span> <span> </span><span class="NLM_article-title">Mutant IDH is sufficient to initiate enchondromatosis in mice</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">2829</span>– <span class="NLM_lpage">2834</span>, <span class="refDoi"> DOI: 10.1073/pnas.1424400112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1073%2Fpnas.1424400112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=25730874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFajs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=2829-2834&author=M.+Hirataauthor=M.+Sasakiauthor=R.+A.+Cairnsauthor=S.+Inoueauthor=V.+Puviindranauthor=W.+Y.+Liauthor=B.+E.+Snowauthor=L.+D.+Jonesauthor=Q.+Weiauthor=S.+Satoauthor=Y.+J.+Tangauthor=P.+Nadesanauthor=J.+Rockelauthor=H.+Whetstoneauthor=R.+Poonauthor=A.+Wengauthor=S.+Grossauthor=K.+Straleyauthor=C.+Gliserauthor=Y.+Xuauthor=J.+Wunderauthor=T.+W.+Makauthor=B.+A.+Alman&title=Mutant+IDH+is+sufficient+to+initiate+enchondromatosis+in+mice&doi=10.1073%2Fpnas.1424400112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Mutant IDH is sufficient to initiate enchondromatosis in mice</span></div><div class="casAuthors">Hirata, Makoto; Sasaki, Masato; Cairns, Rob A.; Inoue, Satoshi; Puviindran, Vijitha; Li, Wanda Y.; Snow, Bryan E.; Jones, Lisa D.; Wei, Qingxia; Sato, Shingo; Tang, Yuning J.; Nadesan, Puviindran; Rockel, Jason; Whetstone, Heather; Poon, Raymond; Weng, Angela; Gross, Stefan; Straley, Kimberly; Gliser, Camelia; Xu, Yingxia; Wunder, Jay; Mak, Tak W.; Alman, Benjamin A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2829-2834</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Enchondromas are benign cartilage tumors and precursors to malignant chondrosarcomas.  Somatic mutations in the isocitrate dehydrogenase genes (IDH1 and IDH2) are present in the majority of these tumor types.  How these mutations cause enchondromas is unclear.  Here, we identified the spectrum of IDH mutations in human enchondromas and chondrosarcomas and studied their effects in mice.  A broad range of mutations was identified, including the previously unreported IDH1-R132Q mutation.  These mutations harbored enzymic activity to catalyze α-ketoglutarate to D-2-hydroxyglutarate (d-2HG).  Mice expressing Idh1-R132Q in one allele in cells expressing type 2 collagen showed a disordered growth plate, with persistence of type X-expressing chondrocytes.  Chondrocyte cell cultures from these animals or controls showed that there was an increase in proliferation and expression of genes characteristic of hypertrophic chondrocytes with expression of Idh1-R132Q or 2HG treatment.  Col2a1-Cre;Idh1-R132Q mutant knock-in mice (mutant allele expressed in chondrocytes) did not survive after the neonatal stage.  Col2a1-Cre/ERT2;Idh1-R132 mutant conditional knock-in mice, in which Cre was induced by tamoxifen after weaning, developed multiple enchondroma-like lesions.  Taken together, these data show that mutant IDH or d-2HG causes persistence of chondrocytes, giving rise to rests of growth-plate cells that persist in the bone as enchondromas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1s2uRLFom1bVg90H21EOLACvtfcHk0lhyzFwDBohm4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFajs7s%253D&md5=4f3cb2cf33b52cb18442b629bcffdc02</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1424400112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1424400112%26sid%3Dliteratum%253Aachs%26aulast%3DHirata%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DCairns%26aufirst%3DR.%2BA.%26aulast%3DInoue%26aufirst%3DS.%26aulast%3DPuviindran%26aufirst%3DV.%26aulast%3DLi%26aufirst%3DW.%2BY.%26aulast%3DSnow%26aufirst%3DB.%2BE.%26aulast%3DJones%26aufirst%3DL.%2BD.%26aulast%3DWei%26aufirst%3DQ.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DY.%2BJ.%26aulast%3DNadesan%26aufirst%3DP.%26aulast%3DRockel%26aufirst%3DJ.%26aulast%3DWhetstone%26aufirst%3DH.%26aulast%3DPoon%26aufirst%3DR.%26aulast%3DWeng%26aufirst%3DA.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DStraley%26aufirst%3DK.%26aulast%3DGliser%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DWunder%26aufirst%3DJ.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DAlman%26aufirst%3DB.%2BA.%26atitle%3DMutant%2520IDH%2520is%2520sufficient%2520to%2520initiate%2520enchondromatosis%2520in%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D2829%26epage%3D2834%26doi%3D10.1073%2Fpnas.1424400112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittinger, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driggers, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantin, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keenan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prins, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liau, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vander Heiden, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S. M.</span></span> <span> </span><span class="NLM_article-title">Cancer-associated IDH1 mutations produce 2-hydroxyglutarate</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>465</i></span>,  <span class="NLM_fpage">966</span>– <span class="NLM_lpage">966</span>, <span class="refDoi"> DOI: 10.1038/nature09132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1038%2Fnature09132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=20559394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsVymu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=966-966&author=L.+Dangauthor=D.+W.+Whiteauthor=S.+Grossauthor=B.+D.+Bennettauthor=M.+A.+Bittingerauthor=E.+M.+Driggersauthor=V.+R.+Fantinauthor=H.+G.+Jangauthor=S.+Jinauthor=M.+C.+Keenanauthor=K.+M.+Marksauthor=R.+M.+Prinsauthor=P.+S.+Wardauthor=K.+E.+Yenauthor=L.+M.+Liauauthor=J.+D.+Rabinowitzauthor=L.+C.+Cantleyauthor=C.+B.+Thompsonauthor=M.+G.+Vander+Heidenauthor=S.+M.+Su&title=Cancer-associated+IDH1+mutations+produce+2-hydroxyglutarate&doi=10.1038%2Fnature09132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. [Erratum to document cited in CA152:054793]</span></div><div class="casAuthors">Dang, Lenny; White, David W.; Gross, Stefan; Bennett, Bryson D.; Bittinger, Mark A.; Driggers, Edward M.; Fantin, Valeria R.; Jang, Hyun Gyung; Jin, Shengfang; Keenan, Marie C.; Marks, Kevin M.; Prins, Robert M.; Ward, Patrick S.; Yen, Katharine E.; Liau, Linda M.; Rabinowitz, Joshua D.; Cantley, Lewis C.; Thompson, Craig B.; Vander Heiden, Matthew G.; Su, Shinsan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7300</span>),
    <span class="NLM_cas:pages">966</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The authors acknowledge that there are other mechanisms by which R(-)<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="6449242c23">[email protected]</a> may promote tumor formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiVTMGVGxJmLVg90H21EOLACvtfcHk0ljPh2NCIfXarA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsVymu7c%253D&md5=9564cf6bbfad7eae449f110e2613d426</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnature09132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09132%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DD.%2BW.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBittinger%26aufirst%3DM.%2BA.%26aulast%3DDriggers%26aufirst%3DE.%2BM.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DJang%26aufirst%3DH.%2BG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKeenan%26aufirst%3DM.%2BC.%26aulast%3DMarks%26aufirst%3DK.%2BM.%26aulast%3DPrins%26aufirst%3DR.%2BM.%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DLiau%26aufirst%3DL.%2BM.%26aulast%3DRabinowitz%26aufirst%3DJ.%2BD.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DSu%26aufirst%3DS.%2BM.%26atitle%3DCancer-associated%2520IDH1%2520mutations%2520produce%25202-hydroxyglutarate%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D966%26epage%3D966%26doi%3D10.1038%2Fnature09132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairns, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puviindran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snow, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadesan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whetstone, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gliser, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wunder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alman, B. A.</span></span> <span> </span><span class="NLM_article-title">Mutant IDH is sufficient to initiate enchondromatosis in mice</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">2829</span>– <span class="NLM_lpage">2834</span>, <span class="refDoi"> DOI: 10.1073/pnas.1424400112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1073%2Fpnas.1424400112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=25730874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFajs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=2829-2834&author=M.+Hirataauthor=M.+Sasakiauthor=R.+A.+Cairnsauthor=S.+Inoueauthor=V.+Puviindranauthor=W.+Y.+Liauthor=B.+E.+Snowauthor=L.+D.+Jonesauthor=Q.+Weiauthor=S.+Satoauthor=Y.+J.+Tangauthor=P.+Nadesanauthor=J.+Rockelauthor=H.+Whetstoneauthor=R.+Poonauthor=A.+Wengauthor=S.+Grossauthor=K.+Straleyauthor=C.+Gliserauthor=Y.+Xuauthor=J.+Wunderauthor=T.+W.+Makauthor=B.+A.+Alman&title=Mutant+IDH+is+sufficient+to+initiate+enchondromatosis+in+mice&doi=10.1073%2Fpnas.1424400112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Mutant IDH is sufficient to initiate enchondromatosis in mice</span></div><div class="casAuthors">Hirata, Makoto; Sasaki, Masato; Cairns, Rob A.; Inoue, Satoshi; Puviindran, Vijitha; Li, Wanda Y.; Snow, Bryan E.; Jones, Lisa D.; Wei, Qingxia; Sato, Shingo; Tang, Yuning J.; Nadesan, Puviindran; Rockel, Jason; Whetstone, Heather; Poon, Raymond; Weng, Angela; Gross, Stefan; Straley, Kimberly; Gliser, Camelia; Xu, Yingxia; Wunder, Jay; Mak, Tak W.; Alman, Benjamin A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2829-2834</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Enchondromas are benign cartilage tumors and precursors to malignant chondrosarcomas.  Somatic mutations in the isocitrate dehydrogenase genes (IDH1 and IDH2) are present in the majority of these tumor types.  How these mutations cause enchondromas is unclear.  Here, we identified the spectrum of IDH mutations in human enchondromas and chondrosarcomas and studied their effects in mice.  A broad range of mutations was identified, including the previously unreported IDH1-R132Q mutation.  These mutations harbored enzymic activity to catalyze α-ketoglutarate to D-2-hydroxyglutarate (d-2HG).  Mice expressing Idh1-R132Q in one allele in cells expressing type 2 collagen showed a disordered growth plate, with persistence of type X-expressing chondrocytes.  Chondrocyte cell cultures from these animals or controls showed that there was an increase in proliferation and expression of genes characteristic of hypertrophic chondrocytes with expression of Idh1-R132Q or 2HG treatment.  Col2a1-Cre;Idh1-R132Q mutant knock-in mice (mutant allele expressed in chondrocytes) did not survive after the neonatal stage.  Col2a1-Cre/ERT2;Idh1-R132 mutant conditional knock-in mice, in which Cre was induced by tamoxifen after weaning, developed multiple enchondroma-like lesions.  Taken together, these data show that mutant IDH or d-2HG causes persistence of chondrocytes, giving rise to rests of growth-plate cells that persist in the bone as enchondromas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1s2uRLFom1bVg90H21EOLACvtfcHk0ljPh2NCIfXarA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFajs7s%253D&md5=4f3cb2cf33b52cb18442b629bcffdc02</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1424400112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1424400112%26sid%3Dliteratum%253Aachs%26aulast%3DHirata%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DCairns%26aufirst%3DR.%2BA.%26aulast%3DInoue%26aufirst%3DS.%26aulast%3DPuviindran%26aufirst%3DV.%26aulast%3DLi%26aufirst%3DW.%2BY.%26aulast%3DSnow%26aufirst%3DB.%2BE.%26aulast%3DJones%26aufirst%3DL.%2BD.%26aulast%3DWei%26aufirst%3DQ.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DY.%2BJ.%26aulast%3DNadesan%26aufirst%3DP.%26aulast%3DRockel%26aufirst%3DJ.%26aulast%3DWhetstone%26aufirst%3DH.%26aulast%3DPoon%26aufirst%3DR.%26aulast%3DWeng%26aufirst%3DA.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DStraley%26aufirst%3DK.%26aulast%3DGliser%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DWunder%26aufirst%3DJ.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DAlman%26aufirst%3DB.%2BA.%26atitle%3DMutant%2520IDH%2520is%2520sufficient%2520to%2520initiate%2520enchondromatosis%2520in%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D2829%26epage%3D2834%26doi%3D10.1073%2Fpnas.1424400112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pansuriya, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Eijk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Adamo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Ruler, M. A. J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuijjer, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oosting, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleton-Jansen, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Oosterwijk, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbeke, S. L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Wezel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nord, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangiorgi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toker, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liegl-Atzwanger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">San-Julian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciot, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limaye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kindblom, L.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daugaard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godfraind, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boon, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vikkula, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurek, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szuhai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bovée, J. V. M. G.</span></span> <span> </span><span class="NLM_article-title">Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in ollier disease and maffucci syndrome</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1256</span>– <span class="NLM_lpage">1261</span>, <span class="refDoi"> DOI: 10.1038/ng.1004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1038%2Fng.1004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=22057234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVagurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2011&pages=1256-1261&author=T.+C.+Pansuriyaauthor=R.+van+Eijkauthor=P.+D%E2%80%99Adamoauthor=M.+A.+J.+H.+van+Rulerauthor=M.+L.+Kuijjerauthor=J.+Oostingauthor=A.-M.+Cleton-Jansenauthor=J.+G.+van+Oosterwijkauthor=S.+L.+J.+Verbekeauthor=D.+Meijerauthor=T.+van+Wezelauthor=K.+H.+Nordauthor=L.+Sangiorgiauthor=B.+Tokerauthor=B.+Liegl-Atzwangerauthor=M.+San-Julianauthor=R.+Sciotauthor=N.+Limayeauthor=L.-G.+Kindblomauthor=S.+Daugaardauthor=C.+Godfraindauthor=L.+M.+Boonauthor=M.+Vikkulaauthor=K.+C.+Kurekauthor=K.+Szuhaiauthor=P.+J.+Frenchauthor=J.+V.+M.+G.+Bov%C3%A9e&title=Somatic+mosaic+IDH1+and+IDH2+mutations+are+associated+with+enchondroma+and+spindle+cell+hemangioma+in+ollier+disease+and+maffucci+syndrome&doi=10.1038%2Fng.1004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome</span></div><div class="casAuthors">Pansuriya, Twinkal C.; van Eijk, Ronald; d'Adamo, Pio; van Ruler, Maayke A. J. H.; Kuijjer, Marieke L.; Oosting, Jan; Cleton-Jansen, Anne-Marie; van Oosterwijk, Jolieke G.; Verbeke, Sofie L. J.; Meijer, Danielle; van Wezel, Tom; Nord, Karolin H.; Sangiorgi, Luca; Toker, Berkin; Liegl-Atzwanger, Bernadette; San-Julian, Mikel; Sciot, Raf; Limaye, Nisha; Kindblom, Lars-Gunnar; Daugaard, Soeren; Godfraind, Catherine; Boon, Laurence M.; Vikkula, Miikka; Kurek, Kyle C.; Szuhai, Karoly; French, Pim J.; Bovee, Judith V. M. G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1256-1261</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ollier disease and Maffucci syndrome are non-hereditary skeletal disorders characterized by multiple enchondromas (Ollier disease) combined with spindle cell hemangiomas (Maffucci syndrome).  We report somatic heterozygous mutations in IDH1 (c.394C>T encoding an R132C substitution and c.395G>A encoding an R132H substitution) or IDH2 (c.516G>C encoding R172S) in 87% of enchondromas (benign cartilage tumors) and in 70% of spindle cell hemangiomas (benign vascular lesions).  In total, 35 of 43 (81%) subjects with Ollier disease and 10 of 13 (77%) with Maffucci syndrome carried IDH1 (98%) or IDH2 (2%) mutations in their tumors.  Fourteen of 16 subjects had identical mutations in sep. lesions.  Immunohistochem. to detect mutant IDH1 R132H protein suggested intraneoplastic and somatic mosaicism.  IDH1 mutations in cartilage tumors were assocd. with hypermethylation and downregulated expression of several genes.  Mutations were also found in 40% of solitary central cartilaginous tumors and in four chondrosarcoma cell lines, which will enable functional studies to assess the role of IDH1 and IDH2 mutations in tumor formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQkb5_RfkGnLVg90H21EOLACvtfcHk0lihPPCO0OCUPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVagurrO&md5=0a501826c538de8832403c0cd99030fa</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fng.1004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.1004%26sid%3Dliteratum%253Aachs%26aulast%3DPansuriya%26aufirst%3DT.%2BC.%26aulast%3Dvan%2BEijk%26aufirst%3DR.%26aulast%3DD%25E2%2580%2599Adamo%26aufirst%3DP.%26aulast%3Dvan%2BRuler%26aufirst%3DM.%2BA.%2BJ.%2BH.%26aulast%3DKuijjer%26aufirst%3DM.%2BL.%26aulast%3DOosting%26aufirst%3DJ.%26aulast%3DCleton-Jansen%26aufirst%3DA.-M.%26aulast%3Dvan%2BOosterwijk%26aufirst%3DJ.%2BG.%26aulast%3DVerbeke%26aufirst%3DS.%2BL.%2BJ.%26aulast%3DMeijer%26aufirst%3DD.%26aulast%3Dvan%2BWezel%26aufirst%3DT.%26aulast%3DNord%26aufirst%3DK.%2BH.%26aulast%3DSangiorgi%26aufirst%3DL.%26aulast%3DToker%26aufirst%3DB.%26aulast%3DLiegl-Atzwanger%26aufirst%3DB.%26aulast%3DSan-Julian%26aufirst%3DM.%26aulast%3DSciot%26aufirst%3DR.%26aulast%3DLimaye%26aufirst%3DN.%26aulast%3DKindblom%26aufirst%3DL.-G.%26aulast%3DDaugaard%26aufirst%3DS.%26aulast%3DGodfraind%26aufirst%3DC.%26aulast%3DBoon%26aufirst%3DL.%2BM.%26aulast%3DVikkula%26aufirst%3DM.%26aulast%3DKurek%26aufirst%3DK.%2BC.%26aulast%3DSzuhai%26aufirst%3DK.%26aulast%3DFrench%26aufirst%3DP.%2BJ.%26aulast%3DBov%25C3%25A9e%26aufirst%3DJ.%2BV.%2BM.%2BG.%26atitle%3DSomatic%2520mosaic%2520IDH1%2520and%2520IDH2%2520mutations%2520are%2520associated%2520with%2520enchondroma%2520and%2520spindle%2520cell%2520hemangioma%2520in%2520ollier%2520disease%2520and%2520maffucci%2520syndrome%26jtitle%3DNat.%2520Genet.%26date%3D2011%26volume%3D43%26spage%3D1256%26epage%3D1261%26doi%3D10.1038%2Fng.1004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Figueroa, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Wahab, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhagwat, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasanthakumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolniak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peeters, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantin, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paietta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Löwenberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Licht, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godley, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delwel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valk, P. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnick, A.</span></span> <span> </span><span class="NLM_article-title">Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">553</span>– <span class="NLM_lpage">567</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2010.11.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1016%2Fj.ccr.2010.11.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=21130701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGhsbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=553-567&author=M.+E.+Figueroaauthor=O.+Abdel-Wahabauthor=C.+Luauthor=P.+S.+Wardauthor=J.+Patelauthor=A.+Shihauthor=Y.+Liauthor=N.+Bhagwatauthor=A.+Vasanthakumarauthor=H.+F.+Fernandezauthor=M.+S.+Tallmanauthor=Z.+Sunauthor=K.+Wolniakauthor=J.+K.+Peetersauthor=W.+Liuauthor=S.+E.+Choeauthor=V.+R.+Fantinauthor=E.+Paiettaauthor=B.+L%C3%B6wenbergauthor=J.+D.+Lichtauthor=L.+A.+Godleyauthor=R.+Delwelauthor=P.+J.+M.+Valkauthor=C.+B.+Thompsonauthor=R.+L.+Levineauthor=A.+Melnick&title=Leukemic+IDH1+and+IDH2+mutations+result+in+a+hypermethylation+phenotype%2C+disrupt+TET2+function%2C+and+impair+hematopoietic+differentiation&doi=10.1016%2Fj.ccr.2010.11.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation</span></div><div class="casAuthors">Figueroa, Maria E.; Abdel-Wahab, Omar; Lu, Chao; Ward, Patrick S.; Patel, Jay; Shih, Alan; Li, Yushan; Bhagwat, Neha; Vasanthakumar, Aparna; Fernandez, Hugo F.; Tallman, Martin S.; Sun, Zhuoxin; Wolniak, Kristy; Peeters, Justine K.; Liu, Wei; Choe, Sung E.; Fantin, Valeria R.; Paietta, Elisabeth; Loewenberg, Bob; Licht, Jonathan D.; Godley, Lucy A.; Delwel, Ruud; Valk, Peter J. M.; Thompson, Craig B.; Levine, Ross L.; Melnick, Ari</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">553-567</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Cancer-assocd. IDH mutations are characterized by neomorphic enzyme activity and resultant 2-hydroxyglutarate (2HG) prodn.  Mutational and epigenetic profiling of a large acute myeloid leukemia (AML) patient cohort revealed that IDH1/2-mutant AMLs display global DNA hypermethylation and a specific hypermethylation signature.  Furthermore, expression of 2HG-producing IDH alleles in cells induced global DNA hypermethylation.  In the AML cohort, IDH1/2 mutations were mutually exclusive with mutations in the α-ketoglutarate-dependent enzyme TET2, and TET2 loss-of-function mutations were assocd. with similar epigenetic defects as IDH1/2 mutants.  Consistent with these genetic and epigenetic data, expression of IDH mutants impaired TET2 catalytic function in cells.  Finally, either expression of mutant IDH1/2 or Tet2 depletion impaired hematopoietic differentiation and increased stem/progenitor cell marker expression, suggesting a shared proleukemogenic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5mMhJR64Z4rVg90H21EOLACvtfcHk0lihPPCO0OCUPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGhsbvJ&md5=f058c7dbd2efd6a25f4044506b5a2ef3</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2010.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2010.11.015%26sid%3Dliteratum%253Aachs%26aulast%3DFigueroa%26aufirst%3DM.%2BE.%26aulast%3DAbdel-Wahab%26aufirst%3DO.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DPatel%26aufirst%3DJ.%26aulast%3DShih%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DBhagwat%26aufirst%3DN.%26aulast%3DVasanthakumar%26aufirst%3DA.%26aulast%3DFernandez%26aufirst%3DH.%2BF.%26aulast%3DTallman%26aufirst%3DM.%2BS.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DWolniak%26aufirst%3DK.%26aulast%3DPeeters%26aufirst%3DJ.%2BK.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DChoe%26aufirst%3DS.%2BE.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DPaietta%26aufirst%3DE.%26aulast%3DL%25C3%25B6wenberg%26aufirst%3DB.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26aulast%3DGodley%26aufirst%3DL.%2BA.%26aulast%3DDelwel%26aufirst%3DR.%26aulast%3DValk%26aufirst%3DP.%2BJ.%2BM.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DMelnick%26aufirst%3DA.%26atitle%3DLeukemic%2520IDH1%2520and%2520IDH2%2520mutations%2520result%2520in%2520a%2520hypermethylation%2520phenotype%252C%2520disrupt%2520TET2%2520function%252C%2520and%2520impair%2520hematopoietic%2520differentiation%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D18%26spage%3D553%26epage%3D567%26doi%3D10.1016%2Fj.ccr.2010.11.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Popovici-Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salituro, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straley, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunii, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantin, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biller, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of the first potent inhibitors of mutant IDH1 that lower tumor 2-HG in vivo</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">850</span>– <span class="NLM_lpage">855</span>, <span class="refDoi"> DOI: 10.1021/ml300225h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300225h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGkurnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=850-855&author=J.+Popovici-Mullerauthor=J.+O.+Saundersauthor=F.+G.+Salituroauthor=J.+M.+Travinsauthor=S.+Yanauthor=F.+Zhaoauthor=S.+Grossauthor=L.+Dangauthor=K.+E.+Yenauthor=H.+Yangauthor=K.+S.+Straleyauthor=S.+Jinauthor=K.+Kuniiauthor=V.+R.+Fantinauthor=S.+Zhangauthor=Q.+Panauthor=D.+Shiauthor=S.+A.+Billerauthor=S.+M.+Su&title=Discovery+of+the+first+potent+inhibitors+of+mutant+IDH1+that+lower+tumor+2-HG+in+vivo&doi=10.1021%2Fml300225h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo</span></div><div class="casAuthors">Popovici-Muller, Janeta; Saunders, Jeffrey O.; Salituro, Francesco G.; Travins, Jeremy M.; Yan, Shunqi; Zhao, Fang; Gross, Stefan; Dang, Lenny; Yen, Katharine E.; Yang, Hua; Straley, Kimberly S.; Jin, Shengfang; Kunii, Kaiko; Fantin, Valeria R.; Zhang, Shunan; Pan, Qiongqun; Shi, Derek; Biller, Scott A.; Su, Shinsan M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">850-855</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optimization of a series of R132H IDH1 inhibitors from a high throughput screen led to the first potent mols. that show robust tumor 2-HG inhibition in a xenograft model.  Compd. 35 shows good potency in the U87 R132H cell based assay and ∼90% tumor 2-HG inhibition in the corresponding mouse xenograft model following BID dosing.  The magnitude and duration of tumor 2-HG inhibition correlates with free plasma concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprvfJ98f1ns7Vg90H21EOLACvtfcHk0lh551OqNSbOVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGkurnE&md5=eabdaa3351155971ed3feceace0d17c4</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fml300225h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300225h%26sid%3Dliteratum%253Aachs%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DSaunders%26aufirst%3DJ.%2BO.%26aulast%3DSalituro%26aufirst%3DF.%2BG.%26aulast%3DTravins%26aufirst%3DJ.%2BM.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DDang%26aufirst%3DL.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DStraley%26aufirst%3DK.%2BS.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKunii%26aufirst%3DK.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DQ.%26aulast%3DShi%26aufirst%3DD.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DSu%26aufirst%3DS.%2BM.%26atitle%3DDiscovery%2520of%2520the%2520first%2520potent%2520inhibitors%2520of%2520mutant%2520IDH1%2520that%2520lower%2520tumor%25202-HG%2520in%2520vivo%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D850%26epage%3D855%26doi%3D10.1021%2Fml300225h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cairns, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">Oncogenic isocitrate dehydrogenase mutations: mechanisms, models, and clinical opportunities</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">730</span>– <span class="NLM_lpage">741</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-13-0083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1158%2F2159-8290.CD-13-0083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=23796461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSrtLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=730-741&author=R.+A.+Cairnsauthor=T.+W.+Mak&title=Oncogenic+isocitrate+dehydrogenase+mutations%3A+mechanisms%2C+models%2C+and+clinical+opportunities&doi=10.1158%2F2159-8290.CD-13-0083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic Isocitrate Dehydrogenase Mutations: Mechanisms, Models, and Clinical Opportunities</span></div><div class="casAuthors">Cairns, Rob A.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">730-741</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Heterozygous mutations in catalytic arginine residues of isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) are common in glioma, acute myeloid leukemia, chondrosarcoma, cholangiocarcinoma, and angioimmunoblastic T-cell lymphoma.  The mutant enzymes acquire a neomorphic activity that converts α-ketoglutarate (α-KG) to D-2-hydroxyglutarate (D2HG), a rare metabolite.  In cells and tissues expressing mutant IDH, D2HG concns. are highly elevated.  D2HG may act as an "oncometabolite" by inhibiting a class of α-KG-dependent enzymes involved in epigenetic regulation, collagen synthesis, and cell signaling.  Knock-in mouse models of IDH1 mutations have shed light on these mechanisms and will provide valuable animal models for further investigation.  Significance: Mutations in IDH1 and IDH2 promote the development of a no. of malignancies.  These active site mutations cause a gain-of-function leading to the accumulation of the rare metabolite D2HG.  Mouse models of these mutations should provide insights into the mechanisms driving tumorigenesis and facilitate evaluation of new treatments.  Cancer Discov; 3(7); 730-41. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh83ISAiWVdrVg90H21EOLACvtfcHk0lh551OqNSbOVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSrtLnL&md5=536f30c7ae2761a3de801e8213522d23</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-13-0083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-13-0083%26sid%3Dliteratum%253Aachs%26aulast%3DCairns%26aufirst%3DR.%2BA.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DOncogenic%2520isocitrate%2520dehydrogenase%2520mutations%253A%2520mechanisms%252C%2520models%252C%2520and%2520clinical%2520opportunities%26jtitle%3DCancer%2520Discovery%26date%3D2013%26volume%3D3%26spage%3D730%26epage%3D741%26doi%3D10.1158%2F2159-8290.CD-13-0083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rohle, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovici-Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palaskas, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turcan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grommes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsoi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldrini, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komisopoulou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunii, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedraza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schalm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kernytsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblum, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biller, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graeber, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellinghoff, I. K.</span></span> <span> </span><span class="NLM_article-title">An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>340</i></span>,  <span class="NLM_fpage">626</span>– <span class="NLM_lpage">630</span>, <span class="refDoi"> DOI: 10.1126/science.1236062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1126%2Fscience.1236062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=23558169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslWksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2013&pages=626-630&author=D.+Rohleauthor=J.+Popovici-Mullerauthor=N.+Palaskasauthor=S.+Turcanauthor=C.+Grommesauthor=C.+Camposauthor=J.+Tsoiauthor=O.+Clarkauthor=B.+Oldriniauthor=E.+Komisopoulouauthor=K.+Kuniiauthor=A.+Pedrazaauthor=S.+Schalmauthor=L.+Silvermanauthor=A.+Millerauthor=F.+Wangauthor=H.+Yangauthor=Y.+Chenauthor=A.+Kernytskyauthor=M.+K.+Rosenblumauthor=W.+Liuauthor=S.+A.+Billerauthor=S.+M.+Suauthor=C.+W.+Brennanauthor=T.+A.+Chanauthor=T.+G.+Graeberauthor=K.+E.+Yenauthor=I.+K.+Mellinghoff&title=An+inhibitor+of+mutant+IDH1+delays+growth+and+promotes+differentiation+of+glioma+cells&doi=10.1126%2Fscience.1236062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells</span></div><div class="casAuthors">Rohle, Dan; Popovici-Muller, Janeta; Palaskas, Nicolaos; Turcan, Sevin; Grommes, Christian; Campos, Carl; Tsoi, Jennifer; Clark, Owen; Oldrini, Barbara; Komisopoulou, Evangelia; Kunii, Kaiko; Pedraza, Alicia; Schalm, Stefanie; Silverman, Lee; Miller, Alexandra; Wang, Fang; Yang, Hua; Chen, Yue; Kernytsky, Andrew; Rosenblum, Marc K.; Liu, Wei; Biller, Scott A.; Su, Shinsan M.; Brennan, Cameron W.; Chan, Timothy A.; Graeber, Thomas G.; Yen, Katharine E.; Mellinghoff, Ingo K.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">6132</span>),
    <span class="NLM_cas:pages">626-630</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The recent discovery of mutations in metabolic enzymes has rekindled interest in harnessing the altered metab. of cancer cells for cancer therapy.  One potential drug target is isocitrate dehydrogenase 1 (IDH1), which is mutated in multiple human cancers.  Here, we examine the role of mutant IDH1 in fully transformed cells with endogenous IDH1 mutations.  A selective R132H-IDH1 inhibitor (AGI-5198) identified through a high-throughput screen blocked, in a dose-dependent manner, the ability of the mutant enzyme (mIDH1) to produce R-2-hydroxyglutarate (R-2HG).  Under conditions of near-complete R-2HG inhibition, the mIDH1 inhibitor induced demethylation of histone H3K9me3 and expression of genes assocd. with gliogenic differentiation.  Blockade of mIDH1 impaired the growth of IDH1-mutant-but not IDH1-wild-type-glioma cells without appreciable changes in genome-wide DNA methylation.  These data suggest that mIDH1 may promote glioma growth through mechanisms beyond its well-characterized epigenetic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz81Au_Pr-4rVg90H21EOLACvtfcHk0lh551OqNSbOVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslWksbg%253D&md5=c4499103628349dcf9866c44924acf3c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1126%2Fscience.1236062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1236062%26sid%3Dliteratum%253Aachs%26aulast%3DRohle%26aufirst%3DD.%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DPalaskas%26aufirst%3DN.%26aulast%3DTurcan%26aufirst%3DS.%26aulast%3DGrommes%26aufirst%3DC.%26aulast%3DCampos%26aufirst%3DC.%26aulast%3DTsoi%26aufirst%3DJ.%26aulast%3DClark%26aufirst%3DO.%26aulast%3DOldrini%26aufirst%3DB.%26aulast%3DKomisopoulou%26aufirst%3DE.%26aulast%3DKunii%26aufirst%3DK.%26aulast%3DPedraza%26aufirst%3DA.%26aulast%3DSchalm%26aufirst%3DS.%26aulast%3DSilverman%26aufirst%3DL.%26aulast%3DMiller%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DKernytsky%26aufirst%3DA.%26aulast%3DRosenblum%26aufirst%3DM.%2BK.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DSu%26aufirst%3DS.%2BM.%26aulast%3DBrennan%26aufirst%3DC.%2BW.%26aulast%3DChan%26aufirst%3DT.%2BA.%26aulast%3DGraeber%26aufirst%3DT.%2BG.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DMellinghoff%26aufirst%3DI.%2BK.%26atitle%3DAn%2520inhibitor%2520of%2520mutant%2520IDH1%2520delays%2520growth%2520and%2520promotes%2520differentiation%2520of%2520glioma%2520cells%26jtitle%3DScience%26date%3D2013%26volume%3D340%26spage%3D626%26epage%3D630%26doi%3D10.1126%2Fscience.1236062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paz, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilky, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galoian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinoco, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodamer, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trent, J. C.</span></span> <span> </span><span class="NLM_article-title">Treatment with a small molecule mutant IDH1 inhibitor suppresses tumorigenic activity and decreases production of the oncometabolite 2-hydroxyglutarate in human chondrosarcoma cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0133813</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0133813</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1371%2Fjournal.pone.0133813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=26368816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC28XosVWjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0133813&author=L.+Liauthor=A.+C.+Pazauthor=B.+A.+Wilkyauthor=B.+Johnsonauthor=K.+Galoianauthor=A.+Rosenbergauthor=G.+Huauthor=G.+Tinocoauthor=O.+Bodamerauthor=J.+C.+Trent&title=Treatment+with+a+small+molecule+mutant+IDH1+inhibitor+suppresses+tumorigenic+activity+and+decreases+production+of+the+oncometabolite+2-hydroxyglutarate+in+human+chondrosarcoma+cells&doi=10.1371%2Fjournal.pone.0133813"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment with a small molecule mutant IDH1 inhibitor suppresses tumorigenic activity and decreases production of the oncometabolite 2-hydroxyglutarate in human chondrosarcoma cells</span></div><div class="casAuthors">Li, Luyuan; Paz, Ana C.; Wilky, Breelyn A.; Johnson, Britt; Galoian, Karina; Rosenberg, Andrew; Hu, Guozhi; Tinoco, Gabriel; Bodamer, Olaf; Trent, Jonathan C.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e0133813/1-e0133813/19</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Chondrosarcomas are malignant bone tumors that produce cartilaginousmatrix.  Mutations in isocitrate dehydrogenase enzymes (IDH1/2) were recently described in several cancers including chondrosarcomas.  The IDH1 inhibitor AGI-5198 abrogates the ability of mutant IDH1 to produce the oncometabolite D-2 hydroxyglutarate (D-2HG) in gliomas.We sought to det. if treatment with AGI-5198 would similarly inhibit tumorigenic activity and D-2HG prodn. in IDH1-mutant human chondrosarcoma cells.  Two human chondrosarcoma cell lines, JJ012 and HT1080 with endogenous IDH1 mutations and a human chondrocyte cell line C28 with wild type IDH1 were employed in our study.  Mutation anal. of IDH was performed by PCR-based DNA sequencing, and D-2HG was detected using tandem mass spectrometry.We confirmed that JJ012 and HT1080 harbor IDH1 R132G and R132C mutation, resp., while C28 has no mutation.  D-2HG was detectable in cell pellets and media of JJ012 and HT1080 cells, as well as plasma and urine from an IDH-mutant chondrosarcoma patient, which decreased after tumor resection.  AGI-5198 treatment decreased D-2HG levels in JJ012 and HT1080 cells in a dose-dependent manner, and dramatically inhibited colony formation and migration, interrupted cell cycling, and induced apoptosis.  In conclusion, our study demonstrates anti-tumor activity of amutant IDH1 inhibitor in human chondrosarcoma cell lines, and suggests that D-2HG is a potential biomarker for IDH mutations in chondrosarcoma cells.  Thus, clin. trials of mutant IDH inhibitors are warranted for patients with IDH-mutant chondrosarcomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodi9R8fnoFPrVg90H21EOLACvtfcHk0lgjns2dUbuByQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosVWjuw%253D%253D&md5=5d7d934b46f2f92dd7f99121ba07623f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0133813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0133813%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DPaz%26aufirst%3DA.%2BC.%26aulast%3DWilky%26aufirst%3DB.%2BA.%26aulast%3DJohnson%26aufirst%3DB.%26aulast%3DGaloian%26aufirst%3DK.%26aulast%3DRosenberg%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DTinoco%26aufirst%3DG.%26aulast%3DBodamer%26aufirst%3DO.%26aulast%3DTrent%26aufirst%3DJ.%2BC.%26atitle%3DTreatment%2520with%2520a%2520small%2520molecule%2520mutant%2520IDH1%2520inhibitor%2520suppresses%2520tumorigenic%2520activity%2520and%2520decreases%2520production%2520of%2520the%2520oncometabolite%25202-hydroxyglutarate%2520in%2520human%2520chondrosarcoma%2520cells%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0133813%26doi%3D10.1371%2Fjournal.pone.0133813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodado, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lita, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowdy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larion, M.</span></span> <span> </span><span class="NLM_article-title">Abstract 2508: profiling the metabolic effects of AGI-5198 treatment on IDH1-mutated gliomas</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">2508</span>– <span class="NLM_lpage">2508</span>, <span class="refDoi"> DOI: 10.1158/1538-7445.AM2017-2508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1158%2F1538-7445.AM2017-2508" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=2508-2508&author=V.+R.+Rodadoauthor=A.+Litaauthor=T.+Dowdyauthor=M.+R.+Gilbertauthor=M.+Larion&title=Abstract+2508%3A+profiling+the+metabolic+effects+of+AGI-5198+treatment+on+IDH1-mutated+gliomas&doi=10.1158%2F1538-7445.AM2017-2508"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2017-2508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2017-2508%26sid%3Dliteratum%253Aachs%26aulast%3DRodado%26aufirst%3DV.%2BR.%26aulast%3DLita%26aufirst%3DA.%26aulast%3DDowdy%26aufirst%3DT.%26aulast%3DGilbert%26aufirst%3DM.%2BR.%26aulast%3DLarion%26aufirst%3DM.%26atitle%3DAbstract%25202508%253A%2520profiling%2520the%2520metabolic%2520effects%2520of%2520AGI-5198%2520treatment%2520on%2520IDH1-mutated%2520gliomas%26jtitle%3DCancer%2520Res.%26date%3D2017%26volume%3D77%26spage%3D2508%26epage%3D2508%26doi%3D10.1158%2F1538-7445.AM2017-2508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Popovici-Muller, J.</span>; <span class="NLM_string-name">Salituro, F. G.</span>; <span class="NLM_string-name">Saunders, J.</span>; <span class="NLM_string-name">Travins, J.</span>; <span class="NLM_string-name">Yan, S.</span></span> <span> </span><span class="NLM_article-title">Therapeutically Active Compounds and Their Methods of Use</span>. <span class="NLM_patent">WO/2012009678 A8</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+Popovici-Muller&author=F.+G.+Salituro&author=J.+Saunders&author=J.+Travins&author=S.+Yan&title=Therapeutically+Active+Compounds+and+Their+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26atitle%3DTherapeutically%2520Active%2520Compounds%2520and%2520Their%2520Methods%2520of%2520Use%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, Y.</span>; <span class="NLM_string-name">Sigel, C.</span>; <span class="NLM_string-name">Lowery, M. A.</span>; <span class="NLM_string-name">Goyal, L.</span>; <span class="NLM_string-name">Gliser, G.</span>; <span class="NLM_string-name">Jiang, L.</span>; <span class="NLM_string-name">Pandya, S.</span>; <span class="NLM_string-name">Wu, B.</span>; <span class="NLM_string-name">Choe, S.</span>; <span class="NLM_string-name">Deshpande, V.</span></span> <span> </span><span class="NLM_article-title">AG-120 (Ivosidenib), a First-in-Class Mutant IDH1 Inhibitor, Promotes Morphologic Changes and Upregulates Liver-Specific Genes in IDH1 Mutant Cholangiocarcinoma</span>.  <i>Abstracts of Papers</i>, AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, Philadelphia, PA, Oct 26–30 <span class="NLM_year">2017</span>; Abstract A071.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=Y.+Ishii&author=C.+Sigel&author=M.+A.+Lowery&author=L.+Goyal&author=G.+Gliser&author=L.+Jiang&author=S.+Pandya&author=B.+Wu&author=S.+Choe&author=V.+Deshpande&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DIshii%26aufirst%3DY.%26atitle%3DAG-120%2520%2528Ivosidenib%2529%252C%2520a%2520First-in-Class%2520Mutant%2520IDH1%2520Inhibitor%252C%2520Promotes%2520Morphologic%2520Changes%2520and%2520Upregulates%2520Liver-Specific%2520Genes%2520in%2520IDH1%2520Mutant%2520Cholangiocarcinoma%26btitle%3DAbstracts%2520of%2520Papers%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quivoron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemieux, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovici-Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadrzadeh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fathi, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gliser, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saada, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micol, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agresta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Botton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penard-Lacronique, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K.</span></span> <span> </span><span class="NLM_article-title">AG-120, an oral, selective, first-in-class, potent inhibitor of mutant IDH1, reduces intracellular 2-HG and induces cellular differentiation in TF-1 R132H cells and primary human IDH1 mutant AML patient samples treated <i>ex vivo</i></span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">3734</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=3734&author=E.+Hansenauthor=C.+Quivoronauthor=K.+Straleyauthor=R.+M.+Lemieuxauthor=J.+Popovici-Mullerauthor=H.+Sadrzadehauthor=A.+T.+Fathiauthor=C.+Gliserauthor=M.+Davidauthor=V.+Saadaauthor=J.-B.+Micolauthor=O.+Bernardauthor=M.+Dorschauthor=H.+Yangauthor=M.+Suauthor=S.+Agrestaauthor=S.+de+Bottonauthor=V.+Penard-Lacroniqueauthor=K.+Yen&title=AG-120%2C+an+oral%2C+selective%2C+first-in-class%2C+potent+inhibitor+of+mutant+IDH1%2C+reduces+intracellular+2-HG+and+induces+cellular+differentiation+in+TF-1+R132H+cells+and+primary+human+IDH1+mutant+AML+patient+samples+treated+ex+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DE.%26aulast%3DQuivoron%26aufirst%3DC.%26aulast%3DStraley%26aufirst%3DK.%26aulast%3DLemieux%26aufirst%3DR.%2BM.%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DSadrzadeh%26aufirst%3DH.%26aulast%3DFathi%26aufirst%3DA.%2BT.%26aulast%3DGliser%26aufirst%3DC.%26aulast%3DDavid%26aufirst%3DM.%26aulast%3DSaada%26aufirst%3DV.%26aulast%3DMicol%26aufirst%3DJ.-B.%26aulast%3DBernard%26aufirst%3DO.%26aulast%3DDorsch%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DAgresta%26aufirst%3DS.%26aulast%3Dde%2BBotton%26aufirst%3DS.%26aulast%3DPenard-Lacronique%26aufirst%3DV.%26aulast%3DYen%26aufirst%3DK.%26atitle%3DAG-120%252C%2520an%2520oral%252C%2520selective%252C%2520first-in-class%252C%2520potent%2520inhibitor%2520of%2520mutant%2520IDH1%252C%2520reduces%2520intracellular%25202-HG%2520and%2520induces%2520cellular%2520differentiation%2520in%2520TF-1%2520R132H%2520cells%2520and%2520primary%2520human%2520IDH1%2520mutant%2520AML%2520patient%2520samples%2520treated%2520ex%2520vivo%26jtitle%3DBlood%26date%3D2014%26volume%3D124%26spage%3D3734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pollyea, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Botton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fathi, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agresta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowden, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, R. M.</span></span> <span> </span><span class="NLM_article-title">1LBA clinical safety and activity in a phase I trial of AG-120, a first in class, selective, potent inhibitor of the IDH1-mutant protein, in patients with IDH1 mutant positive advanced hematologic malignancies</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">195</span>, <span class="refDoi"> DOI: 10.1016/S0959-8049(14)70722-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1016%2FS0959-8049%2814%2970722-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=195&author=D.+A.+Pollyeaauthor=S.+de+Bottonauthor=A.+T.+Fathiauthor=E.+M.+Steinauthor=M.+S.+Tallmanauthor=S.+Agrestaauthor=C.+Bowdenauthor=B.+Fanauthor=M.+Prahauthor=H.+Yangauthor=K.+Yenauthor=R.+M.+Stone&title=1LBA+clinical+safety+and+activity+in+a+phase+I+trial+of+AG-120%2C+a+first+in+class%2C+selective%2C+potent+inhibitor+of+the+IDH1-mutant+protein%2C+in+patients+with+IDH1+mutant+positive+advanced+hematologic+malignancies&doi=10.1016%2FS0959-8049%2814%2970722-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0959-8049%2814%2970722-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-8049%252814%252970722-1%26sid%3Dliteratum%253Aachs%26aulast%3DPollyea%26aufirst%3DD.%2BA.%26aulast%3Dde%2BBotton%26aufirst%3DS.%26aulast%3DFathi%26aufirst%3DA.%2BT.%26aulast%3DStein%26aufirst%3DE.%2BM.%26aulast%3DTallman%26aufirst%3DM.%2BS.%26aulast%3DAgresta%26aufirst%3DS.%26aulast%3DBowden%26aufirst%3DC.%26aulast%3DFan%26aufirst%3DB.%26aulast%3DPrah%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DYen%26aufirst%3DK.%26aulast%3DStone%26aufirst%3DR.%2BM.%26atitle%3D1LBA%2520clinical%2520safety%2520and%2520activity%2520in%2520a%2520phase%2520I%2520trial%2520of%2520AG-120%252C%2520a%2520first%2520in%2520class%252C%2520selective%252C%2520potent%2520inhibitor%2520of%2520the%2520IDH1-mutant%2520protein%252C%2520in%2520patients%2520with%2520IDH1%2520mutant%2520positive%2520advanced%2520hematologic%2520malignancies%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2014%26volume%3D50%26spage%3D195%26doi%3D10.1016%2FS0959-8049%2814%2970722-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nassereddine, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lap, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haroun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabbara, I.</span></span> <span> </span><span class="NLM_article-title">The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia</span>. <i>Ann. Hematol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">1983</span>– <span class="NLM_lpage">1991</span>, <span class="refDoi"> DOI: 10.1007/s00277-017-3161-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1007%2Fs00277-017-3161-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=29090344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslCmtrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2017&pages=1983-1991&author=S.+Nassereddineauthor=C.+J.+Lapauthor=F.+Harounauthor=I.+Tabbara&title=The+role+of+mutant+IDH1+and+IDH2+inhibitors+in+the+treatment+of+acute+myeloid+leukemia&doi=10.1007%2Fs00277-017-3161-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia</span></div><div class="casAuthors">Nassereddine, Samah; Lap, Coen J.; Haroun, Faysal; Tabbara, Imad</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Hematology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1983-1991</span>CODEN:
                <span class="NLM_cas:coden">ANHEE8</span>;
        ISSN:<span class="NLM_cas:issn">0939-5555</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">For decades, researchers have looked into the pathophysiol. of acute myeloid leukemia (AML).  With the advances in mol. techniques, the two-hit hypothesis was replaced by a multi-hit model, which also emphasizes the importance of aberrant epigenetic regulation in the pathogenesis of AML.  IDH1 and IDH2 are two isoforms of isocitrate dehydrogenase that perform crucial roles in cellular metab.  Somatic mutations in either of these two genes impart a neomorphic enzymic activity upon the encoded enzymes resulting in the ability to convert α-ketoglutarate (αKG) into the oncometabolite R2-hydroxyglutarate (R2-HG), which can competitively inhibit multiple αKG-dependent dioxygenases.  Inhibition of various classes of αKG-dependent dioxygenases results in dramatic epigenetic changes in hematopoietic cells, which has been found to directly impair differentiation.  In addn. to a global dysregulation of gene expression, other mechanisms have been described through which R2-HG promotes leukemic transformation including the induction of B cell lymphoma 2 dependency and stimulation of the EglN family of prolyl 4-hydroxylases (EglN).  Due to the fact that mutations in IDH1 and IDH2 are acquired early during AML clonal evolution as well as because these mutations tend to remain stable during AML progression, the pharmaceutical industry has prompted the development of specific mutant IDH enzyme inhibitors.  More recently, the FDA approved the first mutant IDH2 inhibitor, enasidenib (AG-221), for patients with relapsed or refractory IDH2-mutated AML (RR-AML).  This has brought a lot of excitement to researchers, clinicians, and patients, esp. because the treatment of AML remains challenging and is still assocd. with a high mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0MoaTYhzKz7Vg90H21EOLACvtfcHk0lhMaIYpJs6Inw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslCmtrrL&md5=8b84f1581f0beef64cf14e6bf9f1a7c0</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2Fs00277-017-3161-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00277-017-3161-0%26sid%3Dliteratum%253Aachs%26aulast%3DNassereddine%26aufirst%3DS.%26aulast%3DLap%26aufirst%3DC.%2BJ.%26aulast%3DHaroun%26aufirst%3DF.%26aulast%3DTabbara%26aufirst%3DI.%26atitle%3DThe%2520role%2520of%2520mutant%2520IDH1%2520and%2520IDH2%2520inhibitors%2520in%2520the%2520treatment%2520of%2520acute%2520myeloid%2520leukemia%26jtitle%3DAnn.%2520Hematol.%26date%3D2017%26volume%3D96%26spage%3D1983%26epage%3D1991%26doi%3D10.1007%2Fs00277-017-3161-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lemieux, R. M.</span>; <span class="NLM_string-name">Popovici-Muller, J.</span>; <span class="NLM_string-name">Travins, J.</span>; <span class="NLM_string-name">Cai, Z.</span>; <span class="NLM_string-name">Cui, D.</span>; <span class="NLM_string-name">Zhou, D.</span></span> <span> </span><span class="NLM_article-title">Therapeutically Active Compounds and Their Methods of Use</span>. <span class="NLM_patent">WO/2013107291 A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=R.+M.+Lemieux&author=J.+Popovici-Muller&author=J.+Travins&author=Z.+Cai&author=D.+Cui&author=D.+Zhou&title=Therapeutically+Active+Compounds+and+Their+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLemieux%26aufirst%3DR.%2BM.%26atitle%3DTherapeutically%2520Active%2520Compounds%2520and%2520Their%2520Methods%2520of%2520Use%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gu, C.</span></span> <span> </span><span class="NLM_article-title">Pharmaceutical Compositions of Therapeutically Active Compounds</span>. <span class="NLM_patent">WO/2015138837 A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=C.+Gu&title=Pharmaceutical+Compositions+of+Therapeutically+Active+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DC.%26atitle%3DPharmaceutical%2520Compositions%2520of%2520Therapeutically%2520Active%2520Compounds%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gu, C.</span></span> <span> </span><span class="NLM_article-title">Pharmaceutical Compositions of Therapeutically Active Compounds</span>. <span class="NLM_patent">WO/2015138839 A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=C.+Gu&title=Pharmaceutical+Compositions+of+Therapeutically+Active+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DC.%26atitle%3DPharmaceutical%2520Compositions%2520of%2520Therapeutically%2520Active%2520Compounds%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemieux, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovici-Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agresta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkein, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span> <span> </span><span class="NLM_article-title">IDH1 mutant inhibitor induces cellular differentiation and offers a combination benefit with Ara-C in a primary human IDH1 mutant AML xenograft model</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">3946</span>– <span class="NLM_lpage">3946</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2013&pages=3946-3946&author=K.+Yenauthor=R.+Lemieuxauthor=J.+Popovici-Mullerauthor=Y.+Chenauthor=H.+Yangauthor=K.+Straleyauthor=S.+Choeauthor=M.+Dorschauthor=S.+Agrestaauthor=D.+P.+Schenkeinauthor=S.+Billerauthor=M.+Suauthor=F.+Wang&title=IDH1+mutant+inhibitor+induces+cellular+differentiation+and+offers+a+combination+benefit+with+Ara-C+in+a+primary+human+IDH1+mutant+AML+xenograft+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYen%26aufirst%3DK.%26aulast%3DLemieux%26aufirst%3DR.%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DStraley%26aufirst%3DK.%26aulast%3DChoe%26aufirst%3DS.%26aulast%3DDorsch%26aufirst%3DM.%26aulast%3DAgresta%26aufirst%3DS.%26aulast%3DSchenkein%26aufirst%3DD.%2BP.%26aulast%3DBiller%26aufirst%3DS.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DF.%26atitle%3DIDH1%2520mutant%2520inhibitor%2520induces%2520cellular%2520differentiation%2520and%2520offers%2520a%2520combination%2520benefit%2520with%2520Ara-C%2520in%2520a%2520primary%2520human%2520IDH1%2520mutant%2520AML%2520xenograft%2520model%26jtitle%3DBlood%26date%3D2013%26volume%3D122%26spage%3D3946%26epage%3D3946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larkin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, W.</span></span> <span> </span><span class="NLM_article-title">Novel therapies in AML: reason for hope or just hype?</span>. <i>Am. Soc. Clin. Oncol. Educ. B</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">e341</span>– <span class="NLM_lpage">e351</span>, <span class="refDoi"> DOI: 10.14694/EdBook_AM.2014.34.e341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.14694%2FEdBook_AM.2014.34.e341" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=e341-e351&author=K.+Larkinauthor=W.+Blum&title=Novel+therapies+in+AML%3A+reason+for+hope+or+just+hype%3F&doi=10.14694%2FEdBook_AM.2014.34.e341"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.14694%2FEdBook_AM.2014.34.e341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14694%252FEdBook_AM.2014.34.e341%26sid%3Dliteratum%253Aachs%26aulast%3DLarkin%26aufirst%3DK.%26aulast%3DBlum%26aufirst%3DW.%26atitle%3DNovel%2520therapies%2520in%2520AML%253A%2520reason%2520for%2520hope%2520or%2520just%2520hype%253F%26jtitle%3DAm.%2520Soc.%2520Clin.%2520Oncol.%2520Educ.%2520B%26date%3D2014%26volume%3D34%26spage%3De341%26epage%3De351%26doi%3D10.14694%2FEdBook_AM.2014.34.e341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellwood-Yen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemieux, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovici-Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agresta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.</span></span> <span> </span><span class="NLM_article-title">Abstract 1194: IDH1 mutant inhibitor induces cellular differentiation and offers a combination benefit with Ara-C in a primary human IDH1 mutant AML xenograft model</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">1194</span>– <span class="NLM_lpage">1194</span>, <span class="refDoi"> DOI: 10.1158/1538-7445.AM2014-1194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1158%2F1538-7445.AM2014-1194" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=1194-1194&author=K.+Ellwood-Yenauthor=Y.+Chenauthor=F.+Wangauthor=R.+Lemieuxauthor=J.+Popovici-Mullerauthor=H.+Yangauthor=K.+Straleyauthor=S.+Choeauthor=M.+Dorschauthor=S.+Agrestaauthor=D.+Schenkeinauthor=S.+Billerauthor=M.+Su&title=Abstract+1194%3A+IDH1+mutant+inhibitor+induces+cellular+differentiation+and+offers+a+combination+benefit+with+Ara-C+in+a+primary+human+IDH1+mutant+AML+xenograft+model&doi=10.1158%2F1538-7445.AM2014-1194"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2014-1194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2014-1194%26sid%3Dliteratum%253Aachs%26aulast%3DEllwood-Yen%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DLemieux%26aufirst%3DR.%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DStraley%26aufirst%3DK.%26aulast%3DChoe%26aufirst%3DS.%26aulast%3DDorsch%26aufirst%3DM.%26aulast%3DAgresta%26aufirst%3DS.%26aulast%3DSchenkein%26aufirst%3DD.%26aulast%3DBiller%26aufirst%3DS.%26aulast%3DSu%26aufirst%3DM.%26atitle%3DAbstract%25201194%253A%2520IDH1%2520mutant%2520inhibitor%2520induces%2520cellular%2520differentiation%2520and%2520offers%2520a%2520combination%2520benefit%2520with%2520Ara-C%2520in%2520a%2520primary%2520human%2520IDH1%2520mutant%2520AML%2520xenograft%2520model%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26spage%3D1194%26epage%3D1194%26doi%3D10.1158%2F1538-7445.AM2014-1194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Konig, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levis, M.</span></span> <span> </span><span class="NLM_article-title">Is targeted therapy feasible in acute myelogenous leukemia?</span>. <i>Curr. Hematol. Malig. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.1007/s11899-014-0198-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1007%2Fs11899-014-0198-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=24599573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A280%3ADC%252BC2crhtVWrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=118-127&author=H.+Konigauthor=M.+Levis&title=Is+targeted+therapy+feasible+in+acute+myelogenous+leukemia%3F&doi=10.1007%2Fs11899-014-0198-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Is targeted therapy feasible in acute myelogenous leukemia?</span></div><div class="casAuthors">Konig Heiko; Levis Mark</div><div class="citationInfo"><span class="NLM_cas:title">Current hematologic malignancy reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">118-27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The prognosis for patients with acute myeloid leukemia (AML) is determined to a large degree by the biology of the leukemic cell.  In recent years, the identification and characterization of genetic aberrations has vastly improved our understanding of the pathogenesis of AML.  In contrast, however, there has been a lack of clinically meaningful therapeutic advances.  The same chemotherapeutic strategies have been applied to AML for several decades now, and while these regimens are effective in inducing remission, most patients relapse within months after initial treatment.  Hence, there is an urgent need for novel therapies.  We review herein a number of lines of laboratory and clinical trial data supporting the clinical value of targeted treatment approaches that will likely result in improved outcomes for patients with AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRA3Z2jpwOm0lUIs6wFK5xJfW6udTcc2ebLrTMjAIX9g7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crhtVWrtA%253D%253D&md5=e0ed4bdacd9424789c2255c8f2861eca</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1007%2Fs11899-014-0198-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11899-014-0198-1%26sid%3Dliteratum%253Aachs%26aulast%3DKonig%26aufirst%3DH.%26aulast%3DLevis%26aufirst%3DM.%26atitle%3DIs%2520targeted%2520therapy%2520feasible%2520in%2520acute%2520myelogenous%2520leukemia%253F%26jtitle%3DCurr.%2520Hematol.%2520Malig.%2520Rep.%26date%3D2014%26volume%3D9%26spage%3D118%26epage%3D127%26doi%3D10.1007%2Fs11899-014-0198-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M.</span>; <span class="NLM_string-name">Pragani, R.</span>; <span class="NLM_string-name">Popovici-Muller, J.</span>; <span class="NLM_string-name">Gross, S.</span>; <span class="NLM_string-name">Thorne, N.</span>; <span class="NLM_string-name">Salituro, F.</span>; <span class="NLM_string-name">Fantin, V.</span>; <span class="NLM_string-name">Straley, K.</span>; <span class="NLM_string-name">Su, M.</span>; <span class="NLM_string-name">Dang, L.</span>; <span class="NLM_string-name">Simeonov, A.</span>; <span class="NLM_string-name">Shen, M.</span>; <span class="NLM_string-name">Boxer, M. B.</span></span> <span> </span><span class="NLM_article-title">ML309: A Potent Inhibitor of R132H Mutant IDH1 Capable of Reducing 2-Hydroxyglutarate Production in U87 MG Glioblastoma Cells</span>.  <i>Probe Reports from the NIH Molecular Libraries Program</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, K.</span></span>, Ed.; <span class="NLM_publisher-name">National Center for Biotechnology Information</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=M.+Davis&author=R.+Pragani&author=J.+Popovici-Muller&author=S.+Gross&author=N.+Thorne&author=F.+Salituro&author=V.+Fantin&author=K.+Straley&author=M.+Su&author=L.+Dang&author=A.+Simeonov&author=M.+Shen&author=M.+B.+Boxerauthor=K.+Mills&title=Probe+Reports+from+the+NIH+Molecular+Libraries+Program"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%26atitle%3DML309%253A%2520A%2520Potent%2520Inhibitor%2520of%2520R132H%2520Mutant%2520IDH1%2520Capable%2520of%2520Reducing%25202-Hydroxyglutarate%2520Production%2520in%2520U87%2520MG%2520Glioblastoma%2520Cells%26btitle%3DProbe%2520Reports%2520from%2520the%2520NIH%2520Molecular%2520Libraries%2520Program%26aulast%3DMills%26aufirst%3DK.%26pub%3DNational%2520Center%2520for%2520Biotechnology%2520Information%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straley, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pragani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lea, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovici-Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLaBarre, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorne, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auld, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boxer, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span> <span> </span><span class="NLM_article-title">Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate dehydrogenase IDH1</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">13717</span>– <span class="NLM_lpage">13725</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.511030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1074%2Fjbc.M113.511030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=13717-13725&author=M.+I.+Davisauthor=S.+Grossauthor=M.+Shenauthor=K.+S.+Straleyauthor=R.+Praganiauthor=W.+A.+Leaauthor=J.+Popovici-Mullerauthor=B.+DeLaBarreauthor=E.+Artinauthor=N.+Thorneauthor=D.+S.+Auldauthor=Z.+Liauthor=L.+Dangauthor=M.+B.+Boxerauthor=A.+Simeonov&title=Biochemical%2C+cellular%2C+and+biophysical+characterization+of+a+potent+inhibitor+of+mutant+isocitrate+dehydrogenase+IDH1&doi=10.1074%2Fjbc.M113.511030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.511030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.511030%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DStraley%26aufirst%3DK.%2BS.%26aulast%3DPragani%26aufirst%3DR.%26aulast%3DLea%26aufirst%3DW.%2BA.%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DDeLaBarre%26aufirst%3DB.%26aulast%3DArtin%26aufirst%3DE.%26aulast%3DThorne%26aufirst%3DN.%26aulast%3DAuld%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DDang%26aufirst%3DL.%26aulast%3DBoxer%26aufirst%3DM.%2BB.%26aulast%3DSimeonov%26aufirst%3DA.%26atitle%3DBiochemical%252C%2520cellular%252C%2520and%2520biophysical%2520characterization%2520of%2520a%2520potent%2520inhibitor%2520of%2520mutant%2520isocitrate%2520dehydrogenase%2520IDH1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D13717%26epage%3D13725%26doi%3D10.1074%2Fjbc.M113.511030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Merk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartesaghi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falconieri, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pragani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boxer, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Earl, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milne, J. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramaniam, S.</span></span> <span> </span><span class="NLM_article-title">Breaking cryo-EM resolution barriers to facilitate drug discovery</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>165</i></span>,  <span class="NLM_fpage">1698</span>– <span class="NLM_lpage">1707</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.05.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1016%2Fj.cell.2016.05.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=27238019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC28XptVSlsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2016&pages=1698-1707&author=A.+Merkauthor=A.+Bartesaghiauthor=S.+Banerjeeauthor=V.+Falconieriauthor=P.+Raoauthor=M.+I.+Davisauthor=R.+Praganiauthor=M.+B.+Boxerauthor=L.+A.+Earlauthor=J.+L.+S.+Milneauthor=S.+Subramaniam&title=Breaking+cryo-EM+resolution+barriers+to+facilitate+drug+discovery&doi=10.1016%2Fj.cell.2016.05.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Breaking Cryo-EM Resolution Barriers to Facilitate Drug Discovery</span></div><div class="casAuthors">Merk, Alan; Bartesaghi, Alberto; Banerjee, Soojay; Falconieri, Veronica; Rao, Prashant; Davis, Mindy I.; Pragani, Rajan; Boxer, Matthew B.; Earl, Lesley A.; Milne, Jacqueline L. S.; Subramaniam, Sriram</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1698-1707</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Recent advances in single-particle cryo-electron microscopy (cryo-EM) are enabling generation of numerous near-at. resoln. structures for well-ordered protein complexes with sizes ≥ ∼200 kDa.  Whether cryo-EM methods are equally useful for high-resoln. structural anal. of smaller, dynamic protein complexes such as those involved in cellular metab. remains an important question.  Here, we present 3.8 Å resoln. cryo-EM structures of the cancer target isocitrate dehydrogenase (93 kDa) and identify the nature of conformational changes induced by binding of the allosteric small-mol. inhibitor ML309.  We also report 2.8-Å- and 1.8-Å-resoln. structures of lactate dehydrogenase (145 kDa) and glutamate dehydrogenase (334 kDa), resp.  With these results, two perceived barriers in single-particle cryo-EM are overcome: (1) crossing 2 Å resoln. and (2) obtaining structures of proteins with sizes < 100 kDa, demonstrating that cryo-EM can be used to investigate a broad spectrum of drug-target interactions and dynamic conformational states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSVJ4hXEIN07Vg90H21EOLACvtfcHk0lj8GA0x9_e3uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptVSlsb8%253D&md5=8457195c1f1724244caa9f90e0ba4682</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.05.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.05.040%26sid%3Dliteratum%253Aachs%26aulast%3DMerk%26aufirst%3DA.%26aulast%3DBartesaghi%26aufirst%3DA.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DFalconieri%26aufirst%3DV.%26aulast%3DRao%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DPragani%26aufirst%3DR.%26aulast%3DBoxer%26aufirst%3DM.%2BB.%26aulast%3DEarl%26aufirst%3DL.%2BA.%26aulast%3DMilne%26aufirst%3DJ.%2BL.%2BS.%26aulast%3DSubramaniam%26aufirst%3DS.%26atitle%3DBreaking%2520cryo-EM%2520resolution%2520barriers%2520to%2520facilitate%2520drug%2520discovery%26jtitle%3DCell%26date%3D2016%26volume%3D165%26spage%3D1698%26epage%3D1707%26doi%3D10.1016%2Fj.cell.2016.05.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Popovici-Muller, J.</span>; <span class="NLM_string-name">Saunders, J.</span>; <span class="NLM_string-name">Salituro, F. G.</span>; <span class="NLM_string-name">Cai, Z.</span>; <span class="NLM_string-name">Yan, S.</span>; <span class="NLM_string-name">Zhou, D.</span></span> <span> </span><span class="NLM_article-title">Therapeutically Active Compounds and Their Methods of Use</span>. <span class="NLM_patent">WO/2013107405 A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=J.+Popovici-Muller&author=J.+Saunders&author=F.+G.+Salituro&author=Z.+Cai&author=S.+Yan&author=D.+Zhou&title=Therapeutically+Active+Compounds+and+Their+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26atitle%3DTherapeutically%2520Active%2520Compounds%2520and%2520Their%2520Methods%2520of%2520Use%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okoye-Okafor, U. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartholdy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietrak, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rominger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smallwood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiggall, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reif, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joberty, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faelth-Savitski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantscheff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duraiswami, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brady, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanagari, S.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antony-Debre, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kao, Y.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopeit, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvajal, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreyro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paietta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makishima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Will, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Concha, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCabe, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maciejewski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steidl, U.</span></span> <span> </span><span class="NLM_article-title">New IDH1 mutant inhibitors for treatment of acute myeloid leukemia</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">878</span>– <span class="NLM_lpage">886</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1930</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1038%2Fnchembio.1930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=26436839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFKqu7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=878-886&author=U.+C.+Okoye-Okaforauthor=B.+Bartholdyauthor=J.+Cartierauthor=E.+N.+Gaoauthor=B.+Pietrakauthor=A.+R.+Rendinaauthor=C.+Romingerauthor=C.+Quinnauthor=A.+Smallwoodauthor=K.+J.+Wiggallauthor=A.+J.+Reifauthor=S.+J.+Schmidtauthor=H.+Qiauthor=H.+Zhaoauthor=G.+Jobertyauthor=M.+Faelth-Savitskiauthor=M.+Bantscheffauthor=G.+Drewesauthor=C.+Duraiswamiauthor=P.+Bradyauthor=A.+Groyauthor=S.-R.+Narayanagariauthor=I.+Antony-Debreauthor=K.+Mitchellauthor=H.+R.+Wangauthor=Y.-R.+Kaoauthor=M.+Christopeitauthor=L.+Carvajalauthor=L.+Barreyroauthor=E.+Paiettaauthor=H.+Makishimaauthor=B.+Willauthor=N.+Conchaauthor=N.+D.+Adamsauthor=B.+Schwartzauthor=M.+T.+McCabeauthor=J.+Maciejewskiauthor=A.+Vermaauthor=U.+Steidl&title=New+IDH1+mutant+inhibitors+for+treatment+of+acute+myeloid+leukemia&doi=10.1038%2Fnchembio.1930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">New IDH1 mutant inhibitors for treatment of acute myeloid leukemia</span></div><div class="casAuthors">Okoye-Okafor, Ujunwa C.; Bartholdy, Boris; Cartier, Jessy; Gao, Enoch N.; Pietrak, Beth; Rendina, Alan R.; Rominger, Cynthia; Quinn, Chad; Smallwood, Angela; Wiggall, Kenneth J.; Reif, Alexander J.; Schmidt, Stanley J.; Qi, Hongwei; Zhao, Huizhen; Joberty, Gerard; Faelth-Savitski, Maria; Bantscheff, Marcus; Drewes, Gerard; Duraiswami, Chaya; Brady, Pat; Groy, Arthur; Narayanagari, Swathi-Rao; Antony-Debre, Ileana; Mitchell, Kelly; Wang, Heng Rui; Kao, Yun-Ruei; Christopeit, Maximilian; Carvajal, Luis; Barreyro, Laura; Paietta, Elisabeth; Makishima, Hideki; Will, Britta; Concha, Nestor; Adams, Nicholas D.; Schwartz, Benjamin; McCabe, Michael T.; Maciejewski, Jaroslav; Verma, Amit; Steidl, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">878-886</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neomorphic mutations in isocitrate dehydrogenase 1 (IDH1) are driver mutations in acute myeloid leukemia (AML) and other cancers.  The authors report the development of new allosteric inhibitors of mutant IDH1.  Crystallog. and biochem. results demonstrated that compds. of this chem. series bind to an allosteric site and lock the enzyme in a catalytically inactive conformation, thereby enabling inhibition of different clin. relevant IDH1 mutants.  Treatment of IDH1 mutant primary AML cells uniformly led to a decrease in intracellular 2-HG, abrogation of the myeloid differentiation block and induction of granulocytic differentiation at the level of leukemic blasts and more immature stem-like cells, in vitro and in vivo.  Molecularly, treatment with the inhibitors led to a reversal of the DNA cytosine hypermethylation patterns caused by mutant IDH1 in the cells of individuals with AML.  The authors' study provides proof of concept for the mol. and biol. activity of novel allosteric inhibitors for targeting different mutant forms of IDH1 in leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiVGxt4CfctrVg90H21EOLACvtfcHk0lj8GA0x9_e3uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFKqu7vE&md5=96634bed9a8355145dd3e1bce58cc13b</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1930%26sid%3Dliteratum%253Aachs%26aulast%3DOkoye-Okafor%26aufirst%3DU.%2BC.%26aulast%3DBartholdy%26aufirst%3DB.%26aulast%3DCartier%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DE.%2BN.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DRominger%26aufirst%3DC.%26aulast%3DQuinn%26aufirst%3DC.%26aulast%3DSmallwood%26aufirst%3DA.%26aulast%3DWiggall%26aufirst%3DK.%2BJ.%26aulast%3DReif%26aufirst%3DA.%2BJ.%26aulast%3DSchmidt%26aufirst%3DS.%2BJ.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DJoberty%26aufirst%3DG.%26aulast%3DFaelth-Savitski%26aufirst%3DM.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DDuraiswami%26aufirst%3DC.%26aulast%3DBrady%26aufirst%3DP.%26aulast%3DGroy%26aufirst%3DA.%26aulast%3DNarayanagari%26aufirst%3DS.-R.%26aulast%3DAntony-Debre%26aufirst%3DI.%26aulast%3DMitchell%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DH.%2BR.%26aulast%3DKao%26aufirst%3DY.-R.%26aulast%3DChristopeit%26aufirst%3DM.%26aulast%3DCarvajal%26aufirst%3DL.%26aulast%3DBarreyro%26aufirst%3DL.%26aulast%3DPaietta%26aufirst%3DE.%26aulast%3DMakishima%26aufirst%3DH.%26aulast%3DWill%26aufirst%3DB.%26aulast%3DConcha%26aufirst%3DN.%26aulast%3DAdams%26aufirst%3DN.%2BD.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DMcCabe%26aufirst%3DM.%2BT.%26aulast%3DMaciejewski%26aufirst%3DJ.%26aulast%3DVerma%26aufirst%3DA.%26aulast%3DSteidl%26aufirst%3DU.%26atitle%3DNew%2520IDH1%2520mutant%2520inhibitors%2520for%2520treatment%2520of%2520acute%2520myeloid%2520leukemia%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D878%26epage%3D886%26doi%3D10.1038%2Fnchembio.1930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms of “off-on switch” of activities of human IDH1 by tumor-associated mutation R132H</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1188</span>– <span class="NLM_lpage">1200</span>, <span class="refDoi"> DOI: 10.1038/cr.2010.145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1038%2Fcr.2010.145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=20975740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKjtbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1188-1200&author=B.+Yangauthor=C.+Zhongauthor=Y.+Pengauthor=Z.+Laiauthor=J.+Ding&title=Molecular+mechanisms+of+%E2%80%9Coff-on+switch%E2%80%9D+of+activities+of+human+IDH1+by+tumor-associated+mutation+R132H&doi=10.1038%2Fcr.2010.145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of "off-on switch" of activities of human IDH1 by tumor-associated mutation R132H</span></div><div class="casAuthors">Yang, Bei; Zhong, Chen; Peng, Yingjie; Lai, Zheng; Ding, Jianping</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1188-1200</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Human cytosolic NADP-IDH (IDH1) has recently been found to be involved in tumorigenesis.  Notably, the tumor-derived IDH1 mutations identified so far mainly occur at Arg132, and mutation R132H is the most prevalent one.  This mutation impairs the oxidative IDH activity of the enzyme, but renders a new redn. function of converting α-ketoglutarate (αKG) to 2-hydroxyglutarate.  Here, we report the structures of the R132H mutant IDH1 with and without isocitrate (ICT) bound.  The structural data together with mutagenesis and biochem. data reveal a previously undefined initial ICT-binding state and demonstrate that IDH activity requires a conformational change to a closed pre-transition state.  Arg132 plays multiple functional roles in the catalytic reaction; in particular, the R132H mutation hinders the conformational changes from the initial ICT-binding state to the pre-transition state, leading to the impairment of the IDH activity.  Our results describe for the first time that there is an intermediate conformation that corresponds to an initial ICT-binding state and that the R132H mutation can trap the enzyme in this conformation, therefore shedding light on the mol. mechanism of the "off switch" of the potentially tumor-suppressive IDH activity.  Furthermore, we proved the necessity of Tyr139 for the gained αKG redn. activity and propose that Tyr139 may play a vital role by compensating the increased neg. charge on the C2 atom of αKG during the transfer of a hydride anion from NADPH to αKG, which provides new insights into the mechanism of the "on switch" of the hypothetically oncogenic redn. activity of IDH1 by this mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpory1c32RonLVg90H21EOLACvtfcHk0lhvbZ-VoFDb2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKjtbfI&md5=04d83e2a90480837c09eb8c0140ecc88</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fcr.2010.145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2010.145%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DB.%26aulast%3DZhong%26aufirst%3DC.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DZ.%26aulast%3DDing%26aufirst%3DJ.%26atitle%3DMolecular%2520mechanisms%2520of%2520%25E2%2580%259Coff-on%2520switch%25E2%2580%259D%2520of%2520activities%2520of%2520human%2520IDH1%2520by%2520tumor-associated%2520mutation%2520R132H%26jtitle%3DCell%2520Res.%26date%3D2010%26volume%3D20%26spage%3D1188%26epage%3D1200%26doi%3D10.1038%2Fcr.2010.145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, G. Q.</span></span> <span> </span><span class="NLM_article-title">Rearrangements in the second intron of the RARA gene are present in a large majority of patients with acute promyelocytic leukemia and are used as molecular marker for retinoic acid-induced leukemic cell differentiation</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">2696</span>– <span class="NLM_lpage">2701</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1991&pages=2696-2701&author=S.+J.+Chenauthor=Y.+J.+Zhuauthor=J.+H.+Tongauthor=S.+Dongauthor=W.+Huangauthor=Y.+Chenauthor=W.+M.+Xiangauthor=L.+Zhangauthor=X.+S.+Liauthor=G.+Q.+Qian&title=Rearrangements+in+the+second+intron+of+the+RARA+gene+are+present+in+a+large+majority+of+patients+with+acute+promyelocytic+leukemia+and+are+used+as+molecular+marker+for+retinoic+acid-induced+leukemic+cell+differentiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%2BJ.%26aulast%3DZhu%26aufirst%3DY.%2BJ.%26aulast%3DTong%26aufirst%3DJ.%2BH.%26aulast%3DDong%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DXiang%26aufirst%3DW.%2BM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%2BS.%26aulast%3DQian%26aufirst%3DG.%2BQ.%26atitle%3DRearrangements%2520in%2520the%2520second%2520intron%2520of%2520the%2520RARA%2520gene%2520are%2520present%2520in%2520a%2520large%2520majority%2520of%2520patients%2520with%2520acute%2520promyelocytic%2520leukemia%2520and%2520are%2520used%2520as%2520molecular%2520marker%2520for%2520retinoic%2520acid-induced%2520leukemic%2520cell%2520differentiation%26jtitle%3DBlood%26date%3D1991%26volume%3D78%26spage%3D2696%26epage%3D2701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kogiso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span> <span> </span><span class="NLM_article-title">Inhibition of cancer-associated mutant isocitrate dehydrogenases by 2-thiohydantoin compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6899</span>– <span class="NLM_lpage">6908</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00684</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00684" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlequ7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6899-6908&author=F.+Wuauthor=H.+Jiangauthor=B.+Zhengauthor=M.+Kogisoauthor=Y.+Yaoauthor=C.+Zhouauthor=X.+N.+Liauthor=Y.+Song&title=Inhibition+of+cancer-associated+mutant+isocitrate+dehydrogenases+by+2-thiohydantoin+compounds&doi=10.1021%2Facs.jmedchem.5b00684"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds</span></div><div class="casAuthors">Wu, Fangrui; Jiang, Hong; Zheng, Baisong; Kogiso, Mari; Yao, Yuan; Zhou, Chao; Li, Xiao-Nan; Song, Yongcheng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6899-6908</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Somatic mutations of isocitrate dehydrogenase 1 (IDH1) at R132 are frequently found in certain cancers such as glioma.  With losing the activity of wild-type IDH1, the R132H and R132C mutant proteins can reduce α-ketoglutaric acid (α-KG) to D-2-hydroxyglutaric acid (D2HG).  The resulting high concn. of D2HG inhibits many α-KG-dependent dioxygenases, including histone demethylases, to cause broad histone hypermethylation.  These aberrant epigenetic changes are responsible for the initiation of these cancers.  The authors report the synthesis, structure-activity relationships, enzyme kinetics, and binding thermodn. of a novel series of 2-thiohydantoin and related compds. I [R1 = H, Me, Ph, etc.; R2 = 3,4-(HO)2C6H3, pyridin-3-yl, 2-pyridinone-5-yl, etc.], among which several compds. are potent inhibitors of mutant IDH1 with Ki as low as 420 nM.  X-ray crystal structures of IDH1(R132H) in complex with two inhibitors are reported, showing their inhibitor-protein interactions.  These compds. can decrease the cellular concn. of D2HG, reduce the levels of histone methylation, and suppress the proliferation of stem-like cancer cells in BT142 glioma with IDH1 R132H mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHlhXpk4PcnbVg90H21EOLACvtfcHk0lhvbZ-VoFDb2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlequ7nI&md5=57dd47bcd29b65244b33e564910419de</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00684%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DF.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DKogiso%26aufirst%3DM.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DX.%2BN.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DInhibition%2520of%2520cancer-associated%2520mutant%2520isocitrate%2520dehydrogenases%2520by%25202-thiohydantoin%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6899%26epage%3D6908%26doi%3D10.1021%2Facs.jmedchem.5b00684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anglin, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, B. V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span> <span> </span><span class="NLM_article-title">Crystallographic investigation and selective inhibition of mutant isocitrate dehydrogenase</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">542</span>– <span class="NLM_lpage">546</span>, <span class="refDoi"> DOI: 10.1021/ml400036z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400036z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVWrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=542-546&author=B.+Zhengauthor=Y.+Yaoauthor=Z.+Liuauthor=L.+Dengauthor=J.+L.+Anglinauthor=H.+Jiangauthor=B.+V.+V.+Prasadauthor=Y.+Song&title=Crystallographic+investigation+and+selective+inhibition+of+mutant+isocitrate+dehydrogenase&doi=10.1021%2Fml400036z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase</span></div><div class="casAuthors">Zheng, Baisong; Yao, Yuan; Liu, Zhen; Deng, Lisheng; Anglin, Justin L.; Jiang, Hong; Prasad, B. V. Venkataram; Song, Yongcheng</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">542-546</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mutations in isocitrate dehydrogenase (IDH), a key enzyme in the tricarboxylic acid cycle, have recently been found in ∼75% glioma and ∼20% acute myeloid leukemia.  Different from the wild-type enzyme, mutant IDH1 catalyzes the redn. of α-ketoglutaric acid to D-2-hydroxyglutaric acid.  Strong evidence has shown mutant IDH1 represents a novel target for this type of cancer.  We found two 1-hydroxypyridin-2-one compds. that are potent inhibitors of R132H and R132C IDH1 mutants with Ki values as low as 120 nM.  These compds. exhibit >60-fold selectivity against wild-type IDH1 and can inhibit the prodn. of D-2-hydroxyglutaric acid in IDH1 mutated cells, representing novel chem. probes for cancer biol. studies.  We also report the first inhibitor-bound crystal structures of IDH1(R132H), showing these inhibitors have H-bond, electrostatic, and hydrophobic interactions with the mutant enzyme.  Comparison with the substrate-bound IDH1 structures revealed the structural basis for the high enzyme selectivity of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH0vzVLGCPZLVg90H21EOLACvtfcHk0lhvbZ-VoFDb2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVWrtLg%253D&md5=c34c67949fe816bdf151525a578535f3</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fml400036z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400036z%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DAnglin%26aufirst%3DJ.%2BL.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DPrasad%26aufirst%3DB.%2BV.%2BV.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DCrystallographic%2520investigation%2520and%2520selective%2520inhibition%2520of%2520mutant%2520isocitrate%2520dehydrogenase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D542%26epage%3D546%26doi%3D10.1021%2Fml400036z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kogiso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span> <span> </span><span class="NLM_article-title">Inhibition of cancer-associated mutant isocitrate dehydrogenases: synthesis, structure–activity relationship and selective antitumor activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">8307</span>– <span class="NLM_lpage">8318</span>, <span class="refDoi"> DOI: 10.1021/jm500660f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500660f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8307-8318&author=Z.+Liuauthor=Y.+Yaoauthor=M.+Kogisoauthor=B.+Zhengauthor=L.+Dengauthor=J.+J.+Qiuauthor=S.+Dongauthor=H.+Lvauthor=J.+M.+Galloauthor=X.+N.+Liauthor=Y.+Song&title=Inhibition+of+cancer-associated+mutant+isocitrate+dehydrogenases%3A+synthesis%2C+structure%E2%80%93activity+relationship+and+selective+antitumor+activity&doi=10.1021%2Fjm500660f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm500660f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500660f%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DKogiso%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DJ.%2BJ.%26aulast%3DDong%26aufirst%3DS.%26aulast%3DLv%26aufirst%3DH.%26aulast%3DGallo%26aufirst%3DJ.%2BM.%26aulast%3DLi%26aufirst%3DX.%2BN.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DInhibition%2520of%2520cancer-associated%2520mutant%2520isocitrate%2520dehydrogenases%253A%2520synthesis%252C%2520structure%25E2%2580%2593activity%2520relationship%2520and%2520selective%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8307%26epage%3D8318%26doi%3D10.1021%2Fjm500660f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pusch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krausert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrimpf, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capper, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahm, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, A.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jugold, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eichwald, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaulfuss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panknin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehwinkel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillig, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenther, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toschi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haegebart, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess-Stumpp, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wick, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unterberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold-Mende, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platten, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Deimling, A.</span></span> <span> </span><span class="NLM_article-title">Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">629</span>– <span class="NLM_lpage">644</span>, <span class="refDoi"> DOI: 10.1007/s00401-017-1677-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1007%2Fs00401-017-1677-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=28124097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFKitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2017&pages=629-644&author=S.+Puschauthor=S.+Krausertauthor=V.+Fischerauthor=J.+Balssauthor=M.+Ottauthor=D.+Schrimpfauthor=D.+Capperauthor=F.+Sahmauthor=J.+Eiselauthor=A.-C.+Beckauthor=M.+Jugoldauthor=V.+Eichwaldauthor=S.+Kaulfussauthor=O.+Pankninauthor=H.+Rehwinkelauthor=K.+Zimmermannauthor=R.+C.+Hilligauthor=J.+Guentherauthor=L.+Toschiauthor=R.+Neuhausauthor=A.+Haegebartauthor=H.+Hess-Stumppauthor=M.+Bauserauthor=W.+Wickauthor=A.+Unterbergauthor=C.+Herold-Mendeauthor=M.+Plattenauthor=A.+von+Deimling&title=Pan-mutant+IDH1+inhibitor+BAY+1436032+for+effective+treatment+of+IDH1+mutant+astrocytoma+in+vivo&doi=10.1007%2Fs00401-017-1677-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo</span></div><div class="casAuthors">Pusch, Stefan; Krausert, Sonja; Fischer, Viktoria; Balss, Joerg; Ott, Martina; Schrimpf, Daniel; Capper, David; Sahm, Felix; Eisel, Jessica; Beck, Ann-Christin; Jugold, Manfred; Eichwald, Viktoria; Kaulfuss, Stefan; Panknin, Olaf; Rehwinkel, Hartmut; Zimmermann, Katja; Hillig, Roman C.; Guenther, Judith; Toschi, Luisella; Neuhaus, Roland; Haegebart, Andrea; Hess-Stumpp, Holger; Bauser, Markus; Wick, Wolfgang; Unterberg, Andreas; Herold-Mende, Christel; Platten, Michael; von Deimling, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">629-644</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Mutations in codon 132 of isocitrate dehydrogenase (IDH) 1 are frequent in diffuse glioma, acute myeloid leukemia, chondrosarcoma and intrahepatic cholangiocarcinoma.  These mutations result in a neomorphic enzyme specificity which leads to a dramatic increase of intracellular D-2-hydroxyglutarate (2-HG) in tumor cells.  Therefore, mutant IDH1 protein is a highly attractive target for inhibitory drugs.  Here, we describe the development and properties of BAY 1436032, a pan-inhibitor of IDH1 protein with different codon 132 mutations.  BAY 1436032 strongly reduces 2-HG levels in cells carrying IDH1-R132H, -R132C, -R132G, -R132S and -R132L mutations.  Cells not carrying IDH mutations were unaffected.  BAY 1436032 did not exhibit toxicity in vitro or in vivo.  The pharmacokinetic properties of BAY 1436032 allow for oral administration.  In two independent expts., BAY 1436032 has been shown to significantly prolong survival of mice intracerebrally transplanted with human astrocytoma carrying the IDH1R132H mutation.  In conclusion, we developed a pan-inhibitor targeting tumors with different IDH1R132 mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOmrHN_rsuT7Vg90H21EOLACvtfcHk0lgtsubketoZ0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFKitbc%253D&md5=e5a60357948c458ff6644f53575e0c6f</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1007%2Fs00401-017-1677-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-017-1677-y%26sid%3Dliteratum%253Aachs%26aulast%3DPusch%26aufirst%3DS.%26aulast%3DKrausert%26aufirst%3DS.%26aulast%3DFischer%26aufirst%3DV.%26aulast%3DBalss%26aufirst%3DJ.%26aulast%3DOtt%26aufirst%3DM.%26aulast%3DSchrimpf%26aufirst%3DD.%26aulast%3DCapper%26aufirst%3DD.%26aulast%3DSahm%26aufirst%3DF.%26aulast%3DEisel%26aufirst%3DJ.%26aulast%3DBeck%26aufirst%3DA.-C.%26aulast%3DJugold%26aufirst%3DM.%26aulast%3DEichwald%26aufirst%3DV.%26aulast%3DKaulfuss%26aufirst%3DS.%26aulast%3DPanknin%26aufirst%3DO.%26aulast%3DRehwinkel%26aufirst%3DH.%26aulast%3DZimmermann%26aufirst%3DK.%26aulast%3DHillig%26aufirst%3DR.%2BC.%26aulast%3DGuenther%26aufirst%3DJ.%26aulast%3DToschi%26aufirst%3DL.%26aulast%3DNeuhaus%26aufirst%3DR.%26aulast%3DHaegebart%26aufirst%3DA.%26aulast%3DHess-Stumpp%26aufirst%3DH.%26aulast%3DBauser%26aufirst%3DM.%26aulast%3DWick%26aufirst%3DW.%26aulast%3DUnterberg%26aufirst%3DA.%26aulast%3DHerold-Mende%26aufirst%3DC.%26aulast%3DPlatten%26aufirst%3DM.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26atitle%3DPan-mutant%2520IDH1%2520inhibitor%2520BAY%25201436032%2520for%2520effective%2520treatment%2520of%2520IDH1%2520mutant%2520astrocytoma%2520in%2520vivo%26jtitle%3DActa%2520Neuropathol.%26date%3D2017%26volume%3D133%26spage%3D629%26epage%3D644%26doi%3D10.1007%2Fs00401-017-1677-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbst, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pusch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klett, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goparaju, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stichel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaulfuss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panknin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toschi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haegebarth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehwinkel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess-Stumpp, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bochtler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struys, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakkali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geffers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araujo-Cruz, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thol, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabdoulline, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Deimling, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rippe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krämer, A.</span></span> <span> </span><span class="NLM_article-title">Pan-mutant-IDH1 inhibitor BAY- 1436032 is highly effective against human IDH1 mutant acute myeloid leukemia <i>in vivo</i></span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">2020</span>– <span class="NLM_lpage">2028</span>, <span class="refDoi"> DOI: 10.1038/leu.2017.46</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1038%2Fleu.2017.46" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=2020-2028&author=A.+Chaturvediauthor=L.+Herbstauthor=S.+Puschauthor=L.+Klettauthor=R.+Goparajuauthor=D.+Stichelauthor=S.+Kaulfussauthor=O.+Pankninauthor=K.+Zimmermannauthor=L.+Toschiauthor=R.+Neuhausauthor=A.+Haegebarthauthor=H.+Rehwinkelauthor=H.+Hess-Stumppauthor=M.+Bauserauthor=T.+Bochtlerauthor=E.+A.+Struysauthor=A.+Sharmaauthor=A.+Bakkaliauthor=R.+Geffersauthor=M.+M.+Araujo-Cruzauthor=F.+Tholauthor=R.+Gabdoullineauthor=A.+Ganserauthor=A.+D.+Hoauthor=A.+von+Deimlingauthor=K.+Rippeauthor=M.+Heuserauthor=A.+Kr%C3%A4mer&title=Pan-mutant-IDH1+inhibitor+BAY-+1436032+is+highly+effective+against+human+IDH1+mutant+acute+myeloid+leukemia+in+vivo&doi=10.1038%2Fleu.2017.46"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fleu.2017.46&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2017.46%26sid%3Dliteratum%253Aachs%26aulast%3DChaturvedi%26aufirst%3DA.%26aulast%3DHerbst%26aufirst%3DL.%26aulast%3DPusch%26aufirst%3DS.%26aulast%3DKlett%26aufirst%3DL.%26aulast%3DGoparaju%26aufirst%3DR.%26aulast%3DStichel%26aufirst%3DD.%26aulast%3DKaulfuss%26aufirst%3DS.%26aulast%3DPanknin%26aufirst%3DO.%26aulast%3DZimmermann%26aufirst%3DK.%26aulast%3DToschi%26aufirst%3DL.%26aulast%3DNeuhaus%26aufirst%3DR.%26aulast%3DHaegebarth%26aufirst%3DA.%26aulast%3DRehwinkel%26aufirst%3DH.%26aulast%3DHess-Stumpp%26aufirst%3DH.%26aulast%3DBauser%26aufirst%3DM.%26aulast%3DBochtler%26aufirst%3DT.%26aulast%3DStruys%26aufirst%3DE.%2BA.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DBakkali%26aufirst%3DA.%26aulast%3DGeffers%26aufirst%3DR.%26aulast%3DAraujo-Cruz%26aufirst%3DM.%2BM.%26aulast%3DThol%26aufirst%3DF.%26aulast%3DGabdoulline%26aufirst%3DR.%26aulast%3DGanser%26aufirst%3DA.%26aulast%3DHo%26aufirst%3DA.%2BD.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26aulast%3DRippe%26aufirst%3DK.%26aulast%3DHeuser%26aufirst%3DM.%26aulast%3DKr%25C3%25A4mer%26aufirst%3DA.%26atitle%3DPan-mutant-IDH1%2520inhibitor%2520BAY-%25201436032%2520is%2520highly%2520effective%2520against%2520human%2520IDH1%2520mutant%2520acute%2520myeloid%2520leukemia%2520in%2520vivo%26jtitle%3DLeukemia%26date%3D2017%26volume%3D31%26spage%3D2020%26epage%3D2028%26doi%3D10.1038%2Fleu.2017.46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heuser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbst, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pusch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klett, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goparaju, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stichel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaulfuss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panknin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toschi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haegebarth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehwinkel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess-Stumpp, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bochtler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struys, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdellatif, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceffers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruz, M. M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thol, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaboulline, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Deimling, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rippe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraemer, A.</span></span> <span> </span><span class="NLM_article-title">Pan-mutant-IDH1 inhibitor BAY-1436032 is highly effective against human IDH1 mutant acute myeloid leukemia <i>in vivo</i></span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">745</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2016&pages=745&author=M.+Heuserauthor=L.+Herbstauthor=S.+Puschauthor=L.+Klettauthor=R.+Goparajuauthor=D.+Stichelauthor=S.+Kaulfussauthor=O.+Pankninauthor=K.+Zimmermannauthor=L.+Toschiauthor=R.+Neuhausauthor=A.+Haegebarthauthor=H.+Rehwinkelauthor=H.+Hess-Stumppauthor=M.+Bauserauthor=T.+Bochtlerauthor=E.+A.+Struysauthor=A.+Sharmaauthor=A.+Abdellatifauthor=R.+Ceffersauthor=M.+M.+A.+Cruzauthor=F.+Tholauthor=R.+Gaboullineauthor=A.+Ganserauthor=A.+D.+Hoauthor=A.+von+Deimlingauthor=K.+Rippeauthor=A.+Chaturvediauthor=A.+Kraemer&title=Pan-mutant-IDH1+inhibitor+BAY-1436032+is+highly+effective+against+human+IDH1+mutant+acute+myeloid+leukemia+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeuser%26aufirst%3DM.%26aulast%3DHerbst%26aufirst%3DL.%26aulast%3DPusch%26aufirst%3DS.%26aulast%3DKlett%26aufirst%3DL.%26aulast%3DGoparaju%26aufirst%3DR.%26aulast%3DStichel%26aufirst%3DD.%26aulast%3DKaulfuss%26aufirst%3DS.%26aulast%3DPanknin%26aufirst%3DO.%26aulast%3DZimmermann%26aufirst%3DK.%26aulast%3DToschi%26aufirst%3DL.%26aulast%3DNeuhaus%26aufirst%3DR.%26aulast%3DHaegebarth%26aufirst%3DA.%26aulast%3DRehwinkel%26aufirst%3DH.%26aulast%3DHess-Stumpp%26aufirst%3DH.%26aulast%3DBauser%26aufirst%3DM.%26aulast%3DBochtler%26aufirst%3DT.%26aulast%3DStruys%26aufirst%3DE.%2BA.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DAbdellatif%26aufirst%3DA.%26aulast%3DCeffers%26aufirst%3DR.%26aulast%3DCruz%26aufirst%3DM.%2BM.%2BA.%26aulast%3DThol%26aufirst%3DF.%26aulast%3DGaboulline%26aufirst%3DR.%26aulast%3DGanser%26aufirst%3DA.%26aulast%3DHo%26aufirst%3DA.%2BD.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26aulast%3DRippe%26aufirst%3DK.%26aulast%3DChaturvedi%26aufirst%3DA.%26aulast%3DKraemer%26aufirst%3DA.%26atitle%3DPan-mutant-IDH1%2520inhibitor%2520BAY-1436032%2520is%2520highly%2520effective%2520against%2520human%2520IDH1%2520mutant%2520acute%2520myeloid%2520leukemia%2520in%2520vivo%26jtitle%3DBlood%26date%3D2016%26volume%3D128%26spage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rehwinkel, H.</span>; <span class="NLM_string-name">Panknin, O.</span>; <span class="NLM_string-name">Ring, S.</span>; <span class="NLM_string-name">Anlauf, S.</span>; <span class="NLM_string-name">Siebeneicher, H.</span>; <span class="NLM_string-name">Nguyen, D.</span>; <span class="NLM_string-name">Schwede, W.</span>; <span class="NLM_string-name">Bauser, M.</span>; <span class="NLM_string-name">Zimmermann, K.</span>; <span class="NLM_string-name">Kaulfuss, S.</span>; <span class="NLM_string-name">Neuhaus, R.</span>; <span class="NLM_string-name">Blaney, P. M.</span></span> <span> </span><span class="NLM_article-title">Benzimidazol-2-amines as mIDH1 Inhibitors</span>. <span class="NLM_patent">WO/2015121210 A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.+Rehwinkel&author=O.+Panknin&author=S.+Ring&author=S.+Anlauf&author=H.+Siebeneicher&author=D.+Nguyen&author=W.+Schwede&author=M.+Bauser&author=K.+Zimmermann&author=S.+Kaulfuss&author=R.+Neuhaus&author=P.+M.+Blaney&title=Benzimidazol-2-amines+as+mIDH1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRehwinkel%26aufirst%3DH.%26atitle%3DBenzimidazol-2-amines%2520as%2520mIDH1%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schirmer, H.</span></span> <span> </span><span class="NLM_article-title">Inhibitor of the Mutated Isocitrate Dehydrogenase IDH1 R132H</span>. <span class="NLM_patent">WO/2017016992 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=H.+Schirmer&title=Inhibitor+of+the+Mutated+Isocitrate+Dehydrogenase+IDH1+R132H"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchirmer%26aufirst%3DH.%26atitle%3DInhibitor%2520of%2520the%2520Mutated%2520Isocitrate%2520Dehydrogenase%2520IDH1%2520R132H%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McManus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathieu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gee, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLean, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le-Strat, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquette, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooney, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassort, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Englaro, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adrian, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiederschain, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Licht, S.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of mutant isocitrate dehydrogenase 1(IDH1) via disruption of a metal binding network by an allosteric small molecule</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>290</i></span>,  <span class="NLM_fpage">762</span>– <span class="NLM_lpage">774</span>, <span class="refDoi"> DOI: 10.1074/jbc.M114.608497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1074%2Fjbc.M114.608497" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=762-774&author=G.+Dengauthor=J.+Shenauthor=M.+Yinauthor=J.+McManusauthor=M.+Mathieuauthor=P.+Geeauthor=T.+Heauthor=C.+Shiauthor=O.+Bedelauthor=L.+R.+McLeanauthor=F.+Le-Stratauthor=Y.+Zhangauthor=J.+P.+Marquetteauthor=Q.+Gaoauthor=B.+Zhangauthor=A.+Rakauthor=D.+Hoffmannauthor=E.+Rooneyauthor=A.+Vassortauthor=W.+Englaroauthor=Y.+Liauthor=V.+Patelauthor=F.+Adrianauthor=S.+Grossauthor=D.+Wiederschainauthor=H.+Chengauthor=S.+Licht&title=Selective+inhibition+of+mutant+isocitrate+dehydrogenase+1%28IDH1%29+via+disruption+of+a+metal+binding+network+by+an+allosteric+small+molecule&doi=10.1074%2Fjbc.M114.608497"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.608497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.608497%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DG.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DYin%26aufirst%3DM.%26aulast%3DMcManus%26aufirst%3DJ.%26aulast%3DMathieu%26aufirst%3DM.%26aulast%3DGee%26aufirst%3DP.%26aulast%3DHe%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DBedel%26aufirst%3DO.%26aulast%3DMcLean%26aufirst%3DL.%2BR.%26aulast%3DLe-Strat%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMarquette%26aufirst%3DJ.%2BP.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DRak%26aufirst%3DA.%26aulast%3DHoffmann%26aufirst%3DD.%26aulast%3DRooney%26aufirst%3DE.%26aulast%3DVassort%26aufirst%3DA.%26aulast%3DEnglaro%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DAdrian%26aufirst%3DF.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DWiederschain%26aufirst%3DD.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DLicht%26aufirst%3DS.%26atitle%3DSelective%2520inhibition%2520of%2520mutant%2520isocitrate%2520dehydrogenase%25201%2528IDH1%2529%2520via%2520disruption%2520of%2520a%2520metal%2520binding%2520network%2520by%2520an%2520allosteric%2520small%2520molecule%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D762%26epage%3D774%26doi%3D10.1074%2Fjbc.M114.608497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Law, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leiendecker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verho, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamji, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of 8-membered ring sulfonamides as inhibitors of oncogenic mutant isocitrate dehydrogenase 1</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">944</span>– <span class="NLM_lpage">949</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00264</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00264" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOgtrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=944-949&author=J.+M.+Lawauthor=S.+C.+Starkauthor=K.+Liuauthor=N.+E.+Liangauthor=M.+M.+Hussainauthor=M.+Leiendeckerauthor=D.+Itoauthor=O.+Verhoauthor=A.+M.+Sternauthor=S.+E.+Johnstonauthor=Y.+Zhangauthor=G.+P.+Dunnauthor=A.+F.+Shamjiauthor=S.+L.+Schreiber&title=Discovery+of+8-membered+ring+sulfonamides+as+inhibitors+of+oncogenic+mutant+isocitrate+dehydrogenase+1&doi=10.1021%2Facsmedchemlett.6b00264"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 8-Membered Ring Sulfonamides as Inhibitors of Oncogenic Mutant Isocitrate Dehydrogenase 1</span></div><div class="casAuthors">Law, Jason M.; Stark, Sebastian C.; Liu, Ke; Liang, Norah E.; Hussain, Mahmud M.; Leiendecker, Matthias; Ito, Daisuke; Verho, Oscar; Stern, Andrew M.; Johnston, Stephen E.; Zhang, Yan-Ling; Dunn, Gavin P.; Shamji, Alykhan F.; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">944-949</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Evidence suggests that specific mutations of isocitrate dehydrogenases 1 and 2 (IDH1/2) are crit. for the initiation and maintenance of certain tumor types, and that inhibiting these mutant enzymes with small mols. may be therapeutically beneficial.  In order to discover mutant-allele-selective IDH1 inhibitors with chem. features distinct from existing probes, the authors screened a collection of small mols. derived from diversity-oriented synthesis.  The assay identified compds. that inhibit the IDH1-R132H mutant allele commonly found in glioma.  Here, the authors report the discovery of a potent (IC50 = 50 nM) series of IDH1-R132H inhibitors having 8-membered ring sulfonamides as exemplified by the compd. I.  The inhibitors suppress (R)-2-hydroxyglutarate prodn. in cells without apparent toxicity.  Although the soly. and pharmacokinetic properties of the specific inhibitor I prevent its use in vivo, the scaffold presents a validated starting point for the synthesis of future IDH1-R132H inhibitors having improved biol. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVJ2KnOXtLdLVg90H21EOLACvtfcHk0limUM-91UJYgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOgtrfF&md5=aed428e21b3e3de5937fedbd2a7c4b45</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00264%26sid%3Dliteratum%253Aachs%26aulast%3DLaw%26aufirst%3DJ.%2BM.%26aulast%3DStark%26aufirst%3DS.%2BC.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DLiang%26aufirst%3DN.%2BE.%26aulast%3DHussain%26aufirst%3DM.%2BM.%26aulast%3DLeiendecker%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DD.%26aulast%3DVerho%26aufirst%3DO.%26aulast%3DStern%26aufirst%3DA.%2BM.%26aulast%3DJohnston%26aufirst%3DS.%2BE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDunn%26aufirst%3DG.%2BP.%26aulast%3DShamji%26aufirst%3DA.%2BF.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DDiscovery%2520of%25208-membered%2520ring%2520sulfonamides%2520as%2520inhibitors%2520of%2520oncogenic%2520mutant%2520isocitrate%2520dehydrogenase%25201%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D944%26epage%3D949%26doi%3D10.1021%2Facsmedchemlett.6b00264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayton, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ball, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cockerill, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairweather, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitchin, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plant, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinclair, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somervaille, T. C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Small, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waddell, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waszkowycz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigglesworth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiseman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, D. J.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of allosteric inhibitors of mutant isocitrate dehydrogenase 1 (IDH1 R132H) displaying activity in human acute myeloid leukemia cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">11120</span>– <span class="NLM_lpage">11137</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01320</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01320" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=11120-11137&author=S.+Jonesauthor=J.+Ahmetauthor=K.+Aytonauthor=M.+D.+Ballauthor=M.+Cockerillauthor=E.+E.+Fairweatherauthor=N.+Hamiltonauthor=P.+Harperauthor=J.+R.+Hitchinauthor=A.+M.+Jordanauthor=C.+W.+Levyauthor=R.+Lopezauthor=E.+McKenzieauthor=M.+J.+Packerauthor=D.+Plantauthor=L.+Simpsonauthor=P.+Simpsonauthor=L.+Sinclairauthor=T.+C.+P.+Somervailleauthor=H.+Smallauthor=G.+J.+Spencerauthor=G.+J.+Thomsonauthor=M.+Tongeauthor=L.+D.+Waddellauthor=J.+Walshauthor=B.+Waszkowyczauthor=M.+Wigglesworthauthor=D.+Wisemanauthor=D.+J.+Ogilvie&title=Discovery+and+optimization+of+allosteric+inhibitors+of+mutant+isocitrate+dehydrogenase+1+%28IDH1+R132H%29+displaying+activity+in+human+acute+myeloid+leukemia+cells&doi=10.1021%2Facs.jmedchem.6b01320"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01320%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DS.%26aulast%3DAhmet%26aufirst%3DJ.%26aulast%3DAyton%26aufirst%3DK.%26aulast%3DBall%26aufirst%3DM.%2BD.%26aulast%3DCockerill%26aufirst%3DM.%26aulast%3DFairweather%26aufirst%3DE.%2BE.%26aulast%3DHamilton%26aufirst%3DN.%26aulast%3DHarper%26aufirst%3DP.%26aulast%3DHitchin%26aufirst%3DJ.%2BR.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DLevy%26aufirst%3DC.%2BW.%26aulast%3DLopez%26aufirst%3DR.%26aulast%3DMcKenzie%26aufirst%3DE.%26aulast%3DPacker%26aufirst%3DM.%2BJ.%26aulast%3DPlant%26aufirst%3DD.%26aulast%3DSimpson%26aufirst%3DL.%26aulast%3DSimpson%26aufirst%3DP.%26aulast%3DSinclair%26aufirst%3DL.%26aulast%3DSomervaille%26aufirst%3DT.%2BC.%2BP.%26aulast%3DSmall%26aufirst%3DH.%26aulast%3DSpencer%26aufirst%3DG.%2BJ.%26aulast%3DThomson%26aufirst%3DG.%2BJ.%26aulast%3DTonge%26aufirst%3DM.%26aulast%3DWaddell%26aufirst%3DL.%2BD.%26aulast%3DWalsh%26aufirst%3DJ.%26aulast%3DWaszkowycz%26aufirst%3DB.%26aulast%3DWigglesworth%26aufirst%3DM.%26aulast%3DWiseman%26aufirst%3DD.%26aulast%3DOgilvie%26aufirst%3DD.%2BJ.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520allosteric%2520inhibitors%2520of%2520mutant%2520isocitrate%2520dehydrogenase%25201%2520%2528IDH1%2520R132H%2529%2520displaying%2520activity%2520in%2520human%2520acute%2520myeloid%2520leukemia%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D11120%26epage%3D11137%26doi%3D10.1021%2Facs.jmedchem.6b01320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. S.</span>; <span class="NLM_string-name">Levell, J. R.</span>; <span class="NLM_string-name">Liu, G.</span>; <span class="NLM_string-name">Shultz, M. D.</span>; <span class="NLM_string-name">Van Der Plas, S. C.</span></span> <span> </span><span class="NLM_article-title">3-Pyrimidin-4-yl-oxazolidin-2-ones as Inhibitors of Mutant IDH</span>. <span class="NLM_patent">WO/2014141153 A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=Y.+S.+Cho&author=J.+R.+Levell&author=G.+Liu&author=M.+D.+Shultz&author=S.+C.+Van+Der+Plas&title=3-Pyrimidin-4-yl-oxazolidin-2-ones+as+Inhibitors+of+Mutant+IDH"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DY.%2BS.%26atitle%3D3-Pyrimidin-4-yl-oxazolidin-2-ones%2520as%2520Inhibitors%2520of%2520Mutant%2520IDH%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Levell, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caferro, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chenail, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dix, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dooley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giraldes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Growney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulathila, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Plas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slocum, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terranova, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toure, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagliarini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. S.</span></span> <span> </span><span class="NLM_article-title">Optimization of 3-pyrimidin-4-yl-oxazolidin-2-ones as allosteric and mutant specific inhibitors of IDH1</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">156</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00334</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00334" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFSgu7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=151-156&author=J.+R.+Levellauthor=T.+Caferroauthor=G.+Chenailauthor=I.+Dixauthor=J.+Dooleyauthor=B.+Firestoneauthor=P.+D.+Fortinauthor=J.+Giraldesauthor=T.+Gouldauthor=J.+D.+Growneyauthor=M.+D.+Jonesauthor=R.+Kulathilaauthor=F.+Linauthor=G.+Liuauthor=A.+Muellerauthor=S.+van+der+Plasauthor=K.+Slocumauthor=T.+Smithauthor=R.+Terranovaauthor=B.+B.+Toureauthor=V.+Tyagiauthor=T.+Wagnerauthor=X.+Xieauthor=M.+Xuauthor=F.+S.+Yangauthor=L.+X.+Zhouauthor=R.+Pagliariniauthor=Y.+S.+Cho&title=Optimization+of+3-pyrimidin-4-yl-oxazolidin-2-ones+as+allosteric+and+mutant+specific+inhibitors+of+IDH1&doi=10.1021%2Facsmedchemlett.6b00334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Allosteric and Mutant Specific Inhibitors of IDH1</span></div><div class="casAuthors">Levell, Julian R.; Caferro, Thomas; Chenail, Gregg; Dix, Ina; Dooley, Julia; Firestone, Brant; Fortin, Pascal D.; Giraldes, John; Gould, Ty; Growney, Joseph D.; Jones, Michael D.; Kulathila, Raviraj; Lin, Fallon; Liu, Gang; Mueller, Arne; van der Plas, Simon; Slocum, Kelly; Smith, Troy; Terranova, Remi; Toure, B. Barry; Tyagi, Viraj; Wagner, Trixie; Xie, Xiaoling; Xu, Ming; Yang, Fan S.; Zhou, Liping X.; Pagliarini, Raymond; Cho, Young Shin</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-156</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">High throughput screening and subsequent hit validation identified 4-isopropyl-3-(2-((1-phenylethyl)amino)pyrimidin-4-yl)oxazolidin-2-one as a potent inhibitor of IDH1R132H.  Synthesis of the four sep. stereomers identified the (S,S)-diastereomer (IDH125, 1f) as the most potent isomer.  This also showed reasonable cellular activity and excellent selectivity vs. IDH1wt.  Initial SAR exploration identified the key tolerances and potential for optimization.  X-ray crystallog. identified a functionally relevant allosteric binding site amenable to inhibitors which can penetrate the blood-brain barrier, and aided rational optimization.  Potency improvement and modulation of the physico-chem. properties identified (S,S)-oxazolidinone IDH889 (5x) with good exposure and 2-HG inhibitory activity in a mutant IDH1 xenograft mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdfShR2C4h0LVg90H21EOLACvtfcHk0liEYTB2Gy0CNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFSgu7jK&md5=9f754dba792b77c9c64fcac474dc1f0f</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00334%26sid%3Dliteratum%253Aachs%26aulast%3DLevell%26aufirst%3DJ.%2BR.%26aulast%3DCaferro%26aufirst%3DT.%26aulast%3DChenail%26aufirst%3DG.%26aulast%3DDix%26aufirst%3DI.%26aulast%3DDooley%26aufirst%3DJ.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26aulast%3DGiraldes%26aufirst%3DJ.%26aulast%3DGould%26aufirst%3DT.%26aulast%3DGrowney%26aufirst%3DJ.%2BD.%26aulast%3DJones%26aufirst%3DM.%2BD.%26aulast%3DKulathila%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DMueller%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BPlas%26aufirst%3DS.%26aulast%3DSlocum%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DT.%26aulast%3DTerranova%26aufirst%3DR.%26aulast%3DToure%26aufirst%3DB.%2BB.%26aulast%3DTyagi%26aufirst%3DV.%26aulast%3DWagner%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DF.%2BS.%26aulast%3DZhou%26aufirst%3DL.%2BX.%26aulast%3DPagliarini%26aufirst%3DR.%26aulast%3DCho%26aufirst%3DY.%2BS.%26atitle%3DOptimization%2520of%25203-pyrimidin-4-yl-oxazolidin-2-ones%2520as%2520allosteric%2520and%2520mutant%2520specific%2520inhibitors%2520of%2520IDH1%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D151%26epage%3D156%26doi%3D10.1021%2Facsmedchemlett.6b00334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baird, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capka, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chenail, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dooley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farsidjani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohls, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulathila, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sage, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touré, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Plas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagliarini, R. A.</span></span> <span> </span><span class="NLM_article-title">Allosteric mutant IDH1 inhibitors reveal mechanisms for IDH1 mutant and isoform selectivity</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">506</span>– <span class="NLM_lpage">513</span>, <span class="refDoi"> DOI: 10.1016/j.str.2016.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1016%2Fj.str.2016.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=28132785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1KnsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=506-513&author=X.+Xieauthor=D.+Bairdauthor=K.+Bowenauthor=V.+Capkaauthor=J.+Chenauthor=G.+Chenailauthor=Y.+Choauthor=J.+Dooleyauthor=A.+Farsidjaniauthor=P.+Fortinauthor=D.+Kohlsauthor=R.+Kulathilaauthor=F.+Linauthor=D.+McKayauthor=L.+Rodriguesauthor=D.+Sageauthor=B.+B.+Tour%C3%A9author=S.+van+der+Plasauthor=K.+Wrightauthor=M.+Xuauthor=H.+Yinauthor=J.+Levellauthor=R.+A.+Pagliarini&title=Allosteric+mutant+IDH1+inhibitors+reveal+mechanisms+for+IDH1+mutant+and+isoform+selectivity&doi=10.1016%2Fj.str.2016.12.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Mutant IDH1 Inhibitors Reveal Mechanisms for IDH1 Mutant and Isoform Selectivity</span></div><div class="casAuthors">Xie, Xiaoling; Baird, Daniel; Bowen, Kimberly; Capka, Vladimir; Chen, Jinyun; Chenail, Gregg; Cho, Young Shin; Dooley, Julia; Farsidjani, Ali; Fortin, Pascal; Kohls, Darcy; Kulathila, Raviraj; Lin, Fallon; McKay, Daniel; Rodrigues, Lindsey; Sage, David; van der Plas, Simon; Wright, Kirk; Xu, Ming; Yin, Hong; Levell, Julian; Pagliarini, Raymond A.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">506-513</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Oncogenic IDH1 and IDH2 mutations contribute to cancer via prodn. of R-2-hydroxyglutarate (2-HG).  Here, we characterize two structurally distinct mutant- and isoform-selective IDH1 inhibitors that inhibit 2-HG prodn.  Both bind to an allosteric pocket on IDH1, yet shape it differently, highlighting the plasticity of this site.  Oncogenic IDH1R132H mutation destabilizes an IDH1 "regulatory segment," which otherwise restricts compd. access to the allosteric pocket.  Regulatory segment destabilization in wild-type IDH1 promotes inhibitor binding, suggesting that destabilization is crit. for mutant selectivity.  We also report crystal structures of oncogenic IDH2 mutant isoforms, highlighting the fact that the analogous segment of IDH2 is not similarly destabilized.  This intrinsic stability of IDH2 may contribute to obsd. inhibitor IDH1 isoform selectivity.  Moreover, discrete residues in the IDH1 allosteric pocket that differ from IDH2 may also guide IDH1 isoform selectivity.  These data provide a deeper understanding of how IDH1 inhibitors achieve mutant and isoform selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLhnq8F-J4DbVg90H21EOLACvtfcHk0liEYTB2Gy0CNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1KnsbY%253D&md5=58532ad82b6baca40717bbe1c3834ecc</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2016.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2016.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DX.%26aulast%3DBaird%26aufirst%3DD.%26aulast%3DBowen%26aufirst%3DK.%26aulast%3DCapka%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DChenail%26aufirst%3DG.%26aulast%3DCho%26aufirst%3DY.%26aulast%3DDooley%26aufirst%3DJ.%26aulast%3DFarsidjani%26aufirst%3DA.%26aulast%3DFortin%26aufirst%3DP.%26aulast%3DKohls%26aufirst%3DD.%26aulast%3DKulathila%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DMcKay%26aufirst%3DD.%26aulast%3DRodrigues%26aufirst%3DL.%26aulast%3DSage%26aufirst%3DD.%26aulast%3DTour%25C3%25A9%26aufirst%3DB.%2BB.%26aulast%3Dvan%2Bder%2BPlas%26aufirst%3DS.%26aulast%3DWright%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DLevell%26aufirst%3DJ.%26aulast%3DPagliarini%26aufirst%3DR.%2BA.%26atitle%3DAllosteric%2520mutant%2520IDH1%2520inhibitors%2520reveal%2520mechanisms%2520for%2520IDH1%2520mutant%2520and%2520isoform%2520selectivity%26jtitle%3DStructure%26date%3D2017%26volume%3D25%26spage%3D506%26epage%3D513%26doi%3D10.1016%2Fj.str.2016.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khawaja, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiNardo, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janku, F.</span></span> <span> </span><span class="NLM_article-title">Targeting isocitrate dehydrogenase (IDH) in cancer</span>. <i>Discovery Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">380</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=27355333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A280%3ADC%252BC2s7ltFKmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=373-380&author=T.+Fujiiauthor=M.+R.+Khawajaauthor=C.+D.+DiNardoauthor=J.+T.+Atkinsauthor=F.+Janku&title=Targeting+isocitrate+dehydrogenase+%28IDH%29+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting isocitrate dehydrogenase (IDH) in cancer</span></div><div class="casAuthors">Fujii Takeo; Khawaja Muhammad Rizwan; Atkins Johnique T; Janku Filip; Fujii Takeo; Khawaja Muhammad Rizwan; DiNardo Courtney D</div><div class="citationInfo"><span class="NLM_cas:title">Discovery medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">117</span>),
    <span class="NLM_cas:pages">373-80</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Isocitrate dehydrogenase (IDH) is an essential enzyme for cellular respiration in the tricarboxylic acid (TCA) cycle.  Recurrent mutations in IDH1 or IDH2 are prevalent in several cancers including glioma, acute myeloid leukemia (AML), cholangiocarcinoma and chondrosarcoma.  The mutated IDH1 and IDH2 proteins have a gain-of-function, neomorphic activity, catalyzing the reduction of α-ketoglutarate (α-KG) to 2-hydroxyglutarate (2-HG) by NADPH.  Cancer-associated IDH mutations block normal cellular differentiation and promote tumorigenesis via the abnormal production of the oncometabolite 2-HG.  High levels of 2-HG have been shown to inhibit α-KG dependent dioxygenases, including histone and deoxyribonucleic acid (DNA) demethylases, which play a key role in regulating the epigenetic state of cells.  Current targeted inhibitors of IDH1 (AG120, IDH305), IDH2 (AG221), and pan-IDH1/2 (AG881) selectively inhibit mutant IDH protein and induce cell differentiation in in vitro and in vivo models.  Preliminary results from phase I clinical trials with IDH inhibitors in patients with advanced hematologic malignancies have demonstrated an objective response rate ranging from 31% to 40% with durable responses (>1 year) observed.  Furthermore, the IDH inhibitors have demonstrated early signals of activity in solid tumors with IDH mutations, including cholangiocarcinomas and low grade gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSuJxrwgJ7KGmbXvSEQle5fW6udTcc2eYiLEoSXfmCoLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7ltFKmtQ%253D%253D&md5=e7297950531e645cff014cd011230d12</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujii%26aufirst%3DT.%26aulast%3DKhawaja%26aufirst%3DM.%2BR.%26aulast%3DDiNardo%26aufirst%3DC.%2BD.%26aulast%3DAtkins%26aufirst%3DJ.%2BT.%26aulast%3DJanku%26aufirst%3DF.%26atitle%3DTargeting%2520isocitrate%2520dehydrogenase%2520%2528IDH%2529%2520in%2520cancer%26jtitle%3DDiscovery%2520Med.%26date%3D2016%26volume%3D21%26spage%3D373%26epage%3D380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levell, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caferro, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shafer, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costales, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sendzik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chenail, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dooley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalba, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farsidjani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulathila, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heimbach, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slocum, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagliarini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Growney, J. D.</span></span> <span> </span><span class="NLM_article-title">Discovery and evaluation of clinical candidate IDH305, a brain penetrant mutant IDH1 inhibitor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1116</span>– <span class="NLM_lpage">1121</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00342</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00342" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFWjtrbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1116-1121&author=Y.+S.+Choauthor=J.+R.+Levellauthor=G.+Liuauthor=T.+Caferroauthor=J.+Suttonauthor=C.+M.+Shaferauthor=A.+Costalesauthor=J.+R.+Manningauthor=Q.+Zhaoauthor=M.+Sendzikauthor=M.+Shultzauthor=G.+Chenailauthor=J.+Dooleyauthor=B.+Villalbaauthor=A.+Farsidjaniauthor=J.+Chenauthor=R.+Kulathilaauthor=X.+Xieauthor=S.+Doddauthor=T.+Gouldauthor=G.+Liangauthor=T.+Heimbachauthor=K.+Slocumauthor=B.+Firestoneauthor=M.+Puauthor=R.+Pagliariniauthor=J.+D.+Growney&title=Discovery+and+evaluation+of+clinical+candidate+IDH305%2C+a+brain+penetrant+mutant+IDH1+inhibitor&doi=10.1021%2Facsmedchemlett.7b00342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 Inhibitor</span></div><div class="casAuthors">Cho, Young Shin; Levell, Julian R.; Liu, Gang; Caferro, Thomas; Sutton, James; Shafer, Cynthia M.; Costales, Abran; Manning, James R.; Zhao, Qian; Sendzik, Martin; Shultz, Michael; Chenail, Gregg; Dooley, Julia; Villalba, Brian; Farsidjani, Ali; Chen, Jinyun; Kulathila, Raviraj; Xie, Xiaoling; Dodd, Stephanie; Gould, Ty; Liang, Guiqing; Heimbach, Tycho; Slocum, Kelly; Firestone, Brant; Pu, Minying; Pagliarini, Raymond; Growney, Joseph D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1116-1121</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of mutant IDH1 is being evaluated clin. as a promising treatment option for various cancers with hotspot mutation at Arg132.  Having identified an allosteric, induced pocket of IDH1R132H, we have explored 3-pyrimidin-4-yl-oxazolidin-2-ones as mutant IDH1 inhibitors for in vivo modulation of 2-HG prodn. and potential brain penetration.  We report here optimization efforts toward the identification of clin. candidate IDH305 (I), a potent and selective mutant IDH1 inhibitor that has demonstrated brain exposure in rodents.  Preclin. characterization of this compd. exhibited in vivo correlation of 2-HG redn. and efficacy in a patient-derived IDH1 mutant xenograft tumor model.  IDH305 (13) has progressed into human clin. trials for the treatment of cancers with IDH1 mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbHEgOqdDh6bVg90H21EOLACvtfcHk0lj9Qw-1L82zHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFWjtrbL&md5=ab3900c2499e847f7db3ccb0d41f2236</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00342%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DY.%2BS.%26aulast%3DLevell%26aufirst%3DJ.%2BR.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DCaferro%26aufirst%3DT.%26aulast%3DSutton%26aufirst%3DJ.%26aulast%3DShafer%26aufirst%3DC.%2BM.%26aulast%3DCostales%26aufirst%3DA.%26aulast%3DManning%26aufirst%3DJ.%2BR.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DSendzik%26aufirst%3DM.%26aulast%3DShultz%26aufirst%3DM.%26aulast%3DChenail%26aufirst%3DG.%26aulast%3DDooley%26aufirst%3DJ.%26aulast%3DVillalba%26aufirst%3DB.%26aulast%3DFarsidjani%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DKulathila%26aufirst%3DR.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DDodd%26aufirst%3DS.%26aulast%3DGould%26aufirst%3DT.%26aulast%3DLiang%26aufirst%3DG.%26aulast%3DHeimbach%26aufirst%3DT.%26aulast%3DSlocum%26aufirst%3DK.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DPagliarini%26aufirst%3DR.%26aulast%3DGrowney%26aufirst%3DJ.%2BD.%26atitle%3DDiscovery%2520and%2520evaluation%2520of%2520clinical%2520candidate%2520IDH305%252C%2520a%2520brain%2520penetrant%2520mutant%2520IDH1%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D1116%26epage%3D1121%26doi%3D10.1021%2Facsmedchemlett.7b00342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DiNardo, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schimmer, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yee, K. W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochhaus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraemer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvajal, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janku, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schöffski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Bent, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’keeffe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagliarini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuck, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, A.</span></span> <span> </span><span class="NLM_article-title">A phase I study of IDH 305 in patients with advanced malignancies including relapsed/refractory AML and MDS that harbor IDH1 R132 mutations</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">1073</span>– <span class="NLM_lpage">1073</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2016&pages=1073-1073&author=C.+D.+DiNardoauthor=A.+D.+Schimmerauthor=K.+W.+L.+Yeeauthor=A.+Hochhausauthor=A.+Kraemerauthor=R.+D.+Carvajalauthor=F.+Jankuauthor=P.+Bedardauthor=C.+Carpioauthor=A.+Wickauthor=G.+K.+Schwartzauthor=P.+Sch%C3%B6ffskiauthor=P.+Wenauthor=M.+J.+van+den+Bentauthor=M.+Rosenthalauthor=J.+O%E2%80%99keeffeauthor=X.+Chenauthor=R.+Pagliariniauthor=V.+Schuckauthor=A.+Myersauthor=A.+Wei&title=A+phase+I+study+of+IDH+305+in+patients+with+advanced+malignancies+including+relapsed%2Frefractory+AML+and+MDS+that+harbor+IDH1+R132+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiNardo%26aufirst%3DC.%2BD.%26aulast%3DSchimmer%26aufirst%3DA.%2BD.%26aulast%3DYee%26aufirst%3DK.%2BW.%2BL.%26aulast%3DHochhaus%26aufirst%3DA.%26aulast%3DKraemer%26aufirst%3DA.%26aulast%3DCarvajal%26aufirst%3DR.%2BD.%26aulast%3DJanku%26aufirst%3DF.%26aulast%3DBedard%26aufirst%3DP.%26aulast%3DCarpio%26aufirst%3DC.%26aulast%3DWick%26aufirst%3DA.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26aulast%3DSch%25C3%25B6ffski%26aufirst%3DP.%26aulast%3DWen%26aufirst%3DP.%26aulast%3Dvan%2Bden%2BBent%26aufirst%3DM.%2BJ.%26aulast%3DRosenthal%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599keeffe%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DPagliarini%26aufirst%3DR.%26aulast%3DSchuck%26aufirst%3DV.%26aulast%3DMyers%26aufirst%3DA.%26aulast%3DWei%26aufirst%3DA.%26atitle%3DA%2520phase%2520I%2520study%2520of%2520IDH%2520305%2520in%2520patients%2520with%2520advanced%2520malignancies%2520including%2520relapsed%252Frefractory%2520AML%2520and%2520MDS%2520that%2520harbor%2520IDH1%2520R132%2520mutations%26jtitle%3DBlood%26date%3D2016%26volume%3D128%26spage%3D1073%26epage%3D1073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. S.</span>; <span class="NLM_string-name">Levell, J. R.</span>; <span class="NLM_string-name">Shafer, C.</span>; <span class="NLM_string-name">Shultz, M. D.</span></span> <span> </span><span class="NLM_article-title">1-(2-(Ethylamino)pyrimidin-4-yl)pyrrolidin-2-ones as Inhibitors of Mutant IDH</span>. <span class="NLM_patent">WO/2014147586 A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=Y.+S.+Cho&author=J.+R.+Levell&author=C.+Shafer&author=M.+D.+Shultz&title=1-%282-%28Ethylamino%29pyrimidin-4-yl%29pyrrolidin-2-ones+as+Inhibitors+of+Mutant+IDH"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DY.%2BS.%26atitle%3D1-%25282-%2528Ethylamino%2529pyrimidin-4-yl%2529pyrrolidin-2-ones%2520as%2520Inhibitors%2520of%2520Mutant%2520IDH%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashwell, S.</span>; <span class="NLM_string-name">Campbell, A. M.</span>; <span class="NLM_string-name">Caravella, J. A.</span>; <span class="NLM_string-name">Diebold, R. B.</span>; <span class="NLM_string-name">Ericsson, A.</span>; <span class="NLM_string-name">Gustafson, G.</span>; <span class="NLM_string-name">Lancia, D. R.</span>; <span class="NLM_string-name">Lin, J.</span>; <span class="NLM_string-name">Lu, W.</span>; <span class="NLM_string-name">Wang, Z.</span></span> <span> </span><span class="NLM_article-title">Quinolinone Pyrimidines Compositions as Mutant-Isocitrate Dehydrogenase Inhibitors</span>. <span class="NLM_patent">WO/2016044781 A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+Ashwell&author=A.+M.+Campbell&author=J.+A.+Caravella&author=R.+B.+Diebold&author=A.+Ericsson&author=G.+Gustafson&author=D.+R.+Lancia&author=J.+Lin&author=W.+Lu&author=Z.+Wang&title=Quinolinone+Pyrimidines+Compositions+as+Mutant-Isocitrate+Dehydrogenase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAshwell%26aufirst%3DS.%26atitle%3DQuinolinone%2520Pyrimidines%2520Compositions%2520as%2520Mutant-Isocitrate%2520Dehydrogenase%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashwell, S.</span>; <span class="NLM_string-name">Campbell, A. M.</span>; <span class="NLM_string-name">Caravella, J. A.</span>; <span class="NLM_string-name">Diebold, R. B.</span>; <span class="NLM_string-name">Ericsson, A.</span>; <span class="NLM_string-name">Gustafson, G.</span>; <span class="NLM_string-name">Lancia, D. R.</span>; <span class="NLM_string-name">Lin, J.</span>; <span class="NLM_string-name">Lu, W.</span>; <span class="NLM_string-name">Wang, Z.</span></span> <span> </span><span class="NLM_article-title">Phenyl Quinolinone Derivatives as Mutant-Isocitrate Dehydrogenase Inhibitors</span>. <span class="NLM_patent">WO/2016044782 A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+Ashwell&author=A.+M.+Campbell&author=J.+A.+Caravella&author=R.+B.+Diebold&author=A.+Ericsson&author=G.+Gustafson&author=D.+R.+Lancia&author=J.+Lin&author=W.+Lu&author=Z.+Wang&title=Phenyl+Quinolinone+Derivatives+as+Mutant-Isocitrate+Dehydrogenase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAshwell%26aufirst%3DS.%26atitle%3DPhenyl%2520Quinolinone%2520Derivatives%2520as%2520Mutant-Isocitrate%2520Dehydrogenase%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashwell, S.</span>; <span class="NLM_string-name">Campbell, A. M.</span>; <span class="NLM_string-name">Caravella, J. A.</span>; <span class="NLM_string-name">Diebold, R. B.</span>; <span class="NLM_string-name">Ericsson, A.</span>; <span class="NLM_string-name">Gustafson, G.</span>; <span class="NLM_string-name">Lancia, D. R.</span>; <span class="NLM_string-name">Lin, J.</span>; <span class="NLM_string-name">Lu, W.</span>; <span class="NLM_string-name">Wang, Z.</span></span> <span> </span><span class="NLM_article-title">Pyridin-2(1h)-one Quinolinone Derivatives as Mutant-Isocitrate Dehydrogenase Inhibitors</span>. <span class="NLM_patent">WO/2016044789 A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+Ashwell&author=A.+M.+Campbell&author=J.+A.+Caravella&author=R.+B.+Diebold&author=A.+Ericsson&author=G.+Gustafson&author=D.+R.+Lancia&author=J.+Lin&author=W.+Lu&author=Z.+Wang&title=Pyridin-2%281h%29-one+Quinolinone+Derivatives+as+Mutant-Isocitrate+Dehydrogenase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAshwell%26aufirst%3DS.%26atitle%3DPyridin-2%25281h%2529-one%2520Quinolinone%2520Derivatives%2520as%2520Mutant-Isocitrate%2520Dehydrogenase%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="note"><p class="first last">Daiichi Sankyo conducts Japanese phase I trial of DS-1001b in IDH1 mutated gliomas. Thomson Reuters Drug News, February 16, 2017.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palkowitz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, R. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of diverse N -acryloyl azetidines and evaluation of their enhanced thiol reactivities</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2270</span>– <span class="NLM_lpage">2273</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.7b00788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.7b00788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmt1KqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=2270-2273&author=M.+D.+Palkowitzauthor=B.+Tanauthor=H.+Huauthor=K.+Rothauthor=R.+A.+Bauer&title=Synthesis+of+diverse+N+-acryloyl+azetidines+and+evaluation+of+their+enhanced+thiol+reactivities&doi=10.1021%2Facs.orglett.7b00788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Diverse N-Acryloyl Azetidines and Evaluation of Their Enhanced Thiol Reactivities</span></div><div class="casAuthors">Palkowitz, Maximilian D.; Tan, Bo; Hu, Haitao; Roth, Kenneth; Bauer, Renato A.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2270-2273</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acyl azetidines exhibit nonplanar hybridization, leading to lower amide-like character of the corresponding (O)C-N bonds.  This impacts N-acryloyl azetidines by producing enhanced electrophilicy at appended Michael acceptors.  Herein, reactivity data are reported in the presence of glutathione (GSH) in phosphate buffer (pH 7.4) at 37 °C.  Wide reactivity ranges are obsd. by varying substitution at the Michael acceptor or by modulating the electron-withdrawing character of substituents at the C3 position of the azetidine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjUFdHgOWgc7Vg90H21EOLACvtfcHk0liWTpqQQ-4Uuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmt1KqtLw%253D&md5=d65414bda2976c07bc76cd0df6d4a38d</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.7b00788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.7b00788%26sid%3Dliteratum%253Aachs%26aulast%3DPalkowitz%26aufirst%3DM.%2BD.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DRoth%26aufirst%3DK.%26aulast%3DBauer%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520of%2520diverse%2520N%2520-acryloyl%2520azetidines%2520and%2520evaluation%2520of%2520their%2520enhanced%2520thiol%2520reactivities%26jtitle%3DOrg.%2520Lett.%26date%3D2017%26volume%3D19%26spage%3D2270%26epage%3D2273%26doi%3D10.1021%2Facs.orglett.7b00788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, R. A.</span>; <span class="NLM_string-name">Boulet, S. L.</span>; <span class="NLM_string-name">Burkholder, T. P.</span>; <span class="NLM_string-name">Carballares Martin, S.</span>; <span class="NLM_string-name">Gillig, J. P.</span>; <span class="NLM_string-name">Gilmour, R.</span>; <span class="NLM_string-name">Lumeras Amador, W.</span>; <span class="NLM_string-name">Wu, Z.</span>; <span class="NLM_string-name">Schirmer, H.</span></span> <span> </span><span class="NLM_article-title">7-Phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one Compounds and Their Use as Mutant IDH1 Inhibitors</span>. <span class="NLM_patent">WO/2017019429 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=R.+A.+Bauer&author=S.+L.+Boulet&author=T.+P.+Burkholder&author=S.+Carballares+Martin&author=J.+P.+Gillig&author=R.+Gilmour&author=W.+Lumeras+Amador&author=Z.+Wu&author=H.+Schirmer&title=7-Phenylethylamino-4H-pyrimido%5B4%2C5-d%5D%5B1%2C3%5Doxazin-2-one+Compounds+and+Their+Use+as+Mutant+IDH1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBauer%26aufirst%3DR.%2BA.%26atitle%3D7-Phenylethylamino-4H-pyrimido%255B4%252C5-d%255D%255B1%252C3%255Doxazin-2-one%2520Compounds%2520and%2520Their%2520Use%2520as%2520Mutant%2520IDH1%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lumeras Amador, W.</span>; <span class="NLM_string-name">Bauer, R. A.</span>; <span class="NLM_string-name">Boulet, S. L.</span>; <span class="NLM_string-name">Burkholder, T. P.</span>; <span class="NLM_string-name">Gilmour, R.</span>; <span class="NLM_string-name">Hahn, P.
J.</span>; <span class="NLM_string-name">Carballares Martin, S.</span>; <span class="NLM_string-name">Pankovic, Z.</span></span> <span> </span><span class="NLM_article-title">Mutant IDH1 Inhibitors</span>. <span class="NLM_patent">WO/2017213910 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=W.+Lumeras+Amador&author=R.+A.+Bauer&author=S.+L.+Boulet&author=T.+P.+Burkholder&author=R.+Gilmour&author=P.%0AJ.+Hahn&author=S.+Carballares+Martin&author=Z.+Pankovic&title=Mutant+IDH1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLumeras%2BAmador%26aufirst%3DW.%26atitle%3DMutant%2520IDH1%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Witter, D. J.</span>; <span class="NLM_string-name">Biftu, T.</span>; <span class="NLM_string-name">Biju, P.</span>; <span class="NLM_string-name">Bogen, S. L.</span>; <span class="NLM_string-name">Hone, Q.</span>; <span class="NLM_string-name">Huang, C.</span>; <span class="NLM_string-name">Huang, X.</span>; <span class="NLM_string-name">Li, B.</span>; <span class="NLM_string-name">Park, M. K.</span>; <span class="NLM_string-name">Sloman, D. L.</span></span> <span> </span><span class="NLM_article-title">Novel Tricyclic Compounds as Inhibitors of Mutant IDH Enzymes</span>. <span class="NLM_patent">WO/2017074914 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=D.+J.+Witter&author=T.+Biftu&author=P.+Biju&author=S.+L.+Bogen&author=Q.+Hone&author=C.+Huang&author=X.+Huang&author=B.+Li&author=M.+K.+Park&author=D.+L.+Sloman&title=Novel+Tricyclic+Compounds+as+Inhibitors+of+Mutant+IDH+Enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWitter%26aufirst%3DD.%2BJ.%26atitle%3DNovel%2520Tricyclic%2520Compounds%2520as%2520Inhibitors%2520of%2520Mutant%2520IDH%2520Enzymes%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span>; <span class="NLM_string-name">Li, J.</span>; <span class="NLM_string-name">Zhou, Y.</span>; <span class="NLM_string-name">Gao, A.</span>; <span class="NLM_string-name">Gao, L.</span>; <span class="NLM_string-name">Hu, Y.</span>; <span class="NLM_string-name">Li, X.</span>; <span class="NLM_string-name">Gao, J.</span></span> <span> </span><span class="NLM_article-title">Double Aryl Maleimide Compound and Salt Pharmaceutically Accepted and Preparation Method and Application</span>. <span class="NLM_patent">CN1,057,777,51</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=Q.+Ye&author=J.+Li&author=Y.+Zhou&author=A.+Gao&author=L.+Gao&author=Y.+Hu&author=X.+Li&author=J.+Gao&title=Double+Aryl+Maleimide+Compound+and+Salt+Pharmaceutically+Accepted+and+Preparation+Method+and+Application"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DQ.%26atitle%3DDouble%2520Aryl%2520Maleimide%2520Compound%2520and%2520Salt%2520Pharmaceutically%2520Accepted%2520and%2520Preparation%2520Method%2520and%2520Application%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span>; <span class="NLM_string-name">Geng, M.</span>; <span class="NLM_string-name">Zheng, Q.</span>; <span class="NLM_string-name">Huang, M.</span>; <span class="NLM_string-name">Wan, H.</span>; <span class="NLM_string-name">Tang, S.</span>; <span class="NLM_string-name">Fu, X.</span>; <span class="NLM_string-name">Lan, X.</span>; <span class="NLM_string-name">Cao, J.</span>; <span class="NLM_string-name">Liu, F.</span>; <span class="NLM_string-name">Ding, J.</span></span> <span> </span><span class="NLM_article-title">Compound Having Mutant IDH Inhibitory Activity, Preparation Method and Use Thereof</span>. <span class="NLM_patent">WO/2017162133 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=L.+Jiang&author=M.+Geng&author=Q.+Zheng&author=M.+Huang&author=H.+Wan&author=S.+Tang&author=X.+Fu&author=X.+Lan&author=J.+Cao&author=F.+Liu&author=J.+Ding&title=Compound+Having+Mutant+IDH+Inhibitory+Activity%2C+Preparation+Method+and+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DL.%26atitle%3DCompound%2520Having%2520Mutant%2520IDH%2520Inhibitory%2520Activity%252C%2520Preparation%2520Method%2520and%2520Use%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, H.</span></span> <span> </span><span class="NLM_article-title">Discovery and structure activity relationship study of novel conformationally restricted indane analogs for mutant isocitric dehydrogenase 1 (IDH1) inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">5262</span>– <span class="NLM_lpage">5266</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1016%2Fj.bmcl.2017.10.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=5262-5266&author=Q.+Zhengauthor=S.+Tangauthor=X.+Fuauthor=Z.+Chenauthor=Y.+Yeauthor=X.+Lanauthor=L.+Jiangauthor=Y.+Huangauthor=J.+Dingauthor=M.+Gengauthor=M.+Huangauthor=H.+Wan&title=Discovery+and+structure+activity+relationship+study+of+novel+conformationally+restricted+indane+analogs+for+mutant+isocitric+dehydrogenase+1+%28IDH1%29+inhibitors&doi=10.1016%2Fj.bmcl.2017.10.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.029%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DQ.%26aulast%3DTang%26aufirst%3DS.%26aulast%3DFu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DYe%26aufirst%3DY.%26aulast%3DLan%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DH.%26atitle%3DDiscovery%2520and%2520structure%2520activity%2520relationship%2520study%2520of%2520novel%2520conformationally%2520restricted%2520indane%2520analogs%2520for%2520mutant%2520isocitric%2520dehydrogenase%25201%2520%2528IDH1%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D5262%26epage%3D5266%26doi%3D10.1016%2Fj.bmcl.2017.10.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span>; <span class="NLM_string-name">Geng, M.</span>; <span class="NLM_string-name">Zheng, Q.</span>; <span class="NLM_string-name">Huang, M.</span>; <span class="NLM_string-name">Wan, H.</span>; <span class="NLM_string-name">Tang, S.</span>; <span class="NLM_string-name">Fu, X.</span>; <span class="NLM_string-name">Lan, X.</span>; <span class="NLM_string-name">Cao, J.</span>; <span class="NLM_string-name">Ding, J.</span></span> <span> </span><span class="NLM_article-title">Compound Having Inhibitory Activity against Mutant Isocitrate Dehydrogenase, Preparation Method Therefor and Use Thereof</span>. <span class="NLM_patent">WO/2018001332 A1</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=L.+Jiang&author=M.+Geng&author=Q.+Zheng&author=M.+Huang&author=H.+Wan&author=S.+Tang&author=X.+Fu&author=X.+Lan&author=J.+Cao&author=J.+Ding&title=Compound+Having+Inhibitory+Activity+against+Mutant+Isocitrate+Dehydrogenase%2C+Preparation+Method+Therefor+and+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DL.%26atitle%3DCompound%2520Having%2520Inhibitory%2520Activity%2520against%2520Mutant%2520Isocitrate%2520Dehydrogenase%252C%2520Preparation%2520Method%2520Therefor%2520and%2520Use%2520Thereof%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span>; <span class="NLM_string-name">Duan, X.</span>; <span class="NLM_string-name">Dai, L.</span>; <span class="NLM_string-name">Yang, Z.</span>; <span class="NLM_string-name">Yang, Y.</span>; <span class="NLM_string-name">Zhang, H.</span>; <span class="NLM_string-name">Hu, Y.</span>; <span class="NLM_string-name">Peng, Y.</span>; <span class="NLM_string-name">Han, Y.</span>; <span class="NLM_string-name">Zhao, R.</span>; <span class="NLM_string-name">Tian, X.</span>; <span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Sultam Compound and Application Method Thereof</span>. <span class="NLM_patent">WO/2017162157 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=L.+Zhu&author=X.+Duan&author=L.+Dai&author=Z.+Yang&author=Y.+Yang&author=H.+Zhang&author=Y.+Hu&author=Y.+Peng&author=Y.+Han&author=R.+Zhao&author=X.+Tian&author=S.+Wang&title=Sultam+Compound+and+Application+Method+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DL.%26atitle%3DSultam%2520Compound%2520and%2520Application%2520Method%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span>; <span class="NLM_string-name">Yang, Y.</span>; <span class="NLM_string-name">Dai, L.</span>; <span class="NLM_string-name">Duan, X.</span>; <span class="NLM_string-name">Yang, Z.</span>; <span class="NLM_string-name">Zhang, H.</span>; <span class="NLM_string-name">Hu, Y.</span>; <span class="NLM_string-name">Peng, Y.</span>; <span class="NLM_string-name">Han, Y.</span>; <span class="NLM_string-name">Zhao, R.</span>; <span class="NLM_string-name">Tian, X.</span>; <span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Iridinesulfonamide Compound and Use Method Thereof</span>. <span class="NLM_patent">WO/2017162156 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=L.+Zhu&author=Y.+Yang&author=L.+Dai&author=X.+Duan&author=Z.+Yang&author=H.+Zhang&author=Y.+Hu&author=Y.+Peng&author=Y.+Han&author=R.+Zhao&author=X.+Tian&author=S.+Wang&title=Iridinesulfonamide+Compound+and+Use+Method+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DL.%26atitle%3DIridinesulfonamide%2520Compound%2520and%2520Use%2520Method%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boxer, M. B.</span>; <span class="NLM_string-name">Wang, X.</span>; <span class="NLM_string-name">Brimacombe, K. R.</span>; <span class="NLM_string-name">Emily Davis, M. I.</span>; <span class="NLM_string-name">Fang, Y.</span>; <span class="NLM_string-name">Hall, M.</span>; <span class="NLM_string-name">Jadhav, A.</span>; <span class="NLM_string-name">Karavadhi, S.</span>; <span class="NLM_string-name">Liu, L.</span>; <span class="NLM_string-name">Martinez, N.</span>; <span class="NLM_string-name">Mciver, A. L.</span>; <span class="NLM_string-name">Pragani, R.</span>; <span class="NLM_string-name">Rohde, J. M.</span>; <span class="NLM_string-name">Simeonov, A.</span>; <span class="NLM_string-name">Zhao, W.</span>; <span class="NLM_string-name">Shen, M.</span></span> <span> </span><span class="NLM_article-title">Thiazole Derivatives Useful as Mutant IDH1 Inhibitors for Treating Cancer</span>. <span class="NLM_patent">WO/2017223202 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=M.+B.+Boxer&author=X.+Wang&author=K.+R.+Brimacombe&author=M.+I.+Emily+Davis&author=Y.+Fang&author=M.+Hall&author=A.+Jadhav&author=S.+Karavadhi&author=L.+Liu&author=N.+Martinez&author=A.+L.+Mciver&author=R.+Pragani&author=J.+M.+Rohde&author=A.+Simeonov&author=W.+Zhao&author=M.+Shen&title=Thiazole+Derivatives+Useful+as+Mutant+IDH1+Inhibitors+for+Treating+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoxer%26aufirst%3DM.%2BB.%26atitle%3DThiazole%2520Derivatives%2520Useful%2520as%2520Mutant%2520IDH1%2520Inhibitors%2520for%2520Treating%2520Cancer%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruz, M. M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goparaju, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jyotsana, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baehre, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goerlich, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schottmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struys, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kloos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaever, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thol, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuser, M.</span></span> <span> </span><span class="NLM_article-title">A novel inhibitor of mutant IDH1 induces differentiation in vivo and prolongs survival in a mouse model of leukemia</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">3598</span>– <span class="NLM_lpage">3598</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=3598-3598&author=A.+Chaturvediauthor=M.+M.+A.+Cruzauthor=R.+Goparajuauthor=N.+Jyotsanaauthor=H.+Baehreauthor=K.+Goerlichauthor=R.+Schottmannauthor=M.+Prellerauthor=E.+A.+Struysauthor=A.+Kloosauthor=V.+Kaeverauthor=A.+Ganserauthor=F.+Tholauthor=M.+Heuser&title=A+novel+inhibitor+of+mutant+IDH1+induces+differentiation+in+vivo+and+prolongs+survival+in+a+mouse+model+of+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChaturvedi%26aufirst%3DA.%26aulast%3DCruz%26aufirst%3DM.%2BM.%2BA.%26aulast%3DGoparaju%26aufirst%3DR.%26aulast%3DJyotsana%26aufirst%3DN.%26aulast%3DBaehre%26aufirst%3DH.%26aulast%3DGoerlich%26aufirst%3DK.%26aulast%3DSchottmann%26aufirst%3DR.%26aulast%3DPreller%26aufirst%3DM.%26aulast%3DStruys%26aufirst%3DE.%2BA.%26aulast%3DKloos%26aufirst%3DA.%26aulast%3DKaever%26aufirst%3DV.%26aulast%3DGanser%26aufirst%3DA.%26aulast%3DThol%26aufirst%3DF.%26aulast%3DHeuser%26aufirst%3DM.%26atitle%3DA%2520novel%2520inhibitor%2520of%2520mutant%2520IDH1%2520induces%2520differentiation%2520in%2520vivo%2520and%2520prolongs%2520survival%2520in%2520a%2520mouse%2520model%2520of%2520leukemia%26jtitle%3DBlood%26date%3D2014%26volume%3D124%26spage%3D3598%26epage%3D3598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span> <span> </span><span class="NLM_article-title">Structure based discovery of clomifene as a potent inhibitor of cancer-associated mutant IDH1</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">44255</span>– <span class="NLM_lpage">44265</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.17464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.18632%2Foncotarget.17464" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=44255-44265&author=M.+Zhengauthor=W.+Sunauthor=S.+Gaoauthor=S.+Luanauthor=D.+Liauthor=R.+Chenauthor=Q.+Zhangauthor=L.+Chenauthor=J.+Huangauthor=H.+Li&title=Structure+based+discovery+of+clomifene+as+a+potent+inhibitor+of+cancer-associated+mutant+IDH1&doi=10.18632%2Foncotarget.17464"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.17464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.17464%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DS.%26aulast%3DLuan%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26atitle%3DStructure%2520based%2520discovery%2520of%2520clomifene%2520as%2520a%2520potent%2520inhibitor%2520of%2520cancer-associated%2520mutant%2520IDH1%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D44255%26epage%3D44265%26doi%3D10.18632%2Foncotarget.17464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pusch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Deimling, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zha, X.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological activity of 3-pyrazine-2-yl-oxazolidin-2-ones as novel, potent and selective inhibitors of mutant isocitrate dehydrogenase 1</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">6379</span>– <span class="NLM_lpage">6387</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.10.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1016%2Fj.bmc.2017.10.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=6379-6387&author=T.+Maauthor=F.+Zouauthor=S.+Puschauthor=L.+Yangauthor=Q.+Zhuauthor=Y.+Xuauthor=Y.+Guauthor=A.+von+Deimlingauthor=X.+Zha&title=Design%2C+synthesis+and+biological+activity+of+3-pyrazine-2-yl-oxazolidin-2-ones+as+novel%2C+potent+and+selective+inhibitors+of+mutant+isocitrate+dehydrogenase+1&doi=10.1016%2Fj.bmc.2017.10.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DT.%26aulast%3DZou%26aufirst%3DF.%26aulast%3DPusch%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DGu%26aufirst%3DY.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26aulast%3DZha%26aufirst%3DX.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520activity%2520of%25203-pyrazine-2-yl-oxazolidin-2-ones%2520as%2520novel%252C%2520potent%2520and%2520selective%2520inhibitors%2520of%2520mutant%2520isocitrate%2520dehydrogenase%25201%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D6379%26epage%3D6387%26doi%3D10.1016%2Fj.bmc.2017.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feliciano, P.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of mutant IDH1 and IDH2</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">477</span>, <span class="refDoi"> DOI: 10.1038/ng.2630</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1038%2Fng.2630" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2013&pages=477-477&author=P.+Feliciano&title=Inhibitors+of+mutant+IDH1+and+IDH2&doi=10.1038%2Fng.2630"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1038%2Fng.2630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.2630%26sid%3Dliteratum%253Aachs%26aulast%3DFeliciano%26aufirst%3DP.%26atitle%3DInhibitors%2520of%2520mutant%2520IDH1%2520and%2520IDH2%26jtitle%3DNat.%2520Genet.%26date%3D2013%26volume%3D45%26spage%3D477%26epage%3D477%26doi%3D10.1038%2Fng.2630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. Y.C.</span></span> <span> </span><span class="NLM_article-title">Potential mitochondrial isocitrate dehydrogenase R140Q mutant inhibitor from traditional Chinese medicine against cancers</span>. <i>BioMed Res. Int.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2014</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1155/2014/364625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1155%2F2014%2F364625" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2014&publication_year=2014&pages=1-10&author=W.+Y.+Leeauthor=K.+C.+Chenauthor=H.+Y.+Chenauthor=C.+Y.C.+Chen&title=Potential+mitochondrial+isocitrate+dehydrogenase+R140Q+mutant+inhibitor+from+traditional+Chinese+medicine+against+cancers&doi=10.1155%2F2014%2F364625"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1155%2F2014%2F364625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2014%252F364625%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DW.%2BY.%26aulast%3DChen%26aufirst%3DK.%2BC.%26aulast%3DChen%26aufirst%3DH.%2BY.%26aulast%3DChen%26aufirst%3DC.%2BY.C.%26atitle%3DPotential%2520mitochondrial%2520isocitrate%2520dehydrogenase%2520R140Q%2520mutant%2520inhibitor%2520from%2520traditional%2520Chinese%2520medicine%2520against%2520cancers%26jtitle%3DBioMed%2520Res.%2520Int.%26date%3D2014%26volume%3D2014%26spage%3D1%26epage%3D10%26doi%3D10.1155%2F2014%2F364625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E.</span></span> <span> </span><span class="NLM_article-title">Enasidenib: first global approval</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">1705</span>– <span class="NLM_lpage">1711</span>, <span class="refDoi"> DOI: 10.1007/s40265-017-0813-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1007%2Fs40265-017-0813-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=28879540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVyrt7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=1705-1711&author=E.+Kim&title=Enasidenib%3A+first+global+approval&doi=10.1007%2Fs40265-017-0813-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Enasidenib: First Global Approval</span></div><div class="casAuthors">Kim, Esther S.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1705-1711</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Enasidenib (Idhifa) is an oral isocitrate dehydrogenase-2 (IDH2) inhibitor developed by Celgene Corporation under a global, exclusive license from Agios Pharmaceuticals.  Enasidenib has been approved in the USA for the treatment of adults with relapsed or refractory acute myeloid leukemia (AML) and an IDH2 mutation as detected by an FDA-approved test.  It is at various stages of development in other countries for AML, myelodysplastic syndromes and solid tumors.  This article summarizes the milestones in the development of enasidenib leading to this first global approval in the USA for the treatment of adults with relapsed or refractory IDH2-mutated AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQY_z0s-7qX7Vg90H21EOLACvtfcHk0ljLV6e1dS3ciA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVyrt7zJ&md5=337b677cfaab46eccea63b91b16ebf40</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1007%2Fs40265-017-0813-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-017-0813-2%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DE.%26atitle%3DEnasidenib%253A%2520first%2520global%2520approval%26jtitle%3DDrugs%26date%3D2017%26volume%3D77%26spage%3D1705%26epage%3D1711%26doi%3D10.1007%2Fs40265-017-0813-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travins, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padyana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLaBarre, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagaraja, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konteatis, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianchetta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salituro, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quivoron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opolon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saada, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broutin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Botton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marteyn, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilichowska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penard-Lacronique, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biller, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S. S. M.</span></span> <span> </span><span class="NLM_article-title">AG-221, a first-in-class therapy targeting acute myeloid leukemia harboring oncogenic IDH2 mutations</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">478</span>– <span class="NLM_lpage">493</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-16-1034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1158%2F2159-8290.CD-16-1034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=28193778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFemurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=478-493&author=K.+Yenauthor=J.+Travinsauthor=F.+Wangauthor=M.+D.+Davidauthor=E.+Artinauthor=K.+Straleyauthor=A.+Padyanaauthor=S.+Grossauthor=B.+DeLaBarreauthor=E.+Tobinauthor=Y.+Chenauthor=R.+Nagarajaauthor=S.+Choeauthor=L.+Jinauthor=Z.+Konteatisauthor=G.+Cianchettaauthor=J.+O.+Saundersauthor=F.+G.+Salituroauthor=C.+Quivoronauthor=P.+Opolonauthor=O.+Bawaauthor=V.+Saadaauthor=A.+Paciauthor=S.+Broutinauthor=O.+A.+Bernardauthor=S.+de+Bottonauthor=B.+S.+Marteynauthor=M.+Pilichowskaauthor=Y.+Xuauthor=C.+Fangauthor=F.+Jiangauthor=W.+Weiauthor=S.+Jinauthor=L.+Silvermanauthor=W.+Liuauthor=H.+Yangauthor=L.+Dangauthor=M.+Dorschauthor=V.+Penard-Lacroniqueauthor=S.+A.+Billerauthor=S.+S.+M.+Su&title=AG-221%2C+a+first-in-class+therapy+targeting+acute+myeloid+leukemia+harboring+oncogenic+IDH2+mutations&doi=10.1158%2F2159-8290.CD-16-1034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations</span></div><div class="casAuthors">Yen, Katharine; Travins, Jeremy; Wang, Fang; David, Muriel D.; Artin, Erin; Straley, Kimberly; Padyana, Anil; Gross, Stefan; De La Barre, Byron; Tobin, Erica; Chen, Yue; Nagaraja, Raj; Choe, Sung; Jin, Lei; Konteatis, Zenon; Cianchetta, Giovanni; Saunders, Jeffrey O.; Salituro, Francesco G.; Quivoron, Cyril; Opolon, Paule; Bawa, Olivia; Saada, Veronique; Paci, Angelo; Broutin, Sophie; Bernard, Olivier A.; de Botton, Stephane; Marteyn, Benoit S.; Pilichowska, Monika; Xu, Ying Xia; Fang, Cheng; Jiang, Fan; Wei, Wentao; Jin, Shengfang; Silverman, Lee; Liu, Wei; Yang, Hua; Dang, Lenny; Dorsch, Marion; Penard-Lacronique, Virginie; Biller, Scott A.; Su, Shin-San Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">478-493</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Somatic gain-of-function mutations in isocitrate dehydrogenases (IDH) 1 and 2 are found in multiple hematol. and solid tumors, leading to accumulation of the oncometabolite (R)-2-hydroxyglutarate (2HG).  2HG competitively inhibits α-ketoglutarate-dependent dioxygenases, including histone demethylases and methylcytosine dioxygenases of the TET family, causing epigenetic dysregulation and a block in cellular differentiation.  In vitro studies have provided proof of concept for mutant IDH inhibition as a therapeutic approach.  We report the discovery and characterization of AG-221, an orally available, selective, potent inhibitor of the mutant IDH2 enzyme.  AG-221 suppressed 2HG prodn. and induced cellular differentiation in primary human IDH2 mutation-pos. acute myeloid leukemia (AML) cells ex vivo and in xenograft mouse models.  AG-221 also provided a statistically significant survival benefit in an aggressive IDH2R140Q-mutant AML xenograft mouse model.  These findings supported initiation of the ongoing clin. trials of AG-221 in patients with IDH2 mutation-pos. advanced hematol. malignancies.  Significance: Mutations in IDH1/2 are identified in approx. 20% of patients with AML and contribute to leukemia via a block in hematopoietic cell differentiation.  We have shown that the targeted inhibitor AG-221 suppresses the mutant IDH2 enzyme in multiple preclin. models and induces differentiation of malignant blasts, supporting its clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD2cujlZfayrVg90H21EOLACvtfcHk0ljLV6e1dS3ciA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFemurY%253D&md5=b83b3d82491d02befbde03aa392a6914</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-16-1034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-16-1034%26sid%3Dliteratum%253Aachs%26aulast%3DYen%26aufirst%3DK.%26aulast%3DTravins%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DDavid%26aufirst%3DM.%2BD.%26aulast%3DArtin%26aufirst%3DE.%26aulast%3DStraley%26aufirst%3DK.%26aulast%3DPadyana%26aufirst%3DA.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DDeLaBarre%26aufirst%3DB.%26aulast%3DTobin%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DNagaraja%26aufirst%3DR.%26aulast%3DChoe%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DKonteatis%26aufirst%3DZ.%26aulast%3DCianchetta%26aufirst%3DG.%26aulast%3DSaunders%26aufirst%3DJ.%2BO.%26aulast%3DSalituro%26aufirst%3DF.%2BG.%26aulast%3DQuivoron%26aufirst%3DC.%26aulast%3DOpolon%26aufirst%3DP.%26aulast%3DBawa%26aufirst%3DO.%26aulast%3DSaada%26aufirst%3DV.%26aulast%3DPaci%26aufirst%3DA.%26aulast%3DBroutin%26aufirst%3DS.%26aulast%3DBernard%26aufirst%3DO.%2BA.%26aulast%3Dde%2BBotton%26aufirst%3DS.%26aulast%3DMarteyn%26aufirst%3DB.%2BS.%26aulast%3DPilichowska%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DFang%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DSilverman%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DDang%26aufirst%3DL.%26aulast%3DDorsch%26aufirst%3DM.%26aulast%3DPenard-Lacronique%26aufirst%3DV.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DSu%26aufirst%3DS.%2BS.%2BM.%26atitle%3DAG-221%252C%2520a%2520first-in-class%2520therapy%2520targeting%2520acute%2520myeloid%2520leukemia%2520harboring%2520oncogenic%2520IDH2%2520mutations%26jtitle%3DCancer%2520Discovery%26date%3D2017%26volume%3D7%26spage%3D478%26epage%3D493%26doi%3D10.1158%2F2159-8290.CD-16-1034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stein, E. M.</span></span> <span> </span><span class="NLM_article-title">IDH2 inhibition in AML: finally progress?</span>. <i>Best Pract. Res. Clin. Haematol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.1016/j.beha.2015.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1016%2Fj.beha.2015.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=26590767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A280%3ADC%252BC28vktVGisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=112-115&author=E.+M.+Stein&title=IDH2+inhibition+in+AML%3A+finally+progress%3F&doi=10.1016%2Fj.beha.2015.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">IDH2 inhibition in AML: Finally progress?</span></div><div class="casAuthors">Stein Eytan M</div><div class="citationInfo"><span class="NLM_cas:title">Best practice & research. Clinical haematology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">112-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Isocitrate dehydrogenase (IDH) catalyzes the conversion of isocitrate to alpha ketoglutarate.  IDH occurs in three isoforms, IDH1, located in the cytoplasm, IDH2 located in the mitochondria, and IDH3, which functions as part of the TCA cycle.  Mutations in the active site of IDH1 at position R132 and an analogous mutation in the IDH2 gene at position R172 have been discovered.  Notably, many cases of acute myeloid leukemia (AML) have mutations in R172 and R140.  The impact of these mutations and early results of inhibiting mutant IDH2 with the reversible inhibitor AG-221 are discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSk-4M09PezakloaUqgkFHkfW6udTcc2eYdk9EezaiQNrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28vktVGisw%253D%253D&md5=0c0f529709d296c926e5ce700cb55ba4</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.beha.2015.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.beha.2015.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DE.%2BM.%26atitle%3DIDH2%2520inhibition%2520in%2520AML%253A%2520finally%2520progress%253F%26jtitle%3DBest%2520Pract.%2520Res.%2520Clin.%2520Haematol.%26date%3D2015%26volume%3D28%26spage%3D112%26epage%3D115%26doi%3D10.1016%2Fj.beha.2015.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cianchetta, G.</span>; <span class="NLM_string-name">Delabarre, B.</span>; <span class="NLM_string-name">Popovici-Muller, J.</span>; <span class="NLM_string-name">Salituro, F. G.</span>; <span class="NLM_string-name">Saunders, J. O.</span>; <span class="NLM_string-name">Travins, J.</span>; <span class="NLM_string-name">Yan, S.</span>; <span class="NLM_string-name">Guo, T.</span>; <span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">Therapeutically Active Compounds and Their Methods of Use</span>. <span class="NLM_patent">WO/2013102431 A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=G.+Cianchetta&author=B.+Delabarre&author=J.+Popovici-Muller&author=F.+G.+Salituro&author=J.+O.+Saunders&author=J.+Travins&author=S.+Yan&author=T.+Guo&author=L.+Zhang&title=Therapeutically+Active+Compounds+and+Their+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCianchetta%26aufirst%3DG.%26atitle%3DTherapeutically%2520Active%2520Compounds%2520and%2520Their%2520Methods%2520of%2520Use%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stein, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altman, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeAngelo, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fathi, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flinn, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medeiros, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollyea, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roboz, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swords, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agresta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Botton, S.</span></span> <span> </span><span class="NLM_article-title">AG-221, an oral, selective, first-in-class, potent inhibitor of the IDH2 mutant metabolic enzyme, induces durable remissions in a phase I study in patients with IDH2 mutation positive advanced hematologic malignancies</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">115</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=115-115&author=E.+M.+Steinauthor=J.+K.+Altmanauthor=R.+Collinsauthor=D.+J.+DeAngeloauthor=A.+T.+Fathiauthor=I.+Flinnauthor=A.+Frankelauthor=R.+L.+Levineauthor=B.+C.+Medeirosauthor=M.+Patelauthor=D.+A.+Pollyeaauthor=G.+J.+Robozauthor=R.+M.+Stoneauthor=R.+T.+Swordsauthor=M.+S.+Tallmanauthor=S.+Agrestaauthor=B.+Fanauthor=H.+Yangauthor=K.+Yenauthor=S.+de+Botton&title=AG-221%2C+an+oral%2C+selective%2C+first-in-class%2C+potent+inhibitor+of+the+IDH2+mutant+metabolic+enzyme%2C+induces+durable+remissions+in+a+phase+I+study+in+patients+with+IDH2+mutation+positive+advanced+hematologic+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DE.%2BM.%26aulast%3DAltman%26aufirst%3DJ.%2BK.%26aulast%3DCollins%26aufirst%3DR.%26aulast%3DDeAngelo%26aufirst%3DD.%2BJ.%26aulast%3DFathi%26aufirst%3DA.%2BT.%26aulast%3DFlinn%26aufirst%3DI.%26aulast%3DFrankel%26aufirst%3DA.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DMedeiros%26aufirst%3DB.%2BC.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DPollyea%26aufirst%3DD.%2BA.%26aulast%3DRoboz%26aufirst%3DG.%2BJ.%26aulast%3DStone%26aufirst%3DR.%2BM.%26aulast%3DSwords%26aufirst%3DR.%2BT.%26aulast%3DTallman%26aufirst%3DM.%2BS.%26aulast%3DAgresta%26aufirst%3DS.%26aulast%3DFan%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DYen%26aufirst%3DK.%26aulast%3Dde%2BBotton%26aufirst%3DS.%26atitle%3DAG-221%252C%2520an%2520oral%252C%2520selective%252C%2520first-in-class%252C%2520potent%2520inhibitor%2520of%2520the%2520IDH2%2520mutant%2520metabolic%2520enzyme%252C%2520induces%2520durable%2520remissions%2520in%2520a%2520phase%2520I%2520study%2520in%2520patients%2520with%2520IDH2%2520mutation%2520positive%2520advanced%2520hematologic%2520malignancies%26jtitle%3DBlood%26date%3D2014%26volume%3D124%26spage%3D115%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stein, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiNardo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altman, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeAngelo, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantarjian, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekeres, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fathi, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flinn, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankel, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medeiros, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollyea, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roboz, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swords, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attar, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tosolini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakurta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Botton, S.</span></span> <span> </span><span class="NLM_article-title">Safety and efficacy of AG-221, a potent inhibitor of mutant IDH2 that promotes differentiation of myeloid cells in patients with advanced hematologic malignancies: results of a phase 1/2 trial</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">323</span>– <span class="NLM_lpage">323</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2015&pages=323-323&author=E.+M.+Steinauthor=C.+DiNardoauthor=J.+K.+Altmanauthor=R.+Collinsauthor=D.+J.+DeAngeloauthor=H.+M.+Kantarjianauthor=M.+A.+Sekeresauthor=A.+T.+Fathiauthor=W.+Flinnauthor=A.+E.+Frankelauthor=R.+L.+Levineauthor=B.+C.+Medeirosauthor=M.+R.+Patelauthor=D.+Pollyeaauthor=G.+J.+Robozauthor=R.+M.+Stoneauthor=R.+T.+Swordsauthor=M.+S.+Tallmanauthor=K.+Yenauthor=E.+C.+Attarauthor=Q.+Xuauthor=A.+Tosoliniauthor=J.+M.+Meiauthor=A.+Thakurtaauthor=R.+D.+Knightauthor=S.+De+Botton&title=Safety+and+efficacy+of+AG-221%2C+a+potent+inhibitor+of+mutant+IDH2+that+promotes+differentiation+of+myeloid+cells+in+patients+with+advanced+hematologic+malignancies%3A+results+of+a+phase+1%2F2+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DE.%2BM.%26aulast%3DDiNardo%26aufirst%3DC.%26aulast%3DAltman%26aufirst%3DJ.%2BK.%26aulast%3DCollins%26aufirst%3DR.%26aulast%3DDeAngelo%26aufirst%3DD.%2BJ.%26aulast%3DKantarjian%26aufirst%3DH.%2BM.%26aulast%3DSekeres%26aufirst%3DM.%2BA.%26aulast%3DFathi%26aufirst%3DA.%2BT.%26aulast%3DFlinn%26aufirst%3DW.%26aulast%3DFrankel%26aufirst%3DA.%2BE.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DMedeiros%26aufirst%3DB.%2BC.%26aulast%3DPatel%26aufirst%3DM.%2BR.%26aulast%3DPollyea%26aufirst%3DD.%26aulast%3DRoboz%26aufirst%3DG.%2BJ.%26aulast%3DStone%26aufirst%3DR.%2BM.%26aulast%3DSwords%26aufirst%3DR.%2BT.%26aulast%3DTallman%26aufirst%3DM.%2BS.%26aulast%3DYen%26aufirst%3DK.%26aulast%3DAttar%26aufirst%3DE.%2BC.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DTosolini%26aufirst%3DA.%26aulast%3DMei%26aufirst%3DJ.%2BM.%26aulast%3DThakurta%26aufirst%3DA.%26aulast%3DKnight%26aufirst%3DR.%2BD.%26aulast%3DDe%2BBotton%26aufirst%3DS.%26atitle%3DSafety%2520and%2520efficacy%2520of%2520AG-221%252C%2520a%2520potent%2520inhibitor%2520of%2520mutant%2520IDH2%2520that%2520promotes%2520differentiation%2520of%2520myeloid%2520cells%2520in%2520patients%2520with%2520advanced%2520hematologic%2520malignancies%253A%2520results%2520of%2520a%2520phase%25201%252F2%2520trial%26jtitle%3DBlood%26date%3D2015%26volume%3D126%26spage%3D323%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Utley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agresta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span> <span> </span><span class="NLM_article-title">Evaluation of pharmacokinetic-pharmacodynamic (PK-PD) relationship of an oral, selective, first-in-class, potent IDH2 inhibitor, AG-221, from a phase 1 trial in patients with advanced IDH2 mutant positive hematologic malignancies</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">3737</span>– <span class="NLM_lpage">3737</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=3737-3737&author=B.+Fanauthor=Y.+Chenauthor=F.+Wangauthor=K.+Yenauthor=L.+Utleyauthor=C.+Almonauthor=S.+Billerauthor=S.+Agrestaauthor=H.+Yang&title=Evaluation+of+pharmacokinetic-pharmacodynamic+%28PK-PD%29+relationship+of+an+oral%2C+selective%2C+first-in-class%2C+potent+IDH2+inhibitor%2C+AG-221%2C+from+a+phase+1+trial+in+patients+with+advanced+IDH2+mutant+positive+hematologic+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DYen%26aufirst%3DK.%26aulast%3DUtley%26aufirst%3DL.%26aulast%3DAlmon%26aufirst%3DC.%26aulast%3DBiller%26aufirst%3DS.%26aulast%3DAgresta%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DH.%26atitle%3DEvaluation%2520of%2520pharmacokinetic-pharmacodynamic%2520%2528PK-PD%2529%2520relationship%2520of%2520an%2520oral%252C%2520selective%252C%2520first-in-class%252C%2520potent%2520IDH2%2520inhibitor%252C%2520AG-221%252C%2520from%2520a%2520phase%25201%2520trial%2520in%2520patients%2520with%2520advanced%2520IDH2%2520mutant%2520positive%2520hematologic%2520malignancies%26jtitle%3DBlood%26date%3D2014%26volume%3D124%26spage%3D3737%26epage%3D3737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xia, X.</span>; <span class="NLM_string-name">Zhang, D.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic Compounds as IDH2 Inhibitors</span>. <span class="NLM_patent">WO/2016177347 A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=X.+Xia&author=D.+Zhang&title=Heterocyclic+Compounds+as+IDH2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DX.%26atitle%3DHeterocyclic%2520Compounds%2520as%2520IDH2%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span>; <span class="NLM_string-name">Cheng, C.</span></span> <span> </span><span class="NLM_article-title">Deuterated Compounds for Treating Hematologic Malignancies, and Compositions and Methods Thereof</span>. <span class="NLM_patent">WO/2017069878 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=C.+Huang&author=C.+Cheng&title=Deuterated+Compounds+for+Treating+Hematologic+Malignancies%2C+and+Compositions+and+Methods+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%26atitle%3DDeuterated%2520Compounds%2520for%2520Treating%2520Hematologic%2520Malignancies%252C%2520and%2520Compositions%2520and%2520Methods%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, N.</span>; <span class="NLM_string-name">Wang, S.</span>; <span class="NLM_string-name">Liu, S.</span>; <span class="NLM_string-name">Hu, Y.</span>; <span class="NLM_string-name">Zhang, H.</span>; <span class="NLM_string-name">Luo, H.</span>; <span class="NLM_string-name">Peng, Y.</span>; <span class="NLM_string-name">Han, Y.</span>; <span class="NLM_string-name">Zhang, X.</span>; <span class="NLM_string-name">Xu, H.</span></span> <span> </span><span class="NLM_article-title">1,3,5-Triazine Derivative and Method of Using Same</span>. <span class="NLM_patent">WO/2017016513 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=N.+Zhao&author=S.+Wang&author=S.+Liu&author=Y.+Hu&author=H.+Zhang&author=H.+Luo&author=Y.+Peng&author=Y.+Han&author=X.+Zhang&author=H.+Xu&title=1%2C3%2C5-Triazine+Derivative+and+Method+of+Using+Same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DN.%26atitle%3D1%252C3%252C5-Triazine%2520Derivative%2520and%2520Method%2520of%2520Using%2520Same%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, P.</span>; <span class="NLM_string-name">Chen, J.</span>; <span class="NLM_string-name">Yang, J.</span></span> <span> </span><span class="NLM_article-title">IDH2 Mutant Inhibitors and Uses Thereof</span>. <span class="NLM_patent">CN 1,068,105,12</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=P.+Cao&author=J.+Chen&author=J.+Yang&title=IDH2+Mutant+Inhibitors+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DP.%26atitle%3DIDH2%2520Mutant%2520Inhibitors%2520and%2520Uses%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel class of pyridine derivatives that selectively inhibits mutant isocitrate dehydrogenase 2</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">1087</span>– <span class="NLM_lpage">1093</span>, <span class="refDoi"> DOI: 10.1111/cbdd.13139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1111%2Fcbdd.13139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=29120536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsVKisrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2018&pages=1087-1093&author=F.+Wangauthor=Z.+Liauthor=T.+Zhangauthor=G.+Yanauthor=M.+Huauthor=L.+Zhaoauthor=Y.+Zhaoauthor=Y.+Chen&title=Discovery+of+a+novel+class+of+pyridine+derivatives+that+selectively+inhibits+mutant+isocitrate+dehydrogenase+2&doi=10.1111%2Fcbdd.13139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a novel class of pyridine derivatives that selectively inhibits mutant isocitrate dehydrogenase 2</span></div><div class="casAuthors">Wang, Fangying; Li, Zhuoling; Zhang, Tao; Yan, Guoyi; Hu, Mingxing; Zhao, Lifeng; Zhao, Yinglan; Chen, Yuanwei</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1087-1093</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">This paper presents synthesis and structure-activity relationship of pyridine derivs. as inhibitors of mutant isocitrate dehydrogenase 2 (IDH2).  A series of 2,4,6-trisubstituted pyridine derivs. have been prepd. and evaluated in vitro.  Among these compds., 14n (N4-isopropyl-6-phenyl-N2-(4-(trifluoromethyl)pyridin-2-yl)pyridine-2,4-diamine) exhibited excellent inhibition activity with the IC50 of 54.6 nM, which is approx. onefold improvement compared to drug candidate AG-221 (Enasidenib) that is in Phase III trial.  Exquisite selectivity of 14n for IDH2 R140Q mutant isoform was demonstrated by the poor activity against the wild-type IDH1 and IDH2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCOGkXBP02arVg90H21EOLACvtfcHk0liv3f54YT_G2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsVKisrk%253D&md5=c59997ac5c3fca4854f8af6de4bd39be</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.13139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.13139%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DYan%26aufirst%3DG.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520class%2520of%2520pyridine%2520derivatives%2520that%2520selectively%2520inhibits%2520mutant%2520isocitrate%2520dehydrogenase%25202%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2018%26volume%3D91%26spage%3D1087%26epage%3D1093%26doi%3D10.1111%2Fcbdd.13139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span>; <span class="NLM_string-name">Wang, F.
Y.</span>; <span class="NLM_string-name">Chen, Y.
W.</span>; <span class="NLM_string-name">Wei, Y. Q.</span></span> <span> </span><span class="NLM_article-title">Pyridine Compounds and Their Use as IDH Function Variant Mutant Inhibitor Medicine Use</span>. <span class="NLM_patent">CN 1,073,828,40</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=T.+Zhang&author=F.%0AY.+Wang&author=Y.%0AW.+Chen&author=Y.+Q.+Wei&title=Pyridine+Compounds+and+Their+Use+as+IDH+Function+Variant+Mutant+Inhibitor+Medicine+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26atitle%3DPyridine%2520Compounds%2520and%2520Their%2520Use%2520as%2520IDH%2520Function%2520Variant%2520Mutant%2520Inhibitor%2520Medicine%2520Use%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K.</span>; <span class="NLM_string-name">Konteatis, Z.</span>; <span class="NLM_string-name">Straley, K.</span>; <span class="NLM_string-name">Artin, E.</span>; <span class="NLM_string-name">David, M.</span>; <span class="NLM_string-name">Quivoron, C.</span>; <span class="NLM_string-name">Dang, L.</span>; <span class="NLM_string-name">Tobin, E.</span>; <span class="NLM_string-name">Campos, C.</span>; <span class="NLM_string-name">Yang, H.</span>; <span class="NLM_string-name">Nagaraja, R.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Sui, Z.</span>; <span class="NLM_string-name">Kim, H.</span>; <span class="NLM_string-name">Gliser, C.</span>; <span class="NLM_string-name">Nicolay, B.</span>; <span class="NLM_string-name">Olaharski, A.</span>; <span class="NLM_string-name">Silverman, L.</span>; <span class="NLM_string-name">Penard-Lacronique, V.</span>; <span class="NLM_string-name">de Botton, S.</span>; <span class="NLM_string-name">Biller, S.</span>; <span class="NLM_string-name">Su, S. M.</span>; <span class="NLM_string-name">Mellinghoff, I.</span>; <span class="NLM_string-name">Popovici-Muller, J.</span></span> <span> </span><span class="NLM_article-title">AG-881, a brain penetrant, potent, pan-mutant IDH (mIDH) inhibitor for use in mIDH solid and hematologic malignancies</span>.  <i>Abstracts of Papers</i>, AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, Philadelphia, PA, Oct 26–30, <span class="NLM_year">2017</span>; Abstract B126.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=K.+Yen&author=Z.+Konteatis&author=K.+Straley&author=E.+Artin&author=M.+David&author=C.+Quivoron&author=L.+Dang&author=E.+Tobin&author=C.+Campos&author=H.+Yang&author=R.+Nagaraja&author=Y.+Chen&author=Z.+Sui&author=H.+Kim&author=C.+Gliser&author=B.+Nicolay&author=A.+Olaharski&author=L.+Silverman&author=V.+Penard-Lacronique&author=S.+de+Botton&author=S.+Biller&author=S.+M.+Su&author=I.+Mellinghoff&author=J.+Popovici-Muller&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DYen%26aufirst%3DK.%26atitle%3DAG-881%252C%2520a%2520brain%2520penetrant%252C%2520potent%252C%2520pan-mutant%2520IDH%2520%2528mIDH%2529%2520inhibitor%2520for%2520use%2520in%2520mIDH%2520solid%2520and%2520hematologic%2520malignancies%26btitle%3DAbstracts%2520of%2520Papers%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Konteatis, Z. D.</span>; <span class="NLM_string-name">Popovici-Muller, J.</span>; <span class="NLM_string-name">Travins, J. M.</span>; <span class="NLM_string-name">Zahler, R.</span>; <span class="NLM_string-name">Cai, Z.</span>; <span class="NLM_string-name">Zhou, D.</span></span> <span> </span><span class="NLM_article-title">Therapeutically Active Compounds and Their Methods of Use</span>. <span class="NLM_patent">WO/2015003640 A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Z.+D.+Konteatis&author=J.+Popovici-Muller&author=J.+M.+Travins&author=R.+Zahler&author=Z.+Cai&author=D.+Zhou&title=Therapeutically+Active+Compounds+and+Their+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKonteatis%26aufirst%3DZ.%2BD.%26atitle%3DTherapeutically%2520Active%2520Compounds%2520and%2520Their%2520Methods%2520of%2520Use%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hay, D.</span>; <span class="NLM_string-name">Mccarthy, C.</span>; <span class="NLM_string-name">Chappell, R.</span></span> <span> </span><span class="NLM_article-title">Derivatives of 2-Amino-4-(2-oxazolidinon-3-yl)-pyrimidine Fused with a Five-membered Heteroaromatic Ring in 5,6-Position Which Are Useful for the Treatment of Various Cancers</span>. <span class="NLM_patent">WO/2017140758 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=D.+Hay&author=C.+Mccarthy&author=R.+Chappell&title=Derivatives+of+2-Amino-4-%282-oxazolidinon-3-yl%29-pyrimidine+Fused+with+a+Five-membered+Heteroaromatic+Ring+in+5%2C6-Position+Which+Are+Useful+for+the+Treatment+of+Various+Cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHay%26aufirst%3DD.%26atitle%3DDerivatives%2520of%25202-Amino-4-%25282-oxazolidinon-3-yl%2529-pyrimidine%2520Fused%2520with%2520a%2520Five-membered%2520Heteroaromatic%2520Ring%2520in%25205%252C6-Position%2520Which%2520Are%2520Useful%2520for%2520the%2520Treatment%2520of%2520Various%2520Cancers%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travins, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padyana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLaBarre, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagaraja, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konteatis, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianchetta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salituro, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quivoron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opolon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saada, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broutin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Botton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marteyn, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilichowska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penard-Lacronique, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biller, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S.-S. M.</span></span> <span> </span><span class="NLM_article-title">AG-221, a first-in-class therapy targeting acute myeloid leukemia harboring oncogenic IDH2 mutations</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">478</span>– <span class="NLM_lpage">493</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-16-1034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1158%2F2159-8290.CD-16-1034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=28193778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFemurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=478-493&author=K.+Yenauthor=J.+Travinsauthor=F.+Wangauthor=M.+D.+Davidauthor=E.+Artinauthor=K.+Straleyauthor=A.+Padyanaauthor=S.+Grossauthor=B.+DeLaBarreauthor=E.+Tobinauthor=Y.+Chenauthor=R.+Nagarajaauthor=S.+Choeauthor=L.+Jinauthor=Z.+Konteatisauthor=G.+Cianchettaauthor=J.+O.+Saundersauthor=F.+G.+Salituroauthor=C.+Quivoronauthor=P.+Opolonauthor=O.+Bawaauthor=V.+Saadaauthor=A.+Paciauthor=S.+Broutinauthor=O.+A.+Bernardauthor=S.+de+Bottonauthor=B.+S.+Marteynauthor=M.+Pilichowskaauthor=Y.+Xuauthor=C.+Fangauthor=F.+Jiangauthor=W.+Weiauthor=S.+Jinauthor=L.+Silvermanauthor=W.+Liuauthor=H.+Yangauthor=L.+Dangauthor=M.+Dorschauthor=V.+Penard-Lacroniqueauthor=S.+A.+Billerauthor=S.-S.+M.+Su&title=AG-221%2C+a+first-in-class+therapy+targeting+acute+myeloid+leukemia+harboring+oncogenic+IDH2+mutations&doi=10.1158%2F2159-8290.CD-16-1034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations</span></div><div class="casAuthors">Yen, Katharine; Travins, Jeremy; Wang, Fang; David, Muriel D.; Artin, Erin; Straley, Kimberly; Padyana, Anil; Gross, Stefan; De La Barre, Byron; Tobin, Erica; Chen, Yue; Nagaraja, Raj; Choe, Sung; Jin, Lei; Konteatis, Zenon; Cianchetta, Giovanni; Saunders, Jeffrey O.; Salituro, Francesco G.; Quivoron, Cyril; Opolon, Paule; Bawa, Olivia; Saada, Veronique; Paci, Angelo; Broutin, Sophie; Bernard, Olivier A.; de Botton, Stephane; Marteyn, Benoit S.; Pilichowska, Monika; Xu, Ying Xia; Fang, Cheng; Jiang, Fan; Wei, Wentao; Jin, Shengfang; Silverman, Lee; Liu, Wei; Yang, Hua; Dang, Lenny; Dorsch, Marion; Penard-Lacronique, Virginie; Biller, Scott A.; Su, Shin-San Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">478-493</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Somatic gain-of-function mutations in isocitrate dehydrogenases (IDH) 1 and 2 are found in multiple hematol. and solid tumors, leading to accumulation of the oncometabolite (R)-2-hydroxyglutarate (2HG).  2HG competitively inhibits α-ketoglutarate-dependent dioxygenases, including histone demethylases and methylcytosine dioxygenases of the TET family, causing epigenetic dysregulation and a block in cellular differentiation.  In vitro studies have provided proof of concept for mutant IDH inhibition as a therapeutic approach.  We report the discovery and characterization of AG-221, an orally available, selective, potent inhibitor of the mutant IDH2 enzyme.  AG-221 suppressed 2HG prodn. and induced cellular differentiation in primary human IDH2 mutation-pos. acute myeloid leukemia (AML) cells ex vivo and in xenograft mouse models.  AG-221 also provided a statistically significant survival benefit in an aggressive IDH2R140Q-mutant AML xenograft mouse model.  These findings supported initiation of the ongoing clin. trials of AG-221 in patients with IDH2 mutation-pos. advanced hematol. malignancies.  Significance: Mutations in IDH1/2 are identified in approx. 20% of patients with AML and contribute to leukemia via a block in hematopoietic cell differentiation.  We have shown that the targeted inhibitor AG-221 suppresses the mutant IDH2 enzyme in multiple preclin. models and induces differentiation of malignant blasts, supporting its clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD2cujlZfayrVg90H21EOLACvtfcHk0lgtQmIgCz6skQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFemurY%253D&md5=b83b3d82491d02befbde03aa392a6914</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-16-1034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-16-1034%26sid%3Dliteratum%253Aachs%26aulast%3DYen%26aufirst%3DK.%26aulast%3DTravins%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DDavid%26aufirst%3DM.%2BD.%26aulast%3DArtin%26aufirst%3DE.%26aulast%3DStraley%26aufirst%3DK.%26aulast%3DPadyana%26aufirst%3DA.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DDeLaBarre%26aufirst%3DB.%26aulast%3DTobin%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DNagaraja%26aufirst%3DR.%26aulast%3DChoe%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DKonteatis%26aufirst%3DZ.%26aulast%3DCianchetta%26aufirst%3DG.%26aulast%3DSaunders%26aufirst%3DJ.%2BO.%26aulast%3DSalituro%26aufirst%3DF.%2BG.%26aulast%3DQuivoron%26aufirst%3DC.%26aulast%3DOpolon%26aufirst%3DP.%26aulast%3DBawa%26aufirst%3DO.%26aulast%3DSaada%26aufirst%3DV.%26aulast%3DPaci%26aufirst%3DA.%26aulast%3DBroutin%26aufirst%3DS.%26aulast%3DBernard%26aufirst%3DO.%2BA.%26aulast%3Dde%2BBotton%26aufirst%3DS.%26aulast%3DMarteyn%26aufirst%3DB.%2BS.%26aulast%3DPilichowska%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DFang%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DSilverman%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DDang%26aufirst%3DL.%26aulast%3DDorsch%26aufirst%3DM.%26aulast%3DPenard-Lacronique%26aufirst%3DV.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DSu%26aufirst%3DS.-S.%2BM.%26atitle%3DAG-221%252C%2520a%2520first-in-class%2520therapy%2520targeting%2520acute%2520myeloid%2520leukemia%2520harboring%2520oncogenic%2520IDH2%2520mutations%26jtitle%3DCancer%2520Discovery%26date%3D2017%26volume%3D7%26spage%3D478%26epage%3D493%26doi%3D10.1158%2F2159-8290.CD-16-1034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gusyatiner, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegi, M. E.</span></span> <span> </span><span class="NLM_article-title">Glioma epigenetics: from subclassification to novel treatment options</span>. <i>Semin. Cancer Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">1983</span>– <span class="NLM_lpage">1991</span>, <span class="refDoi"> DOI: 10.1016/j.semcancer.2017.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1016%2Fj.semcancer.2017.11.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2017&pages=1983-1991&author=O.+Gusyatinerauthor=M.+E.+Hegi&title=Glioma+epigenetics%3A+from+subclassification+to+novel+treatment+options&doi=10.1016%2Fj.semcancer.2017.11.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2017.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2017.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DGusyatiner%26aufirst%3DO.%26aulast%3DHegi%26aufirst%3DM.%2BE.%26atitle%3DGlioma%2520epigenetics%253A%2520from%2520subclassification%2520to%2520novel%2520treatment%2520options%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2017%26volume%3D96%26spage%3D1983%26epage%3D1991%26doi%3D10.1016%2Fj.semcancer.2017.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nassereddine, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lap, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haroun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabbara, I.</span></span> <span> </span><span class="NLM_article-title">The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia</span>. <i>Ann. Hematol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">1983</span>– <span class="NLM_lpage">1991</span>, <span class="refDoi"> DOI: 10.1007/s00277-017-3161-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1007%2Fs00277-017-3161-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=29090344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslCmtrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2017&pages=1983-1991&author=S.+Nassereddineauthor=C.+J.+Lapauthor=F.+Harounauthor=I.+Tabbara&title=The+role+of+mutant+IDH1+and+IDH2+inhibitors+in+the+treatment+of+acute+myeloid+leukemia&doi=10.1007%2Fs00277-017-3161-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia</span></div><div class="casAuthors">Nassereddine, Samah; Lap, Coen J.; Haroun, Faysal; Tabbara, Imad</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Hematology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1983-1991</span>CODEN:
                <span class="NLM_cas:coden">ANHEE8</span>;
        ISSN:<span class="NLM_cas:issn">0939-5555</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">For decades, researchers have looked into the pathophysiol. of acute myeloid leukemia (AML).  With the advances in mol. techniques, the two-hit hypothesis was replaced by a multi-hit model, which also emphasizes the importance of aberrant epigenetic regulation in the pathogenesis of AML.  IDH1 and IDH2 are two isoforms of isocitrate dehydrogenase that perform crucial roles in cellular metab.  Somatic mutations in either of these two genes impart a neomorphic enzymic activity upon the encoded enzymes resulting in the ability to convert α-ketoglutarate (αKG) into the oncometabolite R2-hydroxyglutarate (R2-HG), which can competitively inhibit multiple αKG-dependent dioxygenases.  Inhibition of various classes of αKG-dependent dioxygenases results in dramatic epigenetic changes in hematopoietic cells, which has been found to directly impair differentiation.  In addn. to a global dysregulation of gene expression, other mechanisms have been described through which R2-HG promotes leukemic transformation including the induction of B cell lymphoma 2 dependency and stimulation of the EglN family of prolyl 4-hydroxylases (EglN).  Due to the fact that mutations in IDH1 and IDH2 are acquired early during AML clonal evolution as well as because these mutations tend to remain stable during AML progression, the pharmaceutical industry has prompted the development of specific mutant IDH enzyme inhibitors.  More recently, the FDA approved the first mutant IDH2 inhibitor, enasidenib (AG-221), for patients with relapsed or refractory IDH2-mutated AML (RR-AML).  This has brought a lot of excitement to researchers, clinicians, and patients, esp. because the treatment of AML remains challenging and is still assocd. with a high mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0MoaTYhzKz7Vg90H21EOLACvtfcHk0ljnq4EKE0zq0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslCmtrrL&md5=8b84f1581f0beef64cf14e6bf9f1a7c0</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1007%2Fs00277-017-3161-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00277-017-3161-0%26sid%3Dliteratum%253Aachs%26aulast%3DNassereddine%26aufirst%3DS.%26aulast%3DLap%26aufirst%3DC.%2BJ.%26aulast%3DHaroun%26aufirst%3DF.%26aulast%3DTabbara%26aufirst%3DI.%26atitle%3DThe%2520role%2520of%2520mutant%2520IDH1%2520and%2520IDH2%2520inhibitors%2520in%2520the%2520treatment%2520of%2520acute%2520myeloid%2520leukemia%26jtitle%3DAnn.%2520Hematol.%26date%3D2017%26volume%3D96%26spage%3D1983%26epage%3D1991%26doi%3D10.1007%2Fs00277-017-3161-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tateishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koerner, M. V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lelic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankar, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batchelor, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iafrate, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cahill, D. P.</span></span> <span> </span><span class="NLM_article-title">The alkylating chemotherapeutic temozolomide induces metabolic stress in IDH1-mutant cancers and potentiates NAD<sup>+</sup> depletion-mediated cytotoxicity</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">4102</span>– <span class="NLM_lpage">4115</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-16-2263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1158%2F0008-5472.CAN-16-2263" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=4102-4115&author=K.+Tateishiauthor=F.+Higuchiauthor=J.+J.+Millerauthor=M.+V.+A.+Koernerauthor=N.+Lelicauthor=G.+M.+Shankarauthor=S.+Tanakaauthor=D.+E.+Fisherauthor=T.+T.+Batchelorauthor=A.+J.+Iafrateauthor=H.+Wakimotoauthor=A.+S.+Chiauthor=D.+P.+Cahill&title=The+alkylating+chemotherapeutic+temozolomide+induces+metabolic+stress+in+IDH1-mutant+cancers+and+potentiates+NAD%2B+depletion-mediated+cytotoxicity&doi=10.1158%2F0008-5472.CAN-16-2263"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-16-2263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-16-2263%26sid%3Dliteratum%253Aachs%26aulast%3DTateishi%26aufirst%3DK.%26aulast%3DHiguchi%26aufirst%3DF.%26aulast%3DMiller%26aufirst%3DJ.%2BJ.%26aulast%3DKoerner%26aufirst%3DM.%2BV.%2BA.%26aulast%3DLelic%26aufirst%3DN.%26aulast%3DShankar%26aufirst%3DG.%2BM.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DFisher%26aufirst%3DD.%2BE.%26aulast%3DBatchelor%26aufirst%3DT.%2BT.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26aulast%3DWakimoto%26aufirst%3DH.%26aulast%3DChi%26aufirst%3DA.%2BS.%26aulast%3DCahill%26aufirst%3DD.%2BP.%26atitle%3DThe%2520alkylating%2520chemotherapeutic%2520temozolomide%2520induces%2520metabolic%2520stress%2520in%2520IDH1-mutant%2520cancers%2520and%2520potentiates%2520NAD%252B%2520depletion-mediated%2520cytotoxicity%26jtitle%3DCancer%2520Res.%26date%3D2017%26volume%3D77%26spage%3D4102%26epage%3D4115%26doi%3D10.1158%2F0008-5472.CAN-16-2263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span> <span> </span><span class="NLM_article-title">Metabolism, activity, and targeting of D- and L-2-hydroxyglutarates</span>. <i>Trends in Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1016/j.trecan.2017.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1016%2Fj.trecan.2017.12.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=151-165&author=D.+Yeauthor=K.+L.+Guanauthor=Y.+Xiong&title=Metabolism%2C+activity%2C+and+targeting+of+D-+and+L-2-hydroxyglutarates&doi=10.1016%2Fj.trecan.2017.12.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.trecan.2017.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trecan.2017.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DD.%26aulast%3DGuan%26aufirst%3DK.%2BL.%26aulast%3DXiong%26aufirst%3DY.%26atitle%3DMetabolism%252C%2520activity%252C%2520and%2520targeting%2520of%2520D-%2520and%2520L-2-hydroxyglutarates%26jtitle%3DTrends%2520in%2520Cancer%26date%3D2018%26volume%3D4%26spage%3D151%26epage%3D165%26doi%3D10.1016%2Fj.trecan.2017.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tateishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iafrate, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loebel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lelic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiederschain, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerszten, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, J.-R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundaram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nigim, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koerner, M. V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roider, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemeny, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuels, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaherty, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batchelor, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cahill, D. P.</span></span> <span> </span><span class="NLM_article-title">Extreme vulnerability of IDH1 mutant cancers to NAD<sup>+</sup> depletion</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">773</span>– <span class="NLM_lpage">784</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2015.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1016%2Fj.ccell.2015.11.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=773-784&author=K.+Tateishiauthor=H.+Wakimotoauthor=A.+J.+Iafrateauthor=S.+Tanakaauthor=F.+Loebelauthor=N.+Lelicauthor=D.+Wiederschainauthor=O.+Bedelauthor=G.+Dengauthor=B.+Zhangauthor=T.+Heauthor=X.+Shiauthor=R.+E.+Gersztenauthor=Y.+Zhangauthor=J.-R.+J.+Yehauthor=W.+T.+Curryauthor=D.+Zhaoauthor=S.+Sundaramauthor=F.+Nigimauthor=M.+V.+A.+Koernerauthor=Q.+Hoauthor=D.+E.+Fisherauthor=E.+M.+Roiderauthor=L.+V.+Kemenyauthor=Y.+Samuelsauthor=K.+T.+Flahertyauthor=T.+T.+Batchelorauthor=A.+S.+Chiauthor=D.+P.+Cahill&title=Extreme+vulnerability+of+IDH1+mutant+cancers+to+NAD%2B+depletion&doi=10.1016%2Fj.ccell.2015.11.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2015.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2015.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DTateishi%26aufirst%3DK.%26aulast%3DWakimoto%26aufirst%3DH.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DLoebel%26aufirst%3DF.%26aulast%3DLelic%26aufirst%3DN.%26aulast%3DWiederschain%26aufirst%3DD.%26aulast%3DBedel%26aufirst%3DO.%26aulast%3DDeng%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DGerszten%26aufirst%3DR.%2BE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYeh%26aufirst%3DJ.-R.%2BJ.%26aulast%3DCurry%26aufirst%3DW.%2BT.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DSundaram%26aufirst%3DS.%26aulast%3DNigim%26aufirst%3DF.%26aulast%3DKoerner%26aufirst%3DM.%2BV.%2BA.%26aulast%3DHo%26aufirst%3DQ.%26aulast%3DFisher%26aufirst%3DD.%2BE.%26aulast%3DRoider%26aufirst%3DE.%2BM.%26aulast%3DKemeny%26aufirst%3DL.%2BV.%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DFlaherty%26aufirst%3DK.%2BT.%26aulast%3DBatchelor%26aufirst%3DT.%2BT.%26aulast%3DChi%26aufirst%3DA.%2BS.%26aulast%3DCahill%26aufirst%3DD.%2BP.%26atitle%3DExtreme%2520vulnerability%2520of%2520IDH1%2520mutant%2520cancers%2520to%2520NAD%252B%2520depletion%26jtitle%3DCancer%2520Cell%26date%3D2015%26volume%3D28%26spage%3D773%26epage%3D784%26doi%3D10.1016%2Fj.ccell.2015.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peterse, E. F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Akker, B. E. W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niessen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oosting, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suijker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danen, E. H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleton-Jansen, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bovée, J. V. M. G.</span></span> <span> </span><span class="NLM_article-title">NAD synthesis pathway interference is a viable therapeutic strategy for chondrosarcoma</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1714</span>– <span class="NLM_lpage">1721</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-17-0293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1158%2F1541-7786.MCR-17-0293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=28860121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWht73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=1714-1721&author=E.+F.+P.+Peterseauthor=B.+E.+W.+M.+van+den+Akkerauthor=B.+Niessenauthor=J.+Oostingauthor=J.+Suijkerauthor=Y.+de+Jongauthor=E.+H.+J.+Danenauthor=A.-M.+Cleton-Jansenauthor=J.+V.+M.+G.+Bov%C3%A9e&title=NAD+synthesis+pathway+interference+is+a+viable+therapeutic+strategy+for+chondrosarcoma&doi=10.1158%2F1541-7786.MCR-17-0293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">NAD Synthesis Pathway Interference Is a Viable Therapeutic Strategy for Chondrosarcoma</span></div><div class="casAuthors">Peterse, Elisabeth F. P.; van den Akker, Brendy E. W. M.; Niessen, Bertine; Oosting, Jan; Suijker, Johnny; de Jong, Yvonne; Danen, Erik H. J.; Cleton-Jansen, Anne-Marie; Bovee, Judith V. M. G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1714-1721</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (NAMPT) and nicotinic acid phosphoribosyltransferase (NAPRT) are rate-limiting enzymes in the NAD+ synthesis pathway.  Chondrosarcoma is a malignant cartilage forming bone tumor, in which mutations altering isocitrate dehydrogenase-1 and -2 (IDH1 and IDH2) activity have been identified as potential driver mutations.  Vulnerability for NAD+ depletion has been reported for IDH1/2-mutant cells.  Here, the potency of NAMPT inhibitors as a treatment of chondrosarcoma was explored.  Eleven chondrosarcoma cell lines were treated with NAMPT inhibitors, in which the effect on cell viability, colony formation, and 3D collagen invasion was assessed.  The expression level of NAMPT and NAPRT transcripts in chondrosarcoma cells was detd. by qRT-PCR.  Methylation of the NAPRT promoter was evaluated using a previously published dataset of genome-wide methylation.  In addn., a methylation dataset was used to det. methylation of the NAPRT promoter in 20 IDH1/2-mutated cartilage tumors.  Chondrosarcoma cells showed a dose-dependent decrease in cell viability, 3D collagen invasion, and colony formation upon treatment with NAMPT inhibitors, in which nearly half of the cell lines demonstrated abs. IC50s in the low nanomolar range.  Increasing IC50s correlated to increasing NAPRT expression levels and decreasing NAPRT promoter methylation.  No correlation between IDH1/2 mutation status and sensitivity for NAMPT inhibitors was obsd.  Strikingly, higher methylation of the NAPRT promoter was obsd. in high-grade vs. low-grade chondrosarcomas.  In conclusion, this study identified NAMPT as a potential target for treatment of chondrosarcoma.  Implications: Chondrosarcoma patients, esp. those of high histol. grade with lower expression and hypermethylation of NAPRT, may benefit from inhibition of the NAD synthesis pathway.  Mol Cancer Res; 15(12); 1714-21. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL556PcRo1p7Vg90H21EOLACvtfcHk0lhmG4PV1dA-Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWht73E&md5=612a76e211bcbcbdbf2e0c4029744699</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-17-0293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-17-0293%26sid%3Dliteratum%253Aachs%26aulast%3DPeterse%26aufirst%3DE.%2BF.%2BP.%26aulast%3Dvan%2Bden%2BAkker%26aufirst%3DB.%2BE.%2BW.%2BM.%26aulast%3DNiessen%26aufirst%3DB.%26aulast%3DOosting%26aufirst%3DJ.%26aulast%3DSuijker%26aufirst%3DJ.%26aulast%3Dde%2BJong%26aufirst%3DY.%26aulast%3DDanen%26aufirst%3DE.%2BH.%2BJ.%26aulast%3DCleton-Jansen%26aufirst%3DA.-M.%26aulast%3DBov%25C3%25A9e%26aufirst%3DJ.%2BV.%2BM.%2BG.%26atitle%3DNAD%2520synthesis%2520pathway%2520interference%2520is%2520a%2520viable%2520therapeutic%2520strategy%2520for%2520chondrosarcoma%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2017%26volume%3D15%26spage%3D1714%26epage%3D1721%26doi%3D10.1158%2F1541-7786.MCR-17-0293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karpel-Massler, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchetti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujiuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banu, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canoll, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegelin, M. D.</span></span> <span> </span><span class="NLM_article-title">Induction of Synthetic Lethality in IDH1-Mutated Gliomas through Inhibition of Bcl-xL</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1067</span>– <span class="NLM_lpage">1080</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-00984-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=10.1038%2Fs41467-017-00984-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=29057925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;key=1%3ACAS%3A280%3ADC%252BC1M7jt1yhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1067-1080&author=G.+Karpel-Masslerauthor=C.+T.+Ishidaauthor=E.+Bianchettiauthor=Y.+Zhangauthor=C.+Shuauthor=T.+Tsujiuchiauthor=M.+A.+Banuauthor=F.+Garciaauthor=K.+A.+Rothauthor=J.+N.+Bruceauthor=P.+Canollauthor=M.+D.+Siegelin&title=Induction+of+Synthetic+Lethality+in+IDH1-Mutated+Gliomas+through+Inhibition+of+Bcl-xL&doi=10.1038%2Fs41467-017-00984-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xL</span></div><div class="casAuthors">Karpel-Massler Georg; Ishida Chiaki Tsuge; Bianchetti Elena; Zhang Yiru; Shu Chang; Garcia Franklin; Roth Kevin A; Canoll Peter; Siegelin Markus D; Karpel-Massler Georg; Tsujiuchi Takashi; Banu Matei A; Bruce Jeffrey N</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1067</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Certain gliomas often harbor a mutation in the activity center of IDH1 (R132H), which leads to the production of the oncometabolite 2-R-2-hydroxyglutarate (2-HG).  In six model systems, including patient-derived stem cell-like glioblastoma cultures, inhibition of Bcl-xL induces significantly more apoptosis in IDH1-mutated cells than in wild-type IDH1 cells.  Anaplastic astrocytoma samples with mutated IDH1 display lower levels of Mcl-1 than IDH1 wild-type tumors and specific knockdown of Mcl-1 broadly sensitizes glioblastoma cells to Bcl-xL inhibition-mediated apoptosis.  Addition of 2-HG to glioblastoma cultures recapitulates the effects of the IDH mutation on intrinsic apoptosis, shuts down oxidative phosphorylation and reduces ATP levels in glioblastoma cells. 2-HG-mediated energy depletion activates AMPK (Threonine 172), blunting protein synthesis and mTOR signaling, culminating in a decline of Mcl-1.  In an orthotopic glioblastoma xenograft model expressing mutated IDH1, Bcl-xL inhibition leads to long-term survival.  These results demonstrate that IDH1-mutated gliomas are particularly vulnerable to Bcl-xL inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLKkCUWpX6UhFwe7cAcrfPfW6udTcc2eb50EvJcJp3kbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7jt1yhsw%253D%253D&md5=b4fbe4439e265d2f9b456bb1f33fc05e</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-00984-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-00984-9%26sid%3Dliteratum%253Aachs%26aulast%3DKarpel-Massler%26aufirst%3DG.%26aulast%3DIshida%26aufirst%3DC.%2BT.%26aulast%3DBianchetti%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DShu%26aufirst%3DC.%26aulast%3DTsujiuchi%26aufirst%3DT.%26aulast%3DBanu%26aufirst%3DM.%2BA.%26aulast%3DGarcia%26aufirst%3DF.%26aulast%3DRoth%26aufirst%3DK.%2BA.%26aulast%3DBruce%26aufirst%3DJ.%2BN.%26aulast%3DCanoll%26aufirst%3DP.%26aulast%3DSiegelin%26aufirst%3DM.%2BD.%26atitle%3DInduction%2520of%2520Synthetic%2520Lethality%2520in%2520IDH1-Mutated%2520Gliomas%2520through%2520Inhibition%2520of%2520Bcl-xL%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D1067%26epage%3D1080%26doi%3D10.1038%2Fs41467-017-00984-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I3L" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I3L','PDB','4I3L'); return false;">PDB: 4I3L</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5SUN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5SUN','PDB','5SUN'); return false;">PDB: 5SUN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UMX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UMX','PDB','4UMX'); return false;">PDB: 4UMX</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5DE1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5DE1','PDB','5DE1'); return false;">PDB: 5DE1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TQH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TQH','PDB','5TQH'); return false;">PDB: 5TQH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L57" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L57','PDB','5L57'); return false;">PDB: 5L57</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5I96" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5I96','PDB','5I96'); return false;">PDB: 5I96</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JA8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JA8','PDB','4JA8'); return false;">PDB: 4JA8</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-NOTES-d7e2604-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i53"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00159">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_11638"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00159">10.1021/acs.jmedchem.8b00159</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Mutant IDH1/2 in clinical trials and physical properties of some mIDH1/2 inhibitors (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00159/suppl_file/jm8b00159_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00159/suppl_file/jm8b00159_si_001.pdf">jm8b00159_si_001.pdf (154.21 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00159&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-20%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00159%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00159" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799393c8cc83c04","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
